Aquí encontrará toda la información relevante que el ICOM Segovia irá comunicando a sus Colegiados, sobre el Virus COVID-19.



31-08-2021 Bloque de Información COVID-19
(ACTUALIZACION - DOCUMENTOS NUEVOS MARCADOS CON N)

Los documentos que consideremos especialmente recomendados se marcarán con una R


 Selecciona la sección a buscar

NOVEDADES DEL DÍA

(R)  (N) Acuerdo de la Comisión de Salud Pública del CISNS sobre Vacunación frente a COVID-19 en Mujeres Embarazadas (3 Agosto 2021)
Pulsa aquí para acceder a la información

(R)  (N) Actualización de la situación epidemiológica de las  variantes de SARS-CoV-2 de mayor impacto e interés en salud pública en España (02/08/21)
Pulsa aquí para acceder a la información

(R) (N) Airborne transmission of respiratory viruses
Chia C. Wang, Kimberly A. Prather, View, Josué Sznitman, Jose L. Jimenez, Seema S. Lakdawala, Zeynep Tufekci, Linsey C. Marr

Science  27 Aug 2021: Vol. 373, Issue 6558, eabd9149 DOI: 10.1126/science.abd9149
Pulsa aquí para acceder a la información

(N) COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19. A Population-Based Cohort Study in Zhejiang Province, China
Yang Ge; Leonardo Martinez; Shengzhi Sun; Zhiping Chen; Feng Zhang; Fangyu Li; Wanwan Sun, MD4; Enfu Chen; Jinren Pan; Changwei Li; Jimin Sun; Andreas Handel; Feng Ling; Ye Shen
JAMA Intern Med. Published online August 23, 2021. doi:10.1001/jamainternmed.2021.4686
Pulsa aquí para acceder a la información

(R) (N) Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Katherine A Twohig, MPH  *; Tommy Nyberg, PhD *; Asad Zaidi, MSc; Simon Thelwall, PhD;  Mary A Sinnathamby, MPH;  Shirin Aliabadi, PhD et al.
The Lancet Infectious diseases :August 27, 2021 DOI:https://doi.org/10.1016/S1473-3099(21)00475-8
Pulsa aquí para acceder a la información

(N) Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial
Prof Stephan Ehrmann, Jie Li, Miguel Ibarra-Estrada, Yonatan Perez, Ivan Pavlov, Bairbre McNicholas, et al.
The Lancet Respiratory Medicine Published:August 20, 2021DOI:https://doi.org/10.1016/S2213-2600(21)00356-8
Pulsa aquí para acceder a la información

(N) Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
Sue Pavord, F.R.C.Path., Marie Scully, M.D., Beverley J. Hunt, M.D., William Lester, M.D., Catherine Bagot, M.D., Brian Craven, M.B., B.Ch., Alex Rampotas, M.R.C.P., Gareth Ambler, Ph.D., and Mike Makris, M.D.
NEJM August 11, 2021  DOI: 10.1056/NEJMoa2109908
Pulsa aquí para acceder a la información

(N) Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
Richard J Perry, Arina Tamborska, Bhagteshwar Singh, Brian Craven, Richard Marigold, Peter Arthur-Farraj and others
The Lancet Published: August 6, 2021
Pulsa aquí para acceder a la información

(R) (N)  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
The REMAP-CAP, ACTIV-4a, and ATTACC Investigators*
NEJM August 26, 2021; 385:777-789  DOI: 10.1056/NEJMoa2103417
Pulsa aquí para acceder a la información

(R) (N) Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
The ATTACC, ACTIV-4a, and REMAP-CAP Investigators*
NEJM August 26, 2021; 385:790-802  DOI: 10.1056/NEJMoa2105911
Pulsa aquí para acceder a la información

(N) COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses (Review)
Filippo Fagni, MD *; David Simon, MD *; Koray Tascilar, MD; Verena Schoenau, MD; Prof Michael Sticherling, MD; Prof Markus F Neurath, MD et al.
The Lancet Rheumatology Published:August 27, 2021DOI:https://doi.org/10.1016/S2665-9913(21)00247-2
Pulsa aquí para acceder a la información

(R) (N) 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
Lixue Huang, Qun Yao, Xiaoying Gu, Qiongya Wang, Lili Ren, Yeming Wang, et al.
The Lancet Volume 398, Issue 10302, p747-758, August 28, 2021, DOI:https://doi.org/10.1016/S0140-6736(21)01755-4
Pulsa aquí para acceder a la información

(N) Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors
Shengding Zhang, Wenxue Bai, Junqing Yue, Lu Qin, Cong Zhang, Shuyun Xu, Xiansheng Liu, Wang Ni & Min Xie
Scientific Reports volume 11, Article number: 13854 (2021) Published: 05 July 2021
Pulsa aquí para acceder a la información

(R) (N) Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
Meagan P. O’Brien, M.D., Eduardo Forleo-Neto, M.D., Bret J. Musser, Ph.D., Flonza Isa, M.D., Kuo-Chen Chan, Ph.D., Neena Sarkar, Ph.D., Katharine J. Bar, M.D., Ruanne V. Barnabas, M.D., Dan H. Barouch, M.D., Ph.D., Myron S. Cohen, M.D., Christopher B. Hurt, M.D., Dale R. Burwen, M.D., M.P.H., et al., for the Covid-19 Phase 3 Prevention Trial Team*
NEJM August 4, 2021 DOI: 10.1056/NEJMoa2109682
Pulsa aquí para acceder a la información

(R) (N) Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Michael Dougan, M.D., Ph.D., Ajay Nirula, M.D., Ph.D., Masoud Azizad, M.D., Bharat Mocherla, M.D., Robert L. Gottlieb, M.D., Ph.D., Peter Chen, M.D., Corey Hebert, M.D., Russell Perry, M.D., Joseph Boscia, M.D., Barry Heller, M.D., Jason Morris, M.D., Chad Crystal, M.D., et al., for the BLAZE-1 Investigators*
NEJM July 14, 2021 DOI: 10.1056/NEJMoa2102685
Pulsa aquí para acceder a la información

(N) JAK Inhibitors — More Than Just Glucocorticoids (Editorial)
Justin Stebbing, M.D., Ph.D., and Volker M. Lauschke, Ph.D.
NEJM July 29, 2021; 385:463-465 DOI: 10.1056/NEJMe2108667
Pulsa aquí para acceder a la información

(R) (N) Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
Evdoxia KyriazopoulouThomas HuetGiulio CavalliAndrea GoriMiltiades KyprianouPeter Pickkersand others
The Lancet Rheumatology Published: August 9, 2021
Pulsa aquí para acceder a la información

(R) (N) Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Noam Barda, M.D., Noa Dagan, M.D., Yatir Ben-Shlomo, B.Sc., Eldad Kepten, Ph.D., Jacob Waxman, M.D., Reut Ohana, M.Sc., Miguel A. Hernán, M.D., Marc Lipsitch, D.Phil., Isaac Kohane, M.D., Doron Netzer, M.D., Ben Y. Reis, Ph.D., and Ran D. Balicer, M.D.
NEJM August 25, 2021  DOI: 10.1056/NEJMoa2110475
Pulsa aquí para acceder a la información

(N) The Importance of Context in Covid-19 Vaccine Safety (Editorial)
Grace M. Lee, M.D., M.P.H.
NEJM August 25, 2021  DOI: 10.1056/NEJMe2112543
Pulsa aquí para acceder a la información

(R) (N) Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
Kashif Ali, M.D., Gary Berman, M.D., Honghong Zhou, Ph.D., Weiping Deng, Ph.D., Veronica Faughnan, B.S., Maria Coronado-Voges, M.S., Baoyu Ding, M.S., Jacqueline Dooley, B.A., Bethany Girard, Ph.D., William Hillebrand, M.S., Rolando Pajon, Ph.D., Jacqueline M. Miller, M.D., et al.
NEJM August 11, 2021 DOI: 10.1056/NEJMoa2109522
Pulsa aquí para acceder a la información

(R) (N) Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W. Frenck, Jr., M.D., Nicola P. Klein, M.D., Ph.D., Nicholas Kitchin, M.D., Alejandra Gurtman, M.D., Judith Absalon, M.D., Stephen Lockhart, D.M., John L. Perez, M.D., Emmanuel B. Walter, M.D., Shelly Senders, M.D., Ruth Bailey, B.Sc., Kena A. Swanson, Ph.D., Hua Ma, Ph.D., et al., for the C4591001 Clinical Trial Group*
NEJM July 15, 2021 385:239-250  DOI: 10.1056/NEJMoa2107456
Pulsa aquí para acceder a la información

(R) (N) Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Jamie Lopez Bernal, F.F.P.H., Ph.D., Nick Andrews, Ph.D., Charlotte Gower, D.Phil., Eileen Gallagher, Ph.D., Ruth Simmons, Ph.D., Simon Thelwall, Ph.D., Julia Stowe, Ph.D., Elise Tessier, M.Sc., Natalie Groves, M.Sc., Gavin Dabrera, M.B., B.S., F.F.P.H., Richard Myers, Ph.D., Colin N.J. Campbell, M.P.H., F.F.P.H., et
NEJM August 12, 2021 N Engl J Med 2021; 385:585-594 DOI:10.1056/NEJMoa2108891
Pulsa aquí para acceder a la información

 (N) Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Xinxue Liu, Robert H Shaw, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews and others
The Lancet Published: August 6, 2021
Pulsa aquí para acceder a la información

(R) (N) Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W. Frenck, Jr., M.D., Nicola P. Klein, M.D., Ph.D., Nicholas Kitchin, M.D., Alejandra Gurtman, M.D., Judith Absalon, M.D., Stephen Lockhart, D.M., John L. Perez, M.D., Emmanuel B. Walter, M.D., Shelly Senders, M.D., Ruth Bailey, B.Sc., Kena A. Swanson, Ph.D., Hua Ma, Ph.D., et al., for the C4591001 Clinical Trial Group*
NEJM July 15, 2021 N Engl J Med 2021; 385:239-250 DOI:10.1056/NEJMoa2107456
Pulsa aquí para acceder a la información

 (N)  Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Moriah Bergwerk, M.B., B.S., Tal Gonen, B.A., Yaniv Lustig, Ph.D., Sharon Amit, M.D., Marc Lipsitch, Ph.D., Carmit Cohen, Ph.D., Michal Mandelboim, Ph.D., Einav Gal Levin, M.D., Carmit Rubin, N.D., Victoria Indenbaum, Ph.D., Ilana Tal, R.N., Ph.D., Malka Zavitan, R.N., M.A., et al.
NEJM July 28, 2021 DOI: 10.1056/NEJMoa2109072
Pulsa aquí para acceder a la información

 (N)  Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Mark G. Thompson, Ph.D., Jefferey L. Burgess, M.D., M.P.H., Allison L. Naleway, Ph.D., Harmony Tyner, M.D., M.P.H., Sarang K. Yoon, D.O., Jennifer Meece, Ph.D., Lauren E.W. Olsho, Ph.D., Alberto J. Caban-Martinez, D.O., Ph.D., M.P.H., C.P.H., Ashley L. Fowlkes, Sc.D., M.P.H., Karen Lutrick, Ph.D., Holly C. Groom, M.P.H., Kayan Dunnigan, M.P.H., et al.
NEJM July 22, 2021; 385:320-329  DOI: 10.1056/NEJMoa2107058
Pulsa aquí para acceder a la información

 


 

NOTAS SACYL DE INTERÉS

INFORMACIÓN COMÚN

TEST SARS-CoV-2- INDICACIONES GENERALES DE CADA TEST
Pulsa aquí para acceder a la información

TEST SARS-CoV-2-ALGORITMO PARA PERSONAS SINTOMÁTICAS EN EL MOMENTO DE REALIZAR EL TEST
Pulsa aquí para acceder a la información

TEST SARS-CoV-2-ALGORITMO PARA PERSONAS ASINTOMÁTICAS EN EL MOMENTO DE REALIZAR EL TEST
Pulsa aquí para acceder a la información

Infografía Por tu seguridad y la de tus pacientes
Pulsa aquí para acceder a la información

PROTOCOLO INTEGRAL DE ACTUACIÓN ANTE SITUACIONES ESPECÍFICAS DE GRAVEDAD, ÚLTIMOS DÍAS Y FALLECIMIENTO EN LA CRISIS COVID-19 (actualizado)
Pulsa aquí para acceder a la información

Infografía 5 recomendaciones profesionales

Pulsa aquí para acceder a la información

Higiene de manos
Pulsa aquí para acceder a la información

Recomendaciones para limpieza y desinfección pantallas faciales
Pulsa aquí para acceder a la información

Autorizacion de forma temporal material protección ocular (31/03/20)

Pulsa aquí para acceder a la información

Priorización de la vacunación de la vacunación en Castilla y León ante la situación de emergencia por COVID-19 (26/03/2020)

Pulsa aquí para acceder a la información

Infografía Cuídate y cuida a los tuyos
Pulsa aquí para acceder a la información

Medidas de humanización para hospitales dependientes de la Gerencia Regional de Salud (21/03/20)

Pulsa aquí para acceder a la información

 

ATENCIÓN PRIMARIA

(R) GUÍA DE MANEJO Y SEGUIMIENTO EN PRIMARIA DE LA INFECCIÓN AGUDA Y POSTAGUDA POR COVID-19 (Abril/2021)
Pulsa aquí para acceder a la información

TEST RÁPIDOS DE DETECCIÓN DE ANTÍGENOS PARA SARS-CoV-2. RECOMENDACIONES DE USO (20/11/20)
Pulsa aquí para acceder a la información

PROCEDIMIENTO DE DIAGNÓSTICO, VIGILANCIA Y CONTROL DE CASOS Y CONTACTOS COVID-19. IMPLEMENTACIÓN EN ATENCIÓN PRIMARIA (25/11/20)
Pulsa aquí para acceder a la información

(R)  APOYOS PARA AUTOCUIDADOS TRAS COVID-19 EN ATENCIÓN PRIMARIA (WHO-EURO-2020)
Pulsa aquí para acceder a la información

Manejo pediátrico en atención primaria del COVID-19 (18/11/20)
Pulsa aquí para acceder a la información

PROTOCOLO INTEGRAL DE ACTUACIÓN ANTE SITUACIONES ESPECÍFICAS DE GRAVEDAD, ÚLTIMOS DÍAS Y FALLECIMIENTO EN LA CRISIS COVID-19

Pulsa aquí para acceder a la información

 

 

ATENCIÓN HOSPITALIZADA

 MANEJO CLINICO DEL PACIENTE PEDIÁTRICO CON INFECCION POR SARS-CoV-2 (15/04/20)
Pulsa aquí para acceder a la información

 MANEJO CLINICO DEL PACIENTE PEDIÁTRICO CON INFECCION POR SARS-CoV-2 (07/04/20)
Pulsa aquí para acceder a la información

Instrucciones relacionadas con el manejo hospitalario de pacientes COVID-19 (actualizado)
Pulsa aquí para acceder a la información

Recomendaciones para atender al paciente en el hospital-Lectura fácil

Pulsa aquí para acceder a la información

Atención al paciente en planta

Pulsa aquí para acceder a la información

Instrucciones para la entrega de medicación a pacientes externos de los hospitales de SACYL en contingencia estado de alarma por COVID-19 (27/03/2020)

Pulsa aquí para acceder a la información

 

RECOMENDACIONES/INFORMES MINISTERIO SANIDAD

(R)  (N) Acuerdo de la Comisión de Salud Pública del CISNS sobre Vacunación frente a COVID-19 en Mujeres Embarazadas (3 Agosto 2021)
Pulsa aquí para acceder a la información

(R)  (N) Actualización de la situación epidemiológica de las  variantes de SARS-CoV-2 de mayor impacto e interés en salud pública en España (02/08/21)
Pulsa aquí para acceder a la información

(R)   Actualización de la situación epidemiológica de las  variantes de SARS-CoV-2 de mayor impacto e interés en salud pública en España (05/07/21)
Pulsa aquí para acceder a la información

(R)   Actualización de la situación epidemiológica de las  variantes de SARS-CoV-2 de mayor impacto e interés en salud pública en España (28/06/21)
Pulsa aquí para acceder a la información

(R) Actualización de la situación epidemiológica de las variantes de importancia en salud pública en España (18/03/21)
Pulsa aquí para acceder a la información

Actualización de la situación epidemiológica de las variantes de importancia en salud pública en España (01/03/21)
Pulsa aquí para acceder a la información

MEDIDAS DE PREVENCIÓN, HIGIENE Y PROMOCIÓN DE LA SALUD FRENTE A COVID-19 PARA CENTROS EDUCATIVOS EN EL CURSO 2020-2021 (Versión 08/02/2021)
Pulsa aquí para acceder a la información

Equidad en Salud y COVID-19. Resumen del documento (18/01/21)
Pulsa aquí para acceder a la información

MEDIDAS DE PREVENCIÓN, HIGIENE Y PROMOCIÓN DE LA SALUD FRENTE A COVID-19 PARA CENTROS EDUCATIVOS EN EL CURSO 2020-2021 (Versión 08/02/2021)
Pulsa aquí para acceder a la información

Equidad en Salud y COVID-19. Resumen del documento (18/01/21)
Pulsa aquí para acceder a la información

RECOMENDACIONES SOBRE ESTRATEGIAS COMUNICATIVAS FRENTE A LA FATIGA PANDÉMICA (Consejo Interterritorial del SNS) (16/12/20)

Pulsa aquí para acceder a la información

(R) Recomendaciones para utilizar con seguridad las vacunas frente a la COVID-19
(VERSIÓN 12/01/2021)

Pulsa aquí para acceder a la información

(R) ESTUDIO ENE-COVID: CUARTA RONDA. ESTUDIO NACIONAL DE SERO-EPIDEMIOLOGÍA DE LA INFECCIÓN POR SARS-COV-2 EN ESPAÑA (15 DE DICIEMBRE DE 2020)
Pulsa aquí para acceder a la información


(R) ESTUDIO ENE-COVID: CUARTA RONDA. ESTUDIO NACIONAL DE SERO-EPIDEMIOLOGÍA DE LA INFECCIÓN POR SARS-COV-2 EN ESPAÑA (15 DE DICIEMBRE DE 2020)

Pulsa aquí para acceder a la información

(R) Evaluación del riesgo de la transmisión de SARS-CoV-2 mediante aerosoles. Medidas de prevención y recomendaciones (18.11.2020)
Pulsa aquí para acceder a la información

(R) Equidad en Salud y COVID-19. Análisis y propuestas para abordar la vulnerabilidad epidemiológica vinculada a las desigualdades sociales (29.10.2020)
Pulsa aquí para acceder a la información

(R) ACTUACIONES DE RESPUESTA COORDINADA PARA EL CONTROL DE LA TRANSMISIÓN DE COVID-19 (Actualizado a 22 de octubre de 2020)
Pulsa aquí para acceder a la información

(R) ESTRATEGIA DE DETECCIÓN PRECOZ, VIGILANCIA Y CONTROL DE COVID-19. INDICADORES DE SEGUIMIENTO (actualizado el 12/11/20)
Pulsa aquí para acceder a la información

(R) ESTRATEGIA DE DETECCIÓN PRECOZ, VIGILANCIA Y CONTROL DE COVID-19. INDICADORES DE SEGUIMIENTO (actualizado el 25/09/20)
Pulsa aquí para acceder a la información

(R) ESTRATEGIA DE DETECCIÓN PRECOZ, VIGILANCIA Y CONTROL DE COVID-19. INDICADORES DE SEGUIMIENTO (actualizado el 25/09/20)
Pulsa aquí para acceder a la información

(R) ESTUDIO ENE-COVID: INFORME FINAL ESTUDIO NACIONAL DE SERO-EPIDEMIOLOGÍA DE LA INFECCIÓN POR SARS-COV-2 EN ESPAÑA (6 DE JULIO DE 2020)
Pulsa aquí para acceder a la información

 Manejo en urgencias del COVID-19 (26/06/20)
Pulsa aquí para acceder a la información

 Resumen visual Manejo en Urgencias
Pulsa aquí para acceder a la información

Recomendaciones de seguridad del paciente y profesionales en procedimientos intervencionistas en la fase de transición de la pandemia COVID-19 (26/06/20)
Pulsa aquí para acceder a la información

RECOMENDACIONES SOBRE EL USO DE MASCARILLAS EN LA COMUNIDAD EN EL CONTEXTO DEL COVID-19 (10/06/20)
Pulsa aquí para acceder a la información

RECOMENDACIONES DEL MINISTERIO DE SANIDAD PARA LA RECUPERACIÓN DE LAS ACTIVIDADES DE TIEMPO LIBRE DIRIGIDAS A LA POBLACIÓN INFANTIL Y JUVENIL (10/06/20)
Pulsa aquí para acceder a la información

Manejo en atención primaria y domiciliaria del COVID-19 (actualizado el 04/06/20)
Pulsa aquí para acceder a la información

Guía para la toma y transporte de muestras para diagnóstico por PCR de SARS-CoV-2 (18/05/20)
Pulsa aquí para acceder a la información

(R) Información científico técnica Enfermedad por Coronavirus COVID-19 (actualizado el 02/06/20)
Pulsa aquí para acceder a la información

(R) Guía para la identificación y seguimiento de contactos de casos COVID-19 (13/05/2020)
Pulsa aquí para acceder a la información

Recomendaciones para la programación de cirugía en condiciones de seguridad durante el periodo de transición de la pandemia (actualizado el 02/06/2020 )
Pulsa aquí para acceder a la información

Resumen priorización general
Pulsa aquí para acceder a la información

Resumen priorización quirúrgica
Pulsa aquí para acceder a la información

Manejo de la mujer embarazada y el recién nacido con COVID-19 (13/05/20)
Pulsa aquí para acceder a la información

Resumen visual anestesia en Obstetricia
Pulsa aquí para acceder a la información

Resumen visual mujer embarazada
Pulsa aquí para acceder a la información

Resumen visual recién nacido
Pulsa aquí para acceder a la información

Medidas Higiénicas para la prevención de contagios (06/04/2020)
Pulsa aquí para acceder a la información

PROCEDIMIENTO DE ACTUACIÓN PARA LOS SERVICIOS DE PREVENCION DE RIESGOS LABORALES FRENTE A LA EXPOSICIÓN AL SARS-CoV-2 (Actualizado el 06/07/20)
Pulsa aquí para acceder a la información

NOTA INTERPRETATIVA DE LOS ESCENARIOS DE RIESGO DE EXPOSICIÓN ESTABLECIDOS EN EL PROCEDIMIENTO DE ACTUACIÓN PARA LOS SERVICIOS DE PREVENCIÓN DE RIESGOS LABORALES FRENTE A LA EXPOSICIÓN AL NUEVO CORONAVIRUS (SARS‐COV‐2) (06/07/2020)
Pulsa aquí para acceder a la información

(R) INTERPRETACIÓN DE LAS PRUEBAS DIAGNÓSTICAS FRENTE A SARS-CoV-2 (24/04/20. Versión 2)
Pulsa aquí para acceder a la información

Nota sobre el uso de productos que utilizan radiaciones Ultravioleta-C para la desinfección del SARS-CoV-2 (03/07/2020)
Pulsa aquí para acceder a la información

Nota sobre el uso de productos que utilizan radiaciones Ultravioleta-C para la desinfección del SARS-CoV-2 (25/06/2020)
Pulsa aquí para acceder a la información

Recomendaciones de operación y mantenimiento de los sistemas de climatización y ventilación de edificios y locales para la prevención de la propagación del SARS-CoV-2 (22/06/2020)
Pulsa aquí para acceder a la información

(R) RECOMENDACIONES SOBRE EL USO DE MASCARILLAS EN LA COMUNIDAD EN EL CONTEXTO DE COVID-19 (Actualizado el 10/06/20)
Pulsa aquí para acceder a la información

Manejo pediátrico en atención primaria del COVID-19 (actualizado el 18/06/20)
Pulsa aquí para acceder a la información

Manejo pediátrico en atención primaria del COVID-19 Resumen visual
Pulsa aquí para acceder a la información

Prevención y control de la infección en el manejo de pacientes con  COVID-19 (Actualizado el 17/06/20)
Pulsa aquí para acceder a la información

Manejo clínico del COVID-19: unidades de cuidados intensivos (18/05/20)
Pulsa aquí para acceder a la información

Manejo clínico del COVID-19: atención hospitalaria (18/05/20)
Pulsa aquí para acceder a la información

Recomendaciones para el manejo, prevención y control de COVID-19 en los servicios de oncología radioterápica (15/04/2020)
Pulsa aquí para acceder a la información

(R) Recomendaciones para la apertura de la actividad en las piscinas tras la crisis del COVID-19 (14/05/20)
Pulsa aquí para acceder a la información

(R) Recomendaciones para la apertura de playas y zonas de baño tras la crisis del COVID-19 (Actualizado el 25/05/20)
Pulsa aquí para acceder a la información

Coronavirus y agua de consumo (06/04/20)
Pulsa aquí para acceder a la informació

Recomendaciones para la obtención de plasma ­ de donantes convalecientes de COVID-19 ­(Actualizado el 15/04/20)
Pulsa aquí para acceder a la información

Recomendaciones para el manejo y control de COVID-19 en Unidades de Diálisis (25/03/20)

Pulsa aquí para acceder a la información

Guía de prevención y control frente al COVID-19 en residencias de mayores y otros centros de servicios sociales de carácter residencial (24/03/20)

Pulsa aquí para acceder a la información

INFORMES DEL GRUPO DE ANALISIS CIENTÍFICO DE CORONAVIRUS DEL ISCIII (GACC-ISCIII)

ENCUESTAS DE SEROVIGILANCIA(27/07/20)
Pulsa aquí para acceder a la información

(R)  LA TECNOLOGÍA CRISPR EN LA INFECCIÓN POR SARS-CoV-2 (27/07/20)
Pulsa aquí para acceder a la información

(R) ANTICUERPOS NEUTRALIZANTES FRENTE A SARS CoV-2 (02/07/20)
Pulsa aquí para acceder a la información

(R) EVOLUCIÓN DEL CORONAVIRUS SARS-CoV-2 (02/07/20)
Pulsa aquí para acceder a la información

(R) PROBLEMAS DE COAGULACIÓN Y TROMBOS EN PACIENTES CON COVID-19 (16/06/20)
Pulsa aquí para acceder a la información

FACTORES DE RIESGO EN LA ENFERMEDAD POR SARS-CoV-2 (COVID-19) (01/06/20)
Pulsa aquí para acceder a la información

DETECCIÓN DE SARS-CoV-2 EN AGUAS RESIDUALES COMO HERRAMIENTA DE VIGILANCIA Y ALERTA RÁPIDA (01/06/20)
Pulsa aquí para acceder a la información

¿ES LA CONTAMINACIÓN ATMOSFÉRICA UN FACTOR DE RIESGO EN COVID-19? (27/05/20)
Pulsa aquí para acceder a la información

DESARROLLO DE VACUNAS FRENTE AL SARS-CoV-2 (27/05/20)
Pulsa aquí para acceder a la información

RECOMENDACIONES DE LA COMISIÓN EUROPEA

(R) RECOMENDACIÓN (UE) 2020/1743 DE LA COMISIÓN de 18 de noviembre de 2020 relativa a la utilización de pruebas rápidas de antígenos para el diagnóstico de la infección por el SARS-CoV-2
Pulsa aquí para acceder a la información

COMUNICADOS SOCIEDADES CIENTÍFICAS

(R) RECOMENDACIONES RELATIVAS AL SEGUIMIENTO DE SOSPECHA DE TROMBOSIS Y TROMBOCITOPENIAS TRAS LA VACUNACION FRENTE A COVID-19. (FACME) (Fecha: 30 de marzo de 2021) (versión 2)
Pulsa aquí para acceder a la información

(R) Alarmas relacionadas con la vacuna de AstraZeneca (Posicionamiento de la Sociedad Española de Trombosis y Hemostasis-SETH) (31/03/21)
Pulsa aquí para acceder a la información

(R)   Documento de consenso de la Sociedad Española de Medicina Preventiva, Salud Pública e Higiene sobre la priorización de vacunación frente a SARS-CoV-2 en adultos con condiciones de riesgo
Pulsa aquí para acceder a la información

Recomendaciones sobre la utilización de la ventilación no invasiva y terapia de alto flujo con cánulas nasales en el paciente adulto, pediátrico y neonatal con insuficiencia respiratoria aguda grave. Documento de Consenso de las Sociedades Científicas Españolas (SEPAR, SEMICYUC, SEMES; SECIP, SENeo, SEDAR, SENP).

Pulsa aquí para acceder a la información

MANEJO DE LA APLASIA MEDULAR EN LA DEFERVESCENCIA DE LA CURVA DE LA COVID-19

Pulsa aquí para acceder a la información

Recomendaciones de PETHEMA para el tratamiento de la leucemia aguda linfoblástica, linfoma linfoblástico y leucemia de Burkitt (Programa para la Terapéutica de Hemopatías Malignas (PETHEMA) - Sociedad Española de Hematología y Hemoterapia (SEHH))

Pulsa aquí para acceder a la información

(R) Para entender cómo y cuándo pedir las pruebas de imagen en la infección COVID-19….si es que se puede (Sociedad Española de Radiología Médica-SERAM)
Pulsa aquí para acceder a la información

(R) Para entender cómo y cuándo pedir las pruebas de imagen en la infección COVID-19….si es que se puede (Sociedad Española de Radiología Médica-SERAM)
Pulsa aquí para acceder a la información

Actuación frente a COVID-19 en receptores de trasplante de progenitores hematopoyéticos y pacientes oncohematológicos (SEHH) (31/03/2020)

Pulsa aquí para acceder a la información

Recomendaciones para el manejo de enfermos con trombopenia inmune en la situación actual de pandemia por Covid-19 (27/03/20)

Pulsa aquí para acceder a la información

Recomendaciones del Grupo Español de Mieloma (GEM-PETHEMA) para el manejo de pacientes con mieloma múltiple durante la crisis motivada por la pandemia por el virus SARS-Cov2 (SEHH) (24/03/20)

Pulsa aquí para acceder a la información

Recomendaciones del Comité Científico del grupo GELTAMO para el manejo de los pacientes con linfoma durante la crisis del Covid-19 (SEHH) (19/03/2020)

Pulsa aquí para acceder a la información

Recomendaciones para el control de anticoagulación en la situación actual de epidemia por coronavirus de la Sociedad Española de Hematología y Hemoterapia (SEHH) y Sociedad Española de Trombosis y Hemostasia (SETH) (24/03/20)

Pulsa aquí para acceder a la información

Protocolo de actuación ante la pandemia de enfermedad por coronavirus en los pacientes de Diálisis y trasplantados renales (17/03/20)

Pulsa aquí para acceder a la información

Recomendaciones Sociedad Española de Neurología para epilepsia, cefaleas, Esclerosis Múltiple, enfermedades neuromusculares, Parkinson, Trastornos de la vigilia y el sueño y trastornos mentales

Pulsa aquí para acceder a la información

Manejo farmacológico de trastornos psicóticos en personas mayores con tratamiento de la infección por COVID19: interacciones y recomendaciones terapéuticas (diversas Sociedades Científicas).

Posicionamiento de la Sociedad Española de Nefrologia sobre hipertension e infeccion por COVID-19 (14/03/2020)

Pulsa aquí para acceder a la información

Implicaciones de la pandemia por Covid-19 para el paciente con insuficiencia cardíaca, trasplante cardíaco y asistencia ventricular./ Recomendacionesde ka Asociación de Insuficiencia Cardíaca de la Sociedad Española de Cardiología

Interim Guidance for COVID-19 and Persons with HIV (NIH)

Pulsa aquí para acceder a la información

Sociedad Española de Neurología (SEN): Recomendación de la SEN sobre pérdida de olfato como posible síntoma precoz de infección por Covid-19 (21/03/20)

Pulsa aquí para acceder a la información

Recomendaciones imagen SERAM (21/03/20)

Pulsa aquí para acceder a la información

COMUNICADOS EMA

AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets (07/04/21)
Pulsa aquí para acceder a la información

COMUNICADOS AEMPS

(R) 10º Informe de Farmacovigilancia de tratamientos utilizados  COVID-19 (04/06/21)
Pulsa aquí para acceder a la información

Vaxzevria (vacuna frente a la COVID-19 de AstraZeneca) y síndrome de fuga capilar sistémica (11/06/21)
Pulsa aquí para acceder a la información

Vacunas frente a la COVID-19: actualización sobre la evaluación de miocarditis/pericarditis (11/06/21)
Pulsa aquí para acceder a la información

Vaxzevria (vacuna frente a la COVID-19 de AstraZeneca) y síndrome de fuga capilar sistémica (11/06/21)
Pulsa aquí para acceder a la información

Vacunas frente a la COVID-19: actualización sobre la evaluación de miocarditis/pericarditis (11/06/21)
Pulsa aquí para acceder a la información

Análisis contextualizado de beneficios y riesgos de la vacuna frente a la COVID-19 de AstraZeneca (23/04/21)
Pulsa aquí para acceder a la información

(R) 5º Informe de Farmacovigilancia sobre Vacunas COVID-19 (11/05/21)
Pulsa aquí para acceder a la información

Análisis contextualizado de beneficios y riesgos de la vacuna frente a la COVID-19 de AstraZeneca (23/04/21)
Pulsa aquí para acceder a la información

Vacuna frente a la COVID-19 de Janssen: conclusiones de la evaluación del riesgo de trombosis junto con trombocitopenia (20/04/21)
Pulsa aquí para acceder a la información

La AEMPS autoriza el primer ensayo clínico que combina diferentes vacunas frente a la COVID-19 en España (19/04/21)
Pulsa aquí para acceder a la información

(R) 4º Informe de Farmacovigilancia sobre Vacunas COVID-19 (09/04/21)
Pulsa aquí para acceder a la información

Conclusiones del Comité para la Evaluación de Riesgos en Farmacovigilancia Europeo (PRAC) (07/04/21)
Pulsa aquí para acceder a la información

Conclusiones del Comité para la Evaluación de Riesgos en Farmacovigilancia Europeo (PRAC) (07/04/21)

Pulsa aquí para acceder a la información

Vacuna frente a la COVID-19 de AstraZeneca: conclusiones de la evaluación del riesgo de tromboembolismo
Pulsa aquí para acceder a la información

Información de interés en relación con los últimos eventos sobre vacunación frente al SARS-CoV-2 con la vacuna de AstraZeneca (para profesionales) (17/03/21)
Pulsa aquí para acceder a la información

El Ministerio de Sanidad suspende a partir de mañana y durante las dos próximas semanas la vacunación con la vacuna frente a la COVID-19 de AstraZeneca (15/03/21)
Pulsa aquí para acceder a la información

La EMA indica que el balance beneficio/riesgo de la vacuna de AstraZeneca continúa siendo favorable (12/03/21)
Pulsa aquí para acceder a la información

 La EMA recomienda la autorización de la cuarta vacuna frente a la COVID-19 (11/03/21)
Pulsa aquí para acceder a la información

Información sobre productos sanitarios especialmente utilizados durante la COVID-19 que han sido detectados en el mercado y no cumplen la regulación (Actualizado a 23/02/21)
Pulsa aquí para acceder a la información

Información sobre investigación clínica sobre la COVID-19, (actualizado a 19 de Noviembre de 2020)

Pulsa aquí para acceder a la información

(R) Sospechas de reacciones adversas notificadas con tratamientos utilizados en COVID-19, (actualizado a 22 de Enero de 2020)
Pulsa aquí para acceder a la información
L
(R) La EMA recomienda la autorización de la tercera vacuna frente a la COVID-19 (29/01/21)
Pulsa aquí para acceder a la información

(R) Información sobre la administración de la segunda dosis de la vacuna Comirnaty frente a la COVID-19 (22/01/21)
Pulsa aquí para acceder a la información

(R) La EMA incluye la posibilidad de utilizar una dosis extra de los viales de la vacuna Comirnaty frente a la COVID-19 (08/01/21)
Pulsa aquí para acceder a la información

(R) La EMA recomienda la autorización de la segunda vacuna frente a la COVID-19 (06/01/21)
Pulsa aquí para acceder a la información

(R) La EMA recomienda la autorización de la primera vacuna frente a la COVID-19 (21/12/20)
Pulsa aquí para acceder a la información

 

(R) La AEMPS autoriza el primer ensayo clínico para la vacuna contra la COVID-19 en España (28/08/20)
Pulsa aquí para acceder a la información

(R) España se suma a la compra centralizada de la CE de la vacuna de Astrazeneca (25/08/20)
Pulsa aquí para acceder a la información

 La AEMPS moviliza del stock sobrante de ensayos clínicos de remdesivir para cubrir las necesidades actuales de pacientes 21/008/20)
Pulsa aquí para acceder a la información

 Recomendaciones para la distribución de tocilizumab (07/08/20)
Pulsa aquí para acceder a la información

(R) Recomendaciones para el tratamiento con remdesivir de pacientes con COVID-19 (28/07/20)
Pulsa aquí para acceder a la información

(R) España formará parte del proceso de producción de la vacuna contra la COVID-19 que desarrolla Moderna (09/07/20)
Pulsa aquí para acceder a la información

La AEMPS alerta sobre el riesgo de que se puedan ofrecer en el mercado español productos y servicios para el diagnóstico de COVID-19 que no cumplan con la legislación vigente

Pulsa aquí para acceder a la información

(R)  Tratamientos disponibles sujetos a condiciones especiales de acceso para el manejo de la infección respiratoria por SARS-CoV-2 (actualizado a 9 de Julio de 2020)
Pulsa aquí para acceder a la información

Información sobre investigación clínica sobre la COVID-19, (actualizado a 9 de Julio de 2020)
Pulsa aquí para acceder a la información

(R) Tratamientos disponibles para el manejo de la infección respiratoria por SARS-CoV-2 (actualizado a 19 de Mayo de 2020)
Pulsa aquí para acceder a la información

(R) Tratamientos disponibles para el manejo de la infección respiratoria por SARS-CoV-2 (actualizado a 4 de Mayo de 2020)
Pulsa aquí para acceder a la información

Información sobre investigación clínica sobre la COVID-19, (actualizado a 26 de Junio de 2020)
Pulsa aquí para acceder a la información

(R) Cloroquina/Hidroxicloroquina: precauciones y vigilancia de posibles reacciones adversas en pacientes con COVID-19 (22/04/2020)
Pulsa aquí para acceder a la información

(R) Cloroquina/Hidroxicloroquina: precauciones y vigilancia de posibles reacciones adversas en pacientes con COVID-19 ((actualizado a 14 de mayo de 2020)
Pulsa aquí para acceder a la información

Medidas excepcionales aplicables a los ensayos clínicos y estudios observacionales para gestionar los problemas derivados de la emergencia por COVID-19 (Actualizado el 05/05/20)

Pulsa aquí para acceder a la información

La AEMPS informa sobre el buen uso de medicamentos relacionados con COVID-19 (06/04/20)

Pulsa aquí para acceder a la información

Información sobre el suministro de mascarillas, guantes y soluciones desinfectantes a fabricantes de medicamentos, principios activos, productos sanitarios o biocidas AEMPS (20/03/20)

Pulsa aquí para acceder a la información

La AEMPS informa de la distribución controlada de todo el stock de hidroxicloroquin/cloroquina

Pulsa aquí para acceder a la información

Información sobre el suministro de mascarillas, guantes y soluciones desinfectantes a fabricantes de medicamentos, principios activos, productos sanitarios o biocidas AEMPS (20/03/20)

Pulsa aquí para acceder a la información

CUIDADOS PALIATIVOS

 

Sedación paliativa de pacientes instucionalizados y en el domicilio. Manejo farmacológico

Pulsa aquí para acceder a la información

ORIENTACIONES SOBRE EL CONTROL SINTOMÁTICO DE ENFERMOS GRAVES AFECTADOS POR LA ENFERMEDAD COVID 19 Y QUE REQUIERAN ATENCIÓN PALIATIVA O SE ENCUENTREN PRÓXIMOS AL FINAL DE LA VIDA (Sociedad Española de Cuidados Paliativos-SECPAL) (23/03/20)

Pulsa aquí para acceder a la información

UNIDAD DE SOPORTE DOMICILIARIOS DE CUIDADOS PALIATIVOS DE SEGOVIA

Manejo de final de vida en infección por Covid19

Pulsa aquí para acceder a la información

Sedación

Pulsa aquí para acceder a la información

Vía subcutánea

Pulsa aquí para acceder a la información

Preparación de un infusor

Pulsa aquí para acceder a la información

ASPECTOS ÉTICOS

Recomendaciones de la Comisión de Bioética de Castilla y León para la priorización del tratamiento intensivo durante la pandemia covid-19 (ante una situación excepcional de desastre sanitario)

Pulsa aquí para acceder a la información

Consideraciones Éticas de la Comisión de Bioética de Castilla y León en Residencias de carácter social (Versión segunda, 5 de Abril de 2020)

Pulsa aquí para acceder a la información

Recomendaciones éticas para la toma de decisiones en la situación excepcional de crisis por pandemia COVID-19 en las unidades de cuidados intensivos. (SEMICYUC)

Pulsa aquí para acceder a la información

ASPECTOS LEGALES

Documento OMC sobre Certificados médicos de defunción

Pulsa aquí para acceder a la información

ASPECTOS PSICOLÓGICOS

Sugerencias confinamiento con Diabetes (Grupo de trabajo de Diabetes-Colegio Oficial de Psicólogos de Castilla y León (COPCYL))

Pulsa aquí para acceder a la información

Prevención secundaria del trauma psicológico para médicos (Dras. Anabel González, Carmen Barral y Ania Justo-PAIME)
Pulsa aquí para acceder a la información

 Prevención secundaria del trauma psicológico para médicos (Dras. Anabel González, Carmen Barral y Ania Justo-PAIME)
Pulsa aquí para acceder a la información

Herramientas  de ayuda para afrontar el estrés (SACYL)

Pulsa aquí para acceder a la información

Herramientas  de ayuda para afrontar el estrés (SACYL)

Pulsa aquí para acceder a la información

Recomendaciones Coronavirus Colegio Oficial de Psicólogos de Castilla y León (COPCYL)

Recomendaciones Coronavirus COPCYL.pdf.pdf

Autocuidado y manejo del estrés durante la crisis COVID-19: Juego de herramientas para profesionales de la salud en oncología (National Comprensive Cancer Network)

Pulsa aquí para acceder a la información

Autocuidado y manejo del estrés durante la crisis COVID-19: Juego de herramientas para profesionales de la salud en oncología (National Comprensive Cancer Network)

Pulsa aquí para acceder a la información

Recomendaciones familias con hijos COPCYL

RECOMENDACIONES-FAMILIAS-CON-HIJOS-COPCYL.pdf.pdf

Cuidando la salud mental del personal sanitario (Sociedad Española de Psiquiatría)

Pulsa aquí para acceder a la información

Población general_Cuide su salud mental durante la cuarentena por coronavirus (Sociedad Española de Psiquiatría)

Pulsa aquí para acceder a la información

Recomendaciones dirigidas a la población para un afrontamiento eficaz ante el malestar psicológico generado por el brote de coronavirus-COVID 19 (Colegio Oficial de Psicología de Madrid)

Pulsa aquí para acceder a la información

Bibliografía estrés laboral para sanitarios

Pulsa aquí para acceder a la información

SITUACIÓN EPIDEMIOLÓGICA COVID-19 EN CASTILLA Y LEÓN

Pulsa aquí para acceder a la información

Informe diario de la Red de Vigilancia Epidemiológica de Castilla y León
Pulsa aquí para acceder a la información

 

SITUACIÓN EPIDEMIOLÓGICA COVID-19 EN ESPAÑA

Pulsa aquí para acceder a la información

SITUACIÓN EPIDEMIOLÓGICA COVID-19 EN UNIÓN EUROPEA/REINO UNIDO

Pulsa aquí para acceder a la información

 

SITUACIÓN EPIDEMIOLÓGICA COVID-19 EN EL MUNDO (John Hopkins University)

Pulsa aquí para acceder a la información

Organización mundial de la salud
Pulsa aquí para acceder a la información

(R) ESTRATEGIA DE VACUNACIÓNCOVID-19 EN ESPAÑA (con la última actualización-Actualización nº 7 de 11 de mayo de 2021) (Contiene datos de vacunación diarios)
Pulsa aquí para acceder a la información

 

VIDEOS DE INTERÉS

Emergency Intubation in Covid-19.
Gentle Sunder Shrestha, M.D., Ninadini Shrestha, M.D., Ritesh Lamsal, M.D., D.M., Saurabh Pradhan, M.D., D.M., Anil Shrestha, M.D., Robert Canelli, M.D., and Rafael Ortega, M.D.
NEJM February 18, 2021  DOI: 10.1056/NEJMvcm2007198
Pulsa aquí para acceder a la información

VACUNACIÓN PARA COVID-19. Un reto de eficacia, efectividad y equidad para la sociedad española (Fundación para la Formación de la OMC) (15/01/21)
Pulsa aquí para acceder a la información

Coloquio “La situación sanitaria frente a la pandemia COVID19” (Fundación Ramón Areces) (26/05/20-19,00 horas)
Pulsa aquí para acceder a la información

Coloquio ”Tests, fármacos y Covid-19” (Universidad Autónoma de Madrid). (22/05/20-s 17:30 horas)
https://eventos.uam.es/51450/detail/tests-farmacos-y-covid-19.html

(R) Encuentro digital “Genética y Covid-19”
Pulsa aquí para acceder a la información

(R) Webinar de la Sociedad Española de Trpmbosis y Hemostasia (SETH) sobre “Coagulación, anticoagulación y COVID-19”
Pulsa aquí para acceder a la información

How to Obtain a Nasopharyngeal Swab Specimen
Francisco M. Marty, M.D., Kaiwen Chen, B.S., and Kelly A. Verrill, R.N.
The New England Journal of Medicine April 17, 2020
DOI: 10.1056/NEJMvcm2010260
Pulsa aquí para acceder a la información

Webinar sobre los tratamientos respiratorios con oxigenoterapia (Jefe de Servicio de Anestesia de la Clínica Puerta de Hierro de Madrid) (08/04/20)
Pulsa aquí para acceder a la información

Webinar de la Sociedad Española de Neurología sobre aspectos neurológicos de la enfermedad (06/04/20)
Pulsa aquí para acceder a la información

Webinar de la Sociedad Española de Inmunología (06/04/20)
Pulsa aquí para acceder a la información

Webinar de la Sociedad Española de Enfermedades Infecciosas y Microbiologia Clínica (SEIMC), titulado “An update on SARS-CoV-19 and COVID-19” (03/04/20)
Pulsa aquí para acceder a la información

Webinar de la Sociedad Española de Enfermedades Infecciosas y Microbiologia Clínica (SEIMC), titulado “An update on SARS-CoV-19 and COVID-19” (03/04/20)
Pulsa aquí para acceder a la información

Webinar maratón internacional Sociedad Europea Medicina Intensiva (28/03/20) (inglés)

Pulsa aquí para acceder a la información

 

 

ARTÍCULOS DE INTERÉS

ETIOLOGIA/PATOGENIA/FISIOPATOLOGIA

ETIOLOGIA

(R) Genetic Variants of SARS-CoV-2—What Do They Mean?
Adam S. Lauring, MD, PhD1; Emma B. Hodcroft, PhD2
JAMA. Published online January 6, 2021. doi:10.1001/jama.2020.27124
Pulsa aquí para acceder a la información

PATOGENIA / FISIOPATOLOGIA

In vitro Interleukin-7 treatment partially rescues MAIT cell dysfunction caused by SARS-CoV-2 infection
Satanay Hubrack, Maryam Ali Al-Nesf, Nourhen Agrebi, Christophe Raynaud, Mohammed Abu Khattab, Merlin Thomas, Tayseer Ibrahim, Salma Taha, Said Dermime, Maysaloun Merhi, Michal Kulinski, Martin Steinhoff, Patrick Tang & Bernice Lo
Scientific Reports volume 11, Article number: 14090 (2021) Published: 08 July 2021
Pulsa aquí para acceder a la información

Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity
L. Vanderbeke, P. Van Mol, […]J. Wauters
Nature Communications volume 12, Article number: 4117 (2021 Published: 05 July 2021
Pulsa aquí para acceder a la información

 

(R)   The spatial landscape of lung pathology during COVID-19 progression
André F. Rendeiro, Hiranmayi Ravichandran[…]Robert E. Schwartz
Nature , 1–8  29 March 2021
Pulsa aquí para acceder a la información

(R) Cytokine Storm (Review article)
David C. Fajgenbaum, M.D., and Carl H. June, M.D.
The New England Journal of Medicine December 3, 2020 ; 383:2255-2273
DOI: 10.1056/NEJMra2026131
Pulsa aquí para acceder a la información

Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19
Jenny Meinhardt, Josefine Radke, […]Frank L. Heppner
Nature Neuroscience (2020) Published: 30 November 2020
Pulsa aquí para acceder a la información

Immune suppression in the early stage of COVID-19 disease
Wenmin Tian, Nan Zhang, Ronghua Jin, Yingmei Feng, Siyuan Wang, Shuaixin Gao, Ruqin Gao, Guizhen Wu, Di Tian, Wenjie Tan, Yang Chen, George Fu Gao & Catherine C. L. Wong
Nature Communications volume 11, Article number: 5859 (2020) Published: 17 November 2020
Pulsa aquí para acceder a la información

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
Muge Cevik, Matthew Tate, Ollie Lloyd, Alberto Enrico Maraolo, Jenna Schafers, Antonia Ho
The Lancet Microbe  Published: November 19, 2020
Pulsa aquí para acceder a la información

Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes
Daniel E Leisman, Lukas Ronner, Rachel Pinotti, Matthew D Taylor, Pratik Sinha, Carolyn S Calfee, and others
The Lancet Respiratory Medicine  Published: October 16, 2020
Pulsa aquí para acceder a la información

(R) The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)
Pere Domingo•Isabel Mur•Virginia Pomar•Héctor Corominas•Jordi Casademont•Natividad de Benito
EBioMedicine, Vol. 58 Published: July 29, 2020
Pulsa aquí para acceder a la información

Vascular occlusion by neutrophil extracellular traps in COVID-19
Moritz Leppkes•Jasmin Knopf•Elisabeth Naschberger•Aylin Lindemann•Jeeshan Singh•Irmgard Herrmann•Michael Stürzl•Léonie Staats•Aparna Mahajan•Christine Schauer•Anita N. Kremer•Simon Völkl•Kerstin Amann•Katja Evert•Christina Falkeis•Andreas Wehrfritz•Ralf J. Rieker•Arndt Hartmann•Andreas E. Kremer•Markus F. Neurath•Luis E. Muñoz•Georg Schett•Martin Herrmann
EBioMedicine, Vol. 5 Published: August 1, 2020
Pulsa aquí para acceder a la información

(R) Extrapulmonary manifestations of COVID-19 (Review)
Aakriti Gupta, Mahesh V. Madhavan, […]Donald W. Landry
Nature Medicine Published 10 July 2020
Pulsa aquí para acceder a la información

(R) Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19). A Review
W. Joost Wiersinga, MD, PhD1,2; Andrew Rhodes, MD, PhD3; Allen C. Cheng, MD, PhD4,5; et alSharon J. Peacock, PhD6,7; Hallie C. Prescott, MD, MSc8,9
JAMA. Published online July 10, 2020. doi:10.1001/jama.2020.12839
Pulsa aquí para acceder a la información

MEDIDAS PREVENTIVAS/EPIDEMIOLOGÍA

Índice de Secciones

MEDIDAS DISTANCIA FÍSICA/ENMASCARAMIENTO

COLEGIOS/GUARDERÍAS

RAZA

TRABAJADORES SANITARIOS

VARIANTES DEL SARS-CoV-2

(R) (N) Airborne transmission of respiratory viruses
Chia C. Wang, Kimberly A. Prather, View, Josué Sznitman, Jose L. Jimenez, Seema S. Lakdawala, Zeynep Tufekci, Linsey C. Marr

Science  27 Aug 2021: Vol. 373, Issue 6558, eabd9149 DOI: 10.1126/science.abd9149
Pulsa aquí para acceder a la información

(N) COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19. A Population-Based Cohort Study in Zhejiang Province, China
Yang Ge; Leonardo Martinez; Shengzhi Sun; Zhiping Chen; Feng Zhang; Fangyu Li; Wanwan Sun, MD4; Enfu Chen; Jinren Pan; Changwei Li; Jimin Sun; Andreas Handel; Feng Ling; Ye Shen
JAMA Intern Med. Published online August 23, 2021. doi:10.1001/jamainternmed.2021.4686
Pulsa aquí para acceder a la información

A novel index-based decision support toolkit for safe reopening following a generalized lockdown in low and middle-income countries
Abu S. Shonchoy, Khandker S. Ishtiaq, Sajedul Talukder, Nasar U. Ahmed & Rajiv Chowdhury
Scientific Reports volume 11, Article number: 14108 (2021) Published: 08 July 2021
Pulsa aquí para acceder a la información

First molecular-based detection of SARS-CoV-2 virus in the field-collected houseflies
Aboozar Soltani, Marzieh Jamalidoust, Amin Hosseinpour, Mozaffar Vahedi, Hadi Ashraf & Saeed Yousefinejad
Scientific Reports volume 11, Article number: 13884 (2021) Published: 06 July 2021
Pulsa aquí para acceder a la información

Reduction in life expectancy in Brazil after COVID-19
Marcia C. Castro, Susie Gurzenda, Cassio M. Turra, Sun Kim, Theresa Andrasfay & Noreen Goldman
Nature Medicine (2021) Published: 29 June 2021
Pulsa aquí para acceder a la información

A retrospective cohort study of risk factors for mortality among nursing homes exposed to COVID-19 in SpainClara Suñer, Dan Ouchi[…]Oriol MitjàNature Aging , 1–6 28 June 2021

Pulsa aquí para acceder a la información

The Risk of SARS-CoV-2 Transmission from Patients with Undiagnosed Covid-19 to Roommates in a Large Academic Medical Center
Abraar Karan, MD, MPH, DTM&H, Michael Klompas, MD, MPH, Robert Tucker, MPH CIC, Meghan Baker, MD ScD, Vineeta Vaidya, DMD CIC, Chanu Rhee, MD, MPH, for the CDC Prevention Epicenters Program
Clinical Infectious Diseases, Published: 18 June 2021 ciab564, https://doi.org/10.1093/cid/ciab564
Pulsa aquí para acceder a la información

Community factors and excess mortality in first wave of the COVID-19 pandemic in England
Bethan Davies, Brandon L. Parkes[…]Paul Elliott
Nature Communications 12 , 1–9 18 June 2021
Pulsa aquí para acceder a la información

Neighborhood-level disparities and subway utilization during the COVID-19 pandemic in New York City
Daniel Carrión, Elena Colicino. […], Allan C. Just
Nature Communications 12 , 1–10 17 June 2021
Pulsa aquí para acceder a la información

(R) Real time surveillance of COVID-19 space and time clusters during the summer 2020 in Spain
Nicolás Rosillo, Javier Del-Águila-Mejía, Ayelén Rojas-Benedicto, María Guerrero-Vadillo, Marina Peñuelas, Clara Mazagatos, Jordi Segú-Tell, Rebeca Ramis, Diana Gómez-Barroso
BMC Public Health. 2021 May 21;21(1):961. doi: 10.1186/s12889-021-10961-z.
Pulsa aquí para acceder a la información

A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021
Khitam Muhsen, Wasef Na'aminh, Yelena Lapidot, Sophy Goren, Yonatan Amir, Saritte Perlman and others
The Lancet Regional Health – EuropeVol. 7 Published: June 4, 2021
Pulsa aquí para acceder a la información

A systematic review and meta-analysis on correlation of weather with COVID-19
Poulami Majumder & Partha Pratim Ray
Scientific Reports 11 , 1–10 24 May 2021
Pulsa aquí para acceder a la información

Same-day SARS-CoV-2 antigen test screening in an indoor mass-gathering live music event: a randomised controlled trial
Boris Re
vollo, Ignacio Blanco, Pablo Soler, Jessica Toro, Nuria Izquierdo-Useros, Jordi Puig and others
The Lancet Infectious Diseases Published: May 27, 2021
Pulsa aquí para acceder a la información

A multiplex antigen microarray for simultaneous IgG and IgM detection against SARS-CoV-2 reveals higher seroprevalence than reported
David Ruano-Gallego, Miriam García-Villadangos, Mercedes Moreno-Paz, Javier Gómez-Elvira, Marina Postigo, María Simón-Sacristán, Hugh T. Reyburn, Carlo Carolis, Natalia Rodrigo … See all authors
Microbial Biotechnology First published: 30 April 2021 https://doi.org/10.1111/1751-7915.13801
Pulsa aquí para acceder a la información

The epidemiological impact of the NHS COVID-19 App
Chris Wymant, Luca Ferretti, Daphne Tsallis, Marcos Charalambides, Lucie Abeler-Dörner, David Bonsall, Robert Hinch, Michelle Kendall, Luke Milsom, Matthew Ayres, Chris Holmes, Mark Briers & Christophe Fraser
Nature (2021) Published 12 May 2021
Pulsa aquí para acceder a la información

A multiplex antigen microarray for simultaneous IgG and IgM detection against SARS-CoV-2 reveals higher seroprevalence than reported
David Ruano-Gallego, Miriam García-Villadangos, Mercedes Moreno-Paz, Javier Gómez-Elvira, Marina Postigo, María Simón-Sacristán, Hugh T. Reyburn, Carlo Carolis, Natalia Rodrigo … See all authors
Microbioal Technology First published: 30 April 2021 https://doi.org/10.1111/1751-7915.13801
Pulsa aquí para acceder a la información

Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study
Carlos Álvarez-Antonio, Graciela Meza-Sánchez, Carlos Calampa, Wilma Casanova, Cristiam Carey, Freddy Alava and others
The Lancet Global Health Published: May 19, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 seroprevalence in a strictly-Orthodox Jewish community in the UK: A retrospective cohort study
Katherine M Gaskell, Marina Johnson, Victoria Gould, Adam Hunt, Neil RH Stone, William Waites and others
The Lancet Regional Health – EuropeVol. 6Published: May 18, 2021
Pulsa aquí para acceder a la información

Controlling COVID-19 via test-trace-quarantine
Cliff C. Kerr, Dina Mistry, Robyn M. Stuart, Katherine Rosenfeld, Gregory R. Hart, Rafael C. Núñez, Jamie A. Cohen, Prashanth Selvaraj, Romesh G. Abeysuriya, Michał Jastrzębski, Lauren George, Brittany Hagedorn, Jasmina Panovska-Griffiths, Meaghan Fagalde, Jeffrey Duchin, Michael Famulare & Daniel J. Klein
Nature Communications volume 12, Article number: 2993 (2021) Published: 20 May 2021
Pulsa aquí para acceder a la información

Aerosol generating procedures: are they of relevance for transmission of SARS-CoV-2? (Comment)
Fergus Hamilton, David Arnold, Bryan R Bzdek, James Dodd, AERATOR group, Jonathan Reid and others
The Lancet Respiratory Medicine Published: May 6, 2021
Pulsa aquí para acceder a la información

Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 Pandemic
Gregory A. Roth; Sophia Emmons-Bell; Heather M. Alger et al
JAMA Netw Open. 2021;4(5):e218828. doi:10.1001/jamanetworkopen.2021.8828
Pulsa aquí para acceder a la información

Socioeconomic status determines COVID-19 incidence and related mortality in Santiago, Chile
Gonzalo E. Mena, Pamela P. Martinez, Ayesha S. Mahmud, Pablo A. Marquet, Caroline O. Buckee, Mauricio Santillana
Science Date: 27-Apr-2021 DOI: 10.1126/science.abg5298
Pulsa aquí para acceder a la información

Ten scientific reasons in support of airborne transmission of SARS-CoV-2 (Comment)
Trisha Greenhalgh, Jose L Jimenez, Kimberly A Prather, Zeynep Tufekci, David Fisman, Robert Schooley
The LancetPublished: April 15, 2021
Pulsa aquí para acceder a la información

Effect of socioeconomic inequalities and vulnerabilities on health-system preparedness and response to COVID-19 in Brazil: a comprehensive analysis
Rudi Rocha, Rifat Atún, Adriano Massuda, Beatriz Rache, Paula Spinola, Letícia Nunes and others
The Lancet Global HealthPublished: April 12, 2021
Pulsa aquí para acceder a la información

Mortality Among US Patients Hospitalized With SARS-CoV-2 Infection in 2020
Finelli L, Gupta V, Petigara T, et al.
JAMA Network Open April 8, 2021
Pulsa aquí para acceder a la información

Seroprevalence of SARS-CoV-2 Antibodies in the US Adult Asymptomatic Population as of September 30, 2020
Stout RL, Rigatti SJ
JAMA Network Open March 16, 2021

Pulsa aquí para acceder a la información

SARS-CoV-2 Seroprevalence and Symptom Onset in Culturally Linked Orthodox Jewish Communities Across Multiple Regions in the United States
Zyskind I, Rosenberg AZ, Zimmerman J, et al.
JAMA Network Open March 10, 2021
Pulsa aquí para acceder a la información


(R) Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis
Xinhua Chen, Zhiyuan Chen, Andrew S Azman, Xiaowei Deng, Ruijia Sun, Zeyao Zhao and others
The Lancet Global HealthPublished: March 8, 2021
Pulsa aquí para acceder a la información

Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy
Poletti P, Tirani M, Cereda D, et al.
JAMA Network Open March 10, 2021
Pulsa aquí para acceder a la información

Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey
Lloyd B Mulenga Jonas Z Hines Sombo Fwoloshi Lameck Chirwa Mpanji Siwingwa Samuel Yingst and others
The Lancet Global Health Published: March 9, 2021
Pulsa aquí para acceder a la información


Assessment of a Hotel-Based COVID-19 Isolation and Quarantine Strategy for Persons Experiencing Homelessness
Jonathan D. Fuchs, MD, MPH1,2; Henry Clay Carter, BA2; Jennifer Evans, MPH2,3; et al
JAMA Netw Open. 2021;4(3):e210490. doi:10.1001/jamanetworkopen.2021.0490
Pulsa aquí para acceder a la información

Infection and transmission of SARS-CoV-2 in London care homes reporting no cases or outbreaks of COVID-19: Prospective observational cohort study, England 2020
Anna Jeffery-Smith, Kate Dun-Campbell, Roshni Janarthanan, Jonathan Fok, Emma Crawley-Boevey, Amoolya Vusirikala, and others
The Lancet Regional Health - Europe, Vol. 3 Published: February 25, 2021
Pulsa aquí para acceder a la información

Age groups that sustain resurging COVID-19 epidemics in the United States
Mélodie Monod et al.
Science  2-Feb-2021 DOI: 10.1126/science.abe8372
Pulsa aquí para acceder a la información

Age groups that sustain resurging COVID-19 epidemics in the United States
Mélodie Monod et al.
Science  2-Feb-2021 DOI: 10.1126/science.abe8372
Pulsa aquí para acceder a la información


(R)   Factors associated with SARS-CoV-2 infection and outbreaks in long-term care facilities in England: a national cross-sectional survey
Laura Shallcross, Danielle Burke, Owen Abbott, Alasdair Donaldson, Gemma Hallatt, Andrew Hayward, and others
The Lancet Healthy Longevity Published: February 11, 2021
Pulsa aquí para acceder a la información

Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2
John T. Brooks, MD1; Jay C. Butler, MD1
JAMA. Published online February 10, 2021. doi:10.1001/jama.2021.1505
Pulsa aquí para acceder a la información

(R) Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study
Thomas Roederer, Bastien Mollo, Charline Vincent, Birgit Nikolay, Augusto E Llosa, Robin Nesbitt, and others
The Lancet Public Health  Published: February 5, 2021
Pulsa aquí para acceder a la información

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study
Michael Marks, Pere Millat-Martinez, Dan Ouchi, Chrissy h Roberts, Andrea Alemany, Marc Corbacho-Monné, and others
The Lancet Infectious Diseases  Published: February 2, 2021
Pulsa aquí para acceder a la información

Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study
Thomas Roederer, Bastien Mollo, Charline Vincent, Birgit Nikolay, Augusto E Llosa, Robin Nesbitt, and others
The Lancet Public Health  Published: February 5, 2021
Pulsa aquí para acceder a la información

Association of Social and Demographic Factors With COVID-19 Incidence and Death Rates in the US
Monita Karmakar ; Paula M. Lantz ; Renuka Tipirneni
JAMA Netw Open. January 29, 2021;4(1):e2036462. doi:10.1001/jamanetworkopen.2020.36462
Pulsa aquí para acceder a la información

Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study
Benjamin RaderLaura F WhiteMichael R BurnsJack ChenJoseph BrilliantJon Cohen and others
The Lancet Digital Health Published: January 19, 2021
Pulsa aquí para acceder a la información

Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study
Fang LiYuan-Yuan LiMing-Jin LiuLi-Qun FangNatalie E DeanGary W K Wong and others
The Lancet Infectious Diseases Published: January 18, 2021
Pulsa aquí para acceder a la información

Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data
Otavio T Ranzani, Leonardo S L Bastos, João Gabriel M Gelli, Janaina F Marchesi, Fernanda Baião, Silvio Hamacher, and others
The Lancet Respiratory Medicine Published: January 15, 2021
Pulsa aquí para acceder a la información

Assessment of Day-7 Postexposure Testing of Asymptomatic Contacts of COVID-19 Patients to Evaluate Early Release from Quarantine —Vermont, May–November 2020
Amanda Jones, MPH1; Veronica Fialkowski, MPH1; Lauren Prinzing, MPH1; Jeffrey Trites, MS1; Patsy Kelso, PhD1; Mark Levine, MD1
MMWR / Vol. 70 / No. 1    January 8, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms
Michael A. Johansson, PhD; Talia M. Quandelacy, PhD, MPH; Sarah Kada, PhD; Pragati Venkata Prasad, MPH; Molly Steele, PhD, MPH; John T. Brooks, MD; Rachel B. Slayton, PhD, MPH; Matthew Biggerstaff, ScD, MPH; Jay C. Butler, MD
JAMA Netw Open. 2021; 4(1):e2035057. January 7, 2021
 doi: 10.1001/jamanetworkopen.2020.35057
Pulsa aquí para acceder a la información

Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys
Frederick J. Angulo, DVM, PhD1; Lyn Finelli, DrPH, MS2; David L. Swerdlow, MD1
Author Affiliations Article Information
JAMA Netw Open. 2021;4(1):e2033706. January 5, 2021
doi:10.1001/jamanetworkopen.2020.33706
Pulsa aquí para acceder a la información

Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
Sophie Uyoga, Ifedayo M. O. Adetifa, Henry K. Karanja, James Nyagwange, James Tuju et al.
Science  01 Jan 2021: Vol. 371, Issue 6524, pp. 79-82
DOI: 10.1126/science.abe1916
Pulsa aquí para acceder a la información

SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study

Hossein Poustchi, Maryam Darvishian, Zahra Mohammadi, Amaneh Shayanrad, Alireza Delavari, Ayad Bahadorimonfared, and others

The Lancet Infectious Diseases Published: December 15, 2020

Pulsa aquí para acceder a la información

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
Kristina L. Bajema, MD, MSc1; Ryan E. Wiegand, MS1; Kendra Cuffe, MPH1; et alSadhna V. Patel, MPH1; Ronaldo Iachan, PhD2; Travis Lim, DrPH1; Adam Lee, MS2; Davia Moyse, MA2; Fiona P. Havers, MD, MHS1; Lee Harding, MS2; Alicia M. Fry, MD, MPH1; Aron J. Hall, DVM, MSPH1; Kelly Martin, MPH2; Marjorie Biel, MPH2; Yangyang Deng, MS2; William A. Meyer III, PhD3; Mohit Mathur, MD, PhD4; Tonja Kyle, MS2; Adi V. Gundlapalli, MD, PhD1; Natalie J. Thornburg, PhD1; Lyle R. Petersen, MD, MPH1; Chris Edens,
JAMA Intern Med. Published online November 24, 2020.
doi:10.1001/jamainternmed.2020.7976
Pulsa aquí para acceder a la información

Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020
Kristina L. Bajema, MD, MSc1; Ryan E. Wiegand, MS1; Kendra Cuffe, MPH1; et alSadhna V. Patel, MPH1; Ronaldo Iachan, PhD2; Travis Lim, DrPH1; Adam Lee, MS2; Davia Moyse, MA2; Fiona P. Havers, MD, MHS1; Lee Harding, MS2; Alicia M. Fry, MD, MPH1; Aron J. Hall, DVM, MSPH1; Kelly Martin, MPH2; Marjorie Biel, MPH2; Yangyang Deng, MS2; William A. Meyer III, PhD3; Mohit Mathur, MD, PhD4; Tonja Kyle, MS2; Adi V. Gundlapalli, MD, PhD1; Natalie J. Thornburg, PhD1; Lyle R. Petersen, MD, MPH1; Chris Edens,
JAMA Intern Med. Published online November 24, 2020.
doi:10.1001/jamainternmed.2020.7976
Pulsa aquí para acceder a la información

SARS-CoV-2 Transmission among Marine Recruits during Quarantine.
Andrew G. Letizia, M.D., Irene Ramos, Ph.D., Ajay Obla, Ph.D., Carl Goforth, Ph.D., Dawn L. Weir, Ph.D., Yongchao Ge, Ph.D., Marcas M. Bamman, Ph.D., Jayeeta Dutta, M.B.A., Ethan Ellis, B.S., Luis Estrella, Ph.D., Mary-Catherine George, Ph.D., Ana S. Gonzalez-Reiche, Ph.D., et al.
The Nwew England Journal of Medicine November 11, 2020
DOI: 10.1056/NEJMoa2029717
Pulsa aquí para acceder a la información

Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study
Krishna P Reddy, Fatma M Shebl, Julia H A Foote, Guy Harling, Justine A Scott, Christopher Panella, and others
The Lancet Global Health Published: November 11, 2020
Pulsa aquí para acceder a la información

 Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
Sophie Uyoga, Ifedayo M. O. Adetifa,  K. Karanja, James Nyagwange, James Tuju et al.
Science  11 Nov 2020:  eabe1916  DOI: 10.1126/science.abe1916
Pulsa aquí para acceder a la información

 Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans
Bas B. Oude Munnink, Reina S. Sikkema, David F. Nieuwenhuijse, Robert Jan Molenaaret al
Science  10 Nov 2020:  eabe5901  DOI: 10.1126/science.abe5901
Pulsa aquí para acceder a la información

(R)  Monitoring life expectancy levels during the COVID-19 pandemic: Example of the unequal impact of the first wave on Spanish regions
Sergi Trias-Llimós ,Tim Riffe,Usama Bilal
Plos One Published: November 5, 2020 https://doi.org/10.1371/journal.pone.0241952
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0241952

SARS-CoV-2 Transmission among Marine Recruits during Quarantine
Andrew G. Letizia, M.D., Irene Ramos, Ph.D., Ajay Obla, Ph.D., Carl Goforth, Ph.D., Dawn L. Weir, Ph.D., Yongchao Ge, Ph.D., Marcas M. Bamman, Ph.D., Jayeeta Dutta, M.B.A., Ethan Ellis, B.S., Luis Estrella, Ph.D., Mary-Catherine George, Ph.D., Ana S. Gonzalez-Reiche, Ph.D., et al.
The New England Journal of Medicine November 11, 2020
DOI: 10.1056/NEJMoa2029717
Pulsa aquí para acceder a la información

An Outbreak of Covid-19 on an Aircraft Carrier
Matthew R. Kasper, Ph.D., Jesse R. Geibe, M.D., Christine L. Sears, M.D., Asha J. Riegodedios, M.S.P.H., Tina Luse, M.P.H., Annette M. Von Thun, M.D., Michael B. McGinnis, M.D., Niels Olson, M.D., Daniel Houskamp, M.D., Robert Fenequito, M.D., Timothy H. Burgess, M.D., Adam W. Armstrong, M.D., et al.
The New England Journal of Medicine November 11, 2020
DOI: 10.1056/NEJMoa2019375
Pulsa aquí para acceder a la información

SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study
Oon Tek Ng•Kalisvar Marimuthu•Vanessa Koh•Junxiong Pang•Kyaw Zaw Linn•Jie Sun•Liang De Wang•Wan Ni Chia•Charles Tiu•Monica Chan•Li Min Ling•Shawn Vasoo•Mohammad Yazid Abdad•Po Ying Chia•Tau Hong Lee•Ray Junhao Lin•Sapna P Sadarangani•Mark I-Cheng Chen•Zubaidah Said•Lalitha Kurupatham•Rachael Pung•Lin-Fa Wang•Alex R Cook•Yee-Sin Leo•Vernon JM Lee
The Lancet Infectious Diseases Published: November 2, 2020
Pulsa aquí para acceder a la información

(R) COVID-19 transmission—up in the air (EDITORIAL)
The Lancet Respiratory Medicine  Published: October 29, 2020
Pulsa aquí para acceder a la información

Estimated Association of Construction Work With Risks of COVID-19 Infection and Hospitalization in Texas
Remy F. Pasco, MEng1; Spencer J. Fox, PhD1; S. Claiborne Johnston, MD, PhD2; et alMichael Pignone, MD, MPH2; Lauren Ancel Meyers, PhD1,3
JAMA Netw Open. 2020;3(10):e2026373. October 29, 2020
doi:10.1001/jamanetworkopen.2020.26373
Pulsa aquí para acceder a la información

Evaluating the effect of demographic factors, socioeconomic factors, and risk aversion on mobility during the COVID-19 epidemic in France under lockdown: a population-based study
Giulia Pullano•Eugenio Valdano•Nicola Scarpa•Stefania Rubrichi•Vittoria Colizza
The Lancet Digital Health  Published: October 28, 2020

Pulsa aquí para acceder a la información

Residential context and COVID-19 mortality among adults aged 70 years and older in Stockholm: a population-based, observational study using individual-level data
Maria Brandén, Siddartha Aradhya, Martin Kolk, Juho Härkönen, Sven Drefahl, Bo Malmberg, and others
The Lancet Healthy Longevity  Published: October 27, 2020
Pulsa aquí para acceder a la información

Association of State Stay-at-Home Orders and State-Level African American Population With COVID-19 Case Rates
Padalabalanarayanan S, Hanumanthu VS, Sen B.
JAMA Network Open October 23, 2020
Pulsa aquí para acceder a la información

(R) The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries
You Li, Harry Campbell, Durga Kulkarni, Alice Harpur, Madhurima Nundy, Xin Wang, and others
The Lancet Infectious Diseases Published: October 22, 2020
Pulsa aquí para acceder a la información



Humoral response and PCR positivity in patients with COVID-19 in the New York City region, USA: an observational study
Ania Wajnberg, Mayce Mansour, Emily Leven, Nicole M Bouvier, Gopi Patel, Adolfo Firpo-Betancourt, and others
The Lancet Microbe  Published: September 25, 2020
Pulsa aquí para acceder a la información

Airborne transmission of SARS-CoV-2 (Letter)
Kimberly A. Prather1, Linsey C. Marr2, Robert T. Schooley3, Melissa A. McDiarmid4, Mary E. Wilson5,6, Donald K. Milton7
Science  05 Oct 2020: eabf0521 DOI: 10.1126/science.abf0521
Pulsa aquí para acceder a la información


Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study
Shuchi Anand, Maria Montez-Rath, Jialin Han, Julie Bozeman, Russell Kerschmann, Paul Beyer, and others
The Lancet Published: September 25, 2020
Pulsa aquí para acceder a la información

Incidence of Nosocomial COVID-19 in Patients Hospitalized at a Large US Academic Medical Center
Rhee C, Baker M, Vaidya V, et al.
JAMA Network Open September 9, 2020
Pulsa aquí para acceder a la información

The emergence of SARS-CoV-2 in Europe and North America
Michael Worobey, Jonathan Pekar, Brendan B. Larsen, Martha I. Nelson, Verity Hill, Jeffrey B. Joy, Andrew Rambaut, Marc A. Suchard, Joel O. Wertheim, Philippe Lemey
Science  10 Sep 2020: eabc8169  DOI: 10.1126/science.abc8169
Pulsa aquí para acceder a la información

Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise BuildingFREE
Min Kang, MSc, Jianjian Wei, PhD, Jun Yuan, MSc, Juxuan Guo, MSc, Yingtao Zhang, MSc, et al.
Annals of Internal Medicine 1 September 2020 https://doi.org/10.7326/M20-0928
Pulsa aquí para acceder a la información

Community Outbreak Investigation of SARS-CoV-2 Transmission Among Bus Riders in Eastern China
Ye Shen, PhD; Changwei Li, PhD; Hongjun Dong, MD; et alZhen Wang, MD; Leonardo Martinez, PhD; Zhou Sun, MD; Andreas Handel, PhD; Zhiping Chen, MD; Enfu Chen, MD; Mark H. Ebell, MD, MS; Fan Wang, MA; Bo Yi, MD; Haibin Wang, MD; Xiaoxiao Wang, MD; Aihong Wang, MD; Bingbing Chen, MD; Yanling Qi, PhD; Lirong Liang, MD, PhD; Yang Li, PhD; Feng Ling, MD; Junfang Chen, MD; Guozhang Xu, MD
JAMA Intern Med. Published online September 1, 2020. doi:10.1001/jamainternmed.2020.5225
Pulsa aquí para acceder a la información

 High prevalence of SARS-CoV-2 antibodies in care homes affected by COVID-19; a prospective cohort study in England
Shamez N Ladhani, Anna J Jeffery-Smith, Monika Patel, Roshni Janarthanan, Jonathan Fok, Emma Crawley-Boevey, Amoolya Vusirikala, Elena Fernandez, Marina Sanchez-Perez, Suzanne Tang, Kate Dun-Campbell, Edward Wynne-Evans, Anita Bell, Bharat Patel, Zahin Amin-Chowdhury, Felicity Aiano, Karthik Paranthaman, Thomas Ma, Maria Saavedra-Campos, Joanna Ellis, Meera Chand, Kevin Brown, Mary E Ramsay, Susan Hopkins, Nandini Shetty, J Yimmy Chow, Robin Gopal, Maria Zambon
MedRxiv Posted August 12, 2020doi: https://doi.org/10.1101/2020.08.10.20171413
Pulsa aquí para acceder a la información
Published: 02 September 2020

Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
Xiangyu Chen, Zhiwei Pan, Shuai Yue, Fei Yu, Junsong Zhang, Yang Yang, Ren Li, Bingfeng Liu, Xiaofan Yang, Leiqiong Gao, Zhirong Li, Yao Lin, Qizhao Huang, Lifan Xu, Jianfang Tang, Li Hu, Jing Zhao, Pinghuang Liu, Guozhong Zhang, Yaokai Chen, Kai Deng & Lilin Ye
Signal Transduction and Targeted Therapy  volume 5, Article number: 180 (2020)
Published: 02 September 2020
Pulsa aquí para acceder a la información

Humoral Immune Response to SARS-CoV-2 in Iceland
Daniel F. Gudbjartsson, Ph.D., Gudmundur L. Norddahl, Ph.D., Pall Melsted, Ph.D., Kristbjorg Gunnarsdottir, M.Sc., Hilma Holm, M.D., Elias Eythorsson, M.D., Ph.D., Asgeir O. Arnthorsson, M.Sc., Dadi Helgason, M.D., Ph.D., Kristbjorg Bjarnadottir, Ph.D., Ragnar F. Ingvarsson, M.D., Brynja Thorsteinsdottir, B.Sc., Steinunn Kristjansdottir, B.Sc., et al.
The New England Journal of Medicine September 1, 2020
DOI: 10.1056/NEJMoa2026116
Pulsa aquí para acceder a la información

Time Course of a Second Outbreak of COVID-19 in Beijing, China, June-July 2020 (Research letter)
Wu Z, Wang Q, Zhao J, et al.
JAMA August 24, 2020

Pulsa aquí para acceder a la información

Epidemiological and clinical characteristics of the COVID-19 epidemic in Brazil
William Marciel de Souza, Lewis Fletcher Buss, Nuno Rodrigues Faria
Nature Human Behaviour volume 4, pages856–865(2020) Published: 31 July 2020
Pulsa aquí para acceder a la información

Contact Settings and Risk for Transmission in 3410 Close Contacts of Patients With COVID-19 in Guangzhou, China: A Prospective Cohort Study
Lei Luo, PhD, Dan Liu, PhD, Xinlong Liao, MSc, Xianbo Wu, PhD, Qinlong Jing, PhD, Jiazhen Zheng, MSc, Fanghua Liu, PhD, Shigui Yang, PhD, Hua Bi, BSc, Zhihao Li, PhD, Jianping Liu, BSc, Weiqi Song, MSc, Wei Zhu, PhD, … et al.
Annals of Internal Medicine 13 August 2020
     Pulsa aquí para acceder a la información

Comparison of Estimated Excess Deaths in New York City During the COVID-19 and 1918 Influenza Pandemics (Research Letter)
Faust JS, Lin Z, del Rio C
JAMA Network Open August 13, 2020
Pulsa aquí para acceder a la información

Sex differential in COVID-19 mortality varies markedly by age (Correspondence)
Sunil S Bhopal, Raj Bhopal
The Lancet Published: August 13, 2020
Pulsa aquí para acceder a la información

The Contribution of the Age Distribution of Cases to COVID-19 Case Fatality Across Countries: A 9-Country Demographic Study
Nikkil Sudharsanan, PhD, Oliver Didzun, Till Bärnighausen, MD, Pascal Geldsetzer, ScD
Annals of Internal Medicine22 July 2020
Pulsa aquí para acceder a la información

Elimination of COVID-19: what would it look like and is it possible? (Comment)
Anita E Heywood, C Raina Macintyre
The Lancet Infectious Diseases  Published: August 6, 2020
Pulsa aquí para acceder a la información

Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea
Seungjae Lee, MD; Tark Kim, MD; Eunjung Lee, MD; et al
JAMA Intern Med. Published online August 6, 2020. doi:10.1001/jamainternmed.2020.3862
Pulsa aquí para acceder a la información

Observations of the global epidemiology of COVID-19 from the prepandemic period using web-based surveillance: a cross-sectional analysis
Fatimah S Dawood, Philip Ricks, Gibril J Njie, Michael Daugherty, William Davis, James A Fuller, and others
The Lancet Infectious Diseases Published: July 29, 202
Pulsa aquí para acceder a la información

 SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study
Kore Schlottau, Melanie Rissmann, Annika Graaf, Jacob Schön, Julia Sehl, Claudia Wylezich, and others
The Lancet Microbe  Published: July 7, 2020
Pulsa aquí para acceder a la información

Worldwide Effect of COVID-19 on Physical Activity: A Descriptive Study
Geoffrey H. Tison, MD, MPH, Robert Avram, MD, MSc, Peter Kuhar, BS et al.
Annals of Internal Medicine 29 Jun 2020 https://doi.org/10.7326/M20-2665
Pulsa aquí para acceder a la información

(R) Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
Marina Pollán, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso, Jesús Oteo, Miguel A Hernán, Mayte Pérez-Olmeda, and others
The Lancet Published: July 6, 2020
Pulsa aquí para acceder a la información

(R) SARS-CoV-2 seroprevalence in COVID-19 hotspots (Comment)
Isabella Eckerle, Benjamin Meyer
The Lancet Published: July 6, 2020
Pulsa aquí para acceder a la información

Estimation of Excess Deaths Associated With the COVID-19 Pandemic in the United States, March to May 2020
Daniel M. Weinberger, PhD; Jenny Chen, BS; Ted Cohen, MD, DPH; et al
JAMA Intern Med. Published online July 1, 2020. doi:10.1001/jamainternmed.2020.3391
Pulsa aquí para acceder a la información

Excess Deaths From COVID-19 and Other Causes, March-April 2020
Steven H. Woolf, MD, MPH; Derek A. Chapman, PhD; Roy T. Sabo, PhD; et al
JAMA. Published online July 1, 2020. doi:10.1001/jama.2020.11787
Pulsa aquí para acceder a la información

Mortality and Morbidity. The Measure of a Pandemic (Editorial)
Jody W. Zylke, MD1; Howard Bauchner, MD2
JAMA. Published online July 1, 2020. doi:10.1001/jama.2020.11761
Pulsa aquí para acceder a la información

The end of social confinement and COVID-19 re-emergence risk
Leonardo López & Xavier Rodó
Nature Human Behaviour Published: 22 June 2020
Pulsa aquí para acceder a la información

Clusters of coronavirus disease in communities, Japan, January–April 2020.
Furuse Y, Sando E, Tsuchiya N, Miyahara R, Yasuda I, Ko YK, et al. Emerg Infect Dis. 2020 Sep Original Publication Date: June 10, 2020 https://doi.org/10.3201/eid2609.202272
Pulsa aquí para acceder a la información

Assessment of Coronavirus Disease 2019 Community Containment Strategies in Shenzhen, China
Xiao-Ming Zhang, MSN1; Hui-Er Zhou, MD1; Wen-Wu Zhang, BMed1; et alQing-Li Dou, PhD1; Ye Li, MD1; Jian Wei, MD1; Rui Hu, MD1; Jiangping Liu, MD1; Andy S. K. Cheng, PhD2
JAMA Netw Open. June 22, 2020; 3(6):e2012934. doi:10.1001/jamanetworkopen.2020.12934
Pulsa aquí para acceder a la información

Age-dependent effects in the transmission and control of COVID-19 epidemics
Nicholas G. Davies, Petra Klepac, Yang Liu, Kiesha Prem, Mark Jit, CMMID COVID-19 working group & Rosalind M. Eggo
Nature Medicine (2020) Published 16 June 2020
Pulsa aquí para acceder a la información

Disparities in Coronavirus 2019 Reported Incidence, Knowledge, and Behavior Among US Adults
Marcella Alsan, MD, MPH, PhD1,2,3; Stefanie Stantcheva, PhD3,4; David Yang, PhD3,4; et alDavid Cutler, PhD3,4
JAMA Netw Open. 2020;3(6):e2012403. doi:10.1001/jamanetworkopen.2020.12403
Pulsa aquí para acceder a la información

Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study
Qin-Long Jing, Ming-Jin Liu, Zhou-Bin Zhang, Li-Qun Fang, Jun Yuan, An-Ran Zhang, and others
The Lancet Infectious Diseases Published: June 17, 2020
Pulsa aquí para acceder a la información

Temperature, Humidity, and Latitude Analysis to Estimate Potential Spread and Seasonality of Coronavirus Disease 2019 (COVID-19)
Sajadi MM, Habibzadeh P, Vintzileos A, Shokouhi S, Miralles-Wilhelm F, Amoroso A
JAMA Network Open June 11, 2020
Pulsa aquí para acceder a la información

  Thinking of Risk in the Era of COVID-19 (Editorial)
Howard Bauchner, MD1; Phil Fontanarosa, MD, MBA1
JAMA. Published online June 4, 2020. doi:10.1001/jama.2020.10242
Pulsa aquí para acceder a la información

 Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
Silvia Stringhini, Ania Wisniak, Giovanni Piumatti, Andrew S Azman, Stephen A Lauer, Hélène Baysson, and others
The Lancet  Published: June 11, 2020
Pulsa aquí para acceder a la información

 Simulated Sunlight Rapidly Inactivates SARS-CoV-2 on Surfaces
Shanna Ratnesar-Shumate, Gregory Williams, Brian Green, Melissa Krause, Brian Holland, Stewart Wood, Jordan Bohannon, Jeremy Boydston, Denise Freeburger, Idris Hooper et al.
The Journal of Infectious Diseases, jiaa274, Published: 20 May 2020https://doi.org/10.1093/infdis/jiaa274
Pulsa aquí para acceder a la información

  Reducing transmission of SARS-CoV-2
Kimberly A. Prather1, Chia C. Wang2,3, Robert T. Schooley4
Science  27 May 2020: eabc6197 DOI: 10.1126/science.abc6197
Pulsa aquí para acceder a la información

Prevalence of Asymptomatic SARS-CoV-2 Infection. A Narrative Review
P. Oran, AM et al
Annals of Internal Medicine 3 Jun 2020 https://doi.org/10.7326/M20-3012
Pulsa aquí para acceder a la información

Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China                                                                                                           
 Xin Xu, Jian Sun, Sheng Nie, Huiyuan Li, Yaozhong Kong, Min Liang, Jinlin Hou, Xianzhong Huang, Dongfeng Li, Tean Ma, Jiaqing Peng, Shikui Gao, Yong Shao, Hong Zhu, Johnson Yiu-Nam Lau, Guangyu Wang, Chunbao Xie, Li Jiang, Ailong Huang, Zhenglin Yang, Kang Zhang & Fan Fan Hou
Nature Medicine (2020) Published: 05 June 2020
Pulsa aquí para acceder a la información

(R) Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study
Nicholas G Davies, Adam J Kucharski, Rosalind M Eggo, Amy Gimma, W John Edmunds on behalf of the Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group, and others
The Lancet Public Health  Published: June 2, 2020
Pulsa aquí para acceder a la información

(R) Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study
Nicholas G Davies, Adam J Kucharski, Rosalind M Eggo, Amy Gimma, W John Edmunds on behalf of the Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group, and others
The Lancet Public Health  Published: June 2, 2020
Pulsa aquí para acceder a la información

Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei province, China: a multicohort study
Kelvin Kai-Wang To, Vincent Chi-Chung Cheng, Jian-Piao Cai, Kwok-Hung Chan, Lin-Lei Chen, Lok-Hin Wong, and others
The Lancet Microbe Published: June 3, 2020
Pulsa aquí para acceder a la información

Digital Smartphone Tracking for COVID-19: Public Health and Civil Liberties in Tension
Cohen IG, Gostin LO, Weitzner DJ
JAMA May 27, 2020   doi:10.1001/jama.2020.8570
Pulsa aquí para acceder a la información

Association of Stay-at-Home Orders With COVID-19 Hospitalizations in 4 States
Sen S, Karaca-Mandic P, Georgiou A
JAMA May 27, 2020  doi:10.1001/jama.2020.9176
Pulsa aquí para acceder a la información


SARS‐CoV‐2 Virulence: Interplay of Floating Virus‐Laden Particles, Climate, and Humans
Vahid Hosseini
Advanced Biosystems First published:25 May 2020 DOI: 10.1002/adbi.202000105
Pulsa aquí para acceder a la información

The basic reproduction number of SARS‐CoV‐2 in Wuhan is about to die out, how about the rest of the World?
Bootan Rahman, Evar Sadraddin, Annamaria Porreca
Reviews in Medical Virology   Published 19 May 2020DOI: 10.1002/rmv.2111

Pulsa aquí para acceder a la información

Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020 (Research letter)
Neeraj Sood, PhD1; Paul Simon, MD2; Peggy Ebner, BA3; et alDaniel Eichner, PhD4; Jeffrey Reynolds, MA5; Eran Bendavid, MD6; Jay Bhattacharya, MD, PhD6
JAMA. Published online May 18, 2020. doi:10.1001/jama.2020.8279
Pulsa aquí para acceder a la información

 The infection fatality rate of COVID-19 inferred from seroprevalence data
Ioannidis, J.
MedRxiv Posted: 2020-05-19
10.1101/2020.05.13.20101253
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es un informe preliminar, que no se ha sido todavía revisado por pares

Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study
Simon de Lusignan, Jienchi Dorward, Ana Correa, Nicholas Jones, Oluwafunmi Akinyemi, Gayatri Amirthalingam, and others
The Lancet Infectious Diseases Published: May 15, 2020
Pulsa aquí para acceder a la información

Comparison of Estimated Rates of Coronavirus Disease 2019 (COVID-19) in Border Counties in Iowa Without a Stay-at-Home Order and Border Counties in Illinois With a Stay-at-Home Order
Lyu W, Wehby GL
JAMA Network Open May 15, 2020
Pulsa aquí para acceder a la información

SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults (Research Letter)
Uri Hamiel, MD; Eran Kozer, MD; Ilan Youngster, MD, MMSc
JAMA. Published online May 13, 2020. doi:10.1001/jama.2020.8189
Pulsa aquí para acceder a la información

Changes in SARS-CoV-2 Positivity Rate in Outpatients in Seattle and Washington State, March 1-April 16, 2020
April Kaur Randhawa, PhD1; Leigh H. Fisher, PhD1; Alexander L. Greninger, MD, PhD2; et alShuying Sue Li, PhD1; Jessica Andriesen, PhD1; Lawrence Corey, MD1; Keith R. Jerome, MD, PhD2
JAMA. Published online May 8, 2020. doi:10.1001/jama.2020.8097
Pulsa aquí para acceder a la información

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application
Stephen A. Lauer, MS, PhD, Kyra H. Grantz, BA, Qifang Bi, MHS, Forrest K. Jones, MPH, … 
Annals of Internal Medicine 5 May 2020  https://doi.org/10.7326/M20-0504
Pulsa aquí para acceder a la información

Effective transmission across the globe: the role of climate in COVID-19 mitigation strategies (Correspondence)
Kathleen M O'Reilly•Megan Auzenbergs•Yalda Jafari•Yang Liu•Stefan Flasche•Rachel Lowe
The Lancet Planetary Health  Published: May 6, 2020
Pulsa aquí para acceder a la información

Public Health Measures and the Reproduction Number of SARS-CoV-2
Thomas V. Inglesby, MD1
JAMA. Published online May 1, 2020. doi:10.1001/jama.2020.7878
Pulsa aquí para acceder a la información

Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study
Qifang Bi•Yongsheng Wu•Shujiang Mei•Chenfei Ye•Xuan Zou•Zhen Zhang•Xiaojian Liu•Lan Wei•Shaun A Truelove•Tong Zhang•Wei Gao•Cong Cheng•Xiujuan Tang•Xiaoliang Wu•Yu Wu•Binbin Sun•Suli Huang•Yu Sun•Juncen Zhang•Ting Ma•Justin Lessler•Tiejian Feng
The Lancet Infectious Diseases Published: April 27, 2020
Pulsa aquí para acceder a la información

Covid-19: Why Germany’s case fatality rate seems so low
Ned Stafford
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1395 (Published 07 April 2020)
Pulsa aquí para acceder a la información

(R) Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility
Melissa M. Arons, R.N., Kelly M. Hatfield, M.S.P.H., Sujan C. Reddy, M.D., Anne Kimball, M.D., Allison James, Ph.D., Jesica R. Jacobs, Ph.D., Joanne Taylor, Ph.D., Kevin Spicer, M.D., Ana C. Bardossy, M.D., Lisa P. Oakley, Ph.D., Sukarma Tanwar, M.Med., Jonathan W. Dyal, M.D., et al., for the Public Health–Seattle and King County and CDC COVID-19 Investigation Team*
The New England Journal of Medicine April 24, 2020
DOI: 10.1056/NEJMoa2008457
Pulsa aquí para acceder a la información

Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: a modelling study
Tim K Tsang•Peng Wu•Yun Lin•Eric H Y Lau•Gabriel M Leung•Benjamin J Cowling
The Lancet Public Health Published: April 21, 2020
Pulsa aquí para acceder a la información

COVID-19 deaths in Lombardy, Italy: data in context (Correspondence)
Anna Odone, Davide Delmonte, Thea Scognamiglio, Carlo Signorelli
The Lancet Public Health Published: April 24, 2020
Pulsa aquí para acceder a la información

Correlation between climate indicators and COVID-19 pandemic in New York, USA
Muhammad Farhan Bashir, Benjiang Ma, Bilal, Bushra Komal, Madiha Bashir
Science of The Total EnvironmentVolume 7281 August 2020Article 138835
Pulsa aquí para acceder a la información

The sensitivity and specificity analyses of ambient temperature and population size on the transmission rate of the novel coronavirus (COVID-19) in different provinces of Iran
Mehdi Jahangiri, Milad Jahangiri, Mohammadamir Najafgholipour
Science of The Total EnvironmentVolume 7281 August 2020Article 138872
Pulsa aquí para acceder a la información

Impact of weather on COVID-19 pandemic in Turkey
Mehmet Şahin
Science of The Total EnvironmentVolume 7281 August 2020Article 138810
Pulsa aquí para acceder a la información

Epidemiological trends of COVID‐19 epidemic in Italy during March 2020. From 1,000 to 100,000 cases
Sebastiano La Maestra  Angelo Abbondandolo  Silvio De Flora
Journal of Medical Virology First published:21 April 2020 https://doi.org/10.1002/jmv.25908
Pulsa aquí para acceder a la información

Spread of SARS-CoV-2 in the Icelandic Population
Daniel F. Gudbjartsson, Ph.D., Agnar Helgason, Ph.D., Hakon Jonsson, Ph.D. Olafur T. Magnusson, Ph.D., Pall Melsted, Ph.D., Gudmundur L. Norddahl, Ph.D., Jona Saemundsdottir, B.Sc., Asgeir Sigurdsson, B.Sc., Patrick Sulem, MD, Arna B. Agustsdottir, M.Sc., Berglind Eiriksdottir, Ejecute Fridriksdottir, M.Sc., et al.
The New England Journal of Medicine April 14, 2020
DOI: 10.1056/NEJMoa2006100
Pulsa aquí para acceder a la información

Covid-19: should the public wear face masks? (Editorial))
Babak Javid, principal investigator ,  Michael P Weekes, principal investigator,  Nicholas J Matheson, principal investigator
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1442 (Published 09 April 2020
Pulsa aquí para acceder a la información

Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study
Benjamin J Cowling, Sheikh Taslim Ali, Tiffany W Y Ng, Tim K Tsang, Julian C M Li, Min Whui Fong, and others
The Lancet Public Health Published: April 17, 2020
Pulsa aquí para acceder a la información

Possibly critical role of wearing masks in general population in controlling COVID‐19
Guangshu Han Yi‐Hua Zhou
Journal of Medical VirologyDOI: 10.1002/jmv.25886
Pulsa aquí para acceder a la información

Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China                                       
An Pan, PhD1; Li Liu, MD, PhD1; Chaolong Wang, PhD1; et alHuan Guo, MD, PhD2; Xingjie Hao, PhD1; Qi Wang, MD, PhD1; Jiao Huang, PhD1; Na He, PhD3; Hongjie Yu, PhD3; Xihong Lin, PhD4,5; Sheng Wei, MD, PhD1; Tangchun Wu, MD, PhD2  JAMA. Published online April 10, 2020. doi:10.1001/jama.2020.6130
Pulsa aquí para acceder a la información


Application and effects of fever screening system in the prevention of nosocomial infection in the only designated hospital of coronavirus disease 2019 (COVID-19) in Shenzhen, China
Ting Huang
Yinsheng GuoShaxi LiYanqun ZhengLin LeiXianhu ZengQiao ZhongYingxia LiuLei Liu
Journal: Infection Control & Hospital Epidemiology / Published online by Cambridge University Press: 13 April 2020, pp. 1-10
Pulsa aquí para acceder a la información

Clinical and demographic characteristics of patients dying from COVID‐19 in Italy versus China

Giuseppe Lippi, Camilla Mattiuzzi, Fabian Sanchis‐Gomar , Brandon M. Henry
Journal of Medical Virology First published:10 April 2020  https://doi.org/10.1002/jmv.25860
https://onlinelibrary.wiley.com/doi/10.1002/jmv.25860

The clinical feature of silent infections of novel coronavirus infection (COVID‐19) in Wenzhou
Guiqing He, Wenjie Sun, Peipei Fang, Jianping Huang, Michelle Gamber, Jing Cai, Jing Wu


Journal of Medical Virology DOI: 10.1002/jmv.25861
Pulsa aquí para acceder a la información

Reducción de la recontaminación manual de los trabajadores de salud durante COVID-19                                                                          
Giorgia Gon , Stephanie Dancer , Robert Dreibelbis , Wendy J. Graham , Claire Kilpatrick   Control de Infecciones y Epidemiología Hospitalaria /Publicado en línea por Cambridge University Press: 06 de abril de 2020 , pp. 1-6
Pulsa aquí para acceder a la información

Environment and Personal Protective Equipment Tests for SARS-CoV-2 in the Isolation Room of an Infant With Infection (Letter)

Chee Fu Yung, MBChB; Kai-qian Kam, MBBS; Michelle S.Y. Wong, PhD; Matthias Maiwald, MD; Yian Kim Tan, PhD; Boon Huan Tan, PhD *; Koh Cheng Thoon, MBBS *

Annals of Internal Medicine 1 Apr 2020

Pulsa aquí para acceder a la información

Community Prevalence of SARS-CoV-2 Among Patients With Influenza-like Illnesses Presenting to a Los Angeles Medical Center in March 2020

Brad Spellberg, MD1Meredith Haddix, MPH2Rebecca Lee, MPH2; et alSusan Butler-Wu, PhD1Paul Holtom, MD1Hal Yee, MD, PhD3Prabhu Gounder, MD2
JAMA. Published online March 31, 2020. doi:10.1001/jama.2020.4958
Pulsa aquí para acceder a la información

Estimates of the severity of coronavirus disease 2019: a model-based analysis

Robert Verity, Lucy C Okell, Ilaria Dorigatti, Peter Winskill, Charles Whittaker, Natsuko Imai, and others
The Lancet Infectious Diseases
Published: March 30, 2020
Pulsa aquí para acceder a la información

COVID-19 epidemic: disentangling the re-emerging controversy about medical facemasks from an epidemiological perspective

Ka Hung Chan, Kwok-Yung Yuen
International Journal of Epidemiology, dyaa044, https://doi.org/10.1093/ije/dyaa044
Published: 31 March 2020
Pulsa aquí para acceder a la información

Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea

Joseph P DudleyNam Taek Lee
Clinical Infectious Diseases, ciaa354, https://doi.org/10.1093/cid/ciaa354
Published: 31 March 2020
Pulsa aquí para acceder a la información

Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington

Temet M. McMichael, Ph.D., Dustin W. Currie, Ph.D., Shauna Clark, R.N., Sargis Pogosjans, M.P.H., Meagan Kay, D.V.M., Noah G. Schwartz, M.D., James Lewis, M.D., Atar Baer, Ph.D., Vance Kawakami, D.V.M., Margaret D. Lukoff, M.D., Jessica Ferro, M.P.H., Claire Brostrom-Smith, M.S.N., et al., for the Public Health–Seattle and King County, EvergreenHealth, and CDC COVID-19 Investigation Team*
New England Journal of Medicine March 27, 2020 DOI: 10.1056/NEJMoa2005412
Pulsa aquí para acceder a la información

Experts’ request to the Spanish Government: move Spain towards complete lockdown (CORRESPONDENCE)

Oriol Mitjà, Àlex Arenas, Xavier Rodó, Aurelio Tobias, Joe Brew, José M Benlloch on behalf of 62 signatories
The Lancet
Published: March 26, 2020

Pulsa aquí para acceder a la información

Covid-19 mass testing facilities could end the epidemic rapidly (Letters The burning building)

BMJ 2020; 368 doi: https://doi.org/10.1136/bmj.m1163 (Published 22 March 2020)

COVID-19 in Europe: the Italian lesson (CORREPONDENCE)                              
Andrea Saglietto, Fabrizio D’Ascenzo, Giuseppe Biondi Zoccai, Gaetano Maria De Ferrari

The Lancet
Published: March 24, 2020
Pulsa aquí para acceder a la información

Covid-19 y estrategias de mitigación comunitaria en una pandemia (Editorial)

BMJ 2020 ; 368 doi: https://doi.org/10.1136/bmj.m1066 (publicado el 17 de marzo de 2020)

Apoyo a los médicos durante la pandemia de COVID-19

Charlene Dewey, MD, MEd; Susan Hingle, MD; Elizabeth Goelz, MD; Mark Linzer, MD  Annals of Internal Medicine. 20 de Marzo de 2020
Pulsa aquí para acceder a la información

Características y lecciones importantes del brote de la enfermedad por coronavirus 2019 (COVID-19) en China. Resumen de un informe de 72 314 casos del Centro chino para el control y la prevención de enfermedades

Zunyou Wu, MD, PhD 1 ; Jennifer M. McGoogan, PhD 1
JAMA Publicado en línea el 24 de febrero de 2020. doi: 10.1001 / jama.2020.2648
Pulsa aquí para acceder a la información

Enfermedad por coronavirus 2019: coronavirus y seguridad de la sangre

Transfusion Medicine Reviews Disponible en línea el 21 de febrero de 2020
Le Chang, Ying Yan, Lunan Wang
Pulsa aquí para acceder a la información

MEDIDAS DISTANCIA FÍSICA/ENMASCARAMIENTO

Impacts of social distancing policies on mobility and COVID-19 case growth in the US
Gregory A. Wellenius, Swapnil Vispute, […]Evgeniy Gabrilovich
Nature Communications volume 12, Article number: 3118 (2021) Published: 25 May 2021
Pulsa aquí para acceder a la información

Effectiveness of 3 Versus 6 ft of Physical Distancing for Controlling Spread of Coronavirus Disease 2019 Among Primary and Secondary Students and Staff: A Retrospective, Statewide Cohort Study
Polly van den Berg, Elissa M Schechter-Perkins, Rebecca S Jack, Isabella Epshtein, Richard Nelson, Emily Oster, Westyn Branch-Elliman
Clinical Infectious Diseases, ciab230, Published: 10 March 2021 https://doi.org/10.1093/cid/ciab230 Pulsa aquí para acceder a la información


Filtering Facepiece Respirator (N95 Respirator) Reprocessing. A Systematic Review

Max A. Schumm, MD1; Joseph E. Hadaya, MD1; Nisha Mody, MLIS, MA, CCC-SLP2; et al
JAMA. Published online March 3, 2021. doi:10.1001/jama.2021.2531
Pulsa aquí para acceder a la información

SARS-CoV-2 Infection Among Community Health Workers in India Before and After Use of Face Shields
Bhaskar ME, Arun S
JAMA August 17, 2020
Pulsa aquí para acceder a la información

Physical distancing interventions and incidence of coronavirus disease 2019: natural experiment in 149 countries
Nazrul Islam, Stephen J Sharp, Gerardo Chowell, Sharmin Shabnam, Ichiro Kawachi, Ben Lacey, Joseph M Massaro, Ralph B D’Agostino Sr, Martin White
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m2743 (Published 15 July 2020)
Pulsa aquí para acceder a la información

Filtration Efficiency of Hospital Face Mask Alternatives Available for Use During the COVID-19 Pandemic
Emily E. Sickbert-Bennett, PhD, MS1; James M. Samet, PhD, MPH2; Phillip W. Clapp, PhD3; et alHao Chen, PhD4; Jon Berntsen, PhD5; Kirby L. Zeman, PhD3; Haiyan Tong, MD, PhD2; David J. Weber, MD, MPH1; William D. Bennett, PhD3
JAMA Intern Med. Published online August 11, 2020. doi:10.1001/jamainternmed.2020.4221
Pulsa aquí para acceder a la información

Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings. A Living Rapid Review
Roger Chou, MD, Tracy Dana, MLS, Rebecca Jungbauer, DrPH, Chandler Weeks, MPH, Marian S. McDonagh, PharmD
Annals of Internal Medicine 24 Jun 2020  https://doi.org/10.7326/M20-3213
Pulsa aquí para acceder a la información

Use of N95, Surgical, and Cloth Masks to Prevent COVID-19 in Health Care and Community Settings: Living Practice Points From the American College of Physicians (Version 1)
Amir Qaseem, MD, PhD, MHA, Itziar Etxeandia-Ikobaltzeta, PharmD, PhD, … View all authors
Annals of Internal Medicine  18 Jun 2020 https://doi.org/10.7326/M20-3234
Pulsa aquí para acceder a la información

 The effects of physical distancing on population mobility during the COVID-19 pandemic in the UK
Thomas M Drake, Annemarie B Docherty, Thomas G Weiser, Steven Yule, Aziz Sheikh, Ewen M Harrison
The Lancet Digital Health Published: June 12, 2020
Pulsa aquí para acceder a la información

Correlation Between N95 Extended Use and Reuse and Fit Failure in an Emergency Department
Nida F. Degesys, MD; Ralph C. Wang, MD, MAS; Elizabeth Kwan, MD; et al
JAMA. Published online June 4, 2020. doi:10.1001/jama.2020.9843
Pulsa aquí para acceder a la información

(R) Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
Derek K Chu, Elie A Akl, Stephanie Duda, Karla Solo, Sally Yaacoub, Holger J Schünemann, and others
The Lancet Published: June 1, 2020
Pulsa aquí para acceder a la información

Risk for COVID-19 Resurgence Related to Duration and Effectiveness of Physical Distancing in Ontario, Canada
Ashleigh R. Tuite, PhD, MPH, Amy L. Greer, MSc, PhD, Steven De Keninck, BICT, …
Annals of Internal Medicine 27 May 2020  https://doi.org/10.7326/M20-2945
Pulsa aquí para acceder a la información

Assessment of Proficiency of N95 Mask Donning Among the General Public in Singapore (Research Letter)
Wesley Yeung, MBBS; Kennedy Ng, MBBS; J. M. Nigel Fong, MBBS; et alJudy Sng, MBBS; Bee Choo Tai, PhD; Sin Eng Chia, MBBS
JAMA Netw Open. 2020;3(5):e209670. doi:10.1001/jamanetworkopen.2020.9670
Pulsa aquí para acceder a la información

A cluster randomised trial of cloth masks compared with medical masks in healthcare workers
C Raina MacIntyre, Holly Seale, Tham Chi Dung, Nguyen Tran Hien, Phan Thi Nga, Abrar Ahmad Chughtai, Bayzidur Rahman, Dominic E Dwyer, Quanyi Wang
BMJ Open 2015;5: e006577. doi:10.1136/ bmjopen-2014-006577
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo de 2015 ha sido incluido por su actualidad y por la nota complementaria incluida actualmente por sus autores

Universal Masking in Hospitals in the COVID-19 era: Is it Time to consider Shielding?
Sonali Advani, Becky Smith, Sarah Lewis, Deverick J. Anderson, Daniel J. Sexton
Journal: Infection Control & Hospital Epidemiology /
Published online by Cambridge University Press: 29 April 2020, pp. 1-9
Pulsa aquí para acceder a la información

Face masks for the public during the covid-19 crisis
Trisha Greenhalgh, professor,  Manuel B Schmid, consultant,  Thomas Czypionka, chief health economist4 ,  Dirk Bassler, professor,  Laurence Gruer, professor
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1435 (Published 09 April 2020)
Pulsa aquí para acceder a la información

Usar o no usar: la guía confusa de la OMS sobre las máscaras en la pandemia de covid-19
Aileen Lai-yam Chan, CC Leung, TH Lam y KK Cheng
BMJ March 11 2020
Pulsa aquí para acceder a la información

Sterilization of Disposable Face Masks by Means of Standardized Dry and Steam Sterilization Processes; An Alternative in the Fight Against Mask Shortages Due to COVID-19
B van Straten 1P de Man 2J van den Dobbelsteen 3H Koeleman 2A van der Eijk 4T Horeman 3
J Hosp Infect  2020 Apr 8[Online ahead of print DOI: 10.1016/j.jhin.2020.04.001
 Pulsa aquí para acceder a la información


Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled Comparison in 4 Patients
Seongman Bae, MD * ; Min-Chul Kim, MD * ; Ji Yeun Kim, PhD * ; Hye-Hee Cha, BS; Joon Seo Lim, PhD; Jiwon Jung, MD; Min-Jae Kim, MD; Dong Kyu Oh, MD; Mi-Kyung Lee, MD; Seong-Ho Choi, MD; Minki Sung, PhD; Sang-Bum Hong, MD; Jin-Won Chung, MD; Sung-Han Kim, MD
Ann Intern Med. 6 April 2020. doi:10.7326/M20-1342
https://www.acpjournals.org/doi/10.7326/M20-1342
Pulsa aquí para acceder a la información


Respiratory virus shedding in exhaled breath and efficacy of face masks    
Nancy H. L. LeungDaniel K. W. Chu, Eunice Y. C. ShiuKwok-Hung ChanJames J. McDevitt, Benien J. P. HauHui-Ling YenYuguo LiDennis K. M. IpJ. S. Malik PeirisWing-Hong SetoGabriel M. LeungDonald K. Milton & Benjamin J. Cowling  NaNature Medicine Brief Communication Published: 03 April 2020

Pulsa aquí para acceder a la información

COLEGIOS/GUARDERÍAS

COVID-19 outbreaks following full reopening of primary and secondary schools in England: Cross-sectional national surveillance, November 2020
Felicity Aiano, Anna A Mensah, Kelsey McOwat, Chinelo Obi, Amoolya Vusirikala, Annabel A Powell and others
The Lancet Regional Health – Europe Vol. 6 Published: May 18, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study
Shamez N Ladhani, Frances Baawuah, Joanne Beckmann, Ifeanichukwu O Okike, Shazaad Ahmad, Joanna Garstang, and others
The Lancet Child & Adolescent Health Published: March 16, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 infection and transmission in primary schools in England in June–December, 2020 (sKIDs): an active, prospective surveillance study
Shamez N Ladhani, Frances Baawuah, Joanne Beckmann, Ifeanichukwu O Okike, Shazaad Ahmad, Joanna Garstang, and others
The Lancet Child & Adolescent Health Published: March 16, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study
Eric Lachassinne, Loïc de Pontual, Marion Caseris, Mathie Lorrot, Carole Guilluy, Aurélie Naud, and others
The Lancet Child & Adolescent Health  Published: February 8, 2021
Pulsa aquí para acceder a la información

Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study
Kristine Macartney, Helen E Quinn, Alexis J Pillsbury, Archana Koirala, Lucy Deng, Noni Winkler, and others
The Lancet Child & Adolescent Health Published: August 3, 2020
Pulsa aquí para acceder a la información

Determining the optimal strategy for reopening schools, the impact of test and trace interventions, and the risk of occurrence of a second COVID-19 epidemic wave in the UK: a modelling study
Jasmina Panovska-Griffiths, Cliff C Kerr, Robyn M Stuart, Dina Mistry, Daniel J Klein, Russell M Viner, and others
The Lancet Child & Adolescent Health Published: August 3, 2020
Pulsa aquí para acceder a la información

Children are unlikely to be the main drivers of the COVID‐19 pandemic – a systematic review
Jonas F Ludvigsson
Acta Paediatrica First published:19 May 2020 https://doi.org/10.1111/apa.15371
Pulsa aquí para acceder a la información


RAZA


Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform
Rohini Mathur, Christopher T Rentsch, Caroline E Morton, William J Hulme, Anna Schultze, Brian MacKenna and others
The Lancet Published: April 30, 2021
Pulsa aquí para acceder a la información


(R)
Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis
Shirley Sze•Daniel Pan•Clareece R. Nevill•Laura J. Gray•Christopher A. Martin•Joshua Nazareth•Jatinder S. Minhas•Pip Divall•Kamlesh Khunti•Keith R. Abrams•Laura B. Nellums•Manish Pareek
EClinicalMedicine Published: November 12, 2020
Pulsa aquí para acceder a la información

Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System
Gu T, Mack JA, Salvatore M, et al.
JAMA Network Open October 21, 2020
Pulsa aquí para acceder a la información

Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York
Rafi Kabarriti, MD1; N. Patrik Brodin, PhD1; Maxim I. Maron, MSc1; et alChandan Guha, MD, PhD1; Shalom Kalnicki, MD1; Madhur K. Garg, MD, MBA
; Andrew D. Racine, MD, PhD

JAMA Netw Open; 3(9):e2019795. September 25, 2020doi:10.1001/jamanetworkopen.2020.19795
Pulsa aquí para acceder a la información

Association of Race With Mortality Among Patients Hospitalized With Coronavirus Disease 2019 (COVID-19) at 92 US Hospitals
Yehia BR, Winegar A, Fogel R, et al.
JAMA Network Open August 18, 20204
Pulsa aquí para acceder a la información

Assessment of COVID-19 Hospitalizations by Race/Ethnicity in 12 States (Research Letter)
Karaca-Mandic P, Georgiou A, Sen S
JAMA Internal Medicine August 17, 2020
Pulsa aquí para acceder a la información

SARS-CoV-2 Positivity Rate for Latinos in the Baltimore-Washington, DC Region
Diego A. Martinez, PhD1; Jeremiah S. Hinson, MD, PhD1; Eili Y. Klein, PhD1; et alNathan A. Irvin, MD1; Mustapha Saheed, MD1; Kathleen R. Page, MD2; Scott R. Levin, PhD1
JAMA. Published online June 18, 2020. doi:10.1001/jama.2020.11374
Pulsa aquí para acceder a la información

Hospitalization and Mortality among Black Patients and White Patients with Covid-19
Eboni G. Price-Haywood, M.D., M.P.H., Jeffrey Burton, Ph.D., Daniel Fort, Ph.D., and Leonardo Seoane, M.D.
The New England Journal of Medicine May 27, 2020
DOI: 10.1056/NEJMsa2011686
Pulsa aquí para acceder a la información

Blacks/African Americans are 5 Times More Likely to Develop COVID-19: Spatial Modeling of New York City ZIP Code-level Testing Results
Charles DiMaggio, Michael Klein, Cherisse Berry, Spiros Frangos
MedRxiv Posted May 19 2020
doi: https://doi.org/10.1101/2020.05.14.20101691
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es un informe preliminar, que no se ha sido todavía revisado por pares

TRABAJADORES SANITARIOS

Outcomes of COVID-19 Among Hospitalized Health Care Workers in North America
Jeong Yun Yang ; Michael D. Parkins ; Andrew Canakis et al for the DMC-19 Study Group and the North American Alliance for the Study of Digestive Manifestations of COVID-19
JAMA Netw Open. January 28,  2021;4(1):e2035699. doi:10.1001/jamanetworkopen.2020.35699
Pulsa aquí para acceder a la información

Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff:a cross-sectional survey
Fuling Zhou•Jingfeng Li•Mengxin Lu•Linlu Ma•Yunbao Pan•Xiaoyan Liu•Xiaobin Zhu•Chao Hu•Sanyun Wu•Liangjun Chen•Yi Wang•Yongchang Wei•Yirong Li•Haibo Xu•Xinghuan Wang•Lin Cai
EClinicalMedicine  Published: September 14, 2020
Pulsa aquí para acceder a la información


Prevalence of SARS-CoV-2 Infection Among Health Care Workers in a Tertiary Community Hospital
Allen Jeremias, MD, MSc; James Nguyen, MD; Joseph Levine, MD; et al
JAMA Intern Med. Published online August 11, 2020. doi:10.1001/jamainternmed.2020.4214
Pulsa aquí para acceder a la información

Prevalence of SARS-CoV-2 Antibodies in Health Care Personnel in the New York City Area (Research Letter)
Joseph Moscola, PA, MBA1; Grace Sembajwe, DSc, MSc, CIH2; Mark Jarrett, MD, MBA, MS1; et alBruce Farber, MD3; Tylis Chang, MD4; Thomas McGinn, MD, MPH2; Karina W. Davidson, PhD, MASc2; for the Northwell Health COVID-19 Research Consortium
JAMA. Published online August 6, 2020. doi:10.1001/jama.2020.1476
Pulsa aquí para acceder a la información

Risk of COVID-19 in health-care workers in Denmark: an observational cohort study
Kasper Iversen•Henning Bundgaard•Rasmus B Hasselbalch•Jonas H KaKristensen•Pernille B Nielsen•Mia Pries-Heje•Andreas D Knudsen•Casper E Christensen•Kamille Fogh•Jakob B Norsk•Ove Andersen•Thea K Fischer•Claus Antonio Juul Jensen•Margit Larsen•Christian Torp-Pedersen•Jørgen Rungby•Sisse B Ditlev•Ida Hageman•Rasmus Møgelvang•Christoffer E Hother•Mikkel Gybel-Brask•Erik Sørensen•Lene Harritshøj•Fredrik Folke•Curt Sten•Thomas Benfield•Susanne Dam Nielsen•Henrik Ullum
The Lancet Infectious Diseases Published: August 3, 2020
Pulsa aquí para acceder a la información

Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study
Long H Nguyen, David A Drew, Mark S Graham, Amit D Joshi, Chuan-Guo Guo, Wenjie Ma, and others
The Lancet Public Health  Published: July 31, 2020
Pulsa aquí para acceder a la información

Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium
Deborah Steensels, PharmD, PhD1; Els Oris, MD1; Laura Coninx, MSc, PhD1; et alDieter Nuyens, MD, PhD1; Marie-Luce Delforge, MD, PhD2; Pieter Vermeersch, MD, PhD3; Line Heylen, MD, PhD
JAMA. Published online June 15, 2020. doi:10.1001/jama.2020.11160
Pulsa aquí para acceder a la información

(R) Use of personal protective equipment against coronavirus disease 2019 by healthcare professionals in Wuhan, China: cross sectional study
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2195 (Published 10 June 2020)
Pulsa aquí para acceder a la información

Transmisión de COVID-19 al personal de atención médica durante la exposición a un paciente hospitalizado - Condado de Solano, California, febrero de 2020           Amy Heinzerling, MD 1 , 2 ; Matthew J. Stuckey, PhD 3 ; Tara Scheuer, MPH 4 ; Kerui Xu, PhD 2 , 3 ; Kiran M. Perkins, MD 3 ; Heather Resseger, MSN 5 ; Shelley Magill, MD, PhD 3 ; Jennifer R. Verani, MD 3 ; Seema Jain, MD 1 ; Meileen Acosta, MPH 4 ; Erin Epson, MD 1 
MMWR Morb Mortal Wkly Rep. Epub: 14 de Abril de 2020 DOI: Pulsa aquí para acceder a la información  
Pulsa aquí para acceder a la información

VARIANTES DEL SARS-CoV-2

(R) (N) Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Katherine A Twohig, MPH  *; Tommy Nyberg, PhD *; Asad Zaidi, MSc; Simon Thelwall, PhD;  Mary A Sinnathamby, MPH;  Shirin Aliabadi, PhD et al.
The Lancet Infectious diseases :August 27, 2021 DOI:https://doi.org/10.1016/S1473-3099(21)00475-8
Pulsa aquí para acceder a la información

Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Jannik Fonager, Morten Rasmussen, Mads Albertsen, Thomas Yssing Michaelsen and others
The Lancet Infectious Diseases Published: June 22, 2021
Pulsa aquí para acceder a la información

Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study
Martina Patone, Karen Thomas, Rob Hatch, Pui San Tan, Carol Coupland, Weiqi Liao and others
The Lancet Infectious Diseases Published: June 22, 2021
Pulsa aquí para acceder a la información

Risk of hospitalisation associated with infection with SARS-CoV-2 lineage B.1.1.7 in Denmark: an observational cohort study
Peter Bager, Jan Wohlfahrt, Jannik Fonager, Morten Rasmussen, Mads Albertsen, Thomas Yssing Michaelsen and others
The Lancet Infectious Diseases Published: June 22, 2021
Pulsa aquí para acceder a la información

Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study
Martina Patone, Karen Thomas, Rob Hatch, Pui San Tan, Carol Coupland, Weiqi Liao and others
The Lancet Infectious Diseases Published: June 22, 2021
Pulsa aquí para acceder a la información

(R) SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness (Correspondence)
Aziz Sheikh, Jim McMenamin,  Bob Taylor, Chris Robertson on behalf of Public Health Scotland and the EAVE II Collaborators,
The Lancet, Published: June 14, 2021
Pulsa aquí para acceder a la información

COVID-19 reinfections in The Gambia by phylogenetically distinct SARS-CoV-2 variants—first two confirmed events in west Africa (Correspondence)
Bakary Sanyang, Abdoulie Kanteh, Effua Usuf, Behzad Nadjm, Sheikh JarjuAlasana Bah and others
The Lancet Global Health Published: June 3, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity (Correspondence)
Muthukumar RamanathanIan,  D Ferguson, Weili Miao, Paul A Khavari
The Lancet Infectious DiseasesPublished: May 19, 2021
Pulsa aquí para acceder a la información

(R) Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil
Nuno R. Faria, Thomas A. Mellan, Charles Whittaker, Ingra M. Claro, Darlan da S. Candido, Swapnil Mishra1, Myuki A. E. Crispim, Flavia C. S. Sales and others
Science  14 Apr 2021: eabh2644  DOI: 10.1126/science.abh2644
Pulsa aquí para acceder a la información

(R) Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study
Mark S Graham, Carole H Sudre, Anna May, Michela Antonelli, Benjamin Murray, Thomas Varsavsky and others
The Lancet Public Health Published: April 12, 2021
Pulsa aquí para acceder a la información

(R) Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study
Dan Frampton, Tommy Rampling, Aidan Cross, Heather Bailey, Judith Heaney, Matthew Byott and others
The Lancet Infectious DiseasesPublished: April 12, 2021
Pulsa aquí para acceder a la información

(R) Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
Nicholas G. Davies, Christopher I. Jarvis, CMMID COVID-19 Working Group, W. John Edmunds, Nicholas P. Jewell, Karla Diaz-Ordaz & Ruth H. Keogh
Nature (2021)  Published: 15 March 2021
Pulsa aquí para acceder a la información

(R) Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, VChristopher I. Jarvis, Adam J. Kucharski, James D. Munday, Carl A. B. Pearson, Timothy W. Russell, Damien C. Tully, Alex D. Washburne, Tom Wenseleers, Amy Gimma, William Waites, Kerry L. M. Wong, Kevin van Zandvoort, Justin D. Silverman, CMMID COVID-19 Working Group, COVID-19 Genomics UK (COG-UK) Consortium, Karla Diaz-Ordaz, Ruth Keogh, Rosalind M. Eggo, Sebastian Funk, Mark Jit, Katherine E. Atkins, W. John Edmunds
Science  03 Mar 2021: eabg3055 DOI: 10.1126/science.abg3055
Pulsa aquí para acceder a la información

CLÍNICA

Índice de Secciones

CARACTERÍSTICAS CLÍNICAS GENERALES

ANATOMÍA PATOLÓGICA

CARDIOVASCULAR

CIRUGÍA

CLÍNICA POST-COVID

CUIDADOS INTENSIVOS

DERMATOLOGÍA

DIGESTIVO

ENDOCRINOLOGÍA

FACTORES PRONÓSTICOS

GERIATRÍA

HEMATOLOGÍA

INFECCIOSAS (OTRAS)

NEFROLOGÍA

NEUROLOGÍA

OBSTETRICIA / GINECOLOGÍA

OFTALMOLOGIA

ONCOLOGÍA

OTORRINOLARINGOLOGÍA

PEDIATRÍA

PSIQUIATRÍA

RESPIRATORIO

REUMATOLOGIA

 

CARACTERÍSTICAS CLÍNICAS GENERALES

Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis
Noémie LefrancqJuliette PaireauNathanaël HozéNoémie CourtejoieYazdan YazdanpanahLila Bouadmaand others
The Lancet Regional Health – Europe Vol. 5Published: March 21, 2021
Pulsa aquí para acceder a la información

(R) Frequency of five unusual presentations in patients with COVID-19: results of the UMC-19-S1
Òscar Miró (a1), Pere Llorens (a2), Sònia Jiménez (a1), Pascual Piñera (a3) ...
Epidemiology and Infection 148, e189, 1–4 Published online by Cambridge University Press: 26 August 2020 DOI: https://doi.org/10.1017/S0950268820001910

Pulsa aquí para acceder a la información

Characteristics and Outcomes of COVID-19 Patients During Initial Peak and Resurgence in the Houston Metropolitan Area
Vahidy FS, Drews AL, Masud FN, et al.
JAMA August 13, 2020
Pulsa aquí para acceder a la información

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study
Christian Karagiannidis•Carina Mostert•Corinna Hentschker•Thomas Voshaar•Jürgen Malzahn•Gerhard Schillinger•Jürgen Klauber•Uwe Janssens•Gernot Marx•Steffen Weber-Carstens•Stefan Kluge•Michael Pfeifer•Linus Grabenhenrich•Tobias Welte•Reinhard Busse
The Lancet Respiratory Medicine Published: July 28, 2020
Pulsa aquí para acceder a la información

Clinical Characteristics of Patients With Coronavirus Disease 2019 (COVID-19) Receiving Emergency Medical Services in King County, Washington
Yang BY, Barnard LM, Emert JM, et al.
JAMA Network Open July 8, 2020
Pulsa aquí para acceder a la información

Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit
Geehan Suleyman, MD, MLS1; Raef A. Fadel, DO2; Kelly M. Malette, MD2; et al
JAMA Netw Open. 16 Jun 2020;3(6):e2012270. doi:10.1001/jamanetworkopen.2020.12270
Pulsa aquí para acceder a la información

Clinical outcomes of 402 patients with COVID‐2019 from a single center in Wuhan, China
Yingjie Wu  Wei Guo  Huan Liu  Bei Qi  Ke Liang  Haibo Xu  Zhiyong Peng  Shu-Yuan Xiao
Journal of Medical Virology First published:12 de junio de 2020 https://doi.org/10.1002/jmv.26168
Pulsa aquí para acceder a la información

Non-febrile COVID-19 patients were common and often became critically ill: a retrospective multicenter cohort study (Research Letter)
Yichen Li, Na Jiao, Lixin Zhu, Sijing Cheng, Ruixin Zhu & Ping Lan
Critical Care volume 24, Article number: 314 (2020) Published 08 Jun 2020)
Pulsa aquí para acceder a la información

Natural History of Asymptomatic SARS-CoV-2 Infection (Correspondence)
A.Sakurai et al.
The New England Journal of Medicine June 12, 2020 DOI: 10.1056/NEJMc2013020
Pulsa aquí para acceder a la información

 Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis
Sakiko Tabata, Kazuo Imai, Shuichi Kawano, Mayu Ikeda, Tatsuya Kodama, Kazuyasu Miyoshi, and others
The Lancet Infectious Diseases Published: June 12, 2020
Pulsa aquí para acceder a la información

SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series
Ivan Fan-Ngai Hung, Vincent Chi-Chung Cheng, Xin Li, Anthony Raymond Tam, Derek Ling-Lung Hung, Kelvin Hei-Yeung Chiu, and others
The Lancet Infectious Diseases Published: June 12, 2020
Pulsa aquí para acceder a la información

Asymptomatic SARS-CoV-2 infection (Comment)
Eng Eong Ooi, Jenny G Low
The Lancet Infectious Diseases Published: June 12, 2020
Pulsa aquí para acceder a la información

Recommendations for the prevention and treatment of the novel coronavirus pneumonia in the elderly in China. Guidelines amnd Consensus
Qiong Chen  Lijing Wang  Weiwei Yu  Huan Xi  Qiang Zhang  Xinyu Chen  Kui Huang  Xiang Lu  Xinmin Liu  CunTai Zhang  Jianye Wang  Chinese Geriatrics Society  National Center of Gerontology
Aging Medicine First published:09 June 2020 https://doi.org/10.1002/agm2.12113
Pulsa aquí para acceder a la información

Clinical and epidemiological characteristics of 320 deceased Covid‐19 patients in an Italian Province: a retrospective observational study
Andrea Biagi MD  Luca Rossi MD  Alessandro Malagoli MD  Alessia Zanni TFCPC  Concetta Sticozzi TFCPC  Greta Comastri TFCPC  Stefano Gandolfi MD  Giovanni Quinto Villani MD
Journal of Medical Virology First published:09 June 2020 https://doi.org/10.1002/jmv.26147
Pulsa aquí para acceder a la información

Clinical characteristics and prognostic factors in COVID‐19 patients aged ≥80 years
Marcello Covino  Giuseppe De Matteis  Michele Santoro  Luca Sabia  Benedetta Simeoni  Marcello Candelli  Veronica Ojetti  Francesco Franceschi
Geriatrics Gerontology First published:09 June 2020 https://doi.org/10.1111/ggi.13960
Pulsa aquí para acceder a la información

Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series                                        

Michael G Argenziano Samuel L Bruce, Cody L Slater, Jonathan R Tiao, Matthew R Baldwin, R Graham Barr, Bernard P Chang, Katherine H Chau, Justin J Choi, Nicholas Gavin, Parag Goyal, Angela M Mills, Ashmi A Patel, Marie-Laure S Romney, Monika M Safford, Neil W Schluger, Soumitra Sengupta, Magdalena E Sobieszczyk, Jason E Zucker, Paul A Asadourian, Fletcher M Bell, Rebekah Boyd, Matthew F Cohen, MacAlistair I Colquhoun, Lucy A Colville, Joseph H de Jonge, Lyle B Dershowitz, Shirin A Dey, Katherine A Eiseman, Zachary P Girvin, Daniella T Goni, Amro A Harb, Nicholas Herzik, Sarah Householder, Lara E Karaaslan, Heather Lee, Evan Lieberman, Andrew Ling, Ree Lu, Arthur Y Shou, Alexander C Sisti, Zachary E Snow, Colin P Sperring, Yuqing Xiong, Henry W Zhou, Karthik Natarajan, George Hripcsak, Ruijun Chen
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1996 (Published 29 May 2020)
Pulsa aquí para acceder a la información

Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China
Yang R, Gui X, Xiong Y
JAMA Network Open May 27, 2020  doi:10.1001/jamanetworkopen.2020.10182
Pulsa aquí para acceder a la información

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
Matthew J Cummings, Matthew R Baldwin, Darryl Abrams, Samuel D Jacobson, Benjamin J Meyer, Elizabeth M Balough, and others
The Lancet Published: May 19, 2020
Pulsa aquí para acceder a la información

(R) A cohort of patients with COVID-19 in a major teaching hospital in Europe
Alberto M Borobia , Antonio J Carcas , Francisco Arnalich , Rodolfo Alvarez-Sala , Jaime Montserrat , Manuel Quintana , Juan C Figueira , Rosario M Torres Santos-Olmo , Julio García-Rodríguez , Alberto Martin-Vega , Elena Ramirez , Antonio Buno , Gonzalo Martinez-Ales , Nicolas Garcia-Arenzana ,Concepcion Nunez Lopez , Milagros Marti de Gracia , Francisco Moreno , Francisco Reinoso-Barbero , Alejandro Martin-Quiros , Angelica Rivera , Jesus Mingorance , Carlos C Carpio , Daniel Prieto Arribas , Esther Rey Cuevas , Maria C Prados , Juan J Rios , Miguel Hernan , Jesús Frías , José R Arribas ,Equipo de trabajo de COVID @ HULP
MedRxiv BMJ May 6 2020
doi:https://doi.org/10.1101/2020.04.29.20080853
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es un informe preliminar, que no se ha sido todavía revisado por pares

(R) Clinical features of covid-19 (Editorial)
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1470 (Published 17 April 2020)
Pulsa aquí para acceder a la información

Clinical characteristics of older patients infected with COVID-19: A descriptive study
Shengmei Niu, Sijia Tian, Jing Lou, Xuqin Kang, Jinjun Zhang
Archives of Gerontology and GeriatricsVolume 89July–August 2020
Pulsa aquí para acceder a la información

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
Richardson S, Hirsch JS, Narasimhan M, et al.
JAMA April 22, 2020
Pulsa aquí para acceder a la información

Detección de síntomas en el inicio de la enfermedad del personal de atención médica con infección por SARS-CoV-2 en el condado de King, Washington
Eric J. Chow, MD, MS, MPH 1 ; Noah G. Schwartz, MD 1 ; Farrell A. Tobolowsky, DO, MS 1 ; et al.Rachael LT Zacks, MD 1 ; Melinda Huntington-Frazier, MSN 2 ; Sujan C. Reddy, MD 3 ; Agam K. Rao, MD 3
JAMA Publicado en línea el 17 de abril de 2020. doi: 10.1001 / jama.2020.6637
Pulsa aquí para acceder a la información

Características clínicas de los pacientes que murieron de la enfermedad por coronavirus 2019 en China
Jianfeng Xie, MD, PhD 1 ; Zhaohui Tong, MD, PhD 2 ; Xiangdong Guan, MD, PhD 3 ; et al.Bin Du, MD 4 ; Haibo Qiu, MD, PhD 1
JAMA Netw Open. 17 de Abril de 2020; 3 (4): e205619. doi: 10.1001 / jamanetworkopen.2020.5619
Pulsa aquí para acceder a la información

Clinical characteristics of 3,062 COVID‐19 patients: a meta‐analysis
Jieyun Zhu Pan Ji Jielong Pang Zhimei Zhong Hongyuan Li Cuiying He Jianfeng Zhang Chunling Zhao
Journal of Medical VirologyDOI: 10.1002/jmv.25884
Pulsa aquí para acceder a la información

Characteristics of Health Care Personnel with COVID-19 — United States, February 12–April 9, 2020                                                             
CDC COVID-19 Response Team
MMWR Morb Mortal Wkly. Epub: 14 de Abril de 2020
DOI: Pulsa aquí para acceder a la información.
Pulsa aquí para acceder a la información

Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy

Grasselli G, Zangrillo A, Zanella A, et al.JAMA April 6, 2020
Pulsa aquí para acceder a la información

Imaging and Clinical Features of Patients With 2019 Novel Coronavirus SARS‐CoV‐2: A systematic review and meta‐analysis
Yinghao Cao , Xiaoling Liu , Lijuan Xiong , Kailin Cai
Revista de Virología Médica First published:03 April 2020
 https://doi.org/10.1002/jmv.25822
 Pulsa aquí para acceder a la información

Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China 

Jianlei Cao, MD, PhDWen-Jun Tu, MD, PhDWenlin Cheng, MD, PhDLei Yu, MD, PhDYa-Kun Liu, MDXiaoyong Hu, MD, PhDQiang Liu, PhD 
Clinical Infectious Diseases, ciaa243,  https://doi.org/10.1093/cid/ciaa243
Published: 02 April 2020
Pulsa aquí para acceder a la información

Covid-19 en pacientes críticos en la región de Seattle - Serie de casos

Pavan K. Bhatraju, MD, Bijan J. Ghassemieh, MD, Michelle Nichols, MD, Richard Kim, MD, Keith R. Jerome, MD, Arun K. Nalla, Ph.D. Alexander L. Greninger, MD, Sudhakar Pipavath, MD, Mark M. Wurfel, MD, Ph.D., Laura Evans, MD, Patricia M. Kritek, MD, T. Eoin West, MD, MPH, et al.
The New  England Journal of Medicine 30 de marzo de 2020 
DOI: 10.1056 / NEJMoa2004500
Pulsa aquí para acceder a la información

Análisis epidemiológico de COVID ‐ 19 y experiencia práctica de China

Qing Ye MD , Bili Wang MS , MD Jianhua Mao , Junfen Fu MD , Shiqiang Shang MS , Qiang Shu MD , Ting Zhang MD
Journal of Medical Virology
Primera publicación:01 de abril de 2020https://doi.org/10.1002/jmv.25813
Pulsa aquí para acceder a la información

Características clínicas de 113 pacientes fallecidos con enfermedad por coronavirus 2019: estudio retrospectivo

Tao Chen , doctor 1 ,  Di Wu , doctor 1 ,  Huilong Chen , doctor 1 ,  Weiming Yan , investigador asociado 1 ,  Danlei Yang , doctor 2 ,  Guang Chen , doctor 1 ,  Ke Ma , doctor 1 ,  Dong Xu , doctor 1 ,  Haijing Yu , doctor 1 ,  Hongwu Wang , doctor 1 ,  Tao Wang , doctor 2 ,  Wei Guo , doctor 1 ,  Jia Chen , doctor 1 ,   Chen Ding , doctor 1 ,  Xiaoping Zhang , doctor 1 ,  Jiaquan Huang , doctor 1 ,  Meifang Han , doctor 1 ,  Shusheng Li , doctor 3 ,  Xiaoping Luo , doctor 4 ,  Jianping Zhao , doctor 2 ,  Qin Ning , doctor 1
BMJ 2020 ; 368 doi: https://doi.org/10.1136/bmj.m1091 (publicado el 26 de marzo de 2020)

Tasa de letalidad y características de los pacientes que mueren en relación con COVID-19 en Italia

Graziano Onder, MD, PhD 1 ; Giovanni Rezza, MD 2 ; Silvio Brusaferro, MD 3
JAMA Publicado en línea el 23 de marzo de 2020. doi: 10.1001 / jama.2020.4683
Pulsa aquí para acceder a la información

Características clínicas de la enfermedad por coronavirus 2019 en China.

Wei-jie Guan, Ph.D., Zheng-yi Ni, MD, Yu Hu, MD, Wen-hua Liang, Ph.D. Chun-quan Ou, Ph.D., Jian-xing He, MD, Lei Liu, MD, Hong Shan, MD, Chun-liang Lei, MD, David SC Hui, MD, Bin Du, MD, Lan-juan Li, MD,et al para el Grupo de expertos en tratamiento médico de China para Covid-19 
NEJM 28 de febrero de 2020 
DOI: 10.1056 / NEJMoa2002032 
Pulsa aquí para acceder a la información

ANATOMÍA PATOLÓGICA

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study
Bernadette Schurink, Eva Roos, Teodora Radonic, Ellis Barbe, Catherine S C Bouman, Hans H de Boer, and others
The Lancet Microbe Published: September 25, 2020
Pulsa aquí para acceder a la información

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study
Bernadette Schurink, Eva Roos, Teodora Radonic, Ellis Barbe, Catherine S C Bouman, Hans H de Boer, and others
The Lancet Microbe Published: September 25, 2020

Pulsa aquí para acceder a la información

COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City
Alain C. Borczuk, Steven P. Salvatore, Surya V. Seshan, Sanjay S. Patel, James B. Bussel, Maria Mostyka, Sarah Elsoukkary, Bing He, Claudia Del Vecchio, Francesco Fortarezza, Federica Pezzuto, Paolo Navalesi, Andrea Crisanti, Mary E. Fowkes, Clare H. Bryce, Fiorella Calabrese & Mary Beth Beasley
Modern Pathology (2020) Published: 02 September 2020
Pulsa aquí para acceder a la información

Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study
Brian Hanley, Kikkeri N Naresh, Candice Roufosse, Andrew G Nicholson, Justin Weir, Graham S Cooke, and others
The Lancet Microbe  Published: August 20, 2020
Pulsa aquí para acceder a la información

Megakaryocytes and platelet-fibrin thrombi characterize multi-organ thrombosis at autopsy in COVID-19: A case series
Amy V. Rapkiewicz, Xingchen Mai, Steven E. Carsons, Stefania Pittaluga, David E. Kleiner, Jeffrey S. Berger, and others
EClinicalMedicine  Published: June 25, 2020
Pulsa aquí para acceder a la información

Brain autpsy seriesin patients with Covid-19 (Correspondence)
I.H.Solomon et al.
The New England Journal of Medicine June 12, 2020 DOI: 10.1056/NEJMc2019373
Pulsa aquí para acceder a la información

Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans
Sharon E Fox, Aibek Akmatbekov, Jack L Harbert, Guang Li, J Quincy Brown, Richard S Vander Heide
The Lancet Respiratory Medicine Published: May 27, 2020
Pulsa aquí para acceder a la información

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann, M.D., Stijn E. Verleden, Ph.D., Mark Kuehnel, Ph.D., Axel Haverich, M.D., Tobias Welte, M.D., Florian Laenger, M.D., Arno Vanstapel, Ph.D., Christopher Werlein, M.D., Helge Stark, Ph.D., Alexandar Tzankov, M.D., William W. Li, M.D., Vincent W. Li, M.D., et al.
The New England Journal of Medicine May 21, 2020
DOI: 10.1056/NEJMoa2015432
Pulsa aquí para acceder a la información

Postmortem Examination of Patients With COVID-19
Tina Schaller, MDKlaus Hirschbühl, MDKatrin Burkhardt, MD et al..
JAMA. Published online May 21, 2020. doi:10.1001/jama.2020.8907
Pulsa aquí para acceder a la información

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case Series
Sigurd F. Lax, MD, PhD, Kristijan Skok, MD, Peter Zechner, MD, Harald H. Kessler, MD, PhD, … View all authors
Annals of Internal Medicine 14 May 2020
https://doi.org/10.7326/M20-2566
Pulsa aquí para acceder a la información

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. A Prospective Cohort Study
Dominic Wichmann, MD, Jan-Peter Sperhake, MD, Marc Lütgehetmann, MD, …
Annals of Internal Medicine 6 May 2020  https://doi.org/10.7326/M20-2003
Pulsa aquí para acceder a la información

CARDIOVASCULAR

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial
Axel Bauer, Michael Schreinlechner, Nikolay Sappler, Theresa Dolejsi, Herbert Tilg, Benedikt A Aulinger and others
The Lancet Respiratory MedicinePublished: June 11, 2021

Pulsa aquí para acceder a la información

New-onset atrial fibrillation: incidence, characteristics, and related events following a national COVID-19 lockdown of 5.6 million people
Anders Holt, Gunnar H Gislason, Morten Schou, Bochra Zareini, Tor Biering-Sørensen, Matthew Phelps, Kristian Kragholm, Charlotte Andersson, Emil L Fosbøl, Morten Lock Hansen, Thomas A Gerds, Lars Køber, Christian Torp-Pedersen, Morten Lamberts
Eur Heart J. 2020 Jun 1;41(32):3072-3079. doi: 10.1093/eurheartj/ehaa494.
Pulsa aquí para acceder a la información

The relationship of large city out-of-hospital cardiac arrests and the prevalence of COVID-19
Kevin E. McVaney, Paul E. Pepe, Lauren M. Maloney, E.Stein Bronsky, Remle P. Crowe, James J. Augustine, and others
EClinicalMedicinePublished: April 7, 2021
Pulsa aquí para acceder a la información

Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
Jordana B Cohen, Thomas C Hanff, Preethi William, Nancy Sweitzer, Nelson R Rosado-Santander, Carola Medina, and others
The Lancet Respiratory Medicine Published: January 7, 2021
Pulsa aquí para acceder a la información

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
Daniel R Morales, Mitchell M Conover, Seng Chan You, Nicole Pratt, Kristin Kostka, Talita Duarte-Salles, and others
The Lancet Digital Health  Published: December 17, 2020
Pulsa aquí para acceder a la información

Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19
Xingwei He, Luyan Wang, Hongjie Wang, Yang Xie, Yongfu Yu, Jianhua Sun, Jiangbo Yan, Yuxin Du, Yin Shen & Hesong Zeng
Scientific Reports volume 10, Article number: 20452 (2020) Published: 24 November 2020
Pulsa aquí para acceder a la información

Outcomes for Out-of-Hospital Cardiac Arrest in the United States During the Coronavirus Disease 2019 Pandemic
Chan PS, Girotra S, Tang Y, et al.
JAMA Cardiology November 14, 2020
Pulsa aquí para acceder a la información

Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study
Jules Mesnier, Yves Cottin, Pierre Coste, Emile Ferrari, François Schiele, Gilles Lemesle, and others
The Lancet Public Health  Published: September 17, 2020
Pulsa aquí para acceder a la información

Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic
Ty J. Gluckman, MD1; Michael A. Wilson, MD1; Shih-Ting Chiu, PhD1; et alBrian W. Penny, BS2; Vinaya B. Chepuri, MD3; John W. Waggoner, MD4; Kateri J. Spinelli, PhD1
JAMA Cardiol. Published online August 7, 2020. doi:10.1001/jamacardio.2020.3629
Pulsa aquí para acceder a la información

Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic
Ahmad Jabri, MD; Ankur Kalra, MD; Ashish Kumar, MBBS; et al
JAMA Netw Open. 2020;3(7):e2014780 Published July 9, 2020. doi:10.1001/jamanetworkopen.2020.1478
Pulsa aquí para acceder a la información

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
Emil L. Fosbøl, MD, PhD1; Jawad H. Butt, MD1; Lauge Østergaard, MD1; et alCharlotte Andersson, MD, PhD2; Christian Selmer, MD, PhD3; Kristian Kragholm, MD, PhD4; Morten Schou, MD, PhD5; Matthew Phelps, MSc6; Gunnar H. Gislason, MD, PhD5,6; Thomas A. Gerds, Dr rer nat6; Christian Torp-Pedersen, MD, DMSc7; Lars Køber, MD, DMSc1
JAMA. Published online June 19, 2020. doi:10.1001/jama.2020.11301
Pulsa aquí para acceder a la información

Characteristics Associated With Out-of-Hospital Cardiac Arrests and Resuscitations During the Novel Coronavirus Disease 2019 Pandemic in New York City
Pamela H. Lai, MD, PhD, MSc1; Elizabeth A. Lancet, DrPH, MPH1; Michael D. Weiden, MS, MD2,3; et alMayris P. Webber, DrPH, MPH2,4; Rachel Zeig-Owens, DrPH, MPH2,4,5; Charles B. Hall, PhD6; David J. Prezant, MD1,2,5
JAMA Cardiol. Published online June 19, 2020. doi:10.1001/jamacardio.2020.2488
Pulsa aquí para acceder a la información

Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID‐19 patients: A meta‐regression and Decision tree analysis
Eman A. Toraih  Rami M. Elshazli  Mohammad H. Hussein  Abdelaziz Elgaml  Mohamed Nasreldien Amin  Mohammed El‐Mowafy  Mohamed El‐Mesery  Assem Ellythy et al.
Journal of Medical Virology First published:12 June 2020 https://doi.org/10.1002/jmv.26166
Pulsa aquí para acceder a la información

 Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID‐19 patients: A meta‐regression and Decision tree analysis
Eman A. Toraih  Rami M. Elshazli  Mohammad H. Hussein  Abdelaziz Elgaml  Mohamed Nasreldien Amin  Mohammed El‐Mowafy  Mohamed El‐Mesery  Assem Ellythy et al.
Journal of Medical Virology First published:12 June 2020 https://doi.org/10.1002/jmv.26166
Pulsa aquí para acceder a la información

Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults. A Living Systematic Review
Katherine Mackey, MD, MPP, Valerie J. King, MD, MPH, Susan Gurley, MD, PhD, …
Annals of Internal Medicine 15 May 2020 https://doi.org/10.7326/M20-1515
Pulsa aquí para acceder a la información

Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study
Eloi Marijon, Nicole Karam, Daniel Jost, David Perrot, Benoit Frattini, Clément Derkenne, and others
The Lancet Public Health Published: May 27, 2020
Pulsa aquí para acceder a la información

Out-of-hospital cardiac arrest during the COVID-19 pandemic in Paris, France: a population-based, observational study
Eloi Marijon, Nicole Karam, Daniel Jost, David Perrot, Benoit Frattini, Clément Derkenne, and others
The Lancet Public Health Published: May 27, 2020
Pulsa aquí para acceder a la información

The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction (Correspondence)
M.D.Solomon and others
The New England Journal of Medicine May 19, 2020
DOI: 10.1056/NEJMc2015630
Pulsa aquí para acceder a la información

Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study
Francisco J de Abajo•Sara Rodríguez-Martín•Victoria Lerma•Gina Mejía-Abril•Mónica Aguilar•Amelia García-Luque•Leonor Laredo•Olga Laosa•Gustavo A Centeno-Soto•Maria Ángeles Gálvez•Miguel Puerro•Esperanza González-Rojano•Laura Pedraza•Itziar de Pablo•Francisco Abad-Santos•Leocadio Rodríguez-Mañas•Miguel Gil•Aurelio Tobías•Antonio Rodríguez-Miguel•Diego Rodríguez-Puyol on behalf of the MED-ACE2-COVID19 study group
The Lancet Published: May 14, 2020
Pulsa aquí para acceder a la información

Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
Neil Mehta, MBBS1; Ankur Kalra, MD2,3; Amy S. Nowacki, PhD4; et alScott Anjewierden, BS1; Zheyi Han, BS1; Pavan Bhat, MD2; Andres E. Carmona-Rubio, MD2; Miriam Jacob, MD2; Gary W. Procop, MD5; Susan Harrington, PhD5; Alex Milinovich, BA4; Lars G. Svensson, MD, PhD6; Lara Jehi, MD7; James B. Young, MD1,2; Mina K. Chung, MD2,8
JAMA Cardiol. Published online May 5, 2020. doi:10.1001/jamacardio.2020.1855
Pulsa aquí para acceder a la información

ST-Segment Elevation in Patients with Covid-19 — A Case Series (Correspondence)
Bangalore et al.
The New England Journal of Medicine April 17, 2020 DOI: 10.1056/NEJMc2009020
https://www.nejm.org/doi/full/10.1056/NEJMc2009020?query=featured_coronavirus

(R) Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Mandeep R. Mehra, M.D., Sapan S. Desai, M.D., Ph.D., SreyRam Kuy, M.D., M.H.S., Timothy D. Henry, M.D., and Amit N. Patel, M.D.
The New England Journal of Medicine May 1, 2020
DOI: 10.1056/NEJMoa2007621
Pulsa aquí para acceder a la información

(R) Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Mandeep R. Mehra, M.D., Sapan S. Desai, M.D., Ph.D., SreyRam Kuy, M.D., M.H.S., Timothy D. Henry, M.D., and Amit N. Patel, M.D.
The New England Journal of Medicine May 1, 2020
DOI: 10.1056/NEJMoa2007621
Pulsa aquí para acceder a la información

Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia, MD, Federico Rea, Ph.D., Monica Ludergnani, M.Sc., Giovanni Apolone, MD, y Giovanni Corrao, Ph.D.
The New England Journal of Medicine May 1, 2020
DOI: 10.1056 / NEJMoa2006923
Pulsa aquí para acceder a la información

Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
Harmony R. Reynolds, M.D., Samrachana Adhikari, Ph.D., Claudia Pulgarin, M.A., M.S., Andrea B. Troxel, Sc.D., Eduardo Iturrate, M.D., M.S.W., Stephen B. Johnson, Ph.D., Anaïs Hausvater, M.D., Jonathan D. Newman, M.D., M.P.H., Jeffrey S. Berger, M.D., Sripal Bangalore, M.D., Stuart D. Katz, M.D., Glenn I. Fishman, M.D., et al.
The New England Journal of Medicine May 1, 2020
DOI: 10.1056/NEJMoa2008975
Pulsa aquí para acceder a la información

Cardiovascular Complications in Patients With COVID-19: Consequences of Viral Toxicities and Host Immune Response
Han Zhu, June-Wha Rhee, Paul Cheng, Sarah Waliany , Amy Chang, Ronald M Witteles, Holden Maecker, Mark M Davis, Patricia K Nguyen, Sean M W
Curr Cardiol Rep. 2020 Apr 21;22(5):32
PMID: 32318865 PMCID: PMC7171437 DOI: 10.1007/s11886-020-01292-3
Pulsa aquí para acceder a la información

Hypertension, the renin–angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of Evidence                                                                                                             
Reinhold Kreutz
Engi Abd El-Hady AlgharablyMichel AziziPiotr DobrowolskiTomasz GuzikAndrzej JanuszewiczAlexandre PersuAleksander PrejbiszThomas Günther RiemerJi-Guang Wang et al   Cardiovascular Research, cvaa097, https://doi.org/10.1093/cvr/cvaa097 Published: 15 April 2020

Pulsa aquí para acceder a la información

Analysis of heart injury laboratory parameters in 273 COVID‐19 patients in one hospital in Wuhan, China

Huan Han, Linlin Xie, Rui Liu, Jie Yang, Fang Liu, Kailang Wu, Lang Chen, Wei Hou, Yong Feng, Chengliang Zhu

Journal of Medical Virology  DOI: 10.1002/jmv.25809

Pulsa aquí para acceder a la información

Implicaciones cardiovasculares de los resultados fatales de pacientes con enfermedad por coronavirus 2019 (COVID-19)

Guo T, Fan Y, Chen M, eT al.JAMA Cardiology 27 de marzo de 2020
Pulsa aquí para acceder a la información

CIRUGÍA

Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy
Francesco Doglietto, MD, PhD; Marika Vezzoli, PhD; Federico Gheza, MD et al
JAMA Surg. Published online June 12, 2020. doi:10.1001/jamasurg.2020.2713
Pulsa aquí para acceder a la información

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
COVIDSurg Collaborative, and others
The Lancet Published: May 29, 2020
Pulsa aquí para acceder a la información

(R) COVID-19: Pandemic surgery guidance
Björn L.D.M. Brücher, Giuseppe Nigri, Andrea Tinelli, Jose Florencio F. Lapeña Jr., Eloy Espin-Basany, Paolo Macri, Edouard Matevossian, Sergio Ralon, Ray Perkins, Rainer Lück, Rainer Kube, Jose MC da Costa, Yoav Mintz, Mesut Tez, Sixtus Allert, Selman Sökmen, Arkadiusz Spychala, Bruno Zilberstein, Frank Marusch, Mohammad Kermansaravi, Witold Kycler, Diego Vicente, Michael A. Scherer, Avraham Rivkind, Nelson Elias, Grzegorz Wallner, Franco Roviello, Lúcio Lara Santos, Raimund J.C. Araujo Jr., Amir Szold, Raúl Oleas, Marjan Slak Rupnik, Jochen Salber, Ijaz S. Jamall, Alexander Engel, for the Pandemic Surgery Guidance Consortium (PSGC)
4Open, 10 April 2020
Pulsa aquí para acceder a la información

CLÍNICA POST-COVID

(R) (N) 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study
Lixue Huang, Qun Yao, Xiaoying Gu, Qiongya Wang, Lili Ren, Yeming Wang, et al.
The Lancet Volume 398, Issue 10302, p747-758, August 28, 2021, DOI:https://doi.org/10.1016/S0140-6736(21)01755-4
Pulsa aquí para acceder a la información

(N) Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors
Shengding Zhang, Wenxue Bai, Junqing Yue, Lu Qin, Cong Zhang, Shuyun Xu, Xiansheng Liu, Wang Ni & Min Xie
Scientific Reports volume 11, Article number: 13854 (2021) Published: 05 July 2021
Pulsa aquí para acceder a la información

Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors
Shengding Zhang, Wenxue Bai, Junqing Yue, Lu Qin, Cong Zhang, Shuyun Xu, Xiansheng Liu, Wang Ni & Min Xie
Scientific Reports volume 11, Article number: 13854 (2021) Published: 05 July 2021
Pulsa aquí para acceder a la información

Follow-up of COVID-19 recovered patients with mild disease
Alina Kashif, Manahil Chaudhry[…]Khadija Shoaib
Scientific Reports 11 , 1–5 28 June 2021
Pulsa aquí para acceder a la información

Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection
Bin Yang, Junpeng Fan[…]Chaoyang Sun
Nature Communications 12 , 1–13 9 June 2021
Pulsa aquí para acceder a la información

Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study
Max Augustin, Philipp Schommers, Melanie Stecher, Felix Dewald, Lutz Gieselmann, Henning Gruell and others
The Lancet Regional Health – Europe Vol. 6 Published: May 17, 2021
Pulsa aquí para acceder a la información

Post-acute effects of SARS-CoV-2 infection in individuals not requiring hospital admission: a Danish population-based cohort study
Lars Christian Lund, Jesper Hallas, Henrik Nielsen, Anders Koch, Stine Hasling Mogensen, Nikolai Constantin Brun and others
The Lancet Infectious Diseases Published: May 10, 2021
Pulsa aquí para acceder a la información

3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study
Xiaojun Wu, Xiaofan Liu, Yilu Zhou, Hongying Yu, Ruiyun Li, Qingyuan Zhan and others
The Lancet Respiratory Medicine Published: May 5, 2021
Pulsa aquí para acceder a la información

Late conditions diagnosed 1–4 months following an initial COVID-19 encounter: a matched cohort study using inpatient and outpatient administrative data — United States, March 1–June 30, 2020
Jennifer R Chevinsky, MD MPH, Guoyu Tao, PhD, Amy M Lavery, PhD, MSPH, Esther A Kukielka, DVM, PhD, Eleanor S Click, MD PhD et al
Clinical Infectious Diseases, ciab338, https://doi.org/10.1093/cid/ciab338
Pulsa aquí para acceder a la información

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records
Maxime TaquetJohn R GeddesMasud HusainSierra LucianoPaul J Harrison
The Lancet PsychiatryPublished: April 6, 2021
Pulsa aquí para acceder a la información

Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study
Daniel Ayoubkhani,  Kamlesh Khunti,  Vahé Nafilyan, Thomas Maddox, Ben Humberstone, Ian Diamond, Amitava Banerjee
BMJ 2021;372:n693 | doi: 10.1136/bmj.n693
Pulsa aquí para acceder a la información

6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records
Maxime TaquetJohn R GeddesMasud HusainSierra LucianoPaul J Harrison
The Lancet PsychiatryPublished: April 6, 2021
Pulsa aquí para acceder a la información

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19
The Writing Committee for the COMEBAC Study Group
JAMA March 17, 2021
Pulsa aquí para acceder a la información

(R) Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge
Mattia Bellan, MD, PhD1,2; Daniele Soddu, MD1,2; Piero Emilio Balbo, MD2; et al
JAMA Netw Open. January 27, 2021;4(1):e2036142. doi:10.1001/jamanetworkopen.2020.36142
Pulsa aquí para acceder a la información

(R) 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
Chaolin Huang, Lixue Huang, Yeming Wang, Xia Li, Lili Ren, Xiaoying Gu, and others
The Lancet Published: January 8, 2021
Pulsa aquí para acceder a la información

Persistent Symptoms in Patients After Acute COVID-19 (Research Letter)
Angelo Carfì, MD1; Roberto Bernabei, MD1; Francesco Landi, MD, PhD1; et alfor the Gemelli Against COVID-19 Post-Acute Care Study Group
JAMA. Published online July 9, 2020. doi:10.1001/jama.2020.12603
Pulsa aquí para acceder a la información

CUIDADOS INTENSIVOS

Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study
Elisa Estenssoro, Cecilia I Loudet, Fernando G Ríos, Vanina S Kanoore Edul, Gustavo Plotnikow, Macarena Andrian and others
The Lancet Respiratory Medicine Published: July 2, 2021
Pulsa aquí para acceder a la información

Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study
The African COVID-19 Critical Care Outcomes Study (ACCCOS) Investigators
The Lancet Vol. 397 No. 10288 Published: May 22, 2021
Pulsa aquí para acceder a la información

Discriminant Accuracy of the SOFA Score for Determining the Probable Mortality of Patients With COVID-19 Pneumonia Requiring Mechanical Ventilation
Robert A. Raschke, MD1; Sumit Agarwal, MBBS, MBA2; Pooja Rangan, MBBS, MPH3; et al
JAMA. Published online February 17, 2021. doi:10.1001/jama.2021.1545
Pulsa aquí para acceder a la información

A simple nomogram for predicting failure of non-invasive respiratory strategies in adults with COVID-19: a retrospective multicentre study
Ling Liu, Jianfeng Xie, Wenjuan Wu, Hui Chen, Shusheng Li, Hongli He, and others
The Lancet Digital Health  Published: February 8, 2021
Pulsa aquí para acceder a la información

Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2,022 critically ill patients with COVID-19 in Spain
Rodríguez A, Botella MR, Matín-Loeches I, Herrera MJ, Solé-Violan J, Gómez J, Bodí M, Trefler S, Papiol E, Díaz E, Suberviola B, Vallverdú M, Mayor-Vázquez E, Moreno AA, Berlanga AC, Sánchez M, Ortíz MdV, Ballesteros JC, Iglesias LM, Marín-Corral J ...... Ferrer R

Critical Care Preprint in review  DOI:  10.21203/rs.3.rs-125422/v2

Pulsa aquí para acceder a la información2
NOTA de la FUNDACION: Este artículo es una prepublicación, que no se ha sido todavía revisado por pares

Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies
R. A. Armstrong  A. D. Kane  E. Kursumovic  F. C. Oglesby  T. M. Cook
Anaesthesia First published: 01 February 2021 https://doi.org/10.1111/anae.15425

Pulsa aquí para acceder a la información

Ventilation management and clinical outcomes in invasively ventilated patients with COVID-19 (PRoVENT-COVID): a national, multicentre, observational cohort study
Michela Botta, Anissa M Tsonas, Janesh Pillay, Leonoor S Boers, Anna Geke Algera, Lieuwe D J Bos, and others
The Lancet Respiratory Medicine Published: October 23, 2020
Pulsa aquí para acceder a la información

Evaluation of PEEP and prone positioning in early COVID-19 ARDS
Mirja Mittermaier•Philipp Pickerodt•Florian Kurth•Laure Bosquillon de Jarcy•Alexander Uhrig•Carmen Garcia•Felix Machleidt•Panagiotis Pergantis•Susanne Weber•Yaosi Li•Astrid Breitbart•Felix Bremer•Philipp Knape•Marc Dewey•Felix Doellinger•Steffen Weber-Carstens•Arthur S. Slutsky•Wolfgang M. Kuebler•Norbert Suttorp•Holger Müller-Redetzky
EClinicalMedicine Published: October 10, 2020
Pulsa aquí para acceder a la información

Patients With COVID-19 in 19 ICUs in Wuhan, China: A Cross-Sectional Study
Yuan Yu 1, Dan Xu 1, Shouzhi Fu 2, Jun Zhang 3, Xiaobo Yang 1, Liang Xu 4, Jiqian Xu 1, Yongran Wu 1, Chaolin Huang 5, Yaqi Ouyang 1, Luyu Yang 2, Minghao Fang 6, Hongwen Xiao 7, Jing Ma 8, Wei Zhu 9, Song Hu 10, Quan Hu 11, Daoyin Ding 11, Ming Hu 12, Guochao Zhu 13, Weijiang Xu 14, Jun Guo 15, Jinglong Xu 15, Haitao Yuan 16, Bin Zhang 17, Zhui Yu 18, Dechang Chen 19, Shiying Yuan 20, You Shang 21
Crit Care. 2020 May 14;24(1):219. doi: 10.1186/s13054-020-02939-x.
PMID: 32410714 PMCID: PMC7223395 DOI: 10.1186/s13054-020-02939-x
Pulsa aquí para acceder a la información

Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic
Marco Vergano ,Guido Bertolini ,Alberto Giannini ,Giuseppe R. Gristina ,Sergio Livigni ,Giovanni Mistraletti ,Luigi Riccioni yFlavia Petrini
Critical Care volume 24, Article number: 165 (22 April 2020)
Pulsa aquí para acceder a la información

Clinical ethics recommendations for the allocation of intensive care treatments in exceptional, resource-limited circumstances: the Italian perspective during the COVID-19 epidemic
Marco Vergano ,Guido Bertolini ,Alberto Giannini ,Giuseppe R. Gristina ,Sergio Livigni ,Giovanni Mistraletti ,Luigi Riccioni yFlavia Petrini
Critical Care volume 24, Article number: 165 (22 April 2020)
Pulsa aquí para acceder a la información

DERMATOLOGÍA

Prevalence of mucocutaneous manifestations in 666 patients with COVID‐19 in a field hospital in Spain: oral and palmoplantar findings
A. Nuno‐Gonzalez  P. Martin‐Carrillo  K. Magaletsky  M.D. Martin Rios  C. Herranz Mañas  J. Artigas Almazan  G. García Casasola  E. Perez Castro  A. Gallego Arenas et al.
British Journal of Dermatology First published: 24 September 2020 https://doi.org/10.1111/bjd.19564
Pulsa aquí para acceder a la información

Skin manifestations reported in association with COVID‐19 infection (Review)
Dirk Tomsitz  Tilo Biedermann  Knut Brockow
JDDG First published: 30 December 2020 https://doi.org/10.1111/ddg.14353
Pulsa aquí para acceder a la información

Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
Farnoosh Seirafianpour  Sogand Sodagar  Arash Pour Mohammad  Parsa Panahi  Samaneh Mozafarpoor  Simin Almasi  Azadeh Goodarzi
Dermatological Therapy First published: 08 July 2020 Pulsa aquí para acceder a la información

Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
Farnoosh Seirafianpour  Sogand Sodagar  Arash Pour Mohammad  Parsa Panahi  Samaneh Mozafarpoor  Simin Almasi  Azadeh Goodarzi
Dermatological Therapy First published: 08 July 2020 Pulsa aquí para acceder a la información

Evaluación de lesiones acrales agudas en una serie de casos de niños y adolescentes durante la pandemia de COVID-19
MD Juncal Roca-Ginés1; Dr. Ignacio Torres-Navarro1; Dr. Javier Sánchez-Arráez1; et alDr. Carlos Abril-Pérez1; Oihana Sabalza-Baztán, BS-M2; Sergio Pardo-Granell, PharmG2; Vicent Martínez i Cózar, MD3; Rafael Botella-Estrada, MD, PhD1,4; Montserrat Évole-Buselli, MD, PhD1
JAMA Dermatol. Publicado en línea el 25 de junio de 2020. doi: 10.1001 / jamadermatol.2020.2340
Pulsa aquí para acceder a la información

Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic
Anne Herman, MD1,2; Caroline Peeters, MD1; Alexia Verroken, MD, PhD3; et alIsabelle Tromme, MD, PhD1; Dominique Tennstedt, MD1; Liliane Marot, MD1,4; Claire Dachelet, MD4; Damien Gruson, PharmD, PhD5; Cedric Hermans, MD, PhD6; Marie Baeck, MD, PhD1,2
JAMA Dermatol. Published online June 25, 2020. doi:10.1001/jamadermatol.2020.2368
Pulsa aquí para acceder a la información

Petechial Skin Rash Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Borja Diaz-Guimaraens, MD1; Miguel Dominguez-Santas, MD1; Ana Suarez-Valle, MD1; et alCristina Pindado-Ortega, MD1; Gerald Selda-Enriquez, MD1; Sonia Bea-Ardebol, MD1; Diego Fernandez-Nieto, MD1
JAMA Dermatol. Published online April 30, 2020. doi:10.1001/jamadermatol.2020.1741
Pulsa aquí para acceder a la información

Classification of the cutaneous manifestations of COVID‐19: a rapid prospective nationwide consensus study in Spain with 375 cases
C. Galván Casas A. Català G. Carretero Hernández P. Rodríguez‐Jiménez D. Fernández Nieto A. Rodríguez‐Villa Lario I. Navarro Fernández R. Ruiz‐Villaverde D. Falkenhain M. Llamas Velasco J. García‐Gavín O. Baniandrés C. González‐Cruz V. Morillas‐Lahuerta X. Cubiró I. Figueras Nart G. Selda‐Enriquez J. Romaní X. Fustà‐Novell A. Melian‐Olivera M. Roncero Riesco P. Burgos‐Blasco J. Sola Ortigosa M. Feito Rodriguez I. García‐Doval
British Journal of DermatologyAccepted Articles
First published: 29 April 2020
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Se recomienda encarecidamente el suplemento S1 que contiene abundante iconografía

Response of a tertiary dermatology department to COVID‐19
Samuel Der Sarkissian , Angelica Tjokrowidjaja, Deshan F Sebaratnam, Monisha Gupta
Australasian Journal of Dermatology 21 April 2020 DOI: 10.1111/ajd.13298
Pulsa aquí para acceder a la información

Cutaneous manifestations in COVID‐19: a first perspective
S. Recalcati
Journal of the European Academy of Dermatology and Veneorology First published:26 March 2020
https://doi.org/10.1111/jdv.16387
Pulsa aquí para acceder a la información

DIGESTIVO

Predicting endoscopic activity recovery in England after COVID-19: a national analysis
Kai Man Alexander Ho, Amitava Banerjee, Mark Lawler, Matthew D Rutter, Laurence B Lovat
The Lancet Gastroenterology & Hepatology  Published: March 10, 2021
Pulsa aquí para acceder a la información

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
Shaji Sebastian, Gareth J Walker, Nicholas A Kennedy, Thomas E Conley, Kamal V Patel, Sreedhar Subramanian, and others
The Lancet Gastroenterology & Hepatology  Published: February 2, 2021
Pulsa aquí para acceder a la información

Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study
Shaji Sebastian, Gareth J Walker, Nicholas A Kennedy, Thomas E Conley, Kamal V Patel, Sreedhar Subramanian, and others
The Lancet Gastroenterology & Hepatology  Published: February 2, 2021
Pulsa aquí para acceder a la información

COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms (Review)
Peijie Zhong, Jing Xu, Dong Yang, Yue Shen, Lu Wang, Yun Feng, Chunling Du, Yuanlin Song, Chaomin Wu, Xianglin Hu & Yangbai Sun
Signal Transduction and Targeted Therapy volume 5, Article number: 256 (2020) Published: 02 November 2020
Pulsa aquí para acceder a la información

Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study
Gwilym J Webb, Thomas Marjot, Jonathan A Cook, Costica Aloman, Matthew J Armstrong, Erica J Brenner, and others
The Lancet Gastroenterology & Hepatology Published: August 28, 2020
Pulsa aquí para acceder a la información

Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19
Anand V. Kulkarni  Pramod Kumar  Harsh Vardhan Tevethia  Madhumita Premkumar  Juan Pablo Arab  Roberto Candia  Rupjyoti Talukdar  Mithun Sharma  Xiaolong Qi et al.
Alimentary Pharmacology and Therapeutics First published: 08 July 2020 https://doi.org/10.1111/apt.15916
Pulsa aquí para acceder a la información

Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement (Review)
Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Alex Thompson, Jidong Jia, Jinlin Hou, Cosmas Rinaldi Adithya Lesmana, and others
The Lancet Gastroenterology & Hepatology Published: June 22, 2020
Pulsa aquí para acceder a la información

Prevalence of Gastrointestinal Symptoms and Fecal Viral Shedding in Patients With Coronavirus Disease 2019. A Systematic Review and Meta-analysis
Sravanthi Parasa, MD; Madhav Desai, MD, MPH; Viveksandeep Thoguluva Chandrasekar, MD; et al.
JAMA Netw Open. 2020;3(6): e2011335. doi:10.1001/jamanetworkopen.2020.11335
Pulsa aquí para acceder a la información

(R) Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis
Ren Mao, Yun Qiu, Jin-Shen He, Jin-Yu Tan, Xue-Hua Li, Jie Liang, and others
The Lancet Gastroenterology & Hepatology Published: May 12, 2020
Pulsa aquí para acceder a la información

Clinical Characteristics of non-ICU Hospitalized Patients With Coronavirus Disease 2019 and Liver Injury: A Retrospective Study
Hansheng Xie , Jianming Zhao , Ningfang Lian , Su Lin , Qunfang Xie , Huichang Zhuo
Liver Int. 2020 Apr 2. doi: 10.1111/liv.14449.  PMID: 32239591 DOI: 10.1111/liv.14449
Pulsa aquí para acceder a la información

Síntomas gastrointestinales de 95 casos con infección por SARS-CoV-2 GRATIS
Lu Lin  ,Xiayang Jiang  ,Zhenling Zhang  ,Siwen Huang  ,Zhenyi Zhang  ,Colmillo Zhaoxiong  ,Zhiqiang Gu  ,Liangqing Gao  ,Honggang Shi  ,Lei Mai  ,Yuan Liu  ,Xianqi Lin  ,Renxu Lai  , Zhixiang Yan 2 ,Xiaofeng Li  ,Hong Shan
BMJ Gut 2020;0:1–5. doi:10.1136/gutjnl-2020-321013
Pulsa aquí para acceder a la información

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
Xi Jin,1 Jiang-­Shan Lian,2 Jian-­Hua Hu,2 Jianguo Gao,1 Lin Zheng,2 Yi-Min Zhang,2 Shao-­Rui Hao,2 Hong-Yu Jia,2 Huan Cai,2 Xiao-­Li Zhang,2 Guo-Dong Yu,2 Kai-Jin Xu,2 Xiao-Yan Wang,2 Jue-Qing Gu,2 Shan-Yan Zhang,2 Chan-Yuan Ye,2 Ci-­Liang Jin,2 Ying-Feng Lu,2 Xia Yu,2 Xiao-Peng Yu,2 Jian-­Rong Huang,2 Kang-­Li Xu,3 Qin Ni,2 Cheng-Bo Yu,2 Biao Zhu,2 Yong-Tao Li,2 Jun Liu,2 Hong Zhao,2 Xuan Zhang,2 Liang Yu,2 Yong-Zheng Guo,2 Jun-Wei Su,2 Jing-Jing Tao,2 Guan-Jing Lang,2 Xiao-Xin Wu,2 Wen-­Rui Wu,2 Ting-Ting Qv,2 Dai-­Rong Xiang,2 Ping Yi,2 Ding Shi,2 Yanfei Chen,2 Yue Ren,1 Yun-Qing Qiu,2 Lan-Juan Li ,2 Jifang Sheng,2 Yida Yang 2
British Medical Journal 17 March 2020 http://dx.doi.org/10.1136/gutjnl-2020-320926
Pulsa aquí para acceder a la información

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China (Correspondence)
Ping An, Mengyao Ji, Haixia Ren, Juan Su, Nik Sheng Ding, Jian Kang, and others
The Lancet Gastroenterology & Hepatology Published: April 17, 2020
Pulsa aquí para acceder a la información

Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period (Rapid Review)
Marietta Iacucci, Rosanna Cannatelli, Nunzia Labarile, Ren Mao, Remo Panaccione, Silvio Danese, and others
The Lancet Gastroenterology & Hepatology Published: April 16, 2020
Pulsa aquí para acceder a la información

Enteric involvement in hospitalised patients with COVID-19 outside Wuhan (Correspondence)
Yunle Wan, Jie Li, Lihan Shen, Yifeng Zou, Linlin Hou, Lixin Zhu, and others
The Lancet Gastroenterology & Hepatology
Published: April 15, 2020
Pulsa aquí para acceder a la información

Diarrea durante la infección por COVID-19: patogénesis, epidemiología, prevención y manejo
Ferdinando D'Amico 1 ,   Daniel C Baumgart 2 ,   Silvio Danese 3 ,   Laurent Peyrin-Biroulet 4 
Clin Gastroenterol Hepatol 8 de abril de 2020[En línea antes de imprimir] DOI: 10.1016 / j.cgh.2020.04.001
https://pubmed.ncbi.nlm.nih.gov/32278065/?from_term=covid&from_sort=date&from_page=2&from_pos=2
Coagulopatía en enfermedades críticas con Covid-19 (Correspondence)
Y. Zhang y otros
The New England Journal of Medicine April 8, 2020
DOI: 10.1056/NEJMc2007575
Pulsa aquí para acceder a la información

ENDOCRINOLOGÍA

Obesity and mortality in critically ill COVID-19 patients with respiratory failure
Richard Dana, Aurélie Bannay[…]Olivier Ziegler
International Journal of Obesity , 1–10 10 June 2021
Pulsa aquí para acceder a la información

Associations between body-mass index and COVID-19 severity in 6·9 million people in England: a prospective, community-based, cohort study
Min Gao, Carmen Piernas, Nerys M Astbury, Julia Hippisley-Cox, Stephen O'Rahilly, Paul Aveyard and others
The Lancet Diabetes & Endocrinology Published: April 28, 2021
Pulsa aquí para acceder a la información

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland
Stuart J McGurnaghan, Amanda Weir, Jen Bishop, Sharon Kennedy, Luke A K Blackbourn, David A McAllister, and others
The Lancet Diabetes & Endocrinology Published: December 23, 2020
Pulsa aquí para acceder a la información


Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis
Carolyn T Bramante, Nicholas E Ingraham, Thomas A Murray, Schelomo Marmor, Shane Hovertsen, Jessica Gronski, and others
The Lancet Healthy Longevity  Published: December 3, 2020
Pulsa aquí para acceder a la información

Metformin Use Is Associated with Increased Incidence of Acidosis but not Mortality in Individuals with COVID-19 and Pre-existing Type 2 Diabetes
Cheng et al.
Cell Metabolism  Published online: August 20, 2020
Pulsa aquí para acceder a la información

Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
Naomi Holman, Peter Knighton, Partha Kar, Jackie O'Keefe, Matt Curley, Andy Weaver, and others
The Lancet Diabetes & Endocrinology  Published: August 13, 2020
Pulsa aquí para acceder a la información

 Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study
Naomi Holman, Peter Knighton, Partha Kar, Jackie O'Keefe, Matt Curley, Andy Weaver, and others
The Lancet Diabetes & Endocrinology  Published: August 13, 2020
Pulsa aquí para acceder a la información

Obesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization
Sara Y. Tartof, PhD, MPH, Lei Qian, PhD, MS, Vennis Hong, MPH, Rong Wei, MA, Ron F. Nadjafi, MD, MS, Heidi Fischer, PhD, MS, Zhuoxin Li, MS, Sally F. Shaw, DrPH, MPH, Susan L. Caparosa, MA, Claudia L. Nau, PhD, MA, … et al.
Annals of Internal Medicine 12 August 2020
Pulsa aquí para acceder a la información

Body Mass Index and Risk for Intubation or Death in SARS-CoV-2 Infection: A Retrospective Cohort Study
Michaela R. Anderson, MD, MS, Joshua Geleris, MD, David R. Anderson, PhD, Jason Zucker, MD, Yael R. Nobel, MD, Daniel Freedberg, MD, MS, Jennifer Small-Saunders, MD, PhD, Kartik N. Rajagopalan, MD, PhD, Richard Greendyk, MD, … et al.
Annals of Internal Medicine 29 July 2020
Pulsa aquí para acceder a la información

Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight
Andrew Higham  Dave Singh
Obesity First published:19 May 2020 https://doi.org/10.1002/oby.22907
Pulsa aquí para acceder a la información

Obesity could shift severe COVID-19 disease to younger ages (Corespondence)
David A Kass, Priya Duggal, Oscar Cingolani
The Lancet Published: April 30, 2020
Pulsa aquí para acceder a la información

Obesidad y SARS-CoV-2: una población para salvaguardar
Mikiko Watanabe  Renata Risi  Dario Tuccinardi  Claudia J Baquero  Silvia Manfrini  Lucio Gnessi
Diabetes Metabolism Research and Reviews Primera publicación:21 de abril de 2020 https://doi.org/10.1002/dmrr.3325
Pulsa aquí para acceder a la información

COVID 19 y el paciente con obesidad: los editores hablan (Editorial)

Donna H. Ryan , Eric Ravussin , Steven Heymsfield
Obesity
Primera publicación:01 de abril de 2020 Pulsa aquí para acceder a la información

Obesity and its Implications for COVID‐19 Mortality

William Dietz , Carlos Santos‐Burgoa
Obesity
First published:01 April 2020 Pulsa aquí para acceder a la información

FACTORES PRONÓSTICOS

Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients
Alhaji H. Janneh, Mohamed Faisal Kassir, Connor J. Dwyer, Paramita Chakraborty, Jason S. Pierce, Patrick A. Flume, Hong Li, Satish N. Nadig, Shikhar Mehrotra & Besim Ogretmen
Scientific Reports volume 11, Article number: 14232 (2021) Published: 09 July 2021
Pulsa aquí para acceder a la información

Risk Categories in COVID-19 Based on Degrees of Inflammation: Data on More Than 17,000 Patients from the Spanish SEMI-COVID-19 Registry
Manuel Rubio-Rivas, Xavier Corbella, Francesc Formiga, Estela Menéndez Fernández, María Dolores Martín Escalante, Isolina Baños Fernández, Francisco Arnalich Fernández, Esther Del Corral-Beamonte, Antonio Lalueza, Alejandro Parra Virto, Emilia Roy Vallejo, José Loureiro-Amigo, Ana María Álvarez Suárez, Jesica Abadía-Otero, María Navarro De La Chica, Raquel Estévez González, Almudena Hernández Milián, María Areses Manrique, Julio César Blázquez Encinar, Amara González Noya, Ruth González Ferrer, María Pérez Aguilera, Ricardo Gil Sánchez, Jesús Millán Núñez-Cortés, José Manuel Casas-Rojo and on behalf of the SEMI-COVID-19 Network
Journal of Clinical Medicine Volume 10  Issue 10  10.3390/jcm10102214 Published: 20 May 2021
Pulsa aquí para acceder a la información

The influence of HLA genotype on the severity of COVID-19 infection
J. Langton, Stephen C. Bourke, Benedicte A. Lie, Gabrielle Reiff, Shonali Natu, Rebecca Darlay, John Burn, Carlos Echevarria
HLA First published: 25 April 2021 https://doi.org/10.1111/tan.14284
Pulsa aquí para acceder a la información

An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: a national validation cohort study in England
Vahé Nafilyan, Ben Humberstone, Nisha MehtaIan Diamond, Carol Coupl and Luke Lorenzi and others
The Lancet Digital HealthPublished: May 25, 2021
Pulsa aquí para acceder a la información

An external validation of the QCovid risk prediction algorithm for risk of mortality from COVID-19 in adults: a national validation cohort study in England
Vahé Nafilyan, Ben Humberstone, Nisha MehtaIan Diamond, Carol Coupl and Luke Lorenzi and others
The Lancet Digital HealthPublished: May 25, 2021
Pulsa aquí para acceder a la información

Risk Factors Associated With SARS-CoV-2 Infections, Hospitalization, and Mortality Among US Nursing Home Residents
Mehta HB, Li S, Goodwin JS
JAMA Network Open March 31, 2021
Pulsa aquí para acceder a la información

Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
Belén Gutiérrez-Gutiérrez, María Dolores del Toro, Alberto M Borobia, Antonio Carcas, Inmaculada Jarrín, María Yllescas and others
The Lancet Infectious DiseasesPublished: February 23, 2021
Pulsa aquí para acceder a la información

Association between periodontitis and severity of COVID‐19 infection: a case‐control study
Nadya Marouf  Wenji Cai  Khalid N. Said  Hanin Daas  Hanan Diab  Venkateswara Rao Chinta  Ali Ait Hssain  Belinda Nicolau  Mariano Sanz  Faleh Tamimi
Journal of Clinical Periodontology First published: 01 February 2021 https://doi.org/10.1111/jcpe.13435
Pulsa aquí para acceder a la información

Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study
Rishi K GuptaEwen M Harrison, Antonia Ho, Annemarie B Docherty, Stephen R Knight Maarten van Smeden and others
The Lancet Respiratory MedicinePublished: January 11, 2021
Pulsa aquí para acceder a la información

Age-severity matched cytokine profiling reveals specific signatures in Covid-19 patients
Roberta Angioni, Ricardo Sánchez-Rodríguez[…]Barbara Molon
Cell Death & Disease 11 , 1–12 Published 6 November 2020
Pulsa aquí para acceder a la información

Laboratory Findings Associated With Severe Illness and Mortality Among Hospitalized Individuals With Coronavirus Disease 2019 in Eastern Massachusetts
Victor M. Castro, MS1,2; Thomas H. McCoy, MD1; Roy H. Perlis, MD, MSc1
JAMA Netw Open. 2020;3(10):e2023934. October 30, 2020
doi:10.1001/jamanetworkopen.2020.23934
Pulsa aquí para acceder a la información

A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19
Oliver J McElvaney•Brian D Hobbs•Dandi Qiao•Oisín F McElvaney•Matthew Moll•Natalie L McEvoy•Jennifer Clarke•Eoin O'Connor•Seán Walsh•Michael H Cho•Gerard F Curley•Noel G McElvaney
EBioMedicine, Vol. 61 Published: October 8, 2020
Pulsa aquí para acceder a la información

Deep learning-based triage and analysis of lesion burden for COVID-19: a retrospective study with external validation
Minghuan Wang•Chen Xia•Lu Huang•Shabei Xu•Chuan Qin•Jun Liu•Ying Cao•Pengxin Yu•Tingting Zhu•Hui Zhu•Chaonan Wu•Rongguo Zhang•Xiangyu Chen•Jianming Wang•Guang Du•Chen Zhang•Shaokang Wang•Kuan Chen•Zheng Liu•Liming Xia•Wei Wang
The Lancet Digital Health, Vol. 2, No. 10 Published: October, 2020
Pulsa aquí para acceder a la información

 Clinical features of COVID-19 mortality: development and validation of a clinical prediction model
Arjun S Yadaw•Yan-chak Li•Sonali Bose•Ravi Iyengar•Supinda Bunyavanich•Gaurav Pandey
The Lancet Digital Health, Vol. 2, No. 10 Published: October, 2020
Pulsa aquí para acceder a la información

 Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study
Brandon J Webb, Ithan D Peltan, Paul Jensen, Daanish Hoda, Bradley Hunter, Aaron Silver, and others
The Lancet Rheumatology  Published: September 29, 2020
Pulsa aquí para acceder a la información

Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection
George N. Ioannou, BMBCh, MS; Emily Locke, MPH; Pamela Green, PhD; et al
JAMA Netw Open. 2020;3(9):e2022310. September 23, 2020doi:10.1001/jamanetworkopen.2020.22310
Pulsa aquí para acceder a la información

Association of Red Blood Cell Distribution Width With Mortality Risk in Hospitalized Adults With SARS-CoV-2 Infection
Brody H. Foy, DPhil1; Jonathan C. T. Carlson, MD, PhD; Erik Reinertsen, MD, PhD; et al
JAMA Netw Open. September 23, 2020 ;3(9):e2022058.:10. doi 1001/jamanetworkopen.2020.22058
Pulsa aquí para acceder a la información

Patient Trajectories Among Persons Hospitalized for COVID-19FREE
A Cohort Study

Brian T. Garibaldi, MD, MEHP, Jacob Fiksel, PhD, John Muschelli, PhD et al.
Annals of Internal Medicine 22 September 2020 https://doi.org/10.7326/M20-3905
Pulsa aquí para acceder a la información

Risk stratification of patients admitted to hospital with covid-19
using the ISARIC WHO Clinical Characterisation Protocol:
development and validation of the 4C Mortality Score

Stephen R Knight, Antonia Ho, Riinu Pius, Iain Buchan, Gail Carson, Thomas M Drake, Jake Dunning, Cameron J Fairfield, Carrol Gamble, Christopher A Green, Rishi Gupta, Sophie Halpin, Hayley E Hardwick, Karl A Holden, Peter W Horby, Clare Jackson, Kenneth A Mclean, Laura Merson, Jonathan  Nguyen-Van-Tam, Lisa Norman, Mahdad Noursadeghi, Piero L Olliaro, Mark G Pritchard, Clark D Russell, Catherine A Shaw, Aziz Sheikh,Tom Solomon, Cathie Sudlow, Olivia V Swann, Lance CW Turtle, Peter JM Openshaw, J Kenneth Baillie, Malcolm G Semple, Annemarie B Docherty, Ewen M Harrison, on behalf of the ISARIC4C investigators
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3339 (Published 09 September 2020)
Pulsa aquí para acceder a la información

Risk stratification of patients admitted to hospital with covid-19using the ISARIC WHO Clinical Characterisation Protocol:development and validation of the 4C Mortality Score
Stephen R Knight, Antonia Ho, Riinu Pius, Iain Buchan, Gail Carson, Thomas M Drake, Jake Dunning, Cameron J Fairfield, Carrol Gamble, Christopher A Green, Rishi Gupta, Sophie Halpin, Hayley E Hardwick, Karl A Holden, Peter W Horby, Clare Jackson, Kenneth A Mclean, Laura Merson, Jonathan  Nguyen-Van-Tam, Lisa Norman, Mahdad Noursadeghi, Piero L Olliaro, Mark G Pritchard, Clark D Russell, Catherine A Shaw, Aziz Sheikh,Tom Solomon, Cathie Sudlow, Olivia V Swann, Lance CW Turtle, Peter JM Openshaw, J Kenneth Baillie, Malcolm G Semple, Annemarie B Docherty, Ewen M Harrison, on behalf of the ISARIC4C investigators
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3339 (Published 09 September 2020)
Pulsa aquí para acceder a la información

Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results
Meltzer DO, Best TJ, Zhang H, et al.
JAMA Network Open September 3, 2020
Pulsa aquí para acceder a la información

An inflammatory cytokine signature predicts COVID-19 severity and survival
Diane Marie Del Valle, Seunghee Kim-Schulze, […]Sacha Gnjatic
Nature Medicine (2020) Published 24 August 2020
Pulsa aquí para acceder a la información

Association between renin–angiotensin–aldosterone system inhibitor treatment, neutrophil–lymphocyte ratio, D-Dimer and clinical severity of COVID-19 in hospitalized patients: a multicenter, observational study
Selcuk Gormez, Erkan Ekicibasi, Aleks Degirmencioglu, Ashok Paudel, Refik Erdim, Hilal Kurtoglu Gumusel, Elif Eroglu, Ibrahim Halil Tanboga, Sinan Dagdelen, Nevin Sariguzel, Ceyda Erel Kirisoglu & Burak Pamukcu
Journal of Human Hypertension (2020) Published: 24 August 2020
Pulsa aquí para acceder a la información

A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. Laing, Anna Lorenc, […]Adrian C. Hayday
Nature Medicine (2020) Published: 17 August 2020
Pulsa aquí para acceder a la información

(R) Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
Barnaby E Young•Siew-Wai Fong•Yi-Hao Chan•Tze-Minn Mak•Li Wei Ang•Danielle E Anderson•Cheryl Yi-Pin Lee•Siti Naqiah Amrun•Bernett Lee•Yun Shan Goh•Yvonne C F Su•Wycliffe E Wei•Shirin Kalimuddin•Louis Yi Ann Chai•Surinder Pada•Seow Yen Tan•Louisa Sun•Purnima Parthasarathy•Yuan Yi Constance Chen•Timothy Barkham•Raymond Tzer Pin Lin•Sebastian Maurer-Stroh•Yee-Sin Leo•Lin-Fa Wang•Laurent Renia•Vernon J Lee•Gavin J D Smith•David Chien Lye•Lisa F P Ng
The Lancet Published: August 18, 2020
Pulsa aquí para acceder a la información

COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
Jessica J Manson, Colin Crooks, Meena Naja, Amanda Ledlie, Bethan Goulden, Trevor Liddle, and others
The Lancet Rheumatology  Published: August 21, 2020
Pulsa aquí para acceder a la información

Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China
Wu F, Liu M, Wang A, et al.
JAMA Internal Medicine August 18, 2020
Pulsa aquí para acceder a la información

Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study
Dan Liu•Pengfei Cui•Shaoqing Zeng•Siyuan Wang•Xinxia Feng•Sen Xu•Ruyuan Li•Yue Gao•Ruidi Yu•Ya Wang•Yuan Yuan•Huayi Li•Xiaofei Jiao•Jianhua Chi•Jiahao Liu•Yang Yu•Xu Zheng•Chunyan Song•Ning Jin•Wenjian Gong•Xingyu Liu•Guangyao Cai•Chunrui Li•Qinglei Gao
EClinicalMedicine Published: July 30, 2020
Pulsa aquí para acceder a la información

(R) Genomewide Association Study of Severe Covid-19 with Respiratory Failure
David Ellinghaus, Ph.D., Frauke Degenhardt, M.Sc., Luis Bujanda, M.D., Ph.D., Maria Buti, M.D., Ph.D., Agustín Albillos, M.D., Ph.D., Pietro Invernizzi, M.D., Ph.D., Javier Fernández, M.D., Ph.D., Daniele Prati, M.D., Guido Baselli, Ph.D., Rosanna Asselta, Ph.D., Marit M. Grimsrud, M.D., Chiara Milani, Ph.D., et al., for The Severe Covid-19 GWAS Group*
The New England Journal of Medicine June 17, 2020
DOI: 10.1056/NEJMoa2020283
Pulsa aquí para acceder a la información

Assessment of Hypokalemia and Clinical Characteristics in Patients With Coronavirus Disease 2019 in Wenzhou, China
Dong Chen, MD; Xiaokun Li, MD; Qifa Song, MD; et al.
JAMA Netw Open. 2020;3(6):e2011122. doi:10.1001/jamanetworkopen.2020.11122
Pulsa aquí para acceder a la información

Higher levels of IL‐6 early after tocilizumab distinguish survivors from non‐survivors in COVID‐19 pneumonia: a possible indication for deeper targeting IL‐6
Luca Quartuccio  Arianna Sonaglia  Davide Pecori  Maddalena Peghin  Martina Fabris  Carlo Tascini  Salvatore De Vita
Journal of Medical Virology First published:09 June 2020 https://doi.org/10.1002/jmv.26149
Pulsa aquí para acceder a la información

Circulating Levels of IL‐2, IL‐4, TNF‐α, IFN‐γ and C reactive protein Are Not Associated with Severity of COVID‐19 Symptoms
Wen Luo  Jia‐Wen Zhang  Wei Zhang  Yuan‐Long Lin  Qi Wang
Journal of Medical Virology First published:10 June 2020 https://doi.org/10.1002/jmv.26156
https://onlinelibrary.wiley.com/doi/10.1002/jmv.26156

Plasma CRP level is positively associated with the severity of COVID-19
Wei Chen, Kenneth I. Zheng, Saiduo Liu, Zhihan Yan, Chongyong Xu & Zengpei Qiao
Annals of Clinical Microbiology and Antimicrobials volume 19, Article number: 18 (2020) Published 15 May 2020
Pulsa aquí para acceder a la información

Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis
Giuseppe Lippia and Mario Plebanib,⁎
Clin Chim Acta. 2020 Jun; 505: 190–191. Published online 2020 Mar 4. doi: 10.1016/j.cca.2020.03.004
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094472/

Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
Wenhua Liang, MD1,2; Hengrui Liang, MD1,2; Limin Ou, MD1; et alBinfeng Chen, MD3; Ailan Chen, MD1,4; Caichen Li, MD1; Yimin Li, MD1,5; Weijie Guan, MD1; Ling Sang, MD1,5,6; Jiatao Lu, MD4; Yuanda Xu, MD1,5,7; Guoqiang Chen, MD8; Haiyan Guo, MD9; Jun Guo, MD10; Zisheng Chen, MD1,11; Yi Zhao, MD1,2; Shiyue Li, MD1; Nuofu Zhang, MD1,4; Nanshan Zhong, MD1; Jianxing He, MD1,2; for the China Medical Treatment Expert Group for COVID-19
JAMA Intern Med. Published online May 12, 2020. doi:10.1001/jamainternmed.2020.2033
Pulsa aquí para acceder a la información

Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis?
Negro F.
Swiss Med Wkly. 2020 Apr 16;150:w20249. doi: 10.4414/smw.2020.20249. eCollection 2020 Apr 6.
Pulsa aquí para acceder a la información

Serum Amyloid (SAA) Is a Biomarker to Distinguish the Severity and Prognosis of Coronavirus Disease 2019 (COVID-19)
Huan Li 1Xiaochen Xiang 2Hongwei Ren 1Lingli Xu 1Lisha Zhao 1Xiaoqiong Chen 1Hui Long 3Qiang Wang 4Qingming Wu
J Infect 2020 Apr 8 [Online ahead of print]  DOI: 10.1016/j.jinf.2020.03.035
Pulsa aquí para acceder a la información

Understanding COVID-19: what does viral RNA load really mean? (Comment)

Gavin M Joynt, William KK Wu
The Lancet Infectious Diseases
Published: March 27, 2020
Pulsa aquí para acceder a la información

NOTA de la FUNDACION: Este artículo es un informe preliminar, que no se ha sido todavía revisado por pares

SARS-CoV-2: virus dynamics and host response (Comment)

Yu Chen, Lanjuan Li
The Lancet Infectious Diseases
Published: March 23, 2020
Pulsa aquí para acceder a la información

Susceptibilidad del huésped a COVID-19 grave y establecimiento de una puntuación de riesgo del huésped: hallazgos de 487 casos fuera de Wuhan

Yu Shi , Xia Yu , Hong Zhao , Hao Wang , Ruihong Zhao y Jifang Sheng 
Cuidados críticos volumen 24 , Número de artículo:  108 ( 2020 ) 
Pulsa aquí para acceder a la información

GERIATRÍA

Older adults with SARS‐CoV2 infection: Utility of the Clinical Frailty Scale to predict mortality
Marine Gilis  Ninon Chagrot  Severine Koeberle  Thomas Tannou  Anne‐Sophie Brunel  Catherine Chirouze  Kevin Bouiller
Journal of Medical Virology First published: 30 December 2020 https://doi.org/10.1002/jmv.26766
Pulsa aquí para acceder a la información

 The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study
Jonathan Hewitt, Ben Carter, Arturo Vilches-Moraga, Terence J Quinn, Philip Braude, Alessia Verduri, and others
The Lancet Public Health Published: June 30, 2020
Pulsa aquí para acceder a la información

HEMATOLOGÍA

(N) Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
Sue Pavord, F.R.C.Path., Marie Scully, M.D., Beverley J. Hunt, M.D., William Lester, M.D., Catherine Bagot, M.D., Brian Craven, M.B., B.Ch., Alex Rampotas, M.R.C.P., Gareth Ambler, Ph.D., and Mike Makris, M.D.
NEJM August 11, 2021  DOI: 10.1056/NEJMoa2109908
Pulsa aquí para acceder a la información

(N) Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study
Richard J Perry, Arina Tamborska, Bhagteshwar Singh, Brian Craven, Richard Marigold, Peter Arthur-Farraj and others
The Lancet Published: August 6, 2021
Pulsa aquí para acceder a la información

(R) (N)  Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
The REMAP-CAP, ACTIV-4a, and ATTACC Investigators*
NEJM August 26, 2021; 385:777-789  DOI: 10.1056/NEJMoa2103417
Pulsa aquí para acceder a la información

(R) (N) Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
The ATTACC, ACTIV-4a, and REMAP-CAP Investigators*
NEJM August 26, 2021; 385:790-802  DOI: 10.1056/NEJMoa2105911
Pulsa aquí para acceder a la información

Antibody epitopes in vaccine-induced immune thrombotic thrombocytopenia
Angela Huynh, John G Kelton, Donald M Arnold, Mercy Daka & Ishac Nazy
Nature (2021) Published 07 July 2021
Pulsa aquí para acceder a la información

(R) Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial
Renato D Lopes, Pedro Gabriel Melo de Barros e Silva, Remo H M Furtado, Ariane Vieira Scarlatelli Macedo, Bruna Bronhara, Lucas Petri Damiani and others
The Lancet Published: June 4, 2021
Pulsa aquí para acceder a la información

PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia (Correspondence)
C. Vayne and Others
NEJM May 19, 2021 DOI: 10.1056/NEJMc2106383
Pulsa aquí para acceder a la información

(R) Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19. Vaccination: Guidance Statement from the GTH
Johannes Oldenbur, Robert Klamroth, Florian Langer, Manuela Albisetti,  Charis von Auer, , Cihan Ay,  Wolfgang Korte,  Rüdiger E. Scharf,  Bernd Pötzsch,  Andreas Greinacher
Hämostaseologie Published online 2021-04-01
DOI https://doi.org/10.1055-a/1469-7481

Pulsa aquí para acceder a la información

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial
INSPIRATION Investigators
JAMA March 18, 2021
Pulsa aquí para acceder a la información

Finding the Optimal Thromboprophylaxis Dose in Patients With COVID-19
Al-Samkari H
JAMA March 18, 2021
Pulsa aquí para acceder a la información

Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
Colin Pawlowski, AJ Venkatakrishnan, Christian Kirkup, Gabriela Berner, Arjun Puranik, John C. O'Horo and others
EClinicalMedicinePublished: March 9, 2021
Pulsa aquí para acceder a la información

Clinical and laboratory features of hypercoagulability in COVID-19 and other respiratory viral infections amongst predominantly younger adults with few comorbidities
Chuen Wen Tan, Jing Yuan Tan, Wan Hui Wong, May Anne Cheong, Ian Matthias Ng, Edwin Philip Conceicao, Jenny Guek Hong Low, Heng Joo Ng & Lai Heng Lee
Scientific Reports volume 11, Article number: 1793 (2021) Published: 19 January 2021
Pulsa aquí para acceder a la informacióny

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
Yu Zuo, Mark Warnock, Alyssa Harbaugh, Srilakshmi Yalavarthi, Kelsey Gockman, Melanie Zuo, Jacqueline A. Madison, Jason S. Knight, Yogendra Kanthi & Daniel A. Lawrence
Scientific Reports volume 11, Article number: 1580 (2021) Published: 15 January 2021
Pulsa aquí para acceder a la información

Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
Akshay SharmaNeel S BhattAndrew St MartinMuhammad Bilal AbidJenni BloomquistRoy F Chemaly and others
The Lancet Haematology Published: January 19, 2021
Pulsa aquí para acceder a la información

Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness. A Population-Based Cohort Study
Joel G. Ray, MD, MSc, Michael J. Schull, MD, MSc, Marian J. Vermeulen, MSc, Alison L. Park, MSc
Annals of Internal Medicine 24 November 2020 Pulsa aquí para acceder a la información https://www.acpjournals.org/doi/10.7326/M20-4511

Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality
Joaquín Martínez-López, María-Victoria Mateos, Cristina Encinas, Anna Sureda, José Ángel Hernández-Rivas, Ana Lopez de la Guía, Diego Conde, Isabel Krsnik, Elena Prieto, Rosalía Riaza Grau, Mercedes Gironella, María Jesús Blanchard, Nerea Caminos, Carlos Fernández de Larrea, María Alicia Senin, Fernando Escalante, José Enrique de la Puerta, Eugenio Giménez, Pilar Martínez-Barranco, Juan José Mateos, Luis Felipe Casado, Joan Bladé, Juan José Lahuerta, Javier de la Cruz & Jesús San-Miguel
Blood Cancer Journal volume 10, Published: 19 October 2020
Article number: 103 (2020)
Pulsa aquí para acceder a la información

The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
Ryan L. Hoiland, Nicholas A. Fergusson, Anish R. Mitra, Donald E. G. Griesdale, Dana V. Devine, Sophie Stukas, Jennifer Cooper, Sonny Thiara, Denise Foster, Luke Y. C. Chen, Agnes Y. Y. Lee, Edward M. Conway, Cheryl L. Wellington, Mypinder S. Sekhon
Blood Adv (2020) 4 (20): 4981–4989. https://doi.org/10.1182/bloodadvances.2020002623
Pulsa aquí para acceder a la información

The association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
Ryan L. Hoiland, Nicholas A. Fergusson, Anish R. Mitra, Donald E. G. Griesdale, Dana V. Devine, Sophie Stukas, Jennifer Cooper, Sonny Thiara, Denise Foster, Luke Y. C. Chen, Agnes Y. Y. Lee, Edward M. Conway, Cheryl L. Wellington, Mypinder S. Sekhon
Blood Adv (2020) 4 (20): 4981–4989. https://doi.org/10.1182/bloodadvances.2020002623
Pulsa aquí para acceder a la información



Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study
Sylvain Lamure•Rémy Duléry•Roberta Di Blasi•Adrien Chauchet•Cécile Laureana•Bénédicte Deau-Fischer•Bernard Drenou•Carole Soussain•Cédric Rossi•Nicolas Noël•Sylvain Choquet•Serge Bologna•Bertrand Joly•Milena Kohn•Sandra Malak•Guillemette Fouquet•Etienne Daguindau•Sophie Bernard•Catherine Thiéblemont•Guillaume Cartron•Karine Lacombe•Caroline Besson
EClinicalMedicine Published: October 12, 2020
Pulsa aquí para acceder a la información

Change in Donor Characteristics and Antibodies to SARS-CoV-2 in Donated Blood in the US, June-August 2020 (Research Letter)
Dodd RY, Xu M, Stramer SL
JAMA September 14, 2020
Pulsa aquí para acceder a la información

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia (Letter)
Lindsey E. Roeker, David A. Knorr, Melissa S. Pessin, Lakshmi V. Ramanathan, Meghan C. Thompson, Lori A. Leslie, Andrew D. Zelenetz & Anthony R. Mato
Leukemia (2020) Published 27 August 2020
Pulsa aquí para acceder a la información

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, Riccardo Bruna, Michele Cavo, Francesco Merli, and others
The Lancet Haematology  Published: August 13, 2020
Pulsa aquí para acceder a la información

Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19) (Research Letter)
Morayma Reyes Gil, MD, PhD1; Mohammad Barouqa, MD1; James Szymanski, MD1; et alJesus D. Gonzalez-Lugo, MD2; Shafia Rahman, MD2; Henny H. Billett, MD2,3
JAMA Netw Open. 2020;3(8):e2017539. August 12, 2020
doi:10.1001/jamanetworkopen.2020.17539
Pulsa aquí para acceder a la información

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study
Danying Liao, Fen Zhou, Lili Luo, Min Xu, Hongbo Wang, Jiahong Xia, and others
The Lancet Haematology  Published: July 10, 202
Pulsa aquí para acceder a la información

Effects of the COVID-19 pandemic on supply and use of blood for transfusion
Simon J Stanworth, Helen V New, Torunn O Apelseth, Susan Brunskill, Rebecca Cardigan, Carolyn Doree, and others
The Lancet Haematology  Published: July 3, 2020
Pulsa aquí para acceder a la información

Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
George Goshua, Alexander B Pine, Matthew L Meizlish, C-Hong Chang, Hanming Zhang, Parveen Bahel, and others
The Lancet Haematology Published: June 30, 2020
Pulsa aquí para acceder a la información

(R) Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
Amer M Zeidan, Prajwal C Boddu, Mrinal M Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K Rampal, and others
The Lancet Haematology  Published: June 18, 2020
Pulsa aquí para acceder a la información

Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill
Mortus JR, Manek SE, Brubaker LS, et al.
JAMA Network Open June 5, 2020
Pulsa aquí para acceder a la información

Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19)
Nahum J, Morichau-Beauchant T, Daviaud F, et al.
JAMA Network Open May 29, 2020
Pulsa aquí para acceder a la información

Intra‐articular injections in people with haemophilia in the COVID‐19 era (Letter)
Hortensia De la Corte‐Rodriguez  E. Carlos Rodriguez‐Merchan  M. Teresa Alvarez‐Roman  Víctor Jimenez‐Yuste
Haemophilia First published:19 May 2020 https://doi.org/10.1111/hae.14070
Pulsa aquí para acceder a la información

Pulmonary Arterial Thrombosis in COVID-19 With Fatal Outcome: Results From a Prospective, Single-Center, Clinicopathologic Case SeriesFREE
Sigurd F. Lax, MD, PhD, Kristijan Skok, MD, Peter Zechner, MD, Harald H. Kessler, MD, PhD, … View all authors
Annals of Internal Medicine 14 May 2020
https://doi.org/10.7326/M20-2566
Pulsa aquí para acceder a la información

Coagulation abnormalities and thrombosis in patients with COVID-19 (Comment)
Marcel Levi, Jecko Thachil, Toshiaki Iba, Jerrold H Levy
The Lancet Haematology Published: May 11, 2020
Pulsa aquí para acceder a la información

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19. A Prospective Cohort Study
Dominic Wichmann, MD, Jan-Peter Sperhake, MD, Marc Lütgehetmann, MD, …
Annals of Internnal Medicine 6 May 2020  https://doi.org/10.7326/M20-2003
Pulsa aquí para acceder a la información

(R) Mecanismos inmunes de la coagulopatía intravascular pulmonar en la neumonía por COVID-19
Dennis McGonagle • James S O'Donnell • Kassem Sharif • Paul Emery • Charles Bridgewood
The Lancet Rheumatology Publicado: 7 de mayo de 2020
Pulsa aquí para acceder a la información

The old but new: Can unfractioned heparin and low molecular weight heparins inhibit proteolytic activation and cellular internalization of SARS-CoV2 by inhibition of host cell proteases?
F. B. Belen-Apak, F. Sarialioglu
Medical HypothesesVolume 142September 2020Article 109743
Pulsa aquí para acceder a la información

(R) COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up
Behnood Bikdeli, MD, MS, Mahesh V. Madhavan, MD, David Jimenez, MD, PhD, Taylor Chuich, PharmD, Isaac Dreyfus, MD, Elissa Driggin, MD, Caroline Der Nigoghossian, PharmD, Walter Ageno, MD, Mohammad Madjid, MD, MS, Yutao Guo, MD, PhD, Liang V. Tang, MD, Yu Hu, MD, Jay Giri, MD, MPH, Mary Cushman, MD, MSc, Isabelle Quéré, MD, PhD, Evangelos P. Dimakakos, MD, C. Michael Gibson, MD, Giuseppe Lippi, MD, Emmanuel J. Favaloro, PhD, Jawed Fareed, PhD, Joseph A. Caprini, MD, MS, Alfonso J. Tafur, MD, MS, John R. Burton, BS, Dominic P. Francese, MPH, Elizabeth Y. Wang, MD, Anna Falanga, MD, Claire McLintock, MD, Beverley J. Hunt, MD, Alex C. Spyropoulos, MD, Geoffrey D. Barnes, MD, MSc, John W. Eikelboom, MBBS, Ido Weinberg, MD, Sam Schulman, MD, PhD, Marc Carrier, MD, MSc, Gregory Piazza, MD, MS, Joshua A. Beckman, MD, P. Gabriel Steg, MD, Gregg W. Stone, MD, Stephan Rosenkranz, MD, Samuel Z. Goldhaber, MD, Sahil A. Parikh, MD, Manuel Monreal, MD, PhD, Harlan M. Krumholz, MD, SM, Stavros V. Konstantinides, MD, PhD, Jeffrey I. Weitz, MD, Gregory Y.H. Lip, MD
Journal of the American College of Cardiology 15 April 2020
https://doi.org/10.1016/j.jacc.2020.04.031
Pulsa aquí para acceder a la información

The Contact Activation System as a Potential Therapeutic Target in Patients with COVID-19
JJ Shatzel, MD, EP DeLoughery , CU Lorentz, PhD, EI Tucker, PhD, JE Aslan, PhD , MT Hinds, Ph2 , D Gailani, MD , JI Weitz, MD FRCP(C) FACP , OJT McCarty, PhD FAHA, A Gruber, MD
Research and practice in thrombosis and hemostasis doi: 10.1002/rth2.12349
Pulsa aquí para acceder a la información

Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19 (Comment)
Tao Wang, Ruchong Chen, Chunli Liu, Wenhua Liang, Weijie Guan, Ruidi Tang, and others
The Lancet Haematology Published: April 9, 2020
Pulsa aquí para acceder a la información

Coagulopatía en enfermedades críticas con Covid-19 (Correspondence)

Y. Zhang y otros
The New England Journal of Medicine April 8, 2020
DOI: 10.1056/NEJMc2007575
Pulsa aquí para acceder a la información

Proporción de neutrófilos a linfocitos y proporción de proteínas de linfocitos a reactivos C en pacientes con enfermedad grave por coronavirus 2019 (COVID-19): un metaanálisis
Francisco Alejandro Lagunas ‐ Rangel
Revista de virología médica 3 Apr 2020  DOI: 10.1002 / jmv.25819
Pulsa aquí para acceder a la información

INFECCIOSAS (OTRAS)

Invasive mould disease in fatal COVID-19: a systematic review of autopsies (Review)
Brittany E Kula, Cornelius J Clancy, M Hong Nguyen, Ilan S Schwartz
The Lancet Microbe Published: June 23, 2021

Pulsa aquí para acceder a la información

Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
Clark D Russell, Cameron J Fairfield, Thomas M Drake, Lance Turtle, R Andrew Seaton, Dan G Wootton and others
The Lancet Microbe Published: June 2, 2021
Pulsa aquí para acceder a la información

Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? (Correspondence)Akshay Raut, Nguyen Tien Huy

The Lancet Respiratory Medicine Published: June 3, 2021
Pulsa aquí para acceder a la información

Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data
Angela B Brueggemann, Melissa J Jansen van Rensburg, David Shaw, Noel D McCarthy, Keith A Jolley, Martin C J Maiden and others
The Lancet Digital Health Vol. 3 No. 6 Published: June, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study
Matthew A Spinelli, Kara L Lynch, Cassandra Yun, David V Glidden, Michael J Peluso, Timothy J Henrich and others
The Lancet HIV Published: April 29, 2021
Pulsa aquí para acceder a la información

The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study
Kate M Mitchell, Dobromir Dimitrov, Romain Silhol, Lily Geidelberg, Mia Moore, Albert Liu, and others
The Lancet HIV  Published: February 19, 2021
Pulsa aquí para acceder a la información

The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis
Jienchi Dorward, Thokozani Khubone, Kelly Gate, Hope Ngobese, Yukteshwar Sookrajh,  Siyabonga Mkhize and others
The Lancet HIV Published: February 4, 2021
Pulsa aquí para acceder a la información

Evaluation of Seasonal Respiratory Virus Activity Before and After the Statewide COVID-19 Shelter-in-Place Order in Northern California
Elizabeth Partridge ; Ellen McCleery ; Ritu Cheema et al
JAMA Netw Open. January 25, 2021;4(1):e2035281. doi:10.1001/jamanetworkopen.2020.35281
Pulsa aquí para acceder a la información

Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
Lionel Piroth, Jonathan Cottenet, Anne-Sophie Mariet, Philippe Bonniaud, Mathieu Blot, Pascale Tubert-Bitter, and others
The Lancet Respiratory Medicine  Published: December 17, 2020
Pulsa aquí para acceder a la información

Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study
Lionel Piroth, Jonathan Cottenet, Anne-Sophie Mariet, Philippe Bonniaud, Mathieu Blot, Pascale Tubert-Bitter, and others
The Lancet Respiratory Medicine  Published: December 17, 2020
Pulsa aquí para acceder a la información

HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform

Krishnan Bhaskaran, Christopher T Rentsch, Brian MacKenna, Anna Schultze, Amir Mehrkar, Chris J Bates, and others

The Lancet HIV  Published: December 11, 2020

Pulsa aquí para acceder a la información

Risk stratification of hospitalized COVID-19 patients through comparative studies of laboratory results with influenza
Yang Mei•Samuel E. Weinberg•Lihui Zhao•Adam Frink•Chao Qi•Amir Behdad•Peng Ji
EClinicalMedicine Published: July 30, 2020
Pulsa aquí para acceder a la información

Rates of coinfection with other respiratory pathogens in patients positive for coronavirus disease 2019 (COVID‐19)
Edward M. Castillo PhD, MPH  Christopher J. Coyne MD, MPH  Jesse J. Brennan MA  Christian A. Tomaszewski MD, MS, MBA
Journal of the American Emergency Physicians First published: 02 July 2020 https://doi.org/10.1002/emp2.12172
Pulsa aquí para acceder a la información

Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy . A Cohort Study
Julia del Amo, MD, PhD, Rosa Polo, MD, PhD, Santiago Moreno, MD, PhD, … View all authors
Annals of Internal Medicine 26 Jun 2020https://doi.org/10.7326/M20-3689
Pulsa aquí para acceder a la información

Tasas de coinfección entre SARS-CoV-2 y otros patógenos respiratorios
David Kim, MD, PhD 1 ; James Quinn, MD, MS 1 ; Benjamin Pinsky, MD, PhD 2 ; y col.Nigam H. Shah, MBBS, PhD 3 ; Ian Brown, MD, MS 1
JAMA Publicado en línea el 15 de abril de 2020. doi: 10.1001 / jama.2020.6266
Pulsa aquí para acceder a la información

COVID-19 in patients with HIV: clinical case series (Correspondence)
Jose L Blanco, Juan Ambrosioni, Felipe Garcia, Esteban Martínez, Alex Soriano, Josep Mallolas, and others
The Lancet HIV
Published: April 15, 2020
Pulsa aquí para acceder a la información

NEFROLOGÍA

Assessment of Acute Kidney Injury and Longitudinal Kidney Function After Hospital Discharge Among Patients With and Without COVID-19
Nugent J, Aklilu A, Yamamoto Y, et al.
JAMA Network Open March 10, 2021
Pulsa aquí para acceder a la información

COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup (Reviews)
Mitra K. Nadim, Lui G. Forni […] John A. Kellum
Nature Reviews Nephrology , 1–18 15 October 2020
Pulsa aquí para acceder a la información

COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup (Reviews)
Mitra K. Nadim, Lui G. Forni […] John A. Kellum
Nature Reviews Nephrology , 1–18 15 October 2020
Pulsa aquí para acceder a la información

Multiorgan and Renal Tropism of SARS-CoV-2
V.G. Puelles and Others
The New England Journal of Medicine May 13, 2020  DOI: 10.1056/NEJMc2011400
Pulsa aquí para acceder a la información

Recomendaciones en el manejo de la pandemia por coronavirus SARS - CoV -2 ( Covid - 19 ) en pacientes con trasplante renal
Verónica López ,Teresa Vázquez ,Juana Alonso-Titos ,Mercedes Cabello ,Grupo de Estudio GREAT (Grupo Español de Actualizaciones en Trasplante)
Nefrología En prensa, prueba corregida Disponible en línea el 3 de abril de 2020)
Pulsa aquí para acceder a la información

NEUROLOGÍA

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium
Chou SH, Beghi E, Helbok R, et al.
JAMA Network Open May 11, 2021
Pulsa aquí para acceder a la información

Acute Ischemic Stroke During the Convalescent Phase of Asymptomatic COVID-2019 Infection in Men
Tu TM, Seet CYH, Koh JS, et al.
JAMA Network Open April 22, 2021
Pulsa aquí para acceder a la información

Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis
Salter A, Fox RJ, Newsome SD, et al.
JAMA Neurology March 19, 2021
Pulsa aquí para acceder a la información

Association of Clinical, Biological, and Brain Magnetic Resonance Imaging Findings With Electroencephalographic Findings for Patients With COVID-19
Lambrecq V, Hanin A, Munoz-Musat E, et al.
JAMA Network Open March 15, 2021
Pulsa aquí para acceder a la información

Neuropathology of patients with COVID-19 in Germany: a post-mortem case series
Jakob Matschke, Marc Lütgehetmann, Christian Hagel, Jan P Sperhake, Ann Sophie Schröder, Carolin Edler, and others
The Lancet Neurology Published: October 5, 2020
Pulsa aquí para acceder a la información

 Effects of COVID-19 on the nervous system (Review)
Iadecola et al.
Cell  Published online: August 19, 2020
Pulsa aquí para acceder a la información

Prevalence and prognostic value of Delirium as the initial presentation of COVID-19 in the elderly with dementia: An Italian retrospective study
Tino Emanuele Poloni•Arenn Faye Carlos•Marco Cairati•Chiara Cutaia•Valentina Medici•Eleonora Marelli•Danila Ferrari•Alberto Galli•Paola Bognetti•Annalisa Davin•Alice Cirrincione•Arcangelo Ceretti•Cristina Cereda•Mauro Ceroni•Livio Tronconi•Silvia Vitali•Antonio Guaita
EClinicalMedicine Published: July 30, 2020
Pulsa aquí para acceder a la información

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
Céline Louapre, MD1; Nicolas Collongues, MD2; Bruno Stankoff, MD1,3; et alClaire Giannesini, MD3; Caroline Papeix, MD1; Caroline Bensa, MD4; Romain Deschamps, MD4; Alain Créange, MD5; Abir Wahab, MD5; Jean Pelletier, MD6; Olivier Heinzlef, MD7; Pierre Labauge, MD8; Laurent Guilloton, MD9; Guido Ahle, MD10; Mathilde Goudot, MD11; Kevin Bigaut, MD2; David-Axel Laplaud, MD12; Sandra Vukusic, MD13; Catherine Lubetzki, MD1; Jérôme De Sèze, MD2; for the Covisep investigators
JAMA Neurol. Published online June 26, 2020. doi:10.1001/jamaneurol.2020.2581
Pulsa aquí para acceder a la información

Neurologic Features in Severe SARS-CoV-2 Infection (Letter)
Julie Helms, M.D., Ph.D., Stéphane Kremer, M.D., Ph.D., Hamid Merdji, M.D. et al.
The New England Journal of Medicine June 4, 2020DOI: 10.1056/NEJMc2008597
Pulsa aquí para acceder a la información

Effects of COVID‐19 on Parkinson's disease clinical features: a community‐based case‐control study
Roberto Cilia MD, Salvatore Bonvegna MD, Giulia Straccia MD, Golfrè Andreasi Nico MD, Antonio E. Elia MD, PhD, Luigi M. Romito MD, PhD, Grazia Devigili MD, PhD, Emanuele Cereda MD, PhD, Roberto Eleopra MD.
Movement Disorders First published:25 May 2020 DOI: 10.1002/mds.28170
Pulsa aquí para acceder a la información

Consensus for prevention and management of coronavirus disease 2019 (COVID-19) for neurologists
Huijuan Jin1, Candong Hong1, Shengcai Chen1, Yifan Zhou1, Yong Wang1, Ling Mao1, Yanan Li1, Quanwei He1, Man Li1, Ying Su1, David Wang2, Longde Wang3, Bo Hu1
BMJ Stroke & Vascular Neurology 2020;0. doi:10.1136/ svn-2020-000382
Pulsa aquí para acceder a la información

Neurologic Features in Severe SARS-CoV-2 Infection (Correspondence)

Julie Helms, M.D., Ph.D., Stéphane Kremer, M.D., Ph.D., Hamid Merdji, M.D., Raphaël Clere-Jehl, M.D., Malika Schenck, M.D., Christine Kummerlen, M.D., Olivier Collange, M.D., Ph.D., Clotilde Boulay, M.D., Samira Fafi-Kremer, Pharm.D., Ph.D.
Mickaël Ohana, M.D., Ph.D., Mathieu Anheim, M.D., Ph.D,  Ferhat Meziani, M.D., Ph.D.
Strasbourg University Hospital, Strasbourg, France
The New England Journal of Medicine April 15, 2020
DOI: 10.1056/NEJMc2008597
Pulsa aquí para acceder a la información

Síndrome de Guillain-Barré asociado con SARS-CoV- (Correspondence)

Gianpaolo Toscano, M.D., Francesco Palmerini, M.D, Sabrina Ravaglia, M.D., Ph.D., Luigi Ruiz, M.D., Paolo Invernizzi, M.D., M. Giovanna Cuzzoni, M.D., Diego Franciotta, M.D., Fausto Baldanti, M.D., Rossana Daturi, M.D., Paolo Postorino, M.D., Anna Cavallini, M.D., Giuseppe Micieli, M.D.
The New England Journal of Medicine  April 17, 2020
DOI: 10.1056/NEJMc2009191
Pulsa aquí para acceder a la información

Management challenges for chronic dysimmune neuropathies during the COVID‐19 pandemic
Yusuf A. Rajabally MD FRCP  H. Stephan Goedee MD PhD  Shahram Attarian MD PhD  Hans‐Peter Hartung MD PhD
Muscle & Nerve First published:20 April 2020 https://doi.org/10.1002/mus.26896
Pulsa aquí para acceder a la información

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China
Ling Mao 1 ; Huijuan Jin 1 ; Mengdie Wang 1 ; y otros
JAMA Neurol. Publicado en línea el 10 de abril de 2020. doi: 10.1001 / jamaneurol.2020.1127
Pulsa aquí para acceder a la información

Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host−Virus Interaction, and Proposed Neurotropic Mechanisms
Abdul Mannan Baig,* Areeba Khaleeq, Usman Ali, and Hira Syeda

ACS Chemical Neuroscience

Pulsa aquí para acceder a la información

Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study

 Yanan Li*, Mengdie Wang*, Yifan Zhou*, Jiang Chang*, Ying Xian, Ling Mao, Candong Hon
The Lancet Prepublicación

Pulsa aquí para acceder a la información

OBSTETRICIA / GINECOLOGÍA

Need for and use of contraception by women before and during COVID-19 in four sub-Saharan African geographies: results from population-based national or regional cohort surveys
Shannon N Wood, Celia Karp, Funmilola Ola, OlorunAkilimali,  Z Pierre, Georges Guiella, Peter Gichangi, and others
The Lancet Global Health Vol. 9 No. 6 Published: June, 2021
Pulsa aquí para acceder a la información

Need for and use of contraception by women before and during COVID-19 in four sub-Saharan African geographies: results from population-based national or regional cohort surveys
Shannon N Wood, Celia Karp, Funmilola Ola, OlorunAkilimali,  Z Pierre, Georges Guiella, Peter Gichangi, and others
The Lancet Global Health Vol. 9 No. 6 Published: June, 2021
Pulsa aquí para acceder a la información

(R) Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19
Karola S. Jering ; Brian L. Claggett ; Jonathan W. Cunningham et al                                                                            
JAMA Intern Med. Published online January 15, 2021. doi:10.1001/jamainternmed.2020.9241
Pulsa aquí para acceder a la información

(R) Clinical Characteristics and Outcomes of Hospitalized Women Giving Birth With and Without COVID-19
Karola S. Jering ; Brian L. Claggett ; Jonathan W. Cunningham et al                                                                            
JAMA Intern Med. Published online January 15, 2021. doi:10.1001/jamainternmed.2020.9241
Pulsa aquí para acceder a la información

Impact of COVID-19 mitigation measures on the incidence of preterm birth: a national quasi-experimental study
Jasper V Been, Lizbeth Burgos Ochoa, Loes C M Bertens, Sam Schoenmakers, Eric A P Steegers, Irwin K M Reiss
The Lancet Public Health Published: October 13, 2020
Pulsa aquí para acceder a la información

Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis
John Allotey, Elena Stallings, Mercedes Bonet, Magnus Yap, Shaunak Chatterjee, Tania Kew, Luke Debenham, Anna Clavé Llavall, Anushka Dixit, Dengyi Zhou, Rishab Balaji, Siang Ing Lee, Xiu Qiu, Mingyang Yuan, Dyuti Coomar, Madelon van Wely, Elizabeth van Leeuwen, Elena Kostova, Heinke Kunst, Asma Khalil, Simon Tiberi, Vanessa Brizuela, Nathalie Broutet, Edna Kara, Caron Rahn Kim, Anna Thorson, Olufemi T Oladapo, Lynne Mofenson, Javier Zamora, Shakila Thangaratinam, for PregCOV-19 Living Systematic Review Consortium
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3320 (Published 01 September 2020)
Pulsa aquí para acceder a la información

Change in the Incidence of Stillbirth and Preterm Delivery During the COVID-19 Pandemic (Research Letter)
Asma Khalil, MD1; Peter von Dadelszen, PhD2; Tim Draycott, MD3; et alAustin Ugwumadu, PhD1; Pat O’Brien, MBBCh, MRCOG, MFFP4; Laura Magee, PhD2
JAMA. Published online July 10, 2020. doi:10.1001/jama.2020.12746
Pulsa aquí para acceder a la información

Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2107 (Published 08 June 2020)
Pulsa aquí para acceder a la información

Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain
Oscar Martínez-Perez, MD, PhD; Manon Vouga, MD, PhD; Sara Cruz Melguizo, MD, PhD; et al
JAMA. Published online June 8, 2020. doi:10.1001/jama.2020.10125
Pulsa aquí para acceder a la información

A Spanish-translated clinical algorithm for management of suspected SARS-CoV-2 infection in pregnant women (Correspondence)
Raigam J Martinez-Portilla, Anna Goncé, Ameth Hawkins-Villarreal, Francesc Figueras
The Lancet Infectious Diseases  Published: April 9, 2020

Pulsa aquí para acceder a la información

Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study

(ARTÍCULO)

Nan Yu, Wei Li, Qingling Kang, Zhi Xiong, Shaoshuai Wang, Xingguang Lin, and others
The Lancet Infectious Diseases
Published: March 24, 2020
Pulsa aquí para acceder a la información

OFTALMOLOGIA

Patient Perceptions of SARS-CoV-2 Exposure Risk and Association With Continuity of Ophthalmic Care
Lindeke-Myers A, Zhao PYC, Meyer BI, et al.
JAMA Ophthalmology March 11, 2021
Pulsa aquí para acceder a la información

Patient Perceptions of SARS-CoV-2 Exposure Risk and Association With Continuity of Ophthalmic Care
Lindeke-Myers A, Zhao PYC, Meyer BI, et al.
JAMA Ophthalmology March 11, 2021
Pulsa aquí para acceder a la información

Retinal findings in patients with COVID-19
Paula M Marinho, Allexya A A Marcos, André C Romano, Heloisa Nascimento, Rubens Belfort Jr
The Lancet  Published: May 12, 2020
Pulsa aquí para acceder a la información

Características de los hallazgos oculares de pacientes con enfermedad por coronavirus 2019 (COVID-19) en la provincia de Hubei, China

Ping Wu, MD  ; Fang Duan, MD  ; Chunhua Luo, MD  ; et al.Qiang Liu, MD  ; Xingguang Qu, MD  ; Liang Liang, MD  ; Kaili Wu, MD
JAMA Ophthalmol. Publicado en línea el 31 de marzo de 2020. doi: 10.1001 / jamaophthalmol.2020.1291
Pulsa aquí para acceder a la información

ONCOLOGÍA

Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis
Anne-Gaëlle Goubet, Agathe Dubuisson, […]Lisa Derosa
Cell Death & Differentiation (2021) Published: 06 July 2021
Pulsa aquí para acceder a la información

Impact of COVID-19 on cancer care in India: a cohort study
Priya Ranganathan, Manju Sengar, Girish Chinnaswamy, Gaurav Agrawal, Rajkumar Arumugham, Rajiv Bhatt and others
The Lancet Oncology Published: May 27, 2021
Pulsa aquí para acceder a la información

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
Lucie de JongeJoachim WorthingtonFrancine van WifferenNicolas Iragorri Elisabeth F P PeterseJie-Bin Lew and others
The Lancet Gastroenterology & HepatologyPublished: February 3, 2021
Pulsa aquí para acceder a la información

The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study
Katie Spencer, Christopher M Jones, Rebecca Girdler, Catherine Roe, Michael Sharpe, Sarah Lawton, and others
The Lancet Oncology Published: January 22, 2021
Pulsa aquí para acceder a la información

Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study
Eva J A Morris, Raphael Goldacre, Enti Spata, Marion Mafham, Paul J Finan, Jon Shelton, and others
The Lancet Gastroenterology & Hepatology Published: January 14, 2021
Pulsa aquí para acceder a la información

Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta‐analysis of cohort studies
Aakash Desai MD, MPH  Rohit Gupta BA  Shailesh Advani MD, PhD  Lara Ouellette MLS  Nicole M. Kuderer MD  Gary H. Lyman MD, MPH (Biostatistics)  Ang Li MD, MS
CANCER First published: 30 December 2020 https://doi.org/10.1002/cncr.33386
Pulsa aquí para acceder a la información

The effect of clinical decision making for initiation of systemic anticancer treatments in response to the COVID-19 pandemic in England: a retrospective analysis
James J Clark, Dominic Dwyer, Nina Pinwill, Peter Clark, Peter Johnson, Allan Hackshaw
The Lancet Oncology Published: November 27, 2020
Pulsa aquí para acceder a la información

Integrated Survival Estimates for Cancer Treatment Delay Among Adults With Cancer During the COVID-19 Pandemic
Holly E. Hartman, MS1; Yilun Sun, PhD1,2; Theresa P. Devasia, MS1; et alElizabeth C. Chase, MS1; Neil K. Jairath, BS2; Robert T. Dess, MD2; William C. Jackson, MD2; Emily Morris, MS1; Pin Li, PhD1; Kimberly A. Hochstedler, MS1; Madeline R. Abbott, MS1; Kelley M. Kidwell, PhD1; Vonn Walter, PhD3; Ming Wang, PhD3; Xi Wang, MS3; Nicholas G. Zaorsky, MD4,5; Matthew J. Schipper, PhD1,2; Daniel E. Spratt, MD2 JAMA Oncol. Published online October 29, 2020.
doi:10.1001/jamaoncol.2020.5403
Pulsa aquí para acceder a la información

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Lennard Y W Lee•Jean-Baptiste Cazier•Thomas Starkey•Sarah E W Briggs•Roland Arnold•Vartika Bisht•Stephen Booth•Naomi A Campton•Vinton W T Cheng•Graham Collins•Helen M Curley•Philip Earwaker•Matthew W Fittall•Spyridon Gennatas•Anshita Goel•Simon Hartley•Daniel J Hughes•David Kerr•Alvin J X Lee•Rebecca J Lee•Siow Ming Lee•Hayley Mckenzie•Chris P Middleton•Nirupa Murugaesu•Tom Newsom-Davis•Anna C Olsson-Brown•Claire Palles•Thomas Powles•Emily A Protheroe•Karin Purshouse•Archana Sharma-Oates•Shivan Sivakumar•Ashley J Smith•Oliver Topping•Chris D Turnbull•Csilla Várnai•Adam D M Briggs•Gary Middleton•Rachel Kerr on behalf of the UK Coronavirus Cancer Monitoring Project Team
The Lancet Oncology Published: August 24, 2020
Pulsa aquí para acceder a la información

Changes in the Number of US Patients With Newly Identified Cancer Before and During the Coronavirus Disease 2019 (COVID-19) Pandemic (Research Letter)
Harvey W. Kaufman, MD; Zhen Chen, MS; Justin Niles, MA; et al
JAMA Netw Open. 2020; 3(8): e2017267. doi:10.1001/jamanetworkopen.2020.17267
Pulsa aquí para acceder a la información

The 3 B's of cancer care amid the COVID‐19 pandemic crisis: “Be safe, be smart, be kind”—A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer
Jung Julie Kang MD, PhD  Richard J. Wong MD  Eric J. Sherman MD  Alisa Rybkin BS  Sean M. McBride MD, MPH  Nadeem Riaz MD, MSc  C. Jillian Tsai MD, PhD  Yao Yu MD … See all authors
Cancer  First published: 08 July 2020 https://doi.org/10.1002/cncr.33031
Pulsa aquí para acceder a la información

Determinants of COVID-19 disease severity in patients with cancer
Elizabeth V. Robilotti, N. Esther Babady, […]Mini Kamboj
Nature Medicine Published: 24 June 2020
Pulsa aquí para acceder a la información

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
Marina Chiara Garassino, Jennifer G Whisenant, Li-Ching Huang, Annalisa Trama, Valter Torri, Francesco Agustoni, and others
The Lancet Oncology Published: June 12, 2020
Pulsa aquí para acceder a la información

Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study
Jianbo Tian, Xianglin Yuan, Jun Xiao, Qiang Zhong, Chunguang Yang, Bo Liu, and others
The Lancet Oncology Published: May 29, 2020
Pulsa aquí para acceder a la información

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study
Kunyu Yang, Yuhan Sheng, Chaolin Huang, Yang Jin, Nian Xiong, Ke Jiang, and others
The Lancet Oncology  Published: May 29, 2020
Pulsa aquí para acceder a la información

COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
Lennard Y W Lee•Jean Baptiste Cazier•T Starkey•C D Turnbull•UK Coronavirus Cancer Monitoring Project Team•Rachel Kerr•Gary Middleton
The Lancet Published: May 28, 2020
Pulsa aquí para acceder a la información

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, Yu Shyr, Samuel M Rubinstein, Donna R Rivera, and others
The Lancet  Published: May 28, 2020
Pulsa aquí para acceder a la información

SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
Jing Yu, MD1,2,3Wen Ouyang, MD1,2,3Melvin L. K. Chua, MBBS, PhD1,4,5; et al.
JAMA Oncol. Published online March 25, 2020. doi:10.1001/jamaoncol.2020.0980
Pulsa aquí para acceder a la información

A War on Two Fronts: Cancer Care in the Time of COVID-19
Alexander Kutikov, MD; David S. Weinberg, MD, MSc; Martin J. Edelman, MD; Eric M. Horwitz, MD; Robert G. Uzzo, MD, MBA; Richard I. Fisher, MD
Ann Intern Med. 27 March 2020. doi:10.7326/M20-1133
Pulsa aquí para acceder a la información

OTORRINOLARINGOLOGÍA

Prevalence and 6‐month recovery of olfactory dysfunction: a multicentre study of 1363 COVID‐19 patients
J. R. Lechien  C. M. Chiesa‐Estomba  E. Beckers  V. Mustin  M. Ducarme  F. Journe  A. Marchant  L. Jouffe  M. R. Barillari  G. Cammaroto  M. P. Circiu  S. Hans  S. Saussez
Journal of Internal Medicine 05 January 2021 https://doi.org/10.1111/joim.13209
Pulsa aquí para acceder a la información

Prevalence of Taste and Smell Dysfunction in Coronavirus Disease 2019
Giuseppe Mercante, MD1,2; Fabio Ferreli, MD1,2; Armando De Virgilio, MD, PhD1,2; et alFrancesca Gaino, MD2; Matteo Di Bari, MD1,2; Giovanni Colombo, MD1,2; Elena Russo, MD1,2; Andrea Costantino, MD1,2; Francesca Pirola, MD1,2; Giovanni Cugini, MD2; Luca Malvezzi, MD2; Emanuela Morenghi, MS, PhD3; Elena Azzolini, MD1,4; Michele Lagioia, MD4; Giuseppe Spriano, MD1,2
JAMA Otolaryngol Head Neck Surg. Published online June 18, 2020. doi:10.1001/jamaoto.2020.1155
https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2767510

Loss of Smell and Taste in 2013 European Patients With Mild to Moderate COVID-19 (Letter)
Jerome R. Lechien, MD, PhD, MS, Carlos M. Chiesa-Estomba, MD, MS, …
Annals of Internal Medicine 26 May 2020  https://doi.org/10.7326/M20-2428
Pulsa aquí para acceder a la información

Olfactory Dysfunction in COVID-19. Diagnosis and Management (Clinical Update)
Katherine Lisa Whitcroft, BSc, MBChB; Thomas Hummel, MD
JAMA. Published online May 20, 2020. doi:10.1001/jama.2020.8391
Pulsa aquí para acceder a la información

Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection (Research Letter)
Giacomo Spinato, MD1; Cristoforo Fabbris, MD1; Jerry Polesel, MD2; et alDiego Cazzador, MD3; Daniele Borsetto, MD4; Claire Hopkins, MA(Oxon), DM4; Paolo Boscolo-Rizzo, MD1
JAMA. Published online April 22, 2020. doi:10.1001/jama.2020.6771
Pulsa aquí para acceder a la información

Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study
Jerome R. Lechien, Carlos M. Chiesa-Estomba, […]Sven Saussez
European Archives of Oto-Rhino-Laryngology (6 April 2020)
Pulsa aquí para acceder a la información

PEDIATRÍA

Treatment of Multisystem Inflammatory Syndrome in Children
Andrew J. McArdle, M.B., B.Chir., Ortensia Vito, M.Sc., Harsita Patel, M.B., B.S., Eleanor G. Seaby, B.M., B.S., Priyen Shah, M.B., B.S., Clare Wilson, M.B., B.Chir., Claire Broderick, M.B., B.S., Ruud Nijman, M.D., Ph.D., Adriana H. Tremoulet, M.D., Daniel Munblit, M.D., Ph.D., Rolando Ulloa-Gutierrez, M.D., Michael J. Carter, B.M., B.Ch., D.Phil., et al., for the BATS Consortium*
NEJM June 16, 2021 DOI: 10.1056/NEJMoa2102968
Pulsa aquí para acceder a la información

Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes

Mary Beth F. Son, M.D., Nancy Murray, M.Sc., Kevin Friedman, M.D., Cameron C. Young, Margaret M. Newhams, M.P.H., Leora R. Feldstein, Ph.D., Laura L. Loftis, M.D., Keiko M. Tarquinio, M.D., Aalok R. Singh, M.D., Sabrina M. Heidemann, M.D., Vijaya L. Soma, M.D., Becky J. Riggs, M.D., et al., for the Overcoming COVID-19 Investigators*
NEJM June 16, 2021 DOI: 10.1056/NEJMoa2102605
Pulsa aquí para acceder a la información

Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics (Editorial)
Roberta L. DeBiasi, M.D.
NEJM June 16, 2021 DOI: 10.1056/NEJMe2108276
Pulsa aquí para acceder a la información

Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study
Jackeline J Rodriguez-Smith, Emely L Verweyen, Gwendolyn M Clay, Ysabella M Esteban, Sarah R de Loizaga, Elizabeth Joy Baker and others
The Lancet Rheumatology Published: June 8, 2021
Pulsa aquí para acceder a la información

Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort study
Christoph Kessel, Ndate Fall, Alexei Grom, Wilco de Jager, Sebastiaan Vastert, Raffaele Strippoli, and others
The Lancet Rheumatology Published: June 8, 2021
Pulsa aquí para acceder a la información

Clinical characteristics and risk factors for death among hospitalised children and adolescents with COVID-19 in Brazil: an analysis of a nationwide database
Eduardo A Oliveira, Enrico A Colosimo, Ana Cristina Simões e Silva, Robert H Mak, Daniella B Martelli, Ludmila R Silva and others
The Lancet Child & Adolescent Health Published: June 10, 2021
Pulsa aquí para acceder a la información

6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study
Justin Penner, Omar Abdel-Mannan, Karlie Grant, Sue Maillard, Filip Kucera, Jane Hassell and others
The Lancet Child & Adolescent HealthPublished: May 24, 2021
Pulsa aquí para acceder a la información

Outcomes During the COVID-19 Pandemic in Ontario, Canada
Simpson AN, Snelgrove JW, Sutradhar R, et al.
JAMA Network Open May 12, 2021
Pulsa aquí para acceder a la información

Assessment of Pediatric Admissions for Kawasaki Disease or Infectious Disease During the COVID-19 State of Emergency in Japan
Hara T, Furuno K, Yamamura K, et al.
JAMA Network Open April 6, 2021
Pulsa aquí para acceder a la información

Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study
Joseph Y Abrams, Matthew E Oster, Shana E Godfred-Cato, Bobbi Bryant, S Deblina Datta, Angela P Campbell, and others
The Lancet Child & Adolescent Health Published: March 9, 2021
Pulsa aquí para acceder a la información

Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
LaRovere KL, Riggs BJ, Poussaint TY, et al.
JAMA Neurology March 5, 2021
Pulsa aquí para acceder a la información

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Leora R. Feldstein, PhD1,2; Mark W. Tenforde, MD1; Kevin G. Friedman, MD3; et alfor the Overcoming COVID-19 Investigators
JAMA. Published online February 24, 2021. doi:10.1001/jama.2021.2091
Pulsa aquí para acceder a la información

Trends in US Pediatric Hospital Admissions in 2020 Compared With the Decade Before the COVID-19 Pandemic
Jonathan H. Pelletier, MD1; Jaskaran Rakkar, MD1; Alicia K. Au, MD, MS1; et alDana Fuhrman, DO, MS1; Robert S. B. Clark, MD1; Christopher M. Horvat, MD, MHA1,2
JAMA Netw Open. 2021;4(2):e2037227. doi:10.1001/jamanetworkopen.2020.37227
Pulsa aquí para acceder a la información

Prevalence and Risk Factors Associated With Self-reported Psychological Distress Among Children and Adolescents During the COVID-19 Pandemic in China
Zuguo Qin ; Lei Shi ; Yaqing Xue et al
JAMA Netw Open. January 26, 2021;4(1):e2035487. doi:10.1001/jamanetworkopen.2020.35487
Pulsa aquí para acceder a la información

Assessment of Maternal and Neonatal Cord Blood SARS-CoV-2 Antibodies and Placental Transfer Ratios
Dustin D. Flannery ; Sigrid Gouma ; Miren B. Dhudasia  et al
JAMA Pediatr. Published online January 29, 2021. doi:10.1001/jamapediatrics.2021.0038
Pulsa aquí para acceder a la información

Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study

Camilla E Lindan, MD, Kshitij Mankad, FRCR, Dipak Ram, FRCPCH, Larry K Kociolek, MD, V Michelle Silvera, MD, Prof Nathalie Boddaert, MD et al.

The Lancet Child & Adolescent Health Published:December 15, 2020DOI:https://doi.org/10.1016/S2352-4642(20)30362-X

Pulsa aquí para acceder a la información

Characteristics and outcomes of neonatal SARS-CoV-2 infection in the UK: a prospective national cohort study using active surveillance
Chris Gale, Maria A Quigley, Anna Placzek, Marian Knight, Shamez Ladhani, Elizabeth S Draper, and others
The Lancet Child & Adolescent Health  Published: November 9, 2020
Pulsa aquí para acceder a la información

(R) Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults. A Systematic Review and Meta-analysis
Russell M. Viner, PhD; Oliver T. Mytton, PhD; Chris Bonell, PhD; et al
JAMA Pediatr. Published online September 25, 2020. doi:10.1001/jamapediatrics.2020.4573
Pulsa aquí para acceder a la información

Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children
Song X, Delaney M, Shah RK, et al.
JAMA Network Open September 8, 2020
Pulsa aquí para acceder a la información

A national consensus management pathway for paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): results of a national Delphi process (Review)
Rachel Harwood, Benjamin Allin, Christine E Jones, Elizabeth Whittaker, Padmanabhan Ramnarayan, Athimalaipet V Ramanan, and others
The Lancet Child & Adolescent Health Published: September 18, 2020
Pulsa aquí para acceder a la información

Multisystem inflammatory syndrome in children: A systematic review
Mubbasheer Ahmed, Shailesh Advani, Axel Moreira, Sarah Zoretic, John Martinez, Kevin Chorath, and others
EClinicalMedicine  Published: September 4, 2020
Pulsa aquí para acceder a la información

Clinical Characteristics and Viral RNA Detection in Children With Coronavirus Disease 2019 in the Republic of Korea
Mi Seon Han, MD, PhD; Eun Hwa Choi, MD, PhD; Sung Hee Chang, MD et al
JAMA Pediatr. Published online August 28, 2020. doi:10.1001/jamapediatrics.2020.3988
Pulsa aquí para acceder a la información

(R) Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
Olivia V Swann,1,2 Karl A Holden,3,4 Lance Turtle,5,6 Louisa Pollock,7
Cameron J Fairfield,8 et al. On behalf of ISARIC4C Investigators
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3249 (Published 27 August 2020)
Pulsa aquí para acceder a la información

Ocular Manifestations and Clinical Characteristics of Children With Laboratory-Confirmed COVID-19 in Wuhan, China
Ma N, Li P, Wang X, et al.
JAMA Ophthalmology August 26, 2020
Pulsa aquí para acceder a la información

COVID-19 and multisystem inflammatory syndrome in children and adolescents (Review)
Li Jiang, Kun Tang, Mike Levin, Omar Irfan, Shaun K Morris, Karen Wilson, and others
The Lancet Infectious Diseases  Published: August 17, 202           
Pulsa aquí para acceder a la información

Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study
Patrick Davies, Claire Evans, Hari Krishnan Kanthimathinathan, Jon Lillie, Joseph Brierley, Gareth Waters, and others
The Lancet Child & Adolescent Health Published: July 9, 2020
Pulsa aquí para acceder a la información

Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis
Naim Ouldali, Marie Pouletty, Patricia Mariani, Constance Beyler, Audrey Blachier, Stephane Bonacorsi, and others
The Lancet Child & Adolescent Health Published: July 2, 2020
Pulsa aquí para acceder a la información

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
Leora R. Feldstein, Ph.D., Erica B. Rose, Ph.D., Steven M. Horwitz, M.D., Jennifer P. Collins, M.D., Margaret M. Newhams, M.P.H., Mary Beth F. Son, M.D., Jane W. Newburger, M.D., M.P.H., Lawrence C. Kleinman, M.D., M.P.H., Sabrina M. Heidemann, M.D., Amarilis A. Martin, M.D., Aalok R. Singh, M.D., Simon Li, M.D., M.P.H., et al., for the Overcoming COVID-19 Investigators, and the CDC COVID-19 Response Team                                                                                                                                                                  The New England Journal of Medicine June 29, 2020
DOI: 10.1056/NEJMoa2021680
Pulsa aquí para acceder a la información

 Multisystem Inflammatory Syndrome in Children in New York State
Elizabeth M. Dufort, M.D., Emilia H. Koumans, M.D., M.P.H., Eric J. Chow, M.D., M.P.H., Elizabeth M. Rosenthal, M.P.H., Alison Muse, M.P.H., Jemma Rowlands, M.P.H., Meredith A. Barranco, M.P.H., Angela M. Maxted, D.V.M., Ph.D., Eli S. Rosenberg, Ph.D., Delia Easton, Ph.D., Tomoko Udo, Ph.D., Jessica Kumar, D.O., et al., for the New York State and Centers for Disease Control and Prevention Multisystem Inflammatory Syndrome in Children Investigation Team*
The New England Journal of Medicine June 29, 2020
DOI: 10.1056/NEJMoa2021756
Pulsa aquí para acceder a la información

Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children
Omar Abdel-Mannan, MD; Michael Eyre, MD; Ulrike Löbel, MD; et al.
Author Affiliations Article Information
JAMA Neurol. Published online July 1, 2020. doi:10.1001/jamaneurol.2020.2687
Pulsa aquí para acceder a la información

COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
Florian Götzinger, Begoña Santiago-García, Antoni Noguera-Julián, Miguel Lanaspa, Laura Lancella, Francesca I Calò Carducci, and others
The Lancet Child & Adolescent Health Published: June 25, 2020
Pulsa aquí para acceder a la información

A multicenter national survey of children with SARS-CoV-2 infection admitted to Spanish Pediatric Intensive Care Units (Letter)
Rafael González Cortés, Alberto García-Salido, David Roca Pascual, María Slöcker Barrio, Juan Carlos de Carlos Vicente & SECIP Study Group on SARS-CoV-2 in Critically Ill Pediatric Patients
Intensive Care Medicine Published: 22 June 2020
Pulsa aquí para acceder a la información

What we know so far about Coronavirus Disease 2019 in children: A meta‐analysis of 551 laboratory‐confirmed cases
Linjie Zhang MD, PhD  Tyele G. Peres  Marcus V. F. Silva  Paulo Camargos MD, PhD
Pediatric Pulmonology First published:10 June 2020 https://doi.org/10.1002/ppul.24869
Pulsa aquí para acceder a la información

Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
Elizabeth Whittaker, MD1,2; Alasdair Bamford, MD3,4; Julia Kenny, MD5,6; et alMyrsini Kaforou, PhD2; Christine E. Jones, MD7; Priyen Shah, MD2; Padmanabhan Ramnarayan, MD1,8; Alain Fraisse, MD9; Owen Miller, MD10,11; Patrick Davies, MD12; Filip Kucera, MD13; Joe Brierley, MD14; Marilyn McDougall, MD6,15; Michael Carter, MD6,15; Adriana Tremoulet, MD16; Chisato Shimizu, MD16; Jethro Herberg, MD1,2; Jane C. Burns, MD16; Hermione Lyall, MD1; Michael Levin, MD2; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia
JAMA. Published online June 8, 2020. doi:10.1001/jama.2020.10369
Pulsa aquí para acceder a la información

Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2094 (Published 03 June 2020)
https://www.bmj.com/content/369/bmj.m2094

Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children’s Hospital in New York City, New York
Zachariah P, Johnson CL, Halabi KC, et al.
JAMA Pediatrics June 3, 2020
Pulsa aquí para acceder a la información

Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China
Wu H, Zhu H, Yuan C, et al.
JAMA Network Open June 3, 2020
Pulsa aquí para acceder a la información

Nasal Gene Expression of Angiotensin-Converting Enzyme 2 in Children and Adults
Bunyavanich S, Do A, Vicencio A
JAMA May 20, 2020
Pulsa aquí para acceder a la información

Gastrointestinal features in children with COVID-19: an observation of varied presentation in eight children (Correspondence)
Lucinda Tullie, Kathryn Ford, May Bisharat, Tom Watson, Hemanshoo Thakkar, Dhanya Mullassery, and others
The Lancet Child & Adolescent Health Published: May 19, 2020
https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(20)30165-6/fulltext

School Closure During the Coronavirus Disease 2019 (COVID-19) Pandemic. An Effective Intervention at the Global Level?
Susanna Esposito, MD; Nicola Principi, MD
JAMA Pediatr. Published online May 13, 2020. doi:10.1001/jamapediatrics.2020.1892
Pulsa aquí para acceder a la información

Kawasaki-like disease: emerging complication during the COVID-19 pandemic (Comment)
Russell M Viner, Elizabeth Whittaker
The Lancet Published: May 13, 2020
Pulsa aquí para acceder a la información

Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units
Lara S. Shekerdemian, MD, MHA1; Nabihah R. Mahmood, MD2; Katie K. Wolfe, MD3; et alBecky J. Riggs, MD4; Catherine E. Ross, MD5; Christine A. McKiernan, MD6; Sabrina M. Heidemann, MD7; Lawrence C. Kleinman, MD, MPH8; Anita I. Sen, MD9; Mark W. Hall, MD10; Margaret A. Priestley, MD11; John K. McGuire, MD12; Konstantinos Boukas, MD13; Matthew P. Sharron, MD14; Jeffrey P. Burns, MD, MPH15; for the International COVID-19 PICU Collaborative
JAMA Pediatr. Published online May 11, 2020. doi:10.1001/jamapediatrics.2020.1948
Pulsa aquí para acceder a la información

Children are not COVID-19 super spreaders: time to go back to school (Viewpoint)
Alasdair P S Munro, Saul N Faust
Arch Dis Child 28 Apr 2020 http://dx.doi.org/10.1136/archdischild-2020-319474
Pulsa aquí para acceder a la información

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents. A Systematic Review
Riccardo Castagnoli, MD; Martina Votto, MD; Amelia Licari, MD; et alIlaria Brambilla, MD, PhD; Raffaele Bruno, MD; Stefano Perlini, MD; Francesca Rovida, PhD; Fausto Baldanti, MD; Gian Luigi Marseglia, MD
JAMA Pediatr. Published online April 22, 2020. doi:10.1001/jamapediatrics.2020.1467
Pulsa aquí para acceder a la información

Detección y gravedad de la enfermedad por coronavirus 2019 (COVID-19) en niños en Madrid, España
Alfredo Tagarro, PhD, MD 1,2 ; Cristina Epalza, PhD, MD 2,3 ; Mar Santos, PhD, MD 4 ; et al.Francisco José Sanz-Santaeufemia, PhD, MD 5 ; Enrique Otheo, PhD, MD 6 ; Cinta Moraleda, PhD, MD 2,3 ; Cristina Calvo, PhD, MD 7
JAMA Pediatr. Publicado en línea el 8 de abril de 2020. doi: 10.1001 / jamapediatrics.2020.1346
Pulsa aquí para acceder a la información

Características epidemiológicas de 2143 pacientes pediátricos con enfermedad por coronavirus 2019 en China

Yuanyuan Dong , Xi Mo , Yabin Hu , Xin Qi , Fang Jiang , Zhongyi Jiang y Shilu Tong
Pediatrics marzo de 2020
 (previo publicación, e20200702;  DOI:https://doi.org/10.1542/peds.2020-0702
Pulsa aquí para acceder a la información

PSIQUIATRÍA

Public mental health problems during COVID-19 pandemic: a large-scale meta-analysis of the evidence
Xuerong Liu, Mengyin Zhu, Rong Zhang, Jingxuan Zhang, Chenyan Zhang, Peiwei Liu, Zhengzhi Feng & Zhiyi Chen
Translational Psychiatry volume 11, Article number: 384 (2021) Published: 09 July 2021
Pulsa aquí para acceder a la información

Possible posttraumatic stress disorder in Chinese frontline healthcare workers who survived COVID-19 6 months after the COVID-19 outbreak: prevalence, correlates, and symptoms
Li-Juan Xiong, Bao-Liang Zhong, Xiong-Jing Cao, Huang-Guo Xiong, Ming Huang, Jing Ding, Wen-Tian Li, Jun Tong, He-Yong Shen, Jia-Hong Xia & Yu Hu
Translational Psychiatry volume 11, Article number: 374 (2021) Published: 05 July 2021
Pulsa aquí para acceder a la información

La pandemia de COVID-19 y la salud mental materna en un entorno frágil y afectado por conflictos en Tumaco, Colombia: un estudio de cohorte
Andrés Moya, Pieter Serneels, Alethea Desrosiers, Vilma Reyes, María José Torres, Alicia Lieberman
The Lancet Global HealthPublicado: 24 de junio de 2021
Pulsa aquí para acceder a la información

Depressive symptoms, mental wellbeing, and substance use among adolescents before and during the COVID-19 pandemic in Iceland: a longitudinal, population-based study
Ingibjorg Eva Thorisdottir, Bryndis Bjork Asgeirsdottir, Alfgeir Logi Kristjansson, Heiddis Bjork Valdimarsdottir, Erla Maria Jonsdottir Tolgyes, Jon Sigfusson and others
The Lancet Psychiatry Published: June 3, 2021
Pulsa aquí para acceder a la información

Mental health responses to the COVID-19 pandemic: a latent class trajectory analysis using longitudinal UK data
Matthias Pierce, Sally McManus, Holly Hope, Matthew Hotopf, Tamsin Ford, Stephani L Hatch and others
The Lancet Psychiatry Published: May 6, 2021
Pulsa aquí para acceder a la información

Mental health responses to the COVID-19 pandemic: a latent class trajectory analysis using longitudinal UK data
Matthias Pierce, Sally McManus, Holly Hope, Matthew Hotopf, Tamsin Ford, Stephani L Hatch and others
The Lancet Psychiatry Published: May 6, 2021
Pulsa aquí para acceder a la información

Suicide trends in the early months of the COVID-19 pandemic: an interrupted time-series analysis of preliminary data from 21 countries
Jane Pirkis, Ann John, , Sangsoo ShinMarcos DelPozo-Banos, Vikas Arya, Pablo Analuisa-Aguilar and others
The Lancet PsychiatryPublished: April 13, 2021
Pulsa aquí para acceder a la información

How COVID-19 Affects the Brain (Review)
Boldrini M, Canoll PD, Klein RS
JAMA Psychiatry March 26, 2021
Pulsa aquí para acceder a la información

How COVID-19 Affects the Brain (Review)
Boldrini M, Canoll PD, Klein RS
JAMA Psychiatry March 26, 2021
Pulsa aquí para acceder a la información

How COVID-19 Affects the Brain (Review)
Boldrini M, Canoll PD, Klein RS
JAMA Psychiatry March 26, 2021
Pulsa aquí para acceder a la información

COVID-19 mental health impact and responses in low-income and middle-income countries: reimagining global mental health (Review)
Lola Kola, Brandon A Kohrt, Charlotte Hanlon, John A Naslund, Siham Sikander, Madhumitha Balaji and others
The Lancet Psychiatry  Published: February 24, 2021
Pulsa aquí para acceder a la información

Association of Psychiatric Disorders With Mortality Among Patients With COVID-19
Katlyn Nemani ; Chenxiang Li ; Mark Olfson  et al
JAMA Psychiatry. Published online January 27, 2021. doi:10.1001/jamapsychiatry.2020.4442
Pulsa aquí para acceder a la información

Effects of the COVID-19 pandemic on primary care-recorded mental illness and self-harm episodes in the UK: a population-based cohort study
Matthew J CarrSarah SteegRoger T WebbNav KapurCarolyn A Chew-GrahamKathryn M Abel and others
The Lancet Public HealthPublished: January 11, 2021

Pulsa aquí para acceder a la información

Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study
Brenda T Pun, Rafael Badenes, Gabriel Heras La Calle, Onur M Orun, Wencong Chen, Rameela Raman, and others
The Lancet Respiratory Medicine Published: January 8, 2021
Pulsa aquí para acceder a la información

Real-time suicide mortality data from police reports in Queensland, Australia, during the COVID-19 pandemic: an interrupted time-series analysis
Stuart Leske, Kairi Kõlves, David Crompton, Ella Arensman, Diego de Leo
The Lancet Psychiatry  Published: November 16, 2020
Pulsa aquí para acceder a la información

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA
Maxime Taquet, Sierra Luciano, John R Geddes, Paul J Harrison
The Lancet Psychiatry Published: November 9, 2020
Pulsa aquí para acceder a la información

Real-time suicide mortality data from police reports in Queensland, Australia, during the COVID-19 pandemic: an interrupted time-series analysis
Stuart Leske, Kairi Kõlves, David Crompton, Ella Arensman, Diego de Leo
The Lancet Psychiatry  Published: November 16, 2020
Pulsa aquí para acceder a la información

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA
Maxime Taquet, Sierra Luciano, John R Geddes, Paul J Harrison
The Lancet Psychiatry Published: November 9, 2020
Pulsa aquí para acceder a la información

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA
Maxime Taquet, Sierra Luciano, John R Geddes, Paul J Harrison
The Lancet Psychiatry Published: November 9, 2020
Pulsa aquí para acceder a la información

Pre-pandemic psychiatric disorders and risk of COVID-19: a UK Biobank cohort analysis
Huazhen Yang, Wenwen Chen, Yao Hu, Yilong Chen, Yu Zeng, Yajing Sun, and others
The Lancet Healthy Longevity  Published: October 26, 2020
Pulsa aquí para acceder a la información

Factors Associated With Mental Health Disorders Among University Students in France Confined During the COVID-19 Pandemic
Wathelet M, Duhem S, Vaiva G, et al.
JAMA Network Open October 23, 2020
Pulsa aquí para acceder a la información

Prevalence of Depression Symptoms in US Adults Before and During the COVID-19 Pandemic
Ettman CK, Abdalla SM, Cohen GH, et al.
JAMA Network Open September 2, 2020
Pulsa aquí para acceder a la información

Association between mental illness and COVID-19 susceptibility and clinical outcomes in South Korea: a nationwide cohort study
Seung Won Lee, Jee Myung Yang, Sung Yong Moon, In Kyung Yoo, Eun Kyo Ha, So Young Kim, and others
The Lancet Psychiatry  Published: September 17, 2020
Pulsa aquí para acceder a la información

Prevalence of and Risk Factors Associated With Mental Health Symptoms Among the General Population in China During the Coronavirus Disease 2019 Pandemic
Le Shi, PhD1; Zheng-An Lu, MSc1; Jian-Yu Que, MSc1; et al
JAMA Netw Open. 2020; 3(7) :e2014053. doi:10.1001/jamanetworkopen.2020.14053
Pulsa aquí para acceder a la información

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic
Jonathan P Rogers, Edward Chesney, Dominic Oliver, Thomas A Pollak, Philip McGuire, Paolo Fusar-Poli, and others
The Lancet Psychiatry Published: May 18, 2020
Pulsa aquí para acceder a la información

Prescripción segura e informada de medicamentos psicotrópicos durante la pandemia de COVID-19
Jurjen J. Luykx (a1) , Sisco MP van Veen (a2) , Arne Risselada (a3) , Paul Naarding (a4) ...
The British Journal of Psichiatry 04 de mayo de 2020 DOI: https://doi.org/10.1192/bjp.2020.92
Pulsa aquí para acceder a la información

Achieving Good Mental Health during COVID-19 Social Isolation
Rowan Diamond, John Willan
The British Journal of Psychiatry /04 May 2020, pp. 1-6
https://www.cambridge.org/core/journals/the-british-journal-of-psychiatry/article/achieving-good-mental-health-during-covid19-social-isolation/BD00D7F2ABBCFF444D806676885EC26B

Cognitive Therapy for Post-Traumatic Stress Disorder following Critical Illness and Intensive Care Unit Admission
Hannah Murray, Nick Grey, Jennifer Wild, Emma Warnock-Parkes, Alice Kerr, David M. Clark, Anke Ehlers
the Cognitive Behaviour Therapist /Published online by Cambridge University Press: 29 April 2020, pp. 1-36
Pulsa aquí para acceder a la información

Treatment concerns for psychiatric symptoms in COVID-19-infected patients with or without psychiatric disorders
Kai Zhang, Xiaoqing Zhou, Huanzhong Liu, Kenji Hashimoto
The British Journal of Psychiatry / Published online by Cambridge University Press: 09 April 2020, pp. 1-3
Pulsa aquí para acceder a la información

RESPIRATORIO

(N) Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial
Prof Stephan Ehrmann, Jie Li, Miguel Ibarra-Estrada, Yonatan Perez, Ivan Pavlov, Bairbre McNicholas, et al.
The Lancet Respiratory Medicine Published:August 20, 2021DOI:https://doi.org/10.1016/S2213-2600(21)00356-8
Pulsa aquí para acceder a la información

Cytokine adsorption in patients with severe COVID-19 pneumonia requiring extracorporeal membrane oxygenation (CYCOV): a single centre, open-label, randomised, controlled trial
Alexander Supady, Enya Weber, Marina Rieder, Achim Lother, Tim Niklaus, Timm Zahn and others
The Lancet Respiratory Medicine Published: May 14, 2021
Pulsa aquí para acceder a la información

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
Sanjay Ramakrishnan, Dan V Nicolau Jr, Beverly Langford, Mahdi Mahdi, Helen Jeffers, Christine Mwasuku and others
The Lancet Respiratory Medicine Published: April 9, 2021
Pulsa aquí para acceder a la información

Association between pre-existing respiratory disease and its treatment, and severe COVID-19: a population cohort study
Paul AveyardMin GaoNicola LindsonJamie Hartmann-BoycePeter WatkinsonDuncan Youngand others
The Lancet Respiratory MedicinePublished: April 1, 2021
Pulsa aquí para acceder a la información

 Mortality and Readmission Rates Among Patients With COVID-19 After Discharge From Acute Care Setting With Supplemental Oxygen
Banerjee J, Canamar CP, Voyageur C, et al.
JAMA Network Open April 1, 2021
Pulsa aquí para acceder a la información

 Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries
Ankit Bharat, Tiago N Machuca, Melissa Querrey, Chitaru Kurihara, Rafael Garza-Castillon Jr, Samuel Kim and others
The Lancet Respiratory Medicine Published: March 31, 2021
Pulsa aquí para acceder a la información

Effect of Helmet Noninvasive Ventilation vs High-Flow Nasal Oxygen on Days Free of Respiratory Support in Patients With COVID-19 and Moderate to Severe Hypoxemic Respiratory Failure: The HENIVOT Randomized Clinical Trial
Grieco DL, Menga LS, Cesarano M, et al.
JAMA March 25, 2021
Pulsa aquí para acceder a la información

Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK
Chloe I Bloom, Thomas M Drake, Annemarie B Docherty, Brian J Lipworth, Sebastian L Johnston, Jonathan S Nguyen-Van-Tam, and others
The Lancet Respiratory Medicine Published: March 4, 2021
Pulsa aquí para acceder a la información

Asthma in COVID-19 Hospitalizations: An Overestimated Risk Factor?
Richard Broadhurst , Ryan Peterson , Juan P. Wisnivesky , Alex Federman , Shanta M Zimmer , Sunita Sharma , Michael Wechsler ; Fernando Holguin
Annals of the American Thoracic Society Published Online: August 31, 2020 Pulsa aquí para acceder a la información
PubMed: 32864985

COVID-19 patients managed in psychiatric inpatient settings due to first-episode mental disorders in Wuhan, China: clinical characteristics, treatments, outcomes, and our experiences
Qin Xie, Fang Fan, Xue-Peng Fan, Xiao-Jiang Wang, Ming-Jian Chen, Bao-Liang Zhong & Helen Fung-Kum Chiu
Translational Psychiatry volume 10, Article number: 337 (2020) Published: 02 October 2020
Pulsa aquí para acceder a la información

Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform
Anna Schultze, Alex J Walker, Brian MacKenna, Caroline E Morton, Krishnan Bhaskaran, Jeremy P Brown, and others
The Lancet Respiratory Medicine  Published: September 24, 2020
Pulsa aquí para acceder a la información

Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
Giacomo Grasselli, Tommaso Tonetti, Alessandro Protti, Thomas Langer, Massimo Girardis, Giacomo Bellani, and others
The Lancet Respiratory Medicine Published August 27, 2020
Pulsa aquí para acceder a la información

Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study
Pratik Sinha, Carolyn S Calfee, Shiney Cherian, David Brealey, Sean Cutler, Charles King, and others
The Lancet Respiratory Medicine   Published: August 27, 2020
Pulsa aquí para acceder a la información

Evaluation for SARS-CoV-2 in Breast Milk From 18 Infected Women (Research Letter)
Chambers C, Krogstad P, Bertrand K, et al.
JAMA August 19, 2020
Pulsa aquí para acceder a la información

Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study
Matthieu Schmidt, David Hajage, Guillaume Lebreton, Antoine Monsel, Guillaume Voiriot, David Levy, and others
The Lancet Respiratory Medicine  Published: August 13, 2020
Pulsa aquí para acceder a la información

Extracorporeal Membrane Oxygenation for Patients With COVID-19 in Severe Respiratory Failure (Research Letter)
Asif K. Mustafa, MD, PhD; Philip J. Alexander, MD; Devang J. Joshi, MD; et al
JAMA Surg. Published online August 11, 2020. doi:10.1001/jamasurg.2020.3950
Pulsa aquí para acceder a la información

A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19
Weihui Fu•Yan Liu•Lu Xia•Min Li•Zhigang Song•Huiliang Hu•Zongguo Yang•Lin Wang•Xiaobo Cheng•Mei Wang•Rongrong Jiang•Li Liu•Xiaoting Mao•Jun Chen•Yun Ling•Lin Zhang•Jin Yan•Fei Shan•Corklin Steinhart•Xiaoyan Zhang•Tongyu Zhu•Jianqing Xu•Hongzhou Lu
EClinicalMedicine Published: July 29, 2020
Pulsa aquí para acceder a la información

Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study
Anna Coppo, Giacomo Bellani, Dario Winterton, Michela Di Pierro, Alessandro Soria, Paola Faverio, and others
The Lancet Respiratory Medicine  Published: June 19, 2020
Pulsa aquí para acceder a la información

Prone Positioning in Awake, Nonintubated Patients With COVID-19 Hypoxemic Respiratory Failure
Alison E. Thompson, MD1; Benjamin L. Ranard, MD1; Ying Wei, PhD2; et alSanja Jelic, MD1
JAMA Intern Med. Published online June 17, 2020. doi:10.1001/jamainternmed.2020.3030
Pulsa aquí para acceder a la información

Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study
Luca Carsana, Aurelio Sonzogni, Ahmed Nasr, Roberta Simona Rossi, Alessandro Pellegrinelli, Pietro Zerbi, and others
The Lancet Infectious Diseases  Published: June 8, 2020
Pulsa aquí para acceder a la información

Association of Noninvasive Oxygenation Strategies With All-Cause Mortality in Adults With Acute Hypoxemic Respiratory Failure: A Systematic Review and Meta-analysis
Ferreyro BL, Angriman F, Munshi L, et al.
JAMA June 4, 2020 doi:10.1001/jama.2020.9524
Pulsa aquí para acceder a la información

Recomendaciones de consenso con respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a la infección por SARS-CoV-2
César Cinesi Gómez,   Óscar Peñuelas Rodríguez,   Manel Luján Torné,   Carlos Egea Santaolalla,   Juan Fernando Masa Jiménez,   Javier García Fernández ,   José Manuel Carratalá Perales,   Sarah Béatrice Heili-Frades,   Miquel Ferrer Monreal,  José M de Andrés Nilsson ,   Eva Lista Arias,   Juan Luis Sánchez Rocamora ,   José Ignacio Garrote,   Miguel J Zamorano Serrano ,   Mónica González Martínez,   Eva Farrero Muñoz,   Olga Mediano San Andrés,   Gemma Rialp Cervera,  Arantxa Mas Serra ,   Gonzalo Hernández Martínez,   Candelaria de Haro López,   Oriol Roca Gas ,   Ricard Ferrer Roca,   Antonio Romero Berrocal,   Carlos Ferrando Ortola
PMID: 32312600 DOI: 10.1016 / j.medin.2020.03.005
Med Intensiva. 2020 30 de marzo; S0210-5691 (20) 30094-2

Pulsa aquí para acceder a la información

The impact of COPD and smoking history on the severity of Covid‐19: A systemic review and meta‐analysis
Qianwen Zhao Meng Meng Rahul Kumar Yinlian Wu Jiaofeng Huang Ningfang Lian Yunlei Deng Su Lin
Journal of Medical Virology DOI: 10.1002/jmv.25889
Pulsa aquí para acceder a la información

Tasas de coinfección entre SARS-CoV-2 y otros patógenos respiratorios
David Kim, MD, PhD ; James Quinn, MD, MS ; Benjamin Pinsky, MD, PhD ; y col.Nigam H. Shah, MBBS, PhD3 ; Ian Brown, MD, MS
JAMA Publicado en línea el 15 de abril de 2020. doi: 10.1001 / jama.2020.6266
Pulsa aquí para acceder a la información

Differences between COVID‐19 and suspected then confirmed SARS‐CoV‐2‐negative pneumonia: a retrospective study from a single center

Xinyi Chen, Yi Yang, Min Huang, Lili Liu, Xianxiang Zhang, Jing Xu, Shaoqing Geng, Bo Han, Jiangfeng Xiao, Yanyun Wan
Journal of Medical Virology DOI:Pulsa aquí para acceder a la información

 

REUMATOLOGIA

(N) COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses (Review)
Filippo Fagni, MD *; David Simon, MD *; Koray Tascilar, MD; Verena Schoenau, MD; Prof Michael Sticherling, MD; Prof Markus F Neurath, MD et al.
The Lancet Rheumatology Published:August 27, 2021DOI:https://doi.org/10.1016/S2665-9913(21)00247-2
Pulsa aquí para acceder a la información

Autoimmune inflammatory rheumatic diseases and COVID-19 outcomes in South Korea: a nationwide cohort study
Youn Ho Shin, Jae Il Shin, Sung Yong ,  Young Jin, So Young Kim, Jee Myung Yang and others
The Lancet Rheumatology Published: June 18, 2021
Pulsa aquí para acceder a la información

Laboratory trends, hyperinflammation, and clinical outcomes for patients with a systemic rheumatic disease admitted to hospital for COVID-19: a retrospective, comparative cohort study
Tiffany Y-T Hsu, Kristin M D'Silva, Naomi J Patel, Jiaqi Wang, Alisa A Mueller, Xiaoqing Fu and others
The Lancet Rheumatology  Published: May 28, 2021
Pulsa aquí para acceder a la información

Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
Amit Saxena, Allison Guttmann, Mala Masson, Mimi Y Kim, Rebecca H Haberman, Rochelle Castillo and others
The Lancet Rheumatology Published: May 27, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study
David Saadoun, Matheus Vieira, Mathieu Vautier, Xenofon BaraliakosIoana Andreica, José A P da Silva and others
The Lancet Rheumatology Published: April 28, 2021

Pulsa aquí para acceder a la información

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study
Jérôme Avouac, Elodie Drumez, Eric Hachulla, Raphaèle Seror, Sophie Georgin-Lavialle, Soumaya El Mahou, and others
The Lancet Rheumatology  Published: March 25, 2021
Pulsa aquí para acceder a la información

Temporal trends in severe COVID-19 outcomes in patients with rheumatic disease: a cohort study
April Jorge, Kristin M D'Silva, Andrew Cohen, Zachary S Wallace, Natalie McCormick, Yuqing Zhang, and others
The Lancet Rheumatology Published: December 23, 2020
Pulsa aquí para acceder a la información

 COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study
Jixin Zhong, Guifen Shen, Huiqin Yang, Anbin Huang, Xiaoqi Chen, Li Dong, and others
The Lancet Rheumatology Published: July 3, 2020
Pulsa aquí para acceder a la información

TRATAMIENTO/VACUNAS

Índice de Secciones

GENERALIDADES

ANTICUERPOS

 

ANTIVIRALES

CORTICOIDES

HIDROXICLOROQUINA

INMUNOSUPRESIÓN

OTROS ARTÍCULOS

OTROS TRATAMIENTOS

PLASMA DE PACIENTES CONVALECIENTES

TERAPIA ANTI-CITOQUINAS

VACUNAS

 

GENERALIDADES

(R) Research in the Context of a Pandemic (Editorial)
H. Clifford Lane, M.D., and Anthony S. Fauci, M.D.
N Engl J Med 2021; 384:755-757 February 25, 2021  DOI: 10.1056/NEJMe2024638
Pulsa aquí para acceder a la información

(R) Emergence of a Highly Fit SARS-CoV-2 Variant

Ralph S. Baric, Ph.D.

The New England Journal of Medicine December 16, 2020

DOI: 10.1056/NEJMcibr2032888

Pulsa aquí para acceder a la información

(R) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Voysey et al.
The Lancet Published: December 08, 2020
Pulsa aquí para acceder a la información

(R) Oxford–AstraZeneca COVID-19 vaccine efficacy (Comment)
Knoll et al.
The Lancet
Published: December 08, 2020
Pulsa aquí para acceder a la información

(R) Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
WHO Solidarity Trial Consortium*
The New England Journal of Medicine December 2, 2020
DOI: 10.1056/NEJMoa2023184
Pulsa aquí para acceder a la información

(R) A Large, Simple Trial Leading to Complex Questions (Editorial)
David P. Harrington, Ph.D.,  Lindsey R. Baden, MD, y Joseph W. Hogan, Sc.D.
The New England Journal of Medicine December 2, 2020
DOI: 10.1056/NEJMe2034294
Pulsa aquí para acceder a la información

(R) Mild or Moderate Covid-19 (Clinical Practice)
Rajesh T. Gandhi, M.D., John B. Lynch, M.D., M.P.H., and Carlos del Rio, M.D.
The New England Journal of Medicine 2020; 383:1757-1766
October 29, 2020 DOI: 10.1056/NEJMcp2009249
Pulsa aquí para acceder a la información

Drug treatments for covid-19: living systematic review and network meta-analysis
Reed AC Siemieniuk, Jessica J Bartoszko, Long Ge, Dena Zeraatkar, Ariel Izcovich, Hector Pardo-Hernandez, Bram Rochwerg et al.
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m2980 (Published 30 July 2020)
Pulsa aquí para acceder a la información

Monoclonal Antibodies for Prevention and Treatment of COVID-19
Mary Marovich, MD1; John R. Mascola, MD1; Myron S. Cohen, MD2
JAMA. Published online June 15, 2020. doi:10.1001/jama.2020.10245
Pulsa aquí para acceder a la información

Immunogenicity of a DNA Vaccine Candidate for COVID-19
Trevor R F Smith , Ami Patel , Stephanie Ramos , Dustin Elwood , Xizhou Zhu , Jian Yan , Ebony N Gary , Susanne N Walker , Katherine Schultheis , Mansi Purwar et al.
Nat Commun. 2020 May 20;11(1):2601. doi: 10.1038/s41467-020-16505-0.
https://pubmed.ncbi.nlm.nih.gov/32433465/

How to Discover Antiviral Drugs Quickly
Jerry M. Parks, Ph.D., and Jeremy C. Smith, Ph.D.
The New England Journal of Medicine  May 20, 202 DOI: 10.1056/NEJMcibr2007042
Pulsa aquí para acceder a la información

(R) Mild or Moderate Covid-19. (Clinical Practice)
Rajesh T. Gandhi, M.D., John B. Lynch, M.D., M.P.H., and Carlos del Rio, M.D.
The New England Journal of Medicine  April 24, 2020                                                 DOI: 10.1056/NEJMcp2009249
Pulsa aquí para acceder a la información

(R) Severe Covid-19 (Clinical Practice)
David A. Berlin, M.D., Roy M. Gulick, M.D., M.P.H., and Fernando J. Martinez, M.D.
The New England Journal of Medicine  May 15, 2020
DOI: 10.1056/NEJMcp2009575
Pulsa aquí para acceder a la información

Randomized Clinical Trials and COVID-19. Managing Expectations (Editorial)
Howard Bauchner, MD1; Phil B. Fontanarosa, MD, MBA2
JAMA. Published online May 4, 2020. doi:10.1001/jama.2020.8115
Pulsa aquí para acceder a la información

(R) A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
Tu YF, Chien CS, Yarmishyn AA, Lin YY, Luo YH, Lin YT, Lai WY, Yang DM, Chou SJ, Yang YP, Wang ML, Chiou SH.
Int J Mol Sci. 2020 Apr 10;21(7):2657. doi: 10.3390/ijms21072657.
Pulsa aquí para acceder a la información

Explorando la relevancia de la senoterapéutica para la actual emergencia de SARS-CoV-2 y futuras amenazas de salud globales similares
Marco Malavolta  ,   Robertina Giacconi  ,   Dario Brunetti  ,   Mauro Provinciali  ,   Fabrizio Maggi
Células. 2020 8 de abril; 9 (4): E909.
doi: 10.3390 / cells9040909.

Pulsa aquí para acceder a la información

(R) Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB
JAMA Publicado en línea el 13 de abril de 2020. doi: 10.1001 / jama.2020.6019
Pulsa aquí para acceder a la información

ANTICUERPOS

(R) (N) Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
Meagan P. O’Brien, M.D., Eduardo Forleo-Neto, M.D., Bret J. Musser, Ph.D., Flonza Isa, M.D., Kuo-Chen Chan, Ph.D., Neena Sarkar, Ph.D., Katharine J. Bar, M.D., Ruanne V. Barnabas, M.D., Dan H. Barouch, M.D., Ph.D., Myron S. Cohen, M.D., Christopher B. Hurt, M.D., Dale R. Burwen, M.D., M.P.H., et al., for the Covid-19 Phase 3 Prevention Trial Team*
NEJM August 4, 2021 DOI: 10.1056/NEJMoa2109682
Pulsa aquí para acceder a la información

(R) (N) Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Michael Dougan, M.D., Ph.D., Ajay Nirula, M.D., Ph.D., Masoud Azizad, M.D., Bharat Mocherla, M.D., Robert L. Gottlieb, M.D., Ph.D., Peter Chen, M.D., Corey Hebert, M.D., Russell Perry, M.D., Joseph Boscia, M.D., Barry Heller, M.D., Jason Morris, M.D., Chad Crystal, M.D., et al., for the BLAZE-1 Investigators*
NEJM July 14, 2021 DOI: 10.1056/NEJMoa2102685
Pulsa aquí para acceder a la información

RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial
Gustavo Lopardo, Waldo H. Belloso, Esteban Nannini, Mariana Colonna, Santiago Sanguineti, Vanesa Zylberman and others
EClinicalMedicine Published: April 11, 2021
Pulsa aquí para acceder a la información

(R) REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
David M. Weinreich, M.D., Sumathi Sivapalasingam, M.D., Thomas Norton, M.D., Shazia Ali, Pharm.D., Haitao Gao, Ph.D., Rafia Bhore, Ph.D., Bret J. Musser, Ph.D., Yuhwen Soo, Ph.D., Diana Rofail, Ph.D., Joseph Im, B.S., Christina Perry, M.B.A., Cynthia Pan, B.Pharm., et al., for the Trial Investigators*
The New England Journal of Medicine December 17, 2020
DOI: 10.1056/NEJMoa2035002
Pulsa aquí para acceder a la información

(R) A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19
ACTIV-3/TICO LY-CoV555 Study Group*
The New England Journal of Medicine December 22, 2020
DOI: 10.1056/NEJMoa2033130
Pulsa aquí para acceder a la información

(R) SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen, M.D., Ajay Nirula, M.D., Ph.D., Barry Heller, M.D., Robert L. Gottlieb, M.D., Ph.D., Joseph Boscia, M.D., Jason Morris, M.D., Gregory Huhn, M.D., M.P.H.T.M., Jose Cardona, M.D., Bharat Mocherla, M.D., Valentina Stosor, M.D., Imad Shawa, M.D., Andrew C. Adams, Ph.D., et al., for the BLAZE-1 Investigators*
The New England Journal odf Medicine October 28, 2020
DOI: 10.1056/NEJMoa2029849
Pulsa aquí para acceder a la información

REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters
Alina Baum1, Dharani Ajithdoss, Richard Copin, Anbo Zhou, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Kusha Mohammadi et al.
Science  09 Oct 2020: eabe2402  DOI: 10.1126/science.abe2402
Pulsa aquí para acceder a la información

ANTIVIRALES

(N) JAK Inhibitors — More Than Just Glucocorticoids (Editorial)
Justin Stebbing, M.D., Ph.D., and Volker M. Lauschke, Ph.D.
NEJM July 29, 2021; 385:463-465 DOI: 10.1056/NEJMe2108667
Pulsa aquí para acceder a la información

(R) Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
Patrícia O. Guimarães, M.D., Ph.D., Daniel Quirk, M.D., M.P.H., Remo H. Furtado, M.D., Ph.D., Lilia N. Maia, M.D., Ph.D., José F. Saraiva, M.D., Ph.D., Murillo O. Antunes, M.D., Ph.D., Roberto Kalil Filho, M.D., Ph.D., Vagner M. Junior, M.D., Alexandre M. Soeiro, M.D., Alexandre P. Tognon, M.D., Ph.D., Viviane C. Veiga, M.D., Ph.D., Priscilla A. Martins, M.D., et al., for the STOP-COVID Trial Investigators*
NEJM June 16, 2021 DOI: 10.1056/NEJMoa2101643
Pulsa aquí para acceder a la información

Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19: The TOGETHER Randomized Clinical Trial
Reis G, Moreira Silva EADS, Medeiros Silva DC, et al.
JAMA Network Open April 22, 2021
Pulsa aquí para acceder a la información

Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19
Garibaldi BT, Wang K, Robinson ML, et al.
JAMA Network Open March 24, 2021
Pulsa aquí para acceder a la información

Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial
López-Medina E, López P, Hurtado IC, et al.
JAMA March 4, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
Angela Wahl, Lisa E. Gralinski, […]J. Victor Garcia
Nature (2021) Published: February 89 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
Angela Wahl, Lisa E. Gralinski, […]J. Victor Garcia
Nature (2021) Published: February 89 2021
Pulsa aquí para acceder a la información

Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Kris M. White, Romel Rosales, Soner Yildiz, Thomas Kehrer, Lisa Miorin1,2, Elena Moreno, Sonia Jangra, […] Adolfo García-Sastre.
Science  25 Jan 2021: eabf4058  DOI: 10.1126/science.abf4058
Pulsa aquí para acceder a la información

The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial
Carlos ChaccourAina CasellasAndrés Blanco-Di MatteoIñigo PinedaAlejandro Fernandez-MonteroPaula Ruiz-Castillo and others
EClinical Medicine Published: January 19, 2021
Pulsa aquí para acceder a la información

(R)   Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

Andre C. Kalil, M.D., M.P.H., Thomas F. Patterson, M.D., Aneesh K. Mehta, M.D., Kay M. Tomashek, M.D., M.P.H., Cameron R. Wolfe, M.B., B.S., M.P.H., Varduhi Ghazaryan, M.D., Vincent C. Marconi, M.D., Guillermo M. Ruiz-Palacios, M.D., Lanny Hsieh, M.D., Susan Kline, M.D., Victor Tapson, M.D., Nicole M. Iovine, M.D., Ph.D., et al.

The New England Journal of Medicine December 11, 2020

DOI: 10.1056/NEJMoa2031994

Pulsa aquí para acceder a la información

Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 1) (Clinical Guidelines)
Amir Qaseem, MD, PhD, MHA, Jennifer Yost, RN, PhD, Itziar Etxeandia-Ikobaltzeta, PharmD, PhD, George M. Abraham, MD, MPH, Janet A. Jokela, MD, MPH, Mary Ann Forciea, MD, Matthew C. Miller, MD, Linda L. Humphrey, MD, MPH
Annals of Internal Medicine 5 October 2020
Pulsa aquí para acceder a la información

(R) Remdesivir for the Treatment of Covid-19 — Final Report
John H. Beigel, M.D., Kay M. Tomashek, M.D., M.P.H., Lori E. Dodd, Ph.D., Aneesh K. Mehta, M.D., Barry S. Zingman, M.D., Andre C. Kalil, M.D., M.P.H., Elizabeth Hohmann, M.D., Helen Y. Chu, M.D., M.P.H., Annie Luetkemeyer, M.D., Susan Kline, M.D., M.P.H., Diego Lopez de Castilla, M.D., M.P.H., Robert W. Finberg, M.D., et al., for the ACTT-1 Study Group Members*
The New England Journal of Medicine November 5, 2020  ; 383:1813-1826  DOI: 10.1056/NEJMoa2007764
Pulsa aquí para acceder a la información

Remdesivir — An Important First Step (Editorial)
Raphael Dolin, M.D., and Martin S. Hirsch, M.D.
The New England Journal of Medicine November 5, 2020; 383:1886-1887
DOI: 10.1056/NEJMe2018715
Pulsa aquí para acceder a la información

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, and others
The Lancet Published: October 5, 2020
Pulsa aquí para acceder a la información

(R) Efficacy of Remdesivir in COVID-19 (Editorial)
McCreary EK, Angus DCJAMA August 21, 2020
Pulsa aquí para acceder a la información

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19
Spinner CD, Gottlieb RL, Criner GJ, et al.
JAMA August 21, 2020
Pulsa aquí para acceder a la información

Safety, Tolerability, and Pharmacokinetics of Remdesivir, an Antiviral for Treatment of COVID‐19, in Healthy Subjects
Rita Humeniuk Anita Mathias Huyen Cao Anu Osinusi Gong Shen Estelle Chng John Ling Amanda Vu Polina German
Clinical and Translational Science First published:26 June 2020 DOI: 10.1111/cts.12840
Pulsa aquí para acceder a la información

Remdesivir durante 5 o 10 días en pacientes con covid-19 grave
Jason D. Goldman, MD, MPH, David CB Lye, MB, BS, David S. Hui, MD, Kristen M. Marks, MD, Raffaele Bruno, MD, Rocio Montejano, MD, Christoph D. Spinner, MD, Massimo Galli, MD, Mi-Young Ahn, MD, Ronald G. Nahass, MD, Yao-Shen Chen, MD, Devi SenGupta, MD, et al.para los investigadores GS-US-540-5773 *
The New England Journal of Medicine 27 de mayo de 2020  DOI: 10.1056 / NEJMoa2015301
Pulsa aquí para acceder a la información

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, Raymond Liu, Tom Wai-Hin Chung, Man-Yee Chu, and others
The Lancet Published: May 8, 2020
Pulsa aquí para acceder a la información

Putative Inhibitors of SARS-CoV-2 Main Protease From A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study
Davide Gentile , Vincenzo Patamia , Angela Scala , Maria Teresa Sciortino , Anna Piperno , Antonio Rescifina
Mar Drugs. 2020 Apr 23;18(4):E225. doi: 10.3390/md18040225.
Pulsa aquí para acceder a la información

Discontinuation of Antiviral Drugs May Be the Reason for Recovered COVID-19 Patients Testing Positive Again
Fanqi Wu, Wenli Zhang, Longguo Zhang, Dan Wang , Yixin Wan
Br J Hosp Med (Lond). 2020 Apr 2;81(4):1-2. doi: 10.12968/hmed.2020.0156. Epub 2020 Apr 21.
Pulsa aquí para acceder a la información

Remdesivir for COVID-19: challenges of underpowered studies (Comment)
John David Norrie
The Lancet Published: April 29, 2020
Pulsa aquí para acceder a la información

(R) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang, Dingyu Zhang, Guanhua Du, Ronghui Du, Jianping Zhao, Yang Jin, and others
The Lancet Published: April 29, 2020
Pulsa aquí para acceder a la información

Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
Abdo A.Elfiky
Life Sciences Volume 253, 15 July 2020, 
https://doi.org/10.1016/j.lfs.2020.117592
Pulsa aquí para acceder a la información

Remdesivir for severe acute respiratory syndrome coronavirus 2 causing COVID-19: An evaluation of the evidence
Yu-chen Cao, Qi-xin Deng, Shi-xue Dai
Travel Medicine and Infectious DiseaseIn press, corrected proofAvailable online 2 April 2020 Article 101647
Pulsa aquí para acceder a la información

Uso compasivo de Remdesivir para pacientes con Covid-19 grave
Jonathan Grein, MD, Norio Ohmagari, MD, Ph.D., Daniel Shin, MD, George Diaz, MD, Erika Asperges, MD, Antonella Castagna, MD, Torsten Feldt, MD, Gary Green, MD, Margaret L. Green, MD, MPH, François-Xavier Lescure, MD, Ph.D., Emanuele Nicastri, MD, Rentaro Oda, MD, et al.
The New England Journal of Medicine 10 de abril de 2020  DOI: 10.1056 / NEJMoa2007016
Pulsa aquí para acceder a la información

The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
LeonCaly1 Julian D.Druce1 Mike G.Catton1 David A.Jans2Kylie M.Wagstaff2  Antiviral Research Available online 3 April 2020, 104787 In Press, Journal Pre-proof https://doi.org/10.1016/j.antiviral.2020.104787
 Pulsa aquí para acceder a la información

COVID-1: Combining antiviral and anti.inflammatory treatment
J.Stebbing, A.Ohelan, I.Griffin, C.Tucker, O.Oechsle, D.Smith et al.
Lancet Infectious Disease. Published 27 February 2020 DOI.org/ 10.1016/S1473 3099(20) 30132-8 .
Pulsa aquí para acceder a la información

Novel coronavirus treatment with ribavirin: Groundwork for evaluation concerning COVID‐19

Jahan S. Khalili , Hai Zhu , Amanda Mak , Yongqi Yan, Yi Zhu
Journal of Medical Virology First published:30 March 2020 Pulsa aquí para acceder a la información
 Pulsa aquí para acceder a la información

Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID‐19)

Jian Wu, Wei Li, Xiaowei Shi, Zhongming Chen, Bin Jiang, Jun Liu, Dawei Wang, Chengyuan Liu, Yiling Meng, Leilei Cui, Jiong Yu, Hongcui Cao, Lanjuan Li


Journal of Internal Medicine DOI:Pulsa aquí para acceder a la información

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS, or COVID‐19: initial assessment

Nathan Ford , Marco Vitoria , Ajay Rangaraj , Susan L Norris , Alexandra Calmy ,Meg Doherty
Journal of the international AIDS SocietyFirst published:26 March 2020 https://doi.org/10.1002/jia2.25489

Pulsa aquí para acceder a la información

Un ensayo de lopinavir-ritonavir en adultos hospitalizados con Covid-19 grave

Bin Cao, MD, Yeming Wang, MD, Danning Wen, MD, Wen Liu, MS Jingli Wang, MD, Guohui Fan, MS, Lianguo Ruan, MD, Bin Song, MD, Yanping Cai, MD, Ming Wei, MD, Xingwang Li, MD, Jiaan Xia, MD, et al.
18 de marzo de 2020  DOI: 10.1056 / NEJMoa2001282 Pulsa aquí para acceder a la información

(R) A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
Tu YF, Chien CS, Yarmishyn AA, Lin YY, Luo YH, Lin YT, Lai WY, Yang DM, Chou SJ, Yang YP, Wang ML, Chiou SH.
Int J Mol Sci. 2020 Apr 10;21(7):2657. doi: 10.3390/ijms21072657.
Pulsa aquí para acceder a la información

Explorando la relevancia de la senoterapéutica para la actual emergencia de SARS-CoV-2 y futuras amenazas de salud globales similares
Marco Malavolta  ,   Robertina Giacconi  ,   Dario Brunetti  ,   Mauro Provinciali  ,   Fabrizio Maggi
Células. 2020 8 de abril; 9 (4): E909.
doi: 10.3390 / cells9040909.

Pulsa aquí para acceder a la información

(R) Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review
Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB
JAMA Publicado en línea el 13 de abril de 2020. doi: 10.1001 / jama.2020.6019
Pulsa aquí para acceder a la información

CORTICOIDES

(R) Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group
N Engl J Med 2021; 384:693-704 February 25, 2021  DOI: 10.1056/NEJMoa2021436
Pulsa aquí para acceder a la información

The RECOVERY Platform (Editorial)
Sharon-Lise T. Normand, Ph.D.
N Engl J Med 2021; 384:757-758 February 25, 2021  DOI: 10.1056/NEJMe2025674
Pulsa aquí para acceder a la información

Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19
Dequin P, Heming N, Meziani F, et al.
JAMA September 2, 2020
Pulsa aquí para acceder a la información

 Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial
Tomazini BM, Maia IS, Cavalcanti AB, et al.
JAMA September 2, 2020
Pulsa aquí para acceder a la información

Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
The Writing Committee for the REMAP-CAP Investigators
JAMA September 2, 2020
Pulsa aquí para acceder a la información

 Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis
The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
JAMA September 2, 2020
Pulsa aquí para acceder a la información

(R)  Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic (Editorial)
Prescott HC, Rice TW
JAMA September 2, 2020
Pulsa aquí para acceder a la información

(R) Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
The RECOVERY Collaborative Group*
The New England Journal of Medicine July 17, 2020 DOI: 10.1056/NEJMoa2021436
Pulsa aquí para acceder a la información

HIDROXICLOROQUINA

Hydroxychloroquine plus standard of care compared with standard of care alone in COVID-19: a meta-analysis of randomized controlled trials
Bahman Amani, Ahmad Khanijahani & Behnam Amani
Scientific Reports 11 , 1–10 7 June 2021
Pulsa aquí para acceder a la información

(R) A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19
Oriol Mitjà, Ph.D., Marc Corbacho-Monné, B.M., Maria Ubals, B.M., Andrea Alemany, B.M., Clara Suñer, Ph.D., Cristian Tebé, Ph.D., Aurelio Tobias, Ph.D., Judith Peñafiel, M.Sc., Ester Ballana, Ph.D., Carla A. Pérez, B.M., Pol Admella, B.M., Núria Riera-Martí, B.M., et al., for the BCN-PEP-CoV2 Research Group*
The New England Journal of Medicine November 24, 2020
DOI: 10.1056/NEJMoa2021801
Pulsa aquí para acceder a la información

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Alexandre B. Cavalcanti, M.D., Ph.D., Fernando G. Zampieri, M.D., Ph.D., Regis G. Rosa, M.D., Ph.D., Luciano C.P. Azevedo, M.D., Ph.D., Viviane C. Veiga, M.D., Ph.D., Alvaro Avezum, M.D., Ph.D., Lucas P. Damiani, M.Sc., Aline Marcadenti, Ph.D., Letícia Kawano-Dourado, M.D., Ph.D., Thiago Lisboa, M.D., Ph.D., Debora L. M. Junqueira, M.D., Pedro G.M. de Barros e Silva, M.D., Ph.D., et al., for the Coalition Covid-19 Brazil I Investigators*
The New England Journal of Medicine November 19, 2020 DOI: 10.1056/NEJMoa2019014
Pulsa aquí para acceder a la información

Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19. A Randomized Clinical Trial
Wesley H. Self, MD, MPH1; Matthew W. Semler, MD2; Lindsay M. Leither, DO3,4; et al
JAMA. Published online November 9, 2020. doi:10.1001/jama.2020.22240
Pulsa aquí para acceder a la información

  Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform
Christopher T Rentsch, Nicholas J DeVito, Brian MacKenna, Caroline E Morton, Krishnan Bhaskaran, Jeremy P Brown, and others
The Lancet Rheumatology Published: November 5, 2020
Pulsa aquí para acceder a la información

Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers. A Randomized Clinical Trial
Benjamin S. Abella, MD, MPhil1; Eliana L. Jolkovsky, BA1; Barbara T. Biney, MPH1; et a and the Prevention and Treatment of COVID-19 With Hydroxychloroquine (PATCH) Investigators
JAMA Intern Med. Published online September 30, 2020. doi:10.1001/jamainternmed.2020.6319
Pulsa aquí para acceder a la información

Long-term hydroxychloroquine use in patients with rheumatic conditions and development of SARS-CoV-2 infection: a retrospective cohort study
Chris A Gentry, Mary Beth Humphrey, Sharanjeet K Thind, Sage C Hendrickson, George Kurdgelashvili, Riley J Williams II
The Lancet Rheumatology  Published: September 21, 2020
Pulsa aquí para acceder a la información

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19: A Randomized Trial
Caleb P. Skipper, MD, Katelyn A. Pastick, BSc, Nicole W. Engen, MS, Ananta S. Bangdiwala, MS, Mahsa Abassi, DO, MPH, Sarah M. Lofgren, MD, Darlisha A. Williams, MPH, Elizabeth C. Okafor, BSc, Matthew F. Pullen, MD, … et al
Annals of Internal Medicine 16 July 2020
Pulsa aquí para acceder a la información

(R) Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
Alexandre B. Cavalcanti, M.D., Ph.D., Fernando G. Zampieri, M.D., Ph.D., Regis G. Rosa, M.D., Ph.D., Luciano C.P. Azevedo, M.D., Ph.D., Viviane C. Veiga, M.D., Ph.D., Alvaro Avezum, M.D., Ph.D., Lucas P. Damiani, M.Sc., Aline Marcadenti, Ph.D., Letícia Kawano-Dourado, M.D., Ph.D., Thiago Lisboa, M.D., Ph.D., Debora L. M. Junqueira, M.D., Pedro G.M. de Barros e Silva, M.D., Ph.D., et al., for the Coalition Covid-19 Brazil I Investigators*
The New England Journal of Medicine July 23, 2020 DOI: 10.1056/NEJMoa2019014
Pulsa aquí para acceder a la información

QT interval prolongation under hydroxychloroquine/ azithromycin association for inpatients with SARS‐CoV‐2 lower respiratory tract infection
Sok‐Sithikun Bun Philippe Taghji Johan Courjon Fabien Squara Didier Scarlatti Guillaume Theodore Delphine Baudouy Benjamin Sartre Mohamed Labbaoui Jean Dellamonica Denis Doyen Charles‐Hugo Marquette Jacques Levraut Vincent Esnault Sok‐Siya Bun Emile Ferrari
Clinical Pharmacology & Therapeutics First published:26 June 2020 DOI: 10.1002/cpt.1968
Pulsa aquí para acceder a la información

Update Alert: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians
Amir Qaseem, MD, PhD, MHA, Jennifer Yost, RN, PhD et al.
Annals of Internal Medicine  17 Jun 2020 https://doi.org/10.7326/M20-3862
Pulsa aquí para acceder a la información

(R) A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware, M.D., M.P.H., Matthew F. Pullen, M.D., Ananta S. Bangdiwala, M.S., Katelyn A. Pastick, B.Sc., Sarah M. Lofgren, M.D., Elizabeth C. Okafor, B.Sc., Caleb P. Skipper, M.D., Alanna A. Nascene, B.A., Melanie R. Nicol, Pharm.D., Ph.D., Mahsa Abassi, D.O., M.P.H., Nicole W. Engen, M.S., Matthew P. Cheng, M.D., et al.
The New England Journal of Medicine June 3, 2020 DOI: 10.1056/NEJMoa2016638
Pulsa aquí para acceder a la información

(R) Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence (Editorial)
Myron S. Cohen, M.D.
The New England Journal of Medicine June 3, 2020 DOI: 10.1056/NEJMe2020388
Pulsa aquí para acceder a la información

(R) A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware, M.D., M.P.H., Matthew F. Pullen, M.D., Ananta S. Bangdiwala, M.S., Katelyn A. Pastick, B.Sc., Sarah M. Lofgren, M.D., Elizabeth C. Okafor, B.Sc., Caleb P. Skipper, M.D., Alanna A. Nascene, B.A., Melanie R. Nicol, Pharm.D., Ph.D., Mahsa Abassi, D.O., M.P.H., Nicole W. Engen, M.S., Matthew P. Cheng, M.D., et al.
The New England Journal of Medicine June 3, 2020 DOI: 10.1056/NEJMoa2016638
Pulsa aquí para acceder a la información

(R) Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence (Editorial)
Myron S. Cohen, M.D.
The New England Journal of Medicine June 3, 2020 DOI: 10.1056/NEJMe2020388
Pulsa aquí para acceder a la información

Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review
Adrian V. Hernandez, MD, PhD, Yuani M. Roman, MD, MPH, Vinay Pasupuleti, MD, MS, PhD, …
Annals of Internal Medicine27 May 2020 https://doi.org/10.7326/M20-2496
Pulsa aquí para acceder a la información

Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians (Version 1) (Special Article)
Amir Qaseem, MD, PhD, MHA, Jennifer Yost, RN, PhD, …
Annals of Internal Medicine 13 May 2020https://doi.org/10.7326/M20-1998
Pulsa aquí para acceder a la información

(R) Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Mandeep R Mehra, Frank Ruschitzka, Amit N Patel
The Lancet Published: June 5, 2020
Pulsa aquí para acceder a la información

Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1844 (Published 14 May 2020)
Pulsa aquí para acceder a la información

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m1849 (Published 14 May 2020)
Pulsa aquí para acceder a la información

 Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris, M.D., Yifei Sun, Ph.D., Jonathan Platt, Ph.D., Jason Zucker, M.D., Matthew Baldwin, M.D., George Hripcsak, M.D., Angelena Labella, M.D., Daniel Manson, M.D., Christine Kubin, Pharm.D., R. Graham Barr, M.D., Dr.P.H., Magdalena E. Sobieszczyk, M.D., M.P.H., and Neil W. Schluger, M.D.
The New England Journal of Medicine May 7, 2020 DOI: 10.1056/NEJMoa2012410
Pulsa aquí para acceder a la información

 An independent appraisal and re-analysis of hydroxychloroquine treatment trial for COVID-19
Intson Katherona, Kumar Sachin A.a, Botta Amyb, Neckels Rachaelc, Leung Connied, Jawaid Alief*
Swiss Med Wkly. 2020;150:w20262 Publication Date: 29.04.2020
DOI: https://doi.org/10.4414/smw.2020.20262
Pulsa aquí para acceder a la información

Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2
Nicholas E. Ingraham, David Boulware, Matthew A. Sparks, Timothy Schacker, Bradley Benson, Jeffrey A. Sparks, Thomas Murray, John Connett, Jeffrey G. Chipman, Anthony Charles & Christopher J. Tignanelli
Critical Care volume 24, Article number: 182 (2020) Published: 28 April 2020

Pulsa aquí para acceder a la información

Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit
Bessière F, Roccia H, Delinière A, et al.
JAMA Cardiology May 1, 2020
Pulsa aquí para acceder a la información

Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation (Editorial)
Robert O. Bonow, MD, MS1,7; Adrian F. Hernandez, MD, MHS2,3,8; Mintu Turakhia, MD, MAS4,5,6,8
JAMA Cardiol. Published online May 1, 2020. doi:10.1001/jamacardio.2020.1782

Pulsa aquí para acceder a la información

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Randomized Clinical Trial
Borba MGS, Val FFA, Sampaio VS, et al.
JAMA Network Open April 24, 2020
Pulsa aquí para acceder a la información

Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019 (Editorial)
Stephan D. Fihn, MD, MPH1,2,3; Eli Perencevich, MD, MS4,5,6; Steven M. Bradley, MD, MPH6,7
JAMA Netw Open. 2020;3(4.23):e209035. doi:10.1001/jamanetworkopen.2020.9035
Pulsa aquí para acceder a la información

Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019 (Editorial)
Stephan D. Fihn, MD, MPH1,2,3; Eli Perencevich, MD, MS4,5,6; Steven M. Bradley, MD, MPH6,7
JAMA Netw Open. 2020;3(4.23):e209035. doi:10.1001/jamanetworkopen.2020.9035
Pulsa aquí para acceder a la información

Safety of hydroxychloroquine, alone and in combination with azithromycin, in light of rapid wide-spread use for COVID-19: a multinational, network cohort and self-controlled case series study
Jennifer C.E Lane James Weaver, Kristin Kostka, Talita Duarte-Salles, Maria Tereza F. Abrahao, Heba Alghoul, Osaid Alser, Thamir M Alshammari, Patricia Biedermann, Edward Burn, Paula Casajust, Mitch Conover, Aedin C. Culhane, Alexander Davydov, Scott L. DuVall, Dmitry Dymshyts, Sergio Fernández Bertolín, Kristina Fišter, Jill Hardin, Laura Hester, George Hripcsak, Seamus Kent, Sajan Khosla, Spyros Kolovos, Christophe G. Lambert, Johan ver der Lei, Ajit A. Londhe, Kristine E. Lynch, Rupa Makadia, Andrea V. Margulis, Michael E. Matheny, Paras Mehta, Daniel R. Morales, Henry Morgan-Stewart, Mees Mosseveld, Danielle Newby, Fredrik Nyberg, Anna Ostropolets, Rae Woong Park, Albert Prats-Uribe, Gowtham A. Rao, Christian Reich, Jenna Reps, Peter Rijnbeek, Selva Muthu Kumaran Sathappan, Martijn Schuemie, Sarah Seager, Anthony Sena, Azza Shoaibi, Matthew Spotnitz, Marc A. Suchard, Joel Swerdel, Carmen Olga Torre, David Vizcaya, Haini Wen, Marcel de Wilde, Seng Chan You, Lin Zhang, Oleg Zhuk, Patrick Ryan, Daniel Prieto-Alhambra
MedRxiv doi: https://doi.org/10.1101/2020.04.08.20054551
Pulsa aquí para acceder a la información

NOTA de la FUNDACION: Este artículo es una prepublicación, que no se ha sido todavía revisado por pares

COVID-19, Chloroquine Repurposing, and Cardiac Safety Concern: Chirality Might Help.
Lentini G, Cavalluzzi MM, Habtemariam S.
Molecules. 2020 Apr 16;25(8):E1834. doi: 10.3390/molecules25081834.
Pulsa aquí para acceder a la información

Reguladores divididos en antipalúdicos para COVID-19
Susan Jaffe
The Lancet , vol. 395 , no 10231 Publicado: 11 de abril de 2020
Pulsa aquí para acceder a la información

Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know 

Jinoos Yazdany, MD, MPH; Alfred H.J. Kim, MD, PhD
Annals of Internal Medicine 31 March 2020
Pulsa aquí para acceder a la información

Hidroxicloroquina y azitromicina como tratamiento de COVID-19 : resultados de un ensayo clínico abierto no aleatorio.

Gautret P 1 , Lagier JC 2 , Parola P 1 , Hoang VT 3 , Meddeb L 4 , Mailhe M 4 , Doudier B 4 , Courjon J 5 , Giordanengo V 6 , Vieira VE 4 , Dupont HT 2 , Honoré S 7 , Colson P 2 , Chabrière E 2 , La Scola B 2 , Rolain JM 2 , Brouqui P 2, Raoult D 8 .
Int J Agentes antimicrobianos. 2020 20 de marzo: 105949. doi: 10.1016 / j.ijantimicag. 2020 .105949. [Epub antes de imprimir]
Pulsa aquí para acceder a la información

INMUNOSUPRESIÓN

Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo-controlled trial
Paul C Cremer, Antonio Abbate, Kristin Hudock, Carla McWilliams, Jinesh Mehta, Steven Y Chang, and others
The Lancet Rheumatology  Published: March 17, 2021
Pulsa aquí para acceder a la información

Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe? (Comment)
Puja Mehta, Rachel C Chambers, Lorenzo Dagna
The Lancet Rheumatology  Published: March 17, 2021

Pulsa aquí para acceder a la información

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
Phillip D Monk, Richard J Marsden, Victoria J Tear, Jody Brookes, Toby N Batten, Marcin Mankowski, and others
The Lancet Respiratory Medicine  Published: November 12, 2020
Pulsa aquí para acceder a la información

Clinical characteristics and outcomes among hospitalized adults with severe COVID-19 admitted to a tertiary medical center and receiving antiviral, antimalarials, glucocorticoids, or immunomodulation with tocilizumab or cyclosporine: A retrospective observational study (COQUIMA cohort)
Pablo Guisado-Vasco•Sofia Valderas-Ortega•Maria Maravillas Carralón-González•Ana Roda-Santacruz•Lucia González-Cortijo•Gabriel Sotres-Fernández•Eva María Martí-Ballesteros•José Manuel Luque-Pinilla•Elena Almagro-Casado•Félix J. La Coma-Lanuza•Ruth Barrena-Puertas•Esteban Javier Malo-Benages•María José Monforte-Gómez•Rocío Diez-Munar•Esther Merino-Lanza•Lorena Comeche-Casanova•Margarita Remirez-de-Esparza-Otero•María Correyero-Plaza•Manuel Recio-Rodríguez•Margarita Rodríguez-López•María Dolores Sánchez-Manzano•Cristina Andreu-Vázquez•Israel John Thuissard-Vasallo•José María Echave-Sustaeta María-Tomé•Daniel Carnevali-Ruiz
EClinicalMedicine Published: October 15, 2020
Pulsa aquí para acceder a la información

Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities (Viewpoint)
Puja Mehta•Joanna C Porter•Jessica J Manson•John D Isaacs•Peter J M Openshaw•Iain B McInnes•Charlotte Summers•Rachel C Chambers
The Lancet Respiratory Medicine Published: June 16, 2020
Pulsa aquí para acceder a la información

GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study
Giacomo De Luca•Giulio Cavalli•Corrado Campochiaro•Emanuel Della-Torre•Piera Angelillo•Alessandro Tomelleri•Nicola Boffini•Stefano Tentori•Francesca Mette•Nicola Farina•Patrizia Rovere-Querini•Annalisa Ruggeri•Teresa D'Aliberti•Paolo Scarpellini•Giovanni Landoni•Francesco De Cobelli•John F Paolini•Alberto Zangrillo•Moreno Tresoldi•Bruce C Trapnell•Fabio Ciceri•Lorenzo Dagna
The Lancet Rheumatology  Published: June 16, 2020
Pulsa aquí para acceder a la información

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
Giulio Cavalli•Giacomo De Luca•Corrado Campochiaro•Emanuel Della-Torre•Marco Ripa•Diana Canetti•Chiara Oltolini•Barbara Castiglioni•Chiara Tassan Din•Nicola Boffini•Alessandro Tomelleri•Nicola Farina•Annalisa Ruggeri•Patrizia Rovere-Querini•Giuseppe Di Lucca•Sabina Martinenghi•Raffaella Scotti•Moreno Tresoldi•Fabio Ciceri•Giovanni Landoni•Alberto Zangrillo•Paolo Scarpellini•Lorenzo Dagna
The Lancet Rheumatology Published: May 7, 2020
Pulsa aquí para acceder a la información

COVID-19: consider cytokine storm syndromes and immunosuppression (Letter)

Puja Mehta, Daniel F McAuley, Michael Brown, Emilie Sanchez, Rachel S Tattersall, *Jessica J Manson, on behalf of the HLH Across Speciality Collaboration, UK
The Lancet. Published online March 13, 2020 https://doi.org/10.1016/S0140-6736(20)30628-0

Pulsa aquí para acceder a la información

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? (CORRESPONDENCE)  Andrew I Ritchie, Aran Singanayagam The LancetPublished: March 24, 2020
Pulsa aquí para acceder a la información

OTROS ARTÍCULOS

COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics
Michaël Schwarzinger, Verity Watson, Pierre Arwidson, François Alla, Stéphane Luchini
The Lancet Public Health Published: February 5, 2021
Pulsa aquí para acceder a la información

Advanced bioinformatics rapidly identifies existing therapeutics for patients with coronavirus disease-2019 (COVID-19)
Jason Kim, Jenny Zhang, Yoonjeong Cha, Sarah Kolitz, Jason Funt, Renan Escalante Chong, Scott Barrett, Rebecca Kusko, Ben Zeskind & Howard Kaufman
Journal of Translational Medicine volume 18, Article number: 257 Published: 25 June 2020
Pulsa aquí para acceder a la información

The potential of cannabidiol in the COVID‐19 pandemic: a hypothesis letter
Giuseppe Esposito  Marcella Pesce  Luisa Seguella  Walter Sanseverino  Jie Lu  Chiara Corpetti  Giovanni Sarnelli
British Journal of Pharmacology First published:10 June 2020 https://doi.org/10.1111/bph.15157
Pulsa aquí para acceder a la información

Respiratory Parameters in Patients With COVID-19 After Using Noninvasive Ventilation in the Prone Position Outside the Intensive Care Unit
Sartini C, Tresoldi M, Scarpellini P, et al.
JAMA May 15, 2020
Pulsa aquí para acceder a la información

Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure
Elharrar X, Trigui Y, Dols A, et al.
JAMA May 15, 2020
Pulsa aquí para acceder a la información

Is the Prone Position Helpful During Spontaneous Breathing in Patients With COVID-19? (Editorial)
Telias I, Katira BH, Brochard L
JAMA May 15, 2020
Pulsa aquí para acceder a la información

Respiratory Parameters in Patients With COVID-19 After Using Noninvasive Ventilation in the Prone Position Outside the Intensive Care Unit
Sartini C, Tresoldi M, Scarpellini P, et al.
JAMA May 15, 2020
Pulsa aquí para acceder a la información

Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure
Elharrar X, Trigui Y, Dols A, et al.
JAMA May 15, 2020
Pulsa aquí para acceder a la información

Is the Prone Position Helpful During Spontaneous Breathing in Patients With COVID-19? (Editorial)
Telias I, Katira BH, Brochard L
JAMA May 15, 2020
Pulsa aquí para acceder a la información

Salvage use of tissue plasminogen activator (tPA) in the setting of acute respiratory distress syndrome (ARDS) due to COVID-19 in the USA: a Markov decision analysis.
Choudhury R, Barrett CD, Moore HB, Moore EE, McIntyre RC, Moore PK, Talmor DS, Nydam TL, Yaffe MB.
World J Emerg Surg. 2020 Apr 20;15(1):29. doi: 10.1186/s13017-020-00305-4.
Pulsa aquí para acceder a la información

Safety testing improvised COVID‐19 personal protective equipment based on a modified full‐face snorkel mask
P.R. Greig, C. Carvalho, K. El‐Boghdadly, S. Ramessur
Anaesthesia DOI: 10.1111/anae.15085
Pulsa aquí para acceder a la información

Tratamiento para el síndrome de dificultad respiratoria aguda grave de COVID-19 

(COMENTARIO)

Michael A Matthay, J Matthew Aldrich, Jeffrey E Gotts
La medicina respiratoria Lancet
Publicado: 20 de marzo de 2020
Pulsa aquí para acceder a la información

OTROS TRATAMIENTOS

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job R Schippers, Patrick J Smeele and others
The Lancet Respiratory Medicine Published: June 17, 2021
Pulsa aquí para acceder a la información

(R) Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial
Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job R Schippers, Patrick J Smeele and others
The Lancet Respiratory Medicine Published: June 17, 2021
Pulsa aquí para acceder a la información

Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
Jean-Claude Tardif, Nadia Bouabdallaoui, Philippe L L'Allier, Daniel Gaudet, Binita Shah, Michael H Pillinger and others
The Lancet Respiratory Medicine Published: May 27, 2021
Pulsa aquí para acceder a la información

Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
Thomas M Drake, Cameron J Fairfield, Riinu Pius, Stephen R Knight, Lisa Norman, Michelle Girvan, and others
The Lancet RheumatologyPublished: May 7, 2021
Pulsa aquí para acceder a la información

Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial
Prasanna Jagannathan, Jason R. Andrews[…]Upinder Singh
Nature Communications 12 , 1–10 30 March 2021
Pulsa aquí para acceder a la información

Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials
David A Jolliffe, Carlos A Camargo Jr, John D Sluyter, Mary Aglipay, John F Aloia, Davaasambuu Ganmaa, and others
The Lancet Diabetes & Endocrinology Published: March 30, 2021
Pulsa aquí para acceder a la información

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
PRINCIPLE Trial Collaborative Group, and others
The Lancet Published: March 4, 2021
Pulsa aquí para acceder a la información

Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19. A Randomized Clinical Trial
Igor H. Murai, PhD1; Alan L. Fernandes, PhD1; Lucas P. Sales, MSc1; etal
JAMA. Published online February 17, 2021. doi:10.1001/jama.2020.26848
Pulsa aquí para acceder a la información

Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial
Jordan J Feld, Christopher Kandel, Mia J Biondi, Robert A Kozak, Muhammad Atif Zahoor, Camille Lemieux, and others
The Lancet Respiratory Medicine  Published: February 5, 2021
Pulsa aquí para acceder a la información

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, and others
The Lancet Published: February 2, 2021
Pulsa aquí para acceder a la información

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19. A Randomized Clinical Trial
Eric J. Lenze, MD1; Caline Mattar, MD2; Charles F. Zorumski, MD1; et al
JAMA. Published online November 12, 2020. doi:10.1001/jama.2020.22760
Pulsa aquí para acceder a la información

Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure (Review)
Nisha Durand, Jorge Mallea & Abba C. Zubair
npj Regenerative Medicine volume 5, Article number: 17 (2020) Published: 26 October 2020

Pulsa aquí para acceder a la información

(R) Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
Alexander P J Vlaar, Sanne de Bruin, Matthias Busch, Sjoerd A M E G Timmermans, Ingeborg E van Zeggeren, Rutger Koning, and others
The Lancet Rheumatology Published: September 28, 2020
Pulsa aquí para acceder a la información

(R) Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
Alexander P J Vlaar, Sanne de Bruin, Matthias Busch, Sjoerd A M E G Timmermans, Ingeborg E van Zeggeren, Rutger Koning, and others
The Lancet Rheumatology Published: September 28, 2020

Pulsa aquí para acceder a la información

Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia
Cheng L, Guan W, Duan C, et al.
JAMA Internal Medicine September 10, 2020
Pulsa aquí para acceder a la información

Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Remo H M Furtado, Otavio Berwanger, Henrique A Fonseca, Thiago D Corrêa, Leonardo R Ferraz, Maura G Lapa, and others
The Lancet  Published: September 4, 2020
Pulsa aquí para acceder a la información

Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trial
Fanping Meng, Ruonan Xu, Siyu Wang, Zhe Xu, Chao Zhang, Yuanyuan Li, Tao Yang, Lei Shi, Junliang Fu, Tianjun Jiang, Lei Huang, Peng Zhao, Xin Yuan, Xing Fan, Ji-Yuan Zhang, Jinwen Song, Dawei Zhang, Yanmei Jiao, Limin Liu, Chunbao Zhou, Markus Maeurer, Alimuddin Zumla, Ming Shi & Fu-Sheng Wang
Signal Transduction and Targeted Therapy volume 5, Article number: 172 (2020) Published: 27 August 2020
Pulsa aquí para acceder a la información

Outomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19 (Research Letter)
van de Veerdonk FL, Kouijzer IJE, de Nooijer AH, et al.
JAMA Network Open August 13, 2020
Pulsa aquí para acceder a la información

Iloprost for COVID-19-related vasculopathy
Carine J Moezinia, Antonio Ji-Xu, Arianna Azari, Serena Horlick, Christopher Denton, Richard Stratton
The Lancet Rheumatology  Published: July 10, 2020
Pulsa aquí para acceder a la información

Boning up: amino-bisphophonates as immunostimulants and endosomal disruptors of dendritic cell in SARS-CoV-2 infection
Adam Brufsky, Juan Luis Gomez Marti, Azadeh Nasrazadani & Michael T. Lotze
Journal of Translational Medicine volume 18, Article number: 261 Published: 29 June 2020
Pulsa aquí para acceder a la información

Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019. The GRECCO-19 Randomized Clinical Trial
Spyridon G. Deftereos, MD, PhD; Georgios Giannopoulos, MD, PhD; Dimitrios A. Vrachatis, MD, MSc, PhD; et al; on behalf of the GRECCO-19 investigators
JAMA Netw Open.  June 24,2020;3(6):e2013136. doi:10.1001/jamanetworkopen.2020.13136
Pulsa aquí para acceder a la información

Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
Daniel E Freedberg, Joseph Conigliaro, Magdalena E Sobieszczyk, David D Markowitz, Aakriti Gupta, Max R. O'Donnell, Jianhua Li, David A Tuveson, Zhezhen Jin, William C Turner, Donald W Landry, Timothy C Wang,  View ORCID ProfileKevin J. Tracey, Michael V Callahan, Julian A Abrams
MedRxiv Posted May 19 2020 doi: https://doi.org/10.1101/2020.05.01.20086694
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es una prepublicación, que no se ha sido todavía revisado por pares

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms
Robert W. Malone, Philip Tisdall, Philip Fremont-Smith, Yongfeng Liu, Xi-Ping Huang, Kris M. White, Lisa Miorin, Elena Moreno Del Olmo, Assaf Alon, Elise Delaforge, Christopher D. Hennecker, Guanyu Wang, Joshua Pottel, Robert Bona, Nora Smith, Julie M. Hall, Gideon Shapiro, Howard Clark, Anthony Mittermaier, Andrew C. Kruse, Adolfo García-Sastre, Bryan L. Roth, Jill Glasspool-Malone, Victor Francone, Norbert Hertzog, Maurice Fremont-Smith, Darrell O. Ricke

Research Square Posted 23 May 2020   DOI:10.21203/rs.3.rs-30934/v1

Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es una prepublicación, que no se ha sido todavía revisado por pares

Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
Valentino Clemente 1, Padraig D'Arcy 2, Martina Bazzaro 3
Int J Mol Sci. 2020 May 15;21(10):E3492. doi: 10.3390/ijms21103492.
Pulsa aquí para acceder a la información

Immunoregulation with mTOR inhibitors to prevent COVID‐19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines (Review)
Yunfeng Zheng  Renfeng Li  Shunai Liu
Journal of Medical Virology First published:15 May 2020 https://doi.org/10.1002/jmv.26009
Pulsa aquí para acceder a la información

The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients
Steven P Treon , Jorge Castillo , Alan P Skarbnik , Jacob D Soumerai , Irene M Ghobrial Maria Luisa Guerrera , Kirsten E. Meid , Guang Yang
Blood April 17, 2020.
https://doi.org/10.1182/blood.2020006288
Pulsa aquí para acceder a la información

Baricitinib for COVID-19: a suitable treatment? – Authors' reply (Correspondence)

Peter J Richardson, Mario Corbellino, Justin Stebbin  The Lancet Infectious Diseases Published: April 3, 202
Pulsa aquí para acceder a la información

Race to find COVID-19 treatments accelerates
Kai Kupferschmidt, Jon Cohen
Science  27 Mar 2020: Vol. 367, Issue 6485, pp. 1412-1413
DOI: 10.1126/science.367.6485.1412
Pulsa aquí para acceder a la información

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Ning Tang , Huan Bai , Xing ChenJiale GongDengju Li ,Ziyong Sun
Journal of Thrombosis and Hemostasis. First published:27 March 2020 https://doi.org/10.1111/jth.14817
Pulsa aquí para acceder a la información

(R) A strategic approach to COVID-19 vaccine R&D
Lawrence Corey, John R. Mascola, Anthony S. Fauci, Francis S. Collins
Science  11 May 2020: eabc5312 DOI: 10.1126/science.abc5312
Pulsa aquí para acceder a la información

Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao1,*, Linlin Bao2,*, Haiyan Mao3,*, Lin Wang1,*, Kangwei Xu4,*, Minnan Yang5,*, Yajing Li1, Ling Zhu5, Nan Wang5, Zhe Lv5, Hong Gao2, Xiaoqin Ge1, Biao Kan6, Yaling Hu1, Jiangning Liu2, Fang Cai1, Deyu Jiang1, Yanhui Yin1, Chengfeng Qin7, Jing Li1, Xuejie Gong1, Xiuyu Lou3, Wen Shi3, Dongdong Wu1, Hengming Zhang1, Lang Zhu1, Wei Deng2, Yurong Li1, Jinxing Lu6,†, Changgui Li4,†, Xiangxi Wang5,†, Weidong Yin1,†, Yanjun Zhang3,†, Chuan Qin2,†
Science  06 May 2020: eabc1932 DOI: 10.1126/science.abc1932
Pulsa aquí para acceder a la información

PLASMA DE PACIENTES CONVALECIENTES

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
Michael A. Thompson; Jeffrey P. Henderson; Pankil K. Shah; Samuel M. Rubinstein; Michael J. Joyner; Toni K. Choueiri; Daniel B. Flora; Elizabeth A. Griffiths; Anthony P. Gulati; Clara Hwang; Vadim S. Koshkin; Esperanza B. Papadopoulos; Elizabeth V. Robilotti, MD; Christopher T. Su; Elizabeth M. Wulff-Burchfield; Zhuoer Xie; Peter Paul Yu; Sanjay Mishra; Jonathon W. Senefeld; Dimpy P. Shah; Jeremy L. Warner; for the COVID-19 and Cancer Consortium
JAMA Oncol. Published online June 17, 2021. doi:10.1001/jamaoncol.2021.1799
Pulsa aquí para acceder a la información

Hyperimmune anti-COVID-19 IVIG (C-IVIG) treatment in severe and critical COVID-19 patients: A phase I/II randomized control trial
Shaukat Ali, Syed Muneeb Uddin, Elisha Shalim, Muneeba Ahsan Sayeed, Fatima Anjum, Farah Saleem and others
EClinicalMedicine Published: June 4, 2021
Pulsa aquí para acceder a la información

(R) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
RECOVERY Collaborative Group
The LancetPublished: May 14, 2021
Pulsa aquí para acceder a la información

(R) Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19. A Systematic Review and Meta-analysis
Perrine Janiaud, PhD1; Cathrine Axfors, MD, PhD2,3; Andreas M. Schmitt, MD1,4; et al.
JAMA. Published online February 26, 2021. doi:10.1001/jama.2021.2747
Pulsa aquí para acceder a la información

(R) (A Little) Clarity on Convalescent Plasma for Covid-19 (Editorial)
Louis M. Katz, M.D.
The New England Journal of Medicine January 13, 2021
DOI: 10.1056/NEJMe2035678
Pulsa aquí para acceder a la información

(R) Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Michael J. Joyner, M.D., Rickey E. Carter, Ph.D., Jonathon W. Senefeld, Ph.D., Stephen A. Klassen, Ph.D., John R. Mills, Ph.D., Patrick W. Johnson, B.S., Elitza S. Theel, Ph.D., Chad C. Wiggins, Ph.D., Katelyn A. Bruno, Ph.D., Allan M. Klompas, M.B., B.Ch., B.A.O., Elizabeth R. Lesser, M.S., Katie L. Kunze, Ph.D., et al.
The New England Journal of Medicine January 13, 2021
DOI: 10.1056/NEJMoa2031893
Pulsa aquí para acceder a la información

(R) A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
Ventura A. Simonovich, M.D., Leandro D. Burgos Pratx, M.D., Paula Scibona, M.D., María V. Beruto, M.D., Marcelo G. Vallone, M.D., Carolina Vázquez, M.D., Nadia Savoy, M.D., Diego H. Giunta, M.D., M.P.H., Ph.D., Lucía G. Pérez, M.D., Marisa del L. Sánchez, M.D., Andrea Vanesa Gamarnik, Ph.D., Diego S. Ojeda, Ph.D., et al., for the PlasmAr Study Group*
The New England Journal of Medicine November 24, 2020
DOI: 10.1056/NEJMoa2031304
Pulsa aquí para acceder a la información

Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel (Special Article)
Alice K. Pau, PharmD, Judith Aberg, MD, Jason Baker, MD, MS, Pamela S. Belperio, PharmD, … View all authors
Annals of Internal Medicine 25 September 2020  https://doi.org/10.7326/M20-6448
Pulsa aquí para acceder a la información

Convalescent Plasma for COVID-19: A multicenter, randomized clinical trial
Cristina Avendano-Sola, Antonio Ramos-Martinez, Elena Munez-Rubio, Belen Ruiz-Antoran, Rosa Malo de Molina, Ferran Torres, Ana Fernandez-Cruz, Alejandro Callejas-Diaz, Jorge Calderon, Concepcion Payares-Herrera, Isabel Salcedo, Irene Romera, Jaime Lora-Tamayo, Mikel Mancheno-Losa, Maria Liz Paciello, Carolina Villegas, Vicente Estrada, Isabel Saez-Serrano, Maria Lourdes Porras-Leal, Maria del Castillo Jarilla-Fernandez, Jose Ramon Pano-Pardo, Jose Antonio Moreno-Chulilla, Itziar Arrieta-Aldea, Alba Bosch, Moncef Belhassen-Garcia, Olga Lopez-Villar, Ascension Ramos-Garrido, Lydia Blanco, Maria Elena Madrigal, Enric Contreras, Eduard Muniz-Diaz, Jose Maria Domingo-Morera, Inmaculada Casas-Flecha, Mayte Perez-Olmeda, Javier Garcia-Perez, Jose Alcami, Jose Luis Bueno, Rafael F Duarte
MedRxiv Posted September 01, 2020   doi: https://doi.org/10.1101/2020.08.26.20182444
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es una prepublicación, que no se ha sido todavía revisado por pares

Stability and neutralising capacity of SARS-CoV-2-specific antibodies in convalescent plasma (Correspondence)
Torsten Tonn, Victor M Corman, Matthias Johnsen, Anja Richter, Roman N Rodionov, Christian Drosten, and others
The Lancet Microbe, Vol. 1, No. 2 Published: June, 2020
Pulsa aquí para acceder a la información

(R) Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial
Li L, Zhang W, Hu Y, et al.
JAMA June 3, 2020
Pulsa aquí para acceder a la información

(R) A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals (Editorial)
Casadevall A, Joyner MJ, Pirofski L
JAMA June 3, 2020
https://jamanetwork.com/journals/jama/fullarticle/2766940

(R) Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial
Li L, Zhang W, Hu Y, et al.
JAMA June 3, 2020
Pulsa aquí para acceder a la información

(R) A Randomized Trial of Convalescent Plasma for COVID-19—Potentially Hopeful Signals (Editorial)
Casadevall A, Joyner MJ, Pirofski L
JAMA June 3, 2020
Pulsa aquí para acceder a la información

Treatment of COVID-19 Patients with Convalescent Plasma in Houston, Texas
Eric Salazar, Katherine K. Perez, Madiha Ashraf, Jian Chen, Brian Castillo, Paul A. Christensen, Taryn Eubank, David W. Bernard, Todd N. Eagar, S. Wesley Long, Sishir Subedi, Randall J. Olsen, Christopher Leveque, Mary R. Schwartz, Monisha Dey, Cheryl Chavez-East, John Rogers, Ahmed Shehabeldin, David Joseph, Guy Williams, Karen Thomas, Faisal Masud, Christina Talley, Katharine G. Dlouhy, Bevin Valdez Lopez, Curt Hampton, Jason Lavinder, Jimmy D. Gollihar, Andre C. Maranhao, Gregory C. Ippolito, Matthew Ojeda Saavedra, Concepcion C. Cantu, Prasanti Yerramilli, Layne Pruitt, James M. Musser
MedRxiv Posted 13 May 2020
doi: https://doi.org/10.1101/2020.05.08.20095471
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es un informe preliminar, que no se ha sido todavía revisado por pares

Treatment with convalescent plasma for COVID‐19 patients in Wuhan, China
Mingxiang Ye MD, PhD Dian Fu MD Yi Ren MD Faxiang Wang MD Dong Wang MD, PhD Fang Zhang MD Xinyi Xia MD Tangfeng Lv
Journal of Medical VirologyDOI: 10.1002/jmv.25882
Pulsa aquí para acceder a la información

Efectividad de la terapia convaleciente en plasma en pacientes con COVID-19 grave
Kai Duan , Bende Liu , Cesheng Li , Huajun Zhang , Ting Yu , Jieming Qu , Min Zhou , Li Chen , Shengli Meng , Yong Hu , Cheng Peng , Mingchao Yuan , Jinyan Huang , Zejun Wang , Jianhong Yu , Xiaoxiao Gao , Dan Wang , Xiaoqi Yu , Li Li , Jiayou Zhang , Xiao Wu , Bei Li , Yanping Xu ,Wei Chen , Yan Peng , Yeqin Hu , Lianzhen Lin , Xuefei Liu , Shihe Huang , Zhijun Zhou , Lianghao Zhang , Yue Wang , Zhi Zhang , Kun Deng , Zhiwu Xia , Qin Gong , Wei Zhang , Xiaobei Zheng , Ying Liu , Huichuan Yang , Dongbo Zhou , Ding Yu , Jifeng Hou , Zhengli Shi , Saijuan Chen , Zhu Chen, Xinxin Zhang y Xiaoming Yang
Proc Natl Acad Sci USA se publicó por primera vez el 6 de abril de 2020. https://doi.org/10.1073/pnas.2004168117
Pulsa aquí para acceder a la información

Tratamiento de 5 pacientes críticos con COVID-19 con plasma convaleciente

Shen C, Wang Z, Zhao F, et al. JAMA 27 de marzo de 2020
Pulsa aquí para acceder a la información

Plasma convaleciente para tratar COVID-19: posibilidades y desafíos

Roback JD, Guarner J. JAMA 27 de marzo de 2020
Pulsa aquí para acceder a la información

TERAPIA ANTI-CITOQUINAS

(R) (N) Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
Evdoxia KyriazopoulouThomas HuetGiulio CavalliAndrea GoriMiltiades KyprianouPeter Pickkersand others
The Lancet Rheumatology Published: August 9, 2021
Pulsa aquí para acceder a la información

(R) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
The Lancet Vol. 397No. 10285 Published: May 01, 2021
Pulsa aquí para acceder a la información

Tocilizumab in COVID-19: some clarity amid controversy
Shruti Gupta, David E Leaf
The Lancet Vol. 397No. 10285 Published: May 01, 2021
Pulsa aquí para acceder a la información

Tocilizumab plus standard care versus standard care in patients in India with moderate to severe COVID-19-associated cytokine release syndrome (COVINTOC): an open-label, multicentre, randomised, controlled, phase 3 trial
Arvinder S Soin, Kuldeep Kumar, Narendra S Choudhary, Pooja Sharma, Yatin Mehta, Sushila Kataria, and others
The Lancet Respiratory Medicine  Published: March 4, 2021
Pulsa aquí para acceder a la información

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
François-Xavier Lescure, Hitoshi Honda, Robert A Fowler, Jennifer Sloane Lazar, Genming Shi, Peter Wung, and others
The Lancet Respiratory Medicine  Published: March 4, 2021
Pulsa aquí para acceder a la información

(R) nterleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
The REMAP-CAP Investigators
NEJM February 25, 2021 DOI: 10.1056/NEJMoa2100433
Pulsa aquí para acceder a la información

(R) Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Ivan O. Rosas, M.D., Norbert Bräu, M.D., Michael Waters, M.D., Ronaldo C. Go, M.D., Bradley D. Hunter, M.D., Sanjay Bhagani, M.D., Daniel Skiest, M.D., Mariam S. Aziz, M.D., Nichola Cooper, M.D., Ivor S. Douglas, M.D., Sinisa Savic, Ph.D., Taryn Youngstein, M.D., Lorenzo Del Sorbo, M.D., Antonio Cubillo Gracian, M.D., David J. De La Zerda, M.D., Andrew Ustianowski, Ph.D., Min Bao, M.D., Sophie Dimonaco, M.Sc., Emily Graham, Ph.D., Balpreet Matharu, M.D., Helen Spotswood, Ph.D., Larry Tsai, M.D., and Atul Malhotra, M.D.
NEJM February 25, 2021 DOI: 10.1056/NEJMoa2028700
Pulsa aquí para acceder a la información

(R) Interleukin-6 Receptor Inhibition in Covid-19 — Cooling the Inflammatory Soup (Editorial)
Eric J. Rubin, M.D., Ph.D., Dan L. Longo, M.D., and Lindsey R. Baden, M.D.
NEJM February 25, 2021 DOI: 10.1056/NEJMe2103108
Pulsa aquí para acceder a la información

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial
The CORIMUNO-19 Collaborative group, and others
The Lancet Respiratory Medicine Published: January 22, 2021
Pulsa aquí para acceder a la información

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 – Preliminary report
The REMAP-CAP Investigators,  Anthony C. Gordon, Paul R. Mouncey, Farah Al-Beidh, Kathryn M. Rowan, Alistair D. Nichol, Yaseen M. e t al.
medRxiv  Posted January 07, 2021  doi:https://doi.org/10.1101/2021.01.07.21249390
Pulsa aquí para acceder a la información

(R) Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia
Carlos Salama, M.D., Jian Han, Ph.D., Linda Yau, Ph.D., William G. Reiss, Pharm.D., Benjamin Kramer, M.D., Jeffrey D. Neidhart, M.D., Gerard J. Criner, M.D., Emma Kaplan-Lewis, M.D., Rachel Baden, M.D., Lavannya Pandit, M.D., Miriam L. Cameron, M.D., Julia Garcia-Diaz, M.D., et al.
The New England Journal of Medicine January 7, 2021
N Engl J Med 2021; 384:20-30  DOI: 10.1056/NEJMoa2030340
Pulsa aquí para acceder a la información

COVIDOSE: A phase 2 clinical trial of low‐dose tocilizumab in the treatment of non‐critical COVID‐19 pneumonia
Garth W. Strohbehn  Brian L. Heiss  Sherin J. Rouhani  Jonathan A. Trujillo  Jovian Yu  Alec J. Kacew  Emily F. Higgs  Jeffrey C. Bloodworth  Alexandra Cabanov  Rachel C. Wright et al.
Clinical Pharmacology & Therapeutics First published: 18 November 2020 https://doi.org/10.1002/cpt.2117
Pulsa aquí para acceder a la información

(R) Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
H. Stone, M.D., M.P.H., Matthew J. Frigault, M.D., Naomi J. Serling-Boyd, M.D., Ana D. Fernandes, M.A., Liam Harvey, B.S., Andrea S. Foulkes, Ph.D., Nora K. Horick, M.S., Brian C. Healy, Ph.D., Ruta Shah, M.D., Ana Maria Bensaci, M.D., Ann E. Woolley, M.D., Sarah Nikiforow, M.D., Ph.D., et al., for the BACC Bay Tocilizumab Trial Investigators*
The New England Journal of Medicine October 21, 2020
DOI: 10.1056/NEJMoa2028836
Pulsa aquí para acceder a la información

(R) Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial
Hermine O, Mariette X, Tharaux P, et al.
JAMA Internal Medicine October 20, 2020
Pulsa aquí para acceder a la información

 Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Jesús Rodríguez-Baño, Jerónimo Pachón, Jordi Carratalà, José Ramón Arribas, Juan Berenguer the SAM-COVID Study Group
Clinical Microbiology and Infection Published:August 26, 2020 DOI:https://doi.org/10.1016/j.cmi.2020.08.010
Pulsa aquí para acceder a la información

Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study
Noa Biran, Andrew Ip, Jaeil Ahn, Ronaldo C Go, Shuqi Wang, Shivam Mathura, and others
The Lancet Rheumatology Published: August 14, 2020
Pulsa aquí para acceder a la información

Serious adverse events with tocilizumab: pharmacovigilance as an aid to prioritize monitoring in COVID‐19
Milo Gatti  Michele Fusaroli  Paolo Caraceni  Elisabetta Poluzzi  Fabrizio De Ponti  Emanuel Raschi
British Journal of Pharmacvology First published: 08 July 2020 https://doi.org/10.1111/bcp.14459
Pulsa aquí para acceder a la información

Potential role of IL‐17 blocking agents in the treatment of severe COVID‐19? (Letter)
Vedrana Bulat  Mirna Situm  Marija Delas Azdajic  Robert Likic
British Pharmalogical Society First published: 05 July 2020 https://doi.org/10.1111/bcp.14437
Pulsa aquí para acceder a la información

 Tocilizumab in patients with severe COVID-19: a retrospective cohort study
Giovanni Guaraldi, Marianna Meschiari, Alessandro Cozzi-Lepri, Jovana Milic, Roberto Tonelli, Marianna Menozzi, and others
The Lancet Rheumatology Published: June 24, 2020
Pulsa aquí para acceder a la información

Canakinumab in a subgroup of patients with COVID-19 (Correspondence)
Claudio Ucciferri, Antonio Auricchio, Marta Di Nicola, Nicola Potere, Antonio Abbate, Francesco Cipollone, and others
The Lancet Rheumatology  Published: June 4, 2020
Pulsa aquí para acceder a la información

Is There a Role for Blood Purification Therapies Targeting Cytokine Storm Syndrome in Critically Severe COVID-19 Patients?
Gang Chen , Yangzhong Zhou , Jie Ma , Peng Xia , Yan Qin , Xuemei Li
Ren Fail. 2020 Nov;42(1):483-488. doi: 10.1080/0886022X.2020.1764369.
Pulsa aquí para acceder a la información

Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19 (Letter)
Stanislas Faguer, MD, PhD, Arnaud Del Bello, MD, Florence Abravanel, PharmD, PhD, …
Annals of Internal Medicine1 8 May 2020 https://doi.org/10.7326/L20-0419
https://www.acpjournals.org/doi/10.7326/L20-0419

Anakinra for severe forms of COVID-19: a cohort study
Thomas Huet, Hélène Beaussier, Olivier Voisin, Stéphane Jouveshomme, Gaëlle Dauriat, Isabelle Lazareth, and others
The Lancet Rheumatology Published: May 29, 2020
Pulsa aquí para acceder a la información

Use of subcutaneous tocilizumab in patients with COVID‐19 pneumonia (Letter)
Maria Mazzitelli  Eugenio Arrighi  Francesca Serapide  Maria Chiara Pelle  Bruno Tassone  Rosaria Lionello  Giuseppina Marrazzo  Domenico Laganà  Francesco Saverio Costanzo et al.
Journal of Medical Virology First published:15 May 2020 https://doi.org/10.1002/jmv.26016
Pulsa aquí para acceder a la información

Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome.
Quartuccio L, Semerano L, Benucci M, Boissier MC, De Vita S.
Joint Bone Spine. 2020 May;87(3):191-193. doi: 10.1016/j.jbspin.2020.03.011.
Pulsa aquí para acceder a la información

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed (Comment)
Marc Feldmann, Ravinder N Maini, James N Woody, Stephen T Holgate, Gregory Winter, Matthew Rowland, and others
The Lancet Published: April 9, 2020
Pulsa aquí para acceder a la información

Preventing COVID-19-induced pneumonia with anticytokine therapy (Correspondence)
Giovanni Monteleone, Pier Carlo Sarzi-Puttini, Sandro Ardizzone
The Lancet Rheumatology
Published: April 6, 2020
Pulsa aquí para acceder a la información

VACUNAS

(R) (N) Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting
Noam Barda, M.D., Noa Dagan, M.D., Yatir Ben-Shlomo, B.Sc., Eldad Kepten, Ph.D., Jacob Waxman, M.D., Reut Ohana, M.Sc., Miguel A. Hernán, M.D., Marc Lipsitch, D.Phil., Isaac Kohane, M.D., Doron Netzer, M.D., Ben Y. Reis, Ph.D., and Ran D. Balicer, M.D.
NEJM August 25, 2021  DOI: 10.1056/NEJMoa2110475
Pulsa aquí para acceder a la información

(N) The Importance of Context in Covid-19 Vaccine Safety (Editorial)
Grace M. Lee, M.D., M.P.H.
NEJM August 25, 2021  DOI: 10.1056/NEJMe2112543
Pulsa aquí para acceder a la información

(R) (N) Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents
Kashif Ali, M.D., Gary Berman, M.D., Honghong Zhou, Ph.D., Weiping Deng, Ph.D., Veronica Faughnan, B.S., Maria Coronado-Voges, M.S., Baoyu Ding, M.S., Jacqueline Dooley, B.A., Bethany Girard, Ph.D., William Hillebrand, M.S., Rolando Pajon, Ph.D., Jacqueline M. Miller, M.D., et al.
NEJM August 11, 2021 DOI: 10.1056/NEJMoa2109522
Pulsa aquí para acceder a la información

(R) (N) Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W. Frenck, Jr., M.D., Nicola P. Klein, M.D., Ph.D., Nicholas Kitchin, M.D., Alejandra Gurtman, M.D., Judith Absalon, M.D., Stephen Lockhart, D.M., John L. Perez, M.D., Emmanuel B. Walter, M.D., Shelly Senders, M.D., Ruth Bailey, B.Sc., Kena A. Swanson, Ph.D., Hua Ma, Ph.D., et al., for the C4591001 Clinical Trial Group*
NEJM July 15, 2021 385:239-250  DOI: 10.1056/NEJMoa2107456
Pulsa aquí para acceder a la información

(R) (N) Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Jamie Lopez Bernal, F.F.P.H., Ph.D., Nick Andrews, Ph.D., Charlotte Gower, D.Phil., Eileen Gallagher, Ph.D., Ruth Simmons, Ph.D., Simon Thelwall, Ph.D., Julia Stowe, Ph.D., Elise Tessier, M.Sc., Natalie Groves, M.Sc., Gavin Dabrera, M.B., B.S., F.F.P.H., Richard Myers, Ph.D., Colin N.J. Campbell, M.P.H., F.F.P.H., et
NEJM August 12, 2021 N Engl J Med 2021; 385:585-594 DOI:10.1056/NEJMoa2108891
Pulsa aquí para acceder a la información

 (N) Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
Xinxue Liu, Robert H Shaw, Arabella S V Stuart, Melanie Greenland, Parvinder K Aley, Nick J Andrews and others
The Lancet Published: August 6, 2021
Pulsa aquí para acceder a la información

(R) (N) Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W. Frenck, Jr., M.D., Nicola P. Klein, M.D., Ph.D., Nicholas Kitchin, M.D., Alejandra Gurtman, M.D., Judith Absalon, M.D., Stephen Lockhart, D.M., John L. Perez, M.D., Emmanuel B. Walter, M.D., Shelly Senders, M.D., Ruth Bailey, B.Sc., Kena A. Swanson, Ph.D., Hua Ma, Ph.D., et al., for the C4591001 Clinical Trial Group*
NEJM July 15, 2021 N Engl J Med 2021; 385:239-250 DOI:10.1056/NEJMoa2107456
Pulsa aquí para acceder a la información

 (N)  Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
Moriah Bergwerk, M.B., B.S., Tal Gonen, B.A., Yaniv Lustig, Ph.D., Sharon Amit, M.D., Marc Lipsitch, Ph.D., Carmit Cohen, Ph.D., Michal Mandelboim, Ph.D., Einav Gal Levin, M.D., Carmit Rubin, N.D., Victoria Indenbaum, Ph.D., Ilana Tal, R.N., Ph.D., Malka Zavitan, R.N., M.A., et al.
NEJM July 28, 2021 DOI: 10.1056/NEJMoa2109072
Pulsa aquí para acceder a la información

 (N)  Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Mark G. Thompson, Ph.D., Jefferey L. Burgess, M.D., M.P.H., Allison L. Naleway, Ph.D., Harmony Tyner, M.D., M.P.H., Sarang K. Yoon, D.O., Jennifer Meece, Ph.D., Lauren E.W. Olsho, Ph.D., Alberto J. Caban-Martinez, D.O., Ph.D., M.P.H., C.P.H., Ashley L. Fowlkes, Sc.D., M.P.H., Karen Lutrick, Ph.D., Holly C. Groom, M.P.H., Kayan Dunnigan, M.P.H., et al.
NEJM July 22, 2021; 385:320-329  DOI: 10.1056/NEJMoa2107058
Pulsa aquí para acceder a la información

(R) Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
Mine Durusu Tanriover, Hamdi Levent Doğanay, Murat Akova, Hatice Rahmet GünerAlpay Azap, Sıla Akhan and others
The Lancet Published: July 8, 2021
Pulsa aquí para acceder a la información

(R) Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
Julia W. Gargano, PhD1,*; Megan Wallace, DrPH1,*; Stephen C. Hadler, MD1; Gayle Langley, MD1; John R. Su, MD, PhD1; Matthew E. Oster, MD1; Karen R. Broder, MD1; Julianne Gee, MPH1; Eric Weintraub, MPH1; Tom Shimabukuro, MD1; Heather M. Scobie, PhD1; Danielle Moulia, MPH1; Lauri E. Markowitz, MD1; Melinda Wharton, MD1; Veronica V. McNally, JD2; José R. Romero, MD3; H. Keipp Talbot, MD4; Grace M. Lee, MD5; Matthew F. Daley, MD6; Sara E. Oliver, MD
MMWR  July 9, 2021 / 70(27);977–982
Pulsa aquí para acceder a la información

(R) Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
Alejandro Jara, Ph.D., Eduardo A. Undurraga, Ph.D., Cecilia González, M.D., Fabio Paredes, M.Sc., Tomás Fontecilla, M.Sc., Gonzalo Jara, B.S.E., Alejandra Pizarro, M.D., Johanna Acevedo, M.S., Katherine Leo, B.S.E., Francisco Leon, M.B.A., Carlos Sans, B.S.E., Paulina Leighton, B.S.E., et al.
NEJM July 7, 2021 DOI: 10.1056/NEJMoa2107715
Pulsa aquí para acceder a la información

 mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
Hiam Chemaitelly, Hadi M. Yassine[…]Laith J. Abu-Raddad
Nature Medicine , 1–89 July 2021                  
Pulsa aquí para acceder a la información

  The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
Satveer K Mahil, Katie Bechman, Antony Raharja, Clara Domingo-Vila, David Baudry, Matthew A Brown and others
The Lancet RheumatologyPublished: July 8, 2021
Pulsa aquí para acceder a la información

   Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
William M Souza, Mariene R Amorim, Renata Sesti-Costa, Lais D Coimbra, Natalia S Brunetti, Daniel A Toledo-Teixeira and others
The Lancet Microbe Published: July 8, 2021
Pulsa aquí para acceder a la información

   Reactivation of IgA vasculitis after COVID-19 vaccination (Correspodence)
Michel Obeid, Craig Fenwick, Giuseppe Pantaleo
The Lancet Rheumatology Published: July 6, 2021
Pulsa aquí para acceder a la información

BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers
Yaniv Lustig, Einav Sapir, Gili Regev-Yochay, Carmit Cohen, Ronen Fluss, Liraz Olmer and others
The Lancet Respiratory Medicine Published: July 2, 2021
Pulsa aquí para acceder a la información

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
Kazimieras Maneikis, Karolis Šablauskas, Ugnė Ringelevičiūtė, Vilmantė Vaitekėnaitė, Rita Čekauskienė, Lina Kryžauskaitė and others
The Lancet Haematology Published: July 2, 2021
Pulsa aquí para acceder a la información

Blunted humoral response after mRNA vaccine in patients with haematological malignancies (Comment)
Mini Kamboj
The Lancet HaematologyPublished: July 2, 2021
Pulsa aquí para acceder a la información

Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma (Comment)
Sean H Lim, Nicola Campbell, Marina Johnson, Debora Joseph-Pietras, Graham P Collins, Ann O'Callaghan and others
The Lancet Haematology Published: July 2, 2021
Pulsa aquí para acceder a la información

(R) Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
Paul T. Heath, F.R.C.P.C.H., Eva P. Galiza, M.B., B.S., David N. Baxter, M.D., Ph.D., Marta Boffito, M.D., Ph.D., Duncan Browne, M.D., Fiona Burns, Ph.D., David R. Chadwick, Ph.D., Rebecca Clark, M.B., Ch.B., Catherine Cosgrove, Ph.D., James Galloway, Ph.D., Anna L. Goodman, D.Phil., Amardeep Heer, M.B., Ch.B., et al., for the 2019nCoV-302 Study Group*
NEJM June 30, 2021  DOI: 10.1056/NEJMoa2107659
Pulsa aquí para acceder a la información

(R) Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Mark G. Thompson, Ph.D., Jefferey L. Burgess, M.D., M.P.H., Allison L. Naleway, Ph.D., Harmony Tyner, M.D., M.P.H., Sarang K. Yoon, D.O., Jennifer Meece, Ph.D., Lauren E.W. Olsho, Ph.D., Alberto J. Caban-Martinez, D.O., Ph.D., M.P.H., C.P.H., Ashley L. Fowlkes, Sc.D., M.P.H., Karen Lutrick, Ph.D., Holly C. Groom, M.P.H., Kayan Dunnigan, M.P.H., et al.
NEJM June 30, 2021  DOI: 10.1056/NEJMoa2107058
Pulsa aquí para acceder a la información

(R) SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
Jackson S. Turner, Jane A. O’Halloran, Elizaveta Kalaidina, Wooseob Kim, Aaron J. Schmitz, Julian Q. Zhou, Tingting Lei, Mahima Thapa, Rita E. Chen, James Brett Case, Fatima Amanat, Adriana M. Rauseo, Alem Haile, Xuping Xie, Michael K. Klebert, Teresa Suessen, William D. Middleton, Pei-Yong Shi, Florian Krammer, Sharlene A. Teefey, Michael S. Diamond, Rachel M. Presti & Ali H. Ellebedy
Nature (2021) Published: 28 June 2021
Pulsa aquí para acceder a la información

COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants
Pinja Jalkanen, Pekka Kolehmainen, […]Ilkka Julkunen
Nature Communications volume 12, Article number: 3991 (2021) Published: 28 June 2021
Pulsa aquí para acceder a la información

(R) Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial
Bihua Han, Yufei SongChanggui Li, Wanqi Yang, Qingxia Ma, Zhiwei Jiang and others
The Lancet Infectious Diseases Published: June 28, 2021
Pulsa aquí para acceder a la información

Paucity and discordance of neutralising antibody responses to SARS-CoV-2 VOCs in vaccinated immunodeficient patients and health-care workers in the UK (Comment)
Angalee NadesalingamDiego CantoniDavid A WellsErnest T AguinamMatteo FerrariPeter Smithand others
The Lancet MicrobePublished: June 28, 2021
Pulsa aquí para acceder a la información

(R)  SARS-CoV-2 Variants and Vaccines
Philip R. Krause, M.D., Thomas R. Fleming, Ph.D., Ira M. Longini, Ph.D., Richard Peto, F.R.S., Sylvie Briand, M.D., David L. Heymann, M.D., Valerie Beral, F.R.C.P., Matthew D. Snape, M.D., Helen Rees, M.R.C.G.P., Alba-Maria Ropero, B.Sc., Ran D. Balicer, M.D., Jakob P. Cramer, M.D., et al.
NEJM June 23, 2021 DOI: 10.1056/NEJMsr2105280
Pulsa aquí para acceder a la información

(R)  Effectiveness of mRNA COVID-19 vaccines in preventing SARS-CoV-2 infections and COVID-19 hospitalisations and deaths in elderly long-term care facility residents, Spain, weeks 53 2020 to 13 2021 separator commenting unavailable
Clara Mazagatos , Susana Monge , Carmen Olmedo , Lorena Vega , Pilar Gallego , Elisa Martín-Merino , María José Sierra , Aurora Limia , Amparo Larrauri , Working Group for the surveillance and control of COVID-19 in Spain
Eurosurveillance  Volume 26, Issue 24, 17/Jun/2021
Pulsa aquí para acceder a la información

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial
Alberto M Borobia, Antonio J Carcas, Mayte Pérez-Olmeda, Luis Castaño, María Jesús Bertran, Javier García-Pérez and others
The Lancet Published: June 25, 2021
Pulsa aquí para acceder a la información

(R)  Heterologous vaccine regimens against COVID-19 (Comment)
Talita Duarte-SallesDaniel Prieto-Alhambra
The LancetPublished: June 25, 2021
Pulsa aquí para acceder a la información

Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
Madhumita Shrotri, Maria Krutikov, Tom Palmer, Rebecca Giddings, Borscha Azmi, Sathyavani Subbarao and others
The Lancet Infectious DiseasesPublished: June 23, 2021
Pulsa aquí para acceder a la información

Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study
Catherine Hyams, Robin Marlow, Zandile Maseko, Jade King, Lana Ward, Kazminder Fox and others
The Lancet Infectious DiseasesPublished: June 23, 2021
Pulsa aquí para acceder a la información

Single-dose SARS-CoV-2 vaccination efficacy in the elderly
Maria Prendecki, Michelle Willicombe
The Lancet Infectious Diseases Published: June 23, 2021
Pulsa aquí para acceder a la información

Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients (Correspondence)
Nassim Kamar, M.D., Ph.D., Florence Abravanel, Pharm.D., Ph.D., Olivier Marion, M.D., Chloé Couat, M.Sc., Jacques Izopet, Pharm.D., Ph.D., Arnaud Del Bello, M.D.
NEJM June 23, 2021 DOI: 10.1056/NEJMc2108861
Pulsa aquí para acceder a la información

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 (Correspondence)
Nicole Doria-Rose, Mehul S. Suthar, Mat Makowski, Sarah O’Connell et al.
NEJM June 10, 2021 384:2259-2261 DOI: 10.1056/NEJMc2103916
Pulsa aquí para acceder a la información

Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
John Frater, Katie J Ewer, Ane Ogbe, Mathew Pace ,Sandra Adele, Emily Adland and others
The Lancet HIV Published: June 18, 2021
Pulsa aquí para acceder a la información

Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia
Alex Bourguignon, M.D., Donald M. Arnold, M.D., Theodore E. Warkentin, M.D., James W. Smith, B.Sc., Tania Pannu, M.D., Jeffrey M. Shrum, M.D., Zainab A.A. Al Maqrashi, M.D., Anjali Shroff, M.D., Marie-Claude Lessard, M.D., Normand Blais, M.D., John G. Kelton, M.D., and Ishac Nazy, Ph.D.
NEJM June 9, 2021 DOI: 10.1056/NEJMoa2107051
Pulsa aquí para acceder a la información

First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland
C. R. Simpson, T. Shi[…]A. Sheikh
Nature Medicine , 1–8 9 June 2021
Pulsa aquí para acceder a la información

(R) Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
Emma Pritchard, Philippa C. Matthews[…]Koen B. Pouwels
Nature Medicine , 1–9 9 June 2021
Pulsa aquí para acceder a la información

(R) BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
Jianying Liu, Yang Liu, Hongjie Xia, Jing Zou, Scott C. Weaver, Kena A. Swanson, Hui Cai, Mark Cutler, David Cooper, Alexander Muik, Kathrin U. Jansen, Ugur Sahin, Xuping Xie, Philip R. Dormitzer & Pei-Yong Shi
Nature (2021) Published 10 June 2021
Pulsa aquí para acceder a la información

(R) Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Galit Alter, Jingyou Yu[…]Dan H. Barouch
Nature , 1–9 9 June 2021
Pulsa aquí para acceder a la información

Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination
Laura Matrajt, Julia Eaton[…]Holly Janes
Nature Communications 12 , 1–18 8 June 2021
Pulsa aquí para acceder a la información

Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines
Weilin Zhou & Wei Wang
Signal Transduction and Targeted Therapy volume 6, Article number: 226 (2021) Published: 09 June 2021
Pulsa aquí para acceder a la información

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination (Correspondence)
Emma C Wall, Mary Wu, Ruth Harvey, Gavin Kelly, Scott Warchal, Sawyer and others
       The Lancet Published: June 3, 2021
Pulsa aquí para acceder a la información

Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study (Correspondence)
S. Takuva and Others
NEJM June 2, 2021 DOI: 10.1056/NEJMc2107920
Pulsa aquí para acceder a la información

Association between previous infection with SARS CoV-2 and the risk of self-reported symptoms after mRNA BNT162b2 vaccination: Data from 3,078 health care workers
Antonella d'Arminio Monforte, Alessandro Tavelli, Pier Mario Perrone, Alessandro Za, Katia Razzini, Daniele Tomasoni and others
EClinicalMedicineVol. 36Published: May 30, 2021

Pulsa aquí para acceder a la información

 

(R) Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
Robert W. Frenck, Jr., M.D., Nicola P. Klein, M.D., Ph.D., Nicholas Kitchin, M.D., Alejandra Gurtman, M.D., Judith Absalon, M.D., Stephen Lockhart, D.M., John L. Perez, M.D., Emmanuel B. Walter, M.D., Shelly Senders, M.D., Ruth Bailey, B.Sc., Kena A. Swanson, Ph.D., Hua Ma, Ph.D., et al., for the C4591001 Clinical Trial Group*
NEJM May 27, 2021  DOI: 10.1056/NEJMoa2107456
Pulsa aquí para acceder a la información

Vaccine-Induced Covid-19 Mimicry” Syndrome:Splice reactions within the SARS-CoV-2 Spike open reading frame result in Spike protein variants that may cause thromboembolic events in patients immunized with vector-based vaccines

Eric Kowarz, Lea Krutzke, Jenny Reis, Silvia Bracharz, Stefan Kochanek y Rolf Marschalek

Research Square DOI: https://doi.org/10.21203/rs.3.rs-558954/v1
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es un informe preliminar, que no se ha sido todavía revisado por pares

Serum neutralising activity against SARS-CoV-2 variants elicited by CoronaVac (Letter)
Yuxin Chen, Han Shen, Rui Huang, Xin Tong, Chao Wu
The Lancet Infectious Diseases Published: May 27, 2021
Pulsa aquí para acceder a la información

Indirect Protection by Reducing Transmission: Ending the Pandemic with SARS-CoV-2 Vaccination
Aaron Richterman, MD, Eric A Meyerowitz, MD, Muge Cevik, MD
Open Forum Infectious Diseases, ofab259, https://doi.org/10.1093/ofid/ofab259 Published: 19 May 2021
Pulsa aquí para acceder a la información

Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
Brian J. Ward, Philipe Gobeil, Annie Séguin, Judith Atkins, Iohann Boulay, Pierre-Yves Charbonneau, Manon Couture, Marc-André D’Aoust, Jiwanjeet Dhaliwall, Carolyn Finkle, Karen Hager, Asif Mahmood, Alexander Makarkov, Matthew P. Cheng, Stéphane Pillet, Patricia Schimke, Sylvie St-Martin, Sonia Trépanier & Nathalie Landry
Nature Medicine (2021) Published: 18 May 2021
Pulsa aquí para acceder a la información

 Can integrated post-exposure vaccination against SARS-COV2 mitigate severe disease? (Viewpoint)
Claude P. Muller
The Lancet Regional Health – Europe Vol. 5 Published: May 17, 2021
Pulsa aquí para acceder a la información

(R) Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna. COVID-19 Vaccines Among Health Care Personnel —33 U.S. Sites, January–March 2021
Tamara Pilishvili, PhD1; Katherine E. Fleming-Dutra, MD1; Jennifer L. Farrar, MPH1; Ryan Gierke, MPH1; Nicholas M. Mohr, MD2; David A. Talan, MD3…and others. Vaccine Effectiveness Among Healthcare Personnel Study Team
MMWR Vol.70 May 14, 2021
Pulsa aquí para acceder a la información

Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
Collier AY, McMahan K, Yu J, et al.
JAMA May 13, 2021
Pulsa aquí para acceder a la información

Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine: A Case Series
Johnston MS, Galan A, Watsky KL, et al.
JAMA Dermatology May 12, 2021
Pulsa aquí para acceder a la información

Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
Robert H Shaw, Arabella Stuart, Melanie Greenland, Xinxue Liu, Jonathan S Nguyen Van-Tam, Matthew D Snape and others
The Lancet Published: May 12, 2021
Pulsa aquí para acceder a la información

BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants (Correspondence)
Y.Liu and others
NEJM May 12, 2021 DOI: 10.1056/NEJMc2106083
Pulsa aquí para acceder a la información

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
Vivek Shinde, M.D., M.P.H., Sutika Bhikha, M.B., B.S., Zaheer Hoosain, M.B., Ch.B., Moherndran Archary, Ph.D., Qasim Bhorat, M.B., B.Ch., Lee Fairlie, M.B., Ch.B., Umesh Lalloo, M.B., Ch.B., Mduduzi S.L. Masilela, M.B., Ch.B., Dhayendre Moodley, Ph.D., Sherika Hanley, M.B., B.S., Leon Fouche, M.B., Ch.B., Cheryl Louw, M.B., Ch.B., et al., for the 2019nCoV-501 Study Group*
NEJM May 5, 2021 DOI: 10.1056/NEJMoa2103055
Pulsa aquí para acceder a la información

 Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants (Correspondence)
L.J. Abu-Raddad, H. Chemaitelly, and A.A. Butt
NEJM May 5, 2021 DOI: 10.1056/NEJMc2104974
Pulsa aquí para acceder a la información

(R)  Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Eric J Haas, Frederick J Angulo, John M McLaughlin, Emilia Anis, Shepherd R Singer, Farid Khan and others
The Lancet Published: May 5, 2021
Pulsa aquí para acceder a la información

 Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
Yoel Angel ; Avishay Spitzer; Oryan Henig et al
JAMA. Published online May 6, 2021. doi:10.1001/jama.2021.7152
Pulsa aquí para acceder a la información

 Asymptomatic and Symptomatic SARS-CoV-2 Infections After BNT162b2 Vaccination in a Routinely Screened Workforce (Letter)
Li Tang; Diego R. Hijano; Aditya H. Gaur et al
JAMA. Published online May 6, 2021. doi:10.1001/jama.2021.6564
Pulsa aquí para acceder a la información

 Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients (Letter)
Brian J. Boyarsky; William A. Werbel; Robin K. Avery  et al
JAMA. Published online May 5, 2021. doi:10.1001/jama.2021.7489
Pulsa aquí para acceder a la información

 Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Ezgi Hacisuleyman, Ph.D., Caryn Hale, Ph.D., Yuhki Saito, Ph.D., Nathalie E. Blachere, Ph.D., Marissa Bergh, B.S.N., Erin G. Conlon, Ph.D., Dennis J. Schaefer-Babajew, Ph.D., Justin DaSilva, M.S., Frauke Muecksch, Ph.D., Christian Gaebler, M.D., Richard Lifton, M.D., Ph.D., Michel C. Nussenzweig, M.D., Ph.D., et al.
NEJM April 21, 2021 DOI: 10.1056/NEJMoa2105000
Pulsa aquí para acceder a la información

Age-dependent immune response to the Biontech/Pfizer BNT162b2 COVID-19 vaccination
Lisa Müller, Marcel Andrée, Wiebke Moskorz, Ingo Drexler, Lara Walotka et al.
Clinical Infectious Diseases, ciab381, https://doi.org/10.1093/cid/ciab381
Pulsa aquí para acceder a la información

Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
Catherine J. Reynolds et al.
Science Date: 30-Apr-2021 DOI: 10.1126/science.abh1282
Pulsa aquí para acceder a la información

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
See I, Su JR, Lale A, et al.
JAMA April 30, 2021
Pulsa aquí para acceder a la información

Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study
Cristina Menni, Kerstin Klaser, Anna May, Lorenzo Polidori, Joan Capdevila, Panayiotis Louca, and others
The Lancet Infectious Diseases Published: April 27, 2021
Pulsa aquí para acceder a la información

Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Leticia Monin, Adam G Laing, Miguel Muñoz-Ruiz, Duncan R McKenzie, Irene del Molino del Barrio, Thanussuyah Alaguthurai and others
The Lancet OncologyPublished: April 27, 2021
Pulsa aquí para acceder a la información

COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
Victoria Jane Hall, Sarah Foulkes, Ayoub Saei, Nick Andrews, Blanche Oguti, Andre Charlett, and others
The LancetPublished: April 23, 2021
Pulsa aquí para acceder a la información

 Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
Eleftheria Vasileiou, Colin R Simpson, Ting Shi, Steven Kerr, Utkarsh Agrawal, Ashley Akbari and others
The LancetPublished: April 23, 2021
Pulsa aquí para acceder a la información

(R) Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
Jerald Sadoff, M.D., Glenda Gray, M.B., B.Ch., An Vandebosch, Ph.D., Vicky Cárdenas, Ph.D., Georgi Shukarev, M.D., Beatriz Grinsztejn, M.D., Paul A. Goepfert, M.D., Carla Truyers, Ph.D., Hein Fennema, Ph.D., Bart Spiessens, Ph.D., Kim Offergeld, M.Sc., Gert Scheper, Ph.D., et al., for the ENSEMBLE Study Group*
NEJM April 21, 2021 DOI: 10.1056/NEJMoa2101544
Pulsa aquí para acceder a la información

(R) Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study
Prof Paul A Goepfert, MD, Bo Fu, PhD, Anne-Laure Chabanon, PhD,Matthew I Bonaparte, PhD, Matthew G Davis, MD, Brandon J Essink, MD et al.
The Lancet Published:April 19, 2021DOI:https://doi.org/10.1016/S1473-3099(21)00147-X
Pulsa aquí para acceder a la información

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
Ezgi Hacisuleyman, Ph.D., Caryn Hale, Ph.D., Yuhki Saito, Ph.D., Nathalie E. Blachere, Ph.D., Marissa Bergh, B.S.N., Erin G. Conlon, Ph.D., Dennis J. Schaefer-Babajew, Ph.D., Justin DaSilva, M.S., Frauke Muecksch, Ph.D., Christian Gaebler, M.D., Richard Lifton, M.D., Ph.D., Michel C. Nussenzweig, M.D., Ph.D., et al.
NEJM April 21, 2021 DOI: 10.1056/NEJMoa2105000
Pulsa aquí para acceder a la información

 COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room (Comment)
Piero Olliaro, Els Torreele, Michel Vaillant
The Lancet Published: April 20, 2021DOI:https://doi.org/10.1016/S2666-5247(21)00069-0
https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(21)00069-0/fulltext

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
Tom T. Shimabukuro, M.D., Shin Y. Kim, M.P.H., Tanya R. Myers, Ph.D., Pedro L. Moro, M.D., Titilope Oduyebo, M.D., Lakshmi Panagiotakopoulos, M.D., Paige L. Marquez, M.S.P.H., Christine K. Olson, M.D., Ruiling Liu, Ph.D., Karen T. Chang, Ph.D., Sascha R. Ellington, Ph.D., Veronica K. Burkel, M.P.H., et al., for the CDC v-safe COVID-19 Pregnancy Registry Team*
NEJM April 21, 2021  DOI: 10.1056/NEJMoa2104983
Pulsa aquí para acceder a la información

(R) Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
Marie Scully, M.D., Deepak Singh, B.Sc., Robert Lown, M.D., Anthony Poles, M.D., Thomas Solomon, M.D., Marcel Levi, M.D., David Goldblatt, M.D., Ph.D., Pavel Kotoucek, M.D., William Thomas, M.D., and William Lester, M.D.
NEJM April 16, 2021 DOI: 10.1056/NEJMoa2105385
Pulsa aquí para acceder a la información

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia (Editorial)
Douglas B. Cines, M.D., and James B. Bussel, M.D.
NEJM April 16, 2021 DOI: 10.1056/NEJMe2106315
Pulsa aquí para acceder a la información

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination (Correspondence)
Kate-Lynn Muir and others
NEJM April 14, 2021 DOI: 10.1056/NEJMc2105869
Pulsa aquí para acceder a la información

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer (Correspondence)
Jerald Sadoff and others
NEJM April 16, 2021 DOI: 10.1056/NEJMc2106075
Pulsa aquí para acceder a la información

Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination
Eun-Ju Lee, Douglas B Cines, Terry Gernsheimer, Craig Kessler, Marc Michel, Michael D Tarantino, John W Semple, Donald M Arnold, Bertrand Godeau, Michele P Lambert, James B Bussel
Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.
Pulsa aquí para acceder a la información

Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2 (Correspondence)
Baoying Huang,  Lianpan Dai, Hui Wang, Zhongyu Hu, Xiaoming Yang, Wenjie Tan and others
The Lancet Microbe Published: April 13, 2021
Pulsa aquí para acceder a la información

(R) Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Andreas Greinacher, M.D., Thomas Thiele, M.D., Theodore , Warkentin, M.D., Karin Weisser, Ph.D., Paul A. Kyrle, M.D., and Sabine Eichinger, M.D.
NEJM April 9, 2021 DOI: 10.1056/NEJMoa2104840
Pulsa aquí para acceder a la información

(R)  Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Brief report
Nina H. Schultz, M.D., Ph.D., Ingvild H. Sørvoll, M.D., Annika E. Michelsen, Ph.D., Ludvig A. Munthe, M.D., Ph.D., Fridtjof Lund-Johansen, M.D., Ph.D., Maria T. Ahlen, Ph.D., Markus Wiedmann, M.D., Ph.D., Anne-Hege Aamodt, M.D., Ph.D., Thor H. Skattør, M.D., Geir E. Tjønnfjord, M.D., Ph.D., and Pål A. Holme, M.D., Ph.D.
NEJM April 9, 2021 DOI: 10.1056/NEJMoa2104882
Pulsa aquí para acceder a la información

Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19 (Correspondence)
Nicole Doria-Rose and others
NEJM April 6, 2021 DOI: 10.1056/NEJMc2103916
Pulsa aquí para acceder a la información

Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort
Ulf M Geisen, Dennis K Berner, Florian Tran,2,3 Melike Sümbül, Lena Vullriede, Maria Ciripoi, Hayley M Reid, Annika Schaffarzyk,5Ann C Longardt, Jeanette Franzenburg, Paula Hoff, Jan H Schirmer, Rainald Zeuner, Anette Friedrichs, Andrea Steinbach,Christine Knies, Robert DH Markewitz , Peter J Morrison, Sascha Gerdes, Stefan Schreiber, Bimba F
Ann Rheum Dis 2021;0:1–6. doi:10.1136/annrheumdis-2021-220272
Pulsa aquí para acceder a la información

Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351 (Correspondence)
X.Shen and others
NEJM April 7, 2021 DOI: 10.1056/NEJMc2103740
Pulsa aquí para acceder a la información

Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2 (Correspondence)
Y.Lustig and others
NEJM April 7, 2021 DOI: 10.1056/NEJMc2104036
Pulsa aquí para acceder a la información

Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization (Correspondence)
G.L.Wang and others
NEJM April 6, 2021 DOI: 10.1056/NEJMc2103022
Pulsa aquí para acceder a la información

(R) Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
Katherine R W Emary, Tanya Golubchik, Parvinder K Aley, Cristina V Ariani, Brian Angus, Sagida Bibi and others
The Lancet Published: March 30, 2021
Pulsa aquí para acceder a la información

BNT162b2 mRNA Covid-19 Vaccine Effectiveness among Health Care Workers (Correspondence)
S. Benenson and others
NEJM March 23, 2021 DOI: 10.1056/NEJMc2101951
Pulsa aquí para acceder a la información

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications (Correspondence)
S.S. Abdool Karim, Tulio de Oliveira and others
NEJM March 24, 2021 DOI: 10.1056/NEJMc2100362
Pulsa aquí para acceder a la información

Antibody Responses after a Single Dose of SARS-CoV-2 Vaccine (Correspondence)
T. Bradley and Others
NEJM March 23, 2021 DOI: 10.1056/NEJMc2102051
Pulsa aquí para acceder a la información

(R) Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
Shabir A. Madhi, Ph.D., Vicky Baillie, Ph.D., Clare L. Cutland, Ph.D., Merryn Voysey, D.Phil., Anthonet L. Koen, M.B., B.Ch., Lee Fairlie, F.C.Paeds., Sherman D. Padayachee, M.B., Ch.B., Keertan Dheda, Ph.D., Shaun L. Barnabas, Ph.D., Qasim E. Bhorat, M.Sc., Carmen Briner, M.B., B.Ch., Gaurav Kwatra, Ph.D., et al., for the NGS-SA Group Wits–VIDA COVID Group*
NEJM March 16, 2021 DOI: 10.1056/NEJMoa2102214
Pulsa aquí para acceder a la información

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine (Correspondence)
Kai Wu and others
NEJM March 17, 2021 DOI: 10.1056/NEJMc2102179
Pulsa aquí para acceder a la información

(R) COVID-19 Vaccines vs Variants—Determining How Much Immunity Is Enough (Editorial)
Rubin R
JAMA March 17, 2021
Pulsa aquí para acceder a la información

(R) Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
Stephenson KE, Le Gars M, Sadoff J, et al.
JAMA March 11, 2021
Pulsa aquí para acceder a la información

(R) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
Raches Ella, Siddharth Reddy, Harsh Jogdand, Vamshi Sarangi, Brunda Ganneru, Sai Prasad, and others
The Lancet Infectious Diseases  Published: March 8, 2021
Pulsa aquí para acceder a la información

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine (Correspondence)
Florian Krammer et al.
NEJM March 10, 2021  DOI: 10.1056/NEJMc2101667
Pulsa aquí para acceder a la información

Previous SARS-CoV-2 infection increases B.1.1.7 cross-neutralization by vaccinated individuals
Benjamin Trinité,  Edwards Pradenas, Silvia Marfil, Carla Rovirosa, Víctor Urrea, Ferran Tarrés-Freixas, Raquel Ortiz, Júlia Vergara-Alert, Joaquim Segalés, Victor Guallar, Rosalba Lepore,  Nuria Izquierdo-Useros, Glòria Trujillo, Jaume Trapé, Carolina González-Fernández, Antonia Flor, Rafel Pérez-Vidal, Anna Chamorro, Roger Paredes, Ignacio Blanco, Eulalia Grau, Marta Massanella, Jorge Carrillo, Bonaventura Clotet,  Julià Blanco
BioRxiv Posted Match 05, 2021 doi: https://doi.org/10.1101/2021.03.05.433800
Pulsa aquí para acceder a la información

(R) Neutralizing Activity of BNT162b2-Elicited Serum — Preliminary Report (Correspondence)
Yang Liu and others
NEJM March 8, 2021  DOI: 10.1056/NEJMc2102017
Pulsa aquí para acceder a la información

 Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 (Correspondence)
Kimberly G. Blumenthal et al.
NEJM March 3, 2021  DOI: 10.1056/NEJMc2102131
Pulsa aquí para acceder a la información

(R) SARS-CoV-2 Vaccines
C. Buddy Creech, MD, MPH1; Shannon C. Walker, MD1; Robert J. Samuels, MBChB1
JAMA. Published online February 26, 2021. doi:10.1001/jama.2021.3199
Pulsa aquí para acceder a la información

(R) BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan, M.D., Noam Barda, M.D., Eldad Kepten, Ph.D., Oren Miron, M.A., Shay Perchik, M.A., Mark A. Katz, M.D., Miguel A. Hernán, M.D., Marc Lipsitch, D.Phil., Ben Reis, Ph.D., and Ran D. Balicer, M.D.
NEJM February 24, 2021  DOI: 10.1056/NEJMoa2101765
Pulsa aquí para acceder a la información

Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals (Correspondence)
Charlotte Manisty. Ashley D Otter, Thomas A Treibe, lÁine McKnight, Daniel M Altmann, Timothy Brooks and others
The Lancet Published: February 25, 2021
Pulsa aquí para acceder a la información

(R) Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, and others
The Lancet  Published: February 19, 2021
Pulsa aquí para acceder a la información



(R) Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine — Preliminary Report (Correspondence)
Kay Wu and others
NEJM February 17, 2021 DOI: 10.1056/NEJMc2102179
Pulsa aquí para acceder a la información

(R) Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients (CORRESPONDENCE)
Sharon Amit, Gili Regev-Yochay, Arnon Afek, Yitshak Kreiss, Eyal Leshem
The Lancet  Published: February 18, 2021
Pulsa aquí para acceder a la información

(R) mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang, Fabian Schmidt, […]Michel C. Nussenzweig
Nature (2021) Published 10 February 2021
Pulsa aquí para acceder a la información

(R) Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021
Tom T. Shimabukuro, MD, MPH, MBA1; Matthew Cole, MPH2; John R. Su, MD, PhD, MPH1
JAMA. Published online February 12, 2021. doi:10.1001/jama.2021.1967
Pulsa aquí para acceder a la información

(R) Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
Denis Y Logunov, Inna V Dolzhikova, Dmitry V Shcheblyakov, Amir I Tukhvatulin, Olga V Zubkova, Alina S Dzharullaeva, and others
The Lancet  Published: February 2, 2021
Pulsa aquí para acceder a la información

Sputnik V COVID-19 vaccine candidate appears safe and effective (Comment)
Ian Jones, Polly Roy
The Lancet  Published: February 2, 2021
Pulsa aquí para acceder a la información

(R) Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Zhiwei WuYaling HuMiao XuZhen ChenWanqi YangZhiwei Jiangand others
The Lancet Infectious DiseasesPublished: February 3, 2021
Pulsa aquí para acceder a la información

(R) Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial
Peter Richmond, Lara Hatchuel, Min Dong, Brenda Ma, Branda Hu, Igor Smolenov, and others
The Lancet Published: January 29, 2021 DOI:https://doi.org/10.1016/S0140-6736(21)00241-5
Pulsa aquí para acceder a la información

Next-generation COVID-19 vaccines: here come the proteins (Comment)
Anna K Blakney, Paul F McKay
The Lancet  Published: January 29, 2021  DOI:https://doi.org/10.1016/S0140-6736(21)00258-0
Pulsa aquí para acceder a la información

(R) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial
Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand, Sai Prasad, Siddharth Reddy, Vamshi Sarangi, and others
The Lancet Infectious Diseases Published: January 21, 2021
Pulsa aquí para acceder a la información

Optimism and caution for an inactivated COVID-19 vaccine (Comment)
Christina A Rostad, Evan J Anderson
The Lancet Infectious Diseases  Published: January 21, 2021
Pulsa aquí para acceder a la información

(R) COVID-19 vaccine candidates based on modified vaccinia virus Ankara expressing the SARS-CoV-2 spike induce robust T- and B-cell immune responses and full efficacy in mice
Juan García-Arriaza, Urtzi Garaigorta, Patricia Pérez, Adrián Lázaro-Frías, Carmen Zamora, Pablo Gastaminza, Carlos Del Fresno, José M. Casasnovas, Carlos Óscar S. Sorzano, David S Posted online 7 January 2021ancho, Mariano Esteban
Journal of Virology Posted online 7 January 2021 doi:10.1128/JVI.02260-20
Pulsa aquí para acceder a la información

(R) Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
Jerald Sadoff, M.D., Mathieu Le Gars, Ph.D., Georgi Shukarev, M.D., Dirk Heerwegh, Ph.D., Carla Truyers, Ph.D., Anne M. de Groot, Ph.D., Jeroen Stoop, Ph.D., Sarah Tete, Ph.D., Wim Van Damme, M.D., Isabel Leroux-Roels, M.D., Pieter-Jan Berghmans, M.D., Murray Kimmel, D.O., et al.
The New England Journal of Medicine January 13, 2021
DOI: 10.1056/NEJMoa2034201
Pulsa aquí para acceder a la información

Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom
Jamie Murphy, Frédérique Vallières, Richard P. Bentall, Mark Shevlin, Orla McBride, Todd K. Hartman, Ryan McKay, Kate Bennett, Liam Mason, Jilly Gibson-Miller, Liat Levita, Anton P. Martinez, Thomas V. A. Stocks, Thanos Karatzias & Philip Hyland
Nature Communications volume 12, Article number: 29 (2021) Published: 04 January 2021
Pulsa aquí para acceder a la información

(R) Maintaining Safety with SARS-CoV-2 Vaccines
Mariana C. Castells, M.D., Ph.D., and Elizabeth J. Phillips, M.D
The New England Journal of Medicine December 30, 2020
DOI: 10.1056/NEJMra2035343
Pulsa aquí para acceder a la información

(R) Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Lindsey R. Baden, MD, Hana M. El Sahly, MD, Brandon Essink, MD, Karen Kotloff, MD, Sharon Frey, MD, Rick Novak, médico, David Diemert, médico, Stephen A. Spector, MD, Nadine Rouphael, MD, C. Buddy Creech, MD, John McGettigan, médico, Shishir Khetan, MD, et al.,para el Grupo de Estudio COVE *
The New England Journal of Medicine 30 de diciembre de 2020
DOI: 10.1056 / NEJMoa2035389
Pulsa aquí para acceder a la información

A New Vaccine to Battle Covid-1 (Editorial)
Barton F. Haynes, M.D.
The New England Journal of Medicine December 30, 2020
DOI: 10.1056/NEJMe2035557
Pulsa aquí para acceder a la información

(R) Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, M.D., Stephen J. Thomas, M.D., Nicholas Kitchin, M.D., Judith Absalon, M.D., Alejandra Gurtman, M.D., Stephen Lockhart, D.M., John L. Perez, M.D., Gonzalo Pérez Marc, M.D., Edson D. Moreira, M.D., Cristiano Zerbini, M.D., Ruth Bailey, B.Sc., Kena A. Swanson, Ph.D., et al., for the C4591001 Clinical Trial Group*

The New England Journal of Medicine  December 10, 2020
DOI: 10.1056/NEJMoa2034577

Pulsa aquí para acceder a la información

SARS-CoV-2 Vaccination — An Ounce (Actually, Much Less) of Prevention (Editorial)

Eric J. Rubin, M.D., Ph.D., and Dan L. Longo, M.D.

The New England Journal of Medicine  December 10, 2020
DOI: 10.1056/NEJMe2034717

Pulsa aquí para acceder a la información

(R) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
Maheshi N Ramasamy, Angela M Minassian, Katie J Ewer, Amy L Flaxman, Pedro M Folegatti, Daniel R Owens, and others
The Lancet Published: November 18, 2020
Pulsa aquí para acceder a la información

(R) Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Yanjun Zhang, Gang Zeng, Hongxing Pan, Changgui Li, Yaling Hu, Kai Chu, and others
The Lancet Infectious Diseases  Published: November 17, 2020
Pulsa aquí para acceder a la información

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials
Devan V. Mehrotra, PhD, Holly E. Janes, PhD, Thomas R. Fleming, PhD, Paula W. Annunziato, MD, Kathleen M. Neuzil, MD, Lindsay N. Carpp, PhD, David Benkeser, PhD, Elizabeth R. Brown, ScD, Marco Carone, PhD, Iksung Cho, MS, … et al.
Annals of Internal Medicine 22 October 2020
Pulsa aquí para acceder a la información

(R) What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
Susanne H Hodgson, Kushal Mansatta, Garry Mallett, Victoria Harris, Katherine R W Emary, Andrew J Pollard
The Lancet Infectious Diseases  Published: October 27, 2020
Pulsa aquí para acceder a la información

(R) Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
Shengli Xia, Yuntao Zhang, Yanxia Wang, Hui Wang, Yunkai Yang, George Fu Gao, and others
The Lancet Infectious Diseases Published: October 15, 2020
Pulsa aquí para acceder a la información

(R)Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh, M.D., Robert W. Frenck, Jr., M.D., Ann R. Falsey, M.D., Nicholas Kitchin, M.D., Judith Absalon, M.D., Alejandra Gurtman, M.D., Stephen Lockhart, D.M., Kathleen Neuzil, M.D., Mark J. Mulligan, M.D., Ruth Bailey, B.Sc., Kena A. Swanson, Ph.D., Ping Li, Ph.D., et al.
The New England Journal of Medicine October 14, 2020
DOI: 10.1056/NEJMoa2027906
Pulsa aquí para acceder a la información

(R)Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett, Ph.D., Barbara Flynn, M.S., Kathryn E. Foulds, Ph.D., Joseph R. Francica, Ph.D., Seyhan Boyoglu-Barnum, Ph.D., Anne P. Werner, B.S., Britta Flach, Ph.D., Sarah O’Connell, M.S., Kevin W. Bock, M.B., Mahnaz Minai, M.S., Bianca M. Nagata, M.S., Hanne Andersen, Ph.D., et al.
The New England Journal of  Medicine 2020; 383:1544-1555 October 15, 2020
DOI: 10.1056/NEJMoa2024671
Pulsa aquí para acceder a la información

(R) Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
Evan J. Anderson, M.D., Nadine G. Rouphael, M.D., Alicia T. Widge, M.D., Lisa A. Jackson, M.D., M.P.H., Paul C. Roberts, Ph.D., Mamodikoe Makhene, M.D., M.P.H., James D. Chappell, M.D., Ph.D., Mark R. Denison, M.D., Laura J. Stevens, M.S., Andrea J. Pruijssers, Ph.D., Adrian B. McDermott, Ph.D., Britta Flach, Ph.D., et al., for the mRNA-1273 Study Group*
The New England Journal of Medicine September 29, 2020                                      DOI: 10.1056/NEJMoa2028436
Pulsa aquí para acceder a la información

(R) Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Denis Y Logunov, DSc,  Inna V Dolzhikova, PhD, Olga V Zubkova, PhD, Amir I Tukhvatullin, PhD, Dmitry V Shcheblyakov, PhD, Alina S Dzharullaeva, MSc et al.
The Lancet  Published:September 04, 2020DOI:https://doi.org/10.1016/S0140-6736(20)31866-3
Pulsa aquí para acceder a la información

(R) COVID-19 and mRNA Vaccines—First Large Test for a New Approach
Abbasi J
JAMA September 3, 2020
Pulsa aquí para acceder a la información

(R) Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Cheryl Keech, M.D., Ph.D., Gary Albert, M.S., Iksung Cho, M.S., Andreana Robertson, M.S., Patricia Reed, B.S., Susan Neal, Joyce S. Plested, Ph.D., Mingzhu Zhu, Ph.D., Shane Cloney-Clark, B.S., Haixia Zhou, Ph.D., Gale Smith, Ph.D., Nita Patel, M.S., et al.
The New England Journal of Medicine September 2, 2020
DOI: 10.1056/NEJMoa2026920
Pulsa aquí para acceder a la información

A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang, Xiao-Feng Li, Yong-Qiang Deng, You-Chun Wang, Bo Ying, Cheng-Feng Qin
Cell VOLUME 182, ISSUE 5, P1271-1283.E16, SEPTEMBER 03, 2020Published:July 23, 2020DOI:https://doi.org/10.1016/j.cell.2020.07.024
Pulsa aquí para acceder a la información

 Immunological considerations for COVID-19 vaccine strategies
Mangalakumari Jeyanathan, Sam Afkhami, Fiona Smaill, Matthew S. Miller, Brian D. Lichty & Zhou Xing
Nature Reviews Immunology (2020) Published: 04 September 2020
Pulsa aquí para acceder a la información

(R) COVID-19 vaccine trials should seek worthwhile efficacy (Editorial)
Philip Krause, Thomas R Fleming, Ira Longini, Ana Maria Henao-Restrepo, Richard Peto for the World Health Organization Solidarity Vaccines Trial Expert Group, and others
The Lancet  Published: August 27, 2020
Pulsa aquí para acceder a la información

(R) RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
Edward E Walsh, Robert Frenck, Ann R Falsey, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, Kathleen Neuzil, Mark J Mulligan, Ruth Bailey, Kena A Swanson, Ping Li, Kenneth Koury, Warren Kalina, David Cooper, Camila Fontes-Garfias, Pei-Yong Shi, Özlem Türeci, Kristin R Thompkins, Kirsten E Lyke, Vanessa Raabe, Philip R Dormitzer, Kathrin U Jansen, Uğur Sahin, William C Gruber
medRxiv 2020 Aug 20;2020.08.17.20176651. doi: 10.1101/2020.08.17.20176651.
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es una prepublicación, que no se ha sido todavía revisado por pares

(R) A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2
Hassan et al.
Cell  Published online: August 19, 2020
Pulsa aquí para acceder a la información

(R) Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes
Xia S, Duan K, Zhang Y, et al.
JAMA August 13, 2020
Pulsa aquí para acceder a la información

(R) Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu, MSc , Prof Xu-Hua Guan, PhD, Prof Yu-Hua Li, PhD, Prof Jian-Ying Huang, MD, Prof Tao Jiang, PhD, Prof Li-Hua Hou, PhD et al.
The Lancet Volume 396, issue 10249, p479-488, august 15, 2020 Published:July 20, 2020DOI:https://doi.org/10.1016/S0140-6736(20)31605-6
Pulsa aquí para acceder a la información

(R) ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen, Teresa Lambe, […]Vincent J. Munster
Nature (2020) Published 30 July 2020
Pulsa aquí para acceder a la información

(R) Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates
Kizzmekia S. Corbett, Ph.D., Barbara Flynn, M.S., Kathryn E. Foulds, Ph.D., Joseph R. Francica, Ph.D., Seyhan Boyoglu-Barnum, Ph.D., Anne P. Werner, B.S., Britta Flach, Ph.D., Sarah O’Connell, M.S., Kevin W. Bock, M.B., Mahnaz Minai, M.S., Bianca M. Nagata, M.S., Hanne Andersen, Ph.D., et al.
The New England Journal of Medicine July 28, 2020 DOI: 10.1056/NEJMoa2024671
Pulsa aquí para acceder a la información

(R) Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado, Roland Zahn, […]Dan H. Barouch
Nature (2020) Published 30 July 2020 Pulsa aquí para acceder a la información
Pulsa aquí para acceder a la información

(R) An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Lisa A. Jackson, M.D., M.P.H., Evan J. Anderson, M.D., Nadine G. Rouphael, M.D., Paul C. Roberts, Ph.D., Mamodikoe Makhene, M.D., M.P.H., Rhea N. Coler, Ph.D., Michele P. McCullough, M.P.H., James D. Chappell, M.D., Ph.D., Mark R. Denison, M.D., Laura J. Stevens, M.S., Andrea J. Pruijssers, Ph.D., Adrian McDermott, Ph.D., et al., for the mRNA-1273 Study Group*
The New England Journal of Medicine July 14, 2020 DOI: 10.1056/NEJMoa2022483
Pulsa aquí para acceder a la información

(R) Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M Folegatti*, Katie J Ewer*, Parvinder K Aley, Brian Angus, Stephan Becker, Sandra Belij-Rammerstorfer, Duncan Bellamy, Sagida Bibi,
Mustapha Bittaye, Elizabeth A Clutterbuck, Christina Dold, Saul N Faust, Adam Finn, Amy L Flaxman, Bassam Hallis, Paul Heath, Daniel Jenkin,
Rajeka Lazarus, Rebecca Makinson, Angela M Minassian, Katrina M Pollock, Maheshi Ramasamy, Hannah Robinson, Matthew Snape,
Richard Tarrant, Merryn Voysey, Catherine Green*, Alexander D Douglas*, Adrian V S Hill*, Teresa Lambe*, Sarah C Gilbert*, Andrew J Pollard*,
on behalf of the Oxford COVID Vaccine Trial Group†
The Lancet July 20, 2020 https://doi.org/10.1016/ S0140-6736(20)31604-4
Pulsa aquí para acceder a la información

Lopinavir/ritonavir is associated with pneumonia resolution in COVID‐19 patients with influenza coinfection: a retrospective matched‐pair cohort study
Chong Yu  Zhiguo Zhang  Yujiao Guo  Jing Shi  Guangchang Pei  Ying Yao  Wenhui Liao  Rui Zeng
Journal of Medical Virology First published: 04 July 2020 https://doi.org/10.1002/jmv.26260
Pulsa aquí para acceder a la información

(R) Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report
Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin,  View ORCID ProfileJudith Absalon, Alejandra Gurtman, Stephen P. Lockhart et al.
medRxiv Posted Julyo1 2020doi: https://doi.org/10.1101/2020.06.30.20142570
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es una prepublicación, que no se ha sido todavía revisado por pares

(R) Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models
Meagan E. Deming, M.D., Ph.D., Nelson L. Michael, M.D., Ph.D., Merlin Robb, M.D., Myron S. Cohen, M.D., and Kathleen M. Neuzil, M.D., M.P.H.
The New England Journal of Medicine July 1, 2020
DOI: 10.1056/NEJMp2020076
Pulsa aquí para acceder a la información

(R) Accelerating Development of SARS-CoV-2 Vaccines — The Role for Controlled Human Infection Models
Meagan E. Deming, M.D., Ph.D., Nelson L. Michael, M.D., Ph.D., Merlin Robb, M.D., Myron S. Cohen, M.D., and Kathleen M. Neuzil, M.D., M.P.H.
The New England Journal of Medicine July 1, 2020
DOI: 10.1056/NEJMp2020076
Pulsa aquí para acceder a la información

(R) Amplifying RNA Vaccine Development
Deborah H. Fuller, Ph.D., and Peter Berglund, Ph.D.
The New England Journal of Medicine 382:2469-2471June 18, 2020
DOI: 10.1056/NEJMcibr2009737
Pulsa aquí para acceder a la información

(R) Amplifying RNA Vaccine Development
Deborah H. Fuller, Ph.D., and Peter Berglund, Ph.D.
The New England Journal of Medicine 382:2469-2471June 18, 2020
DOI: 10.1056/NEJMcibr2009737
Pulsa aquí para acceder a la información

COVID-19 Vaccine Development Pipeline Gears Up
Asher Mullard
Lancet. 2020 Jun 6;395(10239):1751-1752. doi: 10.1016/S0140-6736(20)31252-6.
Pulsa aquí para acceder a la información

Developing Covid-19 Vaccines at Pandemic Speed (Perspective)
Nicole Lurie, M.D., M.S.P.H., Melanie Saville, M.D., Richard Hatchett, M.D., and Jane Halton, A.O., P.S.M.
The New England Journal of Medicine May 21, 2020 382:1969-1973
DOI: 10.1056/NEJMp2005630
Pulsa aquí para acceder a la información

(R) A strategic approach to COVID-19 vaccine R&D
Lawrence Corey, John R. Mascola, Anthony S. Fauci, Francis S. Collins
Science  11 May 2020: eabc5312 DOI: 10.1126/science.abc5312
Pulsa aquí para acceder a la información

An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Fuzhou Wang, Richard M Kream , George B Stefano
Med Sci Monit. 2020 May 5;26:e924700. doi: 10.12659/MSM.924700
Pulsa aquí para acceder a la información

COVID-19 vaccination clinical trials should consider multiple doses of BCG.
Ayoub BM.
Pharmazie. 2020 Apr 6;75(4):159. doi: 10.1691/ph.2020.0444.
Pulsa aquí para acceder a la información

SARS-CoV-2 Vaccines: Status Report.
Amanat F, Krammer F.
Immunity. 2020 Apr 14;52(4):583-589. doi: 10.1016/j.immuni.2020.03.007. Epub 2020 Apr 6.
Pulsa aquí para acceder a la información

Infect volunteers to speed a coronavirus vaccine?
Cohen J.
Science. 2020 Apr 3;368(6486):16. doi: 10.1126/science.368.6486.16.
Pulsa aquí para acceder a la información

The COVID-19 vaccine development landscape
Tung Thanh Le, Zacharias Andreadakis, Arun Kumar, Raúl Gómez Román, Stig Tollefsen, Melanie Saville & Stephen Mayhew
Nature Reviews  9 April 2020
Pulsa aquí para acceder a la información

 

DIAGNÓSTICO

Blood transcriptional biomarkers of acute viral infection for detection of pre-symptomatic SARS-CoV-2 infection: a nested, case-control diagnostic accuracy study
Rishi K GuptaJoshua Rosenheim, Lucy C Bell, Aneesh Chandran, Jose A Guerra-Assuncao, Gabriele Pollara and others
The Lancet Microbe Published: July 6, 2021
Pulsa aquí para acceder a la información

(R) Comparative performance of SARS-CoV-2 lateral flow antigen tests and association with detection of infectious virus in clinical specimens: a single-centre laboratory evaluation study
Suzanne Pickering, Rahul Batra, Blair Merrick, Luke B Snell, Gaia Nebbia, Sam Douthwaite and others
The Lancet Microbe Published: June 30, 2021
Pulsa aquí para acceder a la información

Validation of a rapid antigen test as a screening tool for SARS-CoV-2 infection in asymptomatic populations. Sensitivity, specificity and predictive values
Alejandro Fernandez-Montero, Josepmaria Argemi, José Antonio Rodríguez, Arturo H. Ariño, Laura Moreno-Galarraga
EClinicalMedicinePublished: June 9, 2021
Pulsa aquí para acceder a la información

A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study
Isao Yokota, Peter Y Shane, Kazufumi Okada, Yoko Unoki, Yichi Yang, Sumio Iwasaki and others
The Lancet MicrobePublished: May 19, 2021
Pulsa aquí para acceder a la información

A rapid, accurate, scalable, and portable testing system for COVID-19 diagnosis
Guanhua Xun, Stephan Thomas Lane, Vassily Andrew Petrov, Brandon Elliott Pepa & Huimin Zhao
Nature Communications volume 12, Article number: 2905 (2021) Published: 18 May 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 detection on self-collected saliva or anterior nasal specimens compared with healthcare personnel-collected nasopharyngeal specimens
Grace E Marx, Brad J Biggerstaff, Courtney C Nawrocki, Sarah E Totten, Emily A Travanty ...
Clinical Infectious Diseases, ciab330, https://doi.org/10.1093/cid/ciab330
Pulsa aquí para acceder a la información

Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis
Nicole Ngai Yung Tsang, Hau Chi SoKa Yan Ng, Benjamin J Cowling, Gabriel M Leung, Dennis Kai Ming Ip

The Lancet Infectious Diseases Published: April 12, 2021
Pulsa aquí para acceder a la información

Simultaneous Detection and Mutation Surveillance of SARS-CoV-2 and co-infections of multiple respiratory viruses by Rapid field-deployable sequencing
Chongwei Bi, Gerardo Ramos-Mandujano, Yeteng Tian, Sharif Hala, Jinna Xu, Sara Mfarrej, Concepcion Rodriguez Esteban, Estrella Nuñez Delicado, Fadwa S. Alofi, Asim Khogeer, Anwar M. Hashem, Naif A.M. Almontashiri, Arnab Pain, Juan Carlos Izpisua Belmonte, Mo Li
Med Published:March 31, 2021 DOI:https://doi.org/10.1016/j.medj.2021.03.015
Pulsa aquí para acceder a la información

(R) Identificación y seguimiento rápidos de las variantes preocupantes del SARS-CoV-2 (Correspondence)
Debojyoti Chakraborty, Anurag Agrawal, Souvik Maiti
Lancet Published: March 22 2021 DOI: https://doi.org/10.1016/S0140-6736(21)00470-0
Pulsa aquí para acceder a la información

Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study
Victor M Corman, Verena Claudia Haage, Tobias Bleicker, Marie Luisa Schmidt, Barbara Mühlemann, Marta Zuchowski, and others
The Lancet MicrobePublished: April 7, 2021
Pulsa aquí para acceder a la información

A method for detection of SARS-CoV-2 RNA in healthy human stool: a validation study
Michael P Coryell, Mikhail Iakiviak, Nicole Pereira, Pallavi P Murugkar, Jason Rippe, David B Williams and others
The Lancet MicrobePublished: March 31, 2021
Pulsa aquí para acceder a la información

Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study
Yap Boum, Karl Njuwa Fai, Birgit Nicolay, Akenji Blaise Mboringong, Lisa M Bebell, Mark Ndifon, and others
The Lancet Infectious Diseases Published: March 25, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy
Azzolini C, Donati S, Premi E, et al.
JAMA Ophthalmology March 4, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 on Ocular Surfaces in a Cohort of Patients With COVID-19 From the Lombardy Region, Italy
Azzolini C, Donati S, Premi E, et al.
JAMA Ophthalmology March 4, 2021
Pulsa aquí para acceder a la información

Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Screening Using Reverse Transcriptase–Quantitative Polymerase Chain Reaction or CRISPR-Based Assays in Asymptomatic College Students
Jennifer N. Rauch, PhD1,2; Eric Valois, PhD1; Jose Carlos Ponce-Rojas, PhD1; et al
JAMA Netw Open. 2021;4(2):e2037129. doi:10.1001/jamanetworkopen.2020.37129
Pulsa aquí para acceder a la información

(R) Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2. A Systematic Review and Meta-analysis
Guillaume Butler-Laporte ; Alexander Lawandi ; Ian Schiller; et al
JAMA Intern Med. Published online January 15, 2021. doi:10.1001/jamainternmed.2020.8876
Pulsa aquí para acceder a la información

Saliva viral load is a dynamic unifying correlate of COVID-19 severity and mortality
Julio Silva,  Carolina Lucas, Maria Sundaram, Benjamin Israelow, Patrick Wong, Jon Klein,  Maria Tokuyama et al.

medRxiv Posted January o6, 2021doi: https://doi.org/10.1101/2021.01.04.21249236
Pulsa aquí para acceder a la información
NOTA de la FUNDACION: Este artículo es un informe preliminar, que no ha sido todavía revisado por pares

Real-life validation of the Panbio™ COVID-19 antigen rapid test (Abbott) in community-dwelling subjects with symptoms of potential SARS-CoV-2 infection
Hendrik Gremmels, Beatrice M.F. Winkel, Rob Schuurman, Andert Rosingh, Nicolette A.M. Rigter, Olga Rodriguez, and others
EClinicalMedicine  Published: December 5, 2020
Pulsa aquí para acceder a la información

A CRISPR-Cas12a-based specific enhancer for more sensitive detection of SARS-CoV-2 infection
Weiren Huang•Lei Yu•Donghua Wen•Dong Wei•Yangyang Sun•Huailong Zhao•Yu Ye•Wei Chen•Yongqiang Zhu•Lijun Wang•Li Wang•Wenjuan Wu•Qianqian Zhao•Yong Xu•Dayong Gu•Guohui Nie•Dongyi Zhu•Zhongliang Guo•Xiaoling Ma•Liman Niu•Yikun Huang•Yuchen Liu•Bo Peng•Renli Zhang•Xiuming Zhang•Dechang Li•Yang Liu•Guoliang Yang•Lanzheng Liu•Yunying Zhou•Yunshan Wang•Tieying Hou•Qiuping Gao•Wujiao Li•Shuo Chen•Xuejiao Hu•Mei Han•Huajun Zheng•Jianping Weng•Zhiming Cai•Xinxin Zhang•Fei Song•Guoping Zhao•Jin Wang
EBioMedicine, Vol. 61 Published: October 9, 2020
Pulsa aquí para acceder a la información

Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study
Nathan J Brendish•Stephen Poole•Vasanth V Naidu•Christopher T Mansbridge•Nicholas J Norton•Helen Wheeler•Laura Presland•Stephen Kidd•Nicholas J Cortes•Florina Borca•Hang Phan•Gavin Babbage•Benoit Visseaux•Sean Ewings•Tristan W Clark
The Lancet Respiratory Medicine Published: October 8, 2020
Pulsa aquí para acceder a la información

Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
The National SARS-CoV-2 Serology Assay Evaluation Group, and others
The Lancet Infectious Diseases  Published: September 23, 2020
Pulsa aquí para acceder a la información

Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing (CRISPR-based) (Letter)
J.Joung and others
The New England Journal of Medicine September 16, 2020
DOI: 10.1056/NEJMc2026172
Pulsa aquí para acceder a la información

(R) Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
Anne Louise Wyllie, John Fournier, Arnau Casanovas-Massana, Melissa Campbell, Maria Tokuyama, Pavithra Vijayakumar, Bertie Geng, M. Catherine Muenker, Adam J. Moore, Chantal B. F. Vogels, Mary E. Petrone et al.
The New England Journal of Medicine August 28, 2020
DOI: 10.1056/NEJMc2016359
Pulsa aquí para acceder a la información

Evaluation of SARS-CoV-2 serology assays reveals a range of test performance
Jeffrey D. Whitman, Joseph Hiatt, […]Alexander Marson
Nature Biotechnology (2020) Published: 27 August 2020
Pulsa aquí para acceder a la información

Artificial intelligence for the detection of COVID-19 pneumonia on chest CT using multinational datasets
Stephanie A. Harmon, Thomas H. Sanford, […]Baris Turkbey
Nature Communications volume 11, Article number: 4080 (2020)Published: 14 August 2020
Pulsa aquí para acceder a la información

Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
Kilic et al.
iScience  Published online: July 25, 2020
Pulsa aquí para acceder a la información

Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study
Scott J C Pallett•Michael Rayment•Aatish Patel•Sophia A M Fitzgerald-Smith•Sarah J Denny•Esmita Charani•Annabelle L Mai•Kimberly C Gilmour•James Hatcher•Christopher Scott•Paul Randell•Nabeela Mughal•Rachael Jones•Luke S P Moore•Gary W Davies
The Lancet Respiratory Medicine Published: July 24, 2020
Pulsa aquí para acceder a la información

Clinical Validity of Serum Antibodies to SARS-CoV-2FREE A Case–Control Study
Giorgio Caturegli, BS, Joshua Materi, BS, Brittney M. Howard, MS, … View all authors
Annals of Internal Medicine 6 Jul 2020  https://doi.org/10.7326/M20-2889
Pulsa aquí para acceder a la información

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
Mayara Lisboa Bastos, Gamuchirai Tavaziva, Syed Kunal Abidi, Jonathon R Campbell, Louis-Patrick Haraoui, James C Johnston, Zhiyi Lan, Stephanie Law, Emily MacLean, Anete Trajman, Dick Menzies, Andrea Benedetti, Faiz Ahmad Khan
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m2516 (Published 01 July 2020)
Pulsa aquí para acceder a la información

Antibody testing for coronavirus disease 2019: not ready for prime time (Editorial)
Yen T Duong, senior technical advisor for laboratory surveillance,  Connor G Wright, program coordinator,  Jessica Justman, associate professor of medicine in epidemiology
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m2655 (Published 03 July 2020)
Pulsa aquí para acceder a la información

Assessment of Sensitivity and Specificity of Patient-Collected Lower Nasal Specimens for Sudden Acute Respiratory Syndrome Coronavirus 2 Testing
Jonathan Altamirano, MS; Prasanthi Govindarajan, MBBS, MAS; Andra L. Blomkalns, MD, MBA; et al
JAMA Netw Open 2020;3(6):e2012005.doi:10.1001/jamanetworkopen.2020.1200
Pulsa aquí para acceder a la información

Serodiagnostics for Severe Acute Respiratory Syndrome–Related Coronavirus-2. A Narrative Review
Matthew P. Cheng, MDCM, Cedric P. Yansouni, MD, Nicole E. Basta, PhD, MPhil, et al.
Annals of Internal Medicine 4 Jun 2020 https://doi.org/10.7326/M20-2854
Pulsa aquí para acceder a la información

(R) False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications
Steven Woloshin, M.D., Neeraj Patel, B.A., and Aaron S. Kesselheim, M.D., J.D., M.P.H.
The New England Journal of Medicine June 5, 2020 DOI: 10.1056/NEJMp2015897
Pulsa aquí para acceder a la información

Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing (Letter)
Yuan-Po Tu, M.D., Everett Clinic, Everett, WA et al.
The New England Journal of Medicine June 3, 2020  DOI: 10.1056/NEJMc2016321
Pulsa aquí para acceder a la información

Practice recommendations for the neurovascular ultrasound investigations of acute stroke patients in the setting of COVID‐19 pandemic: an expert consensus from the European Society of Neurosonology and Cerebral Hemodynamics
C. Baracchini  A. Pieroni  M. Kneihsl  E. Azevedo  M. Diomedi  L. Pascazio  J. Wojczal  C. Lucas  E. Bartels  NM. Bornstein  L. Csiba  J. Valdueza  G. Tsvigoulis  B. Malojcic et al.
European Journal of Neurology First published:19 May 2020 https://doi.org/10.1111/ene.14334
Pulsa aquí para acceder a la información

Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases (Correspondence)
Jialin Teng, Jin Dai, Yutong Su, Zhuochao Zhou, Huihui Chi, Liyan Wan, and others
The Lancet Rheumatology  Published: May 18, 2020
Pulsa aquí para acceder a la información

Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure
Lauren M. Kucirka, MD, PhD, Stephen A. Lauer, PhD, Oliver Laeyendecker, PhD, MBA et al.
Annals of Internal Medicine 13 May 2020
https://doi.org/10.7326/M20-1495
Pulsa aquí para acceder a la información

Serology assays to manage COVID-19 (Perspective)
Florian Krammer1, Viviana Simon1,2,3
Science  15 May 2020:  eabc1227   DOI: 10.1126/science.abc1227
Pulsa aquí para acceder a la información

Pharynx gargle samples are suitable for SARS-CoV-2 diagnostic and save personal protective equipment and swabs
Monika Malecki , Jessica Lüsebrink , Stefanie Teves and Andreas F. Wendel
Infection Control & Hospital Epidemiology May 2020 , pp. 1-7
Published online by Cambridge University Press: 11 May 2020
DOI: https://doi.org/10.1017/ice.2020.229
Pulsa aquí para acceder a la información

Interpreting Diagnostic Tests for SARS-CoV-2
Nandini Sethuraman, MD1; Sundararaj Stanleyraj Jeremiah, MD2; Akihide Ryo, MD, PhD2
JAMA. Published online May 6, 2020. doi:10.1001/jama.2020.8259
Pulsa aquí para acceder a la información

Antibody responses to SARS-CoV-2 in patients with COVID-19  
Quan-Xin Long, Bai-Zhong Liu, […]Ai-Long Huang
Nature Medicine (2020) Published 29 April 2020
Pulsa aquí para acceder a la información

CT imaging features of 4,121 patients with COVID‐19: a meta‐analysis 
Jieyun Zhu  Zhimei Zhong  Hongyuan Li  Pan Ji  Jielong Pang  Bocheng Li  Jianfeng Zhang 
 Journal of MedicalVirology First published:21 April 2020 https://doi.org/10.1002/jmv.25910          Pulsa aquí para acceder a la información

CT imaging features of 4,121 patients with COVID‐19: a meta‐analysis         
Jieyun Zhu  Zhimei Zhong  Hongyuan Li  Pan Ji  Jielong Pang  Bocheng Li  Jianfeng Zhang  Journal of MedicalVirology First published:21 April 2020 https://doi.org/10.1002/jmv.25910          Pulsa aquí para acceder a la información

Just the Facts: Recommendations on Point of Care Ultrasound Use and Machine Infection Control During the COVID-19 Pandemic  Daniel J. Kim, Tomislav Jelic, Michael Y. Woo, Claire Heslop, Paul Olszynski Journal: Canadian Journal of Emergency Medicine / Published online by Cambridge University Press: 09 April 2020, pp. 1-7

Pulsa aquí para acceder a la información

Chest Computed Tomography for Detection of Coronavirus Disease 2019 (COVID-19): Don't Rush the Science

Michael D. Hope, MD; Constantine A. Raptis, MD; Travis S. Henry, MD
Ann Intern Med. 8 de abril de 2020. doi: 10.7326 / M20-1382
Pulsa aquí para acceder a la información

Detección de anticuerpos contra el SARS-CoV-2 en pacientes con COVID-19
Zhe Du, Fengxue Zhu, Fuzheng Guo, Bo Yang, Tianbing Wang

Revista de virología médica. 3 Apr 2020   DOI: 10.1002 / jmv.25820

Pulsa aquí para acceder a la información

Developing antibody tests for SARS-CoV-2 (World Report)
Anna Petherick
The Lancet, Vol. 395, No. 10230   Published: April 04, 2020
Pulsa aquí para acceder a la información

Detección de anticuerpos contra el SARS-CoV-2 en pacientes con COVID-19
Zhe Du, Fengxue Zhu, Fuzheng Guo, Bo Yang, Tianbing Wang

Revista de virología médica. 3 Apr 2020   DOI: 10.1002 / jmv.25820

Pulsa aquí para acceder a la información


SARS-CoV-2 is not detectable in the vaginal fluid of women with severe COVID-19 infection 
Lin QiuXia LiuMeng XiaoJing XieWei Cao ...
Clinical Infectious Diseases, ciaa375, https://doi.org/10.1093/cid/ciaa375
Pulsa aquí para acceder a la información

Proposal for international standardization of the use of lung ultrasound for COVID-19 patients; a simple, quantitative, reproducible method.

Soldati G, Smargiassi A, Inchingolo R, Buonsenso D, Perrone T, Briganti DF, Perlini S, Torri E, Mariani A, Mossolani EE, Tursi F, Mento F, Demi L.
J Ultrasound Med. 2020 Mar 30. doi: 10.1002/jum.15285. [Epub ahead of print]

Pulsa aquí para acceder a la información

Performance of VivaDiagTM COVID‐19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID‐19 in acute patients referring to emergency room department (Letter)

Irene Cassaniti, Federica Novazzi, Federica Giardina, Francesco Salivaro, Michele Sachs, Stefano Perlini, Raffaele Bruno, Francesco Mojoli, Fausto Baldanti for the San Matteo Pavia COVID‐19 Task Force

Journal of Medical Virology  DOI: 10.1002/jmv.25800
Pulsa aquí para acceder a la información

SARS-CoV-2–Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19

Ann Intern Med. 30 March 2020. doi:10.7326/M20-0991
Pulsa aquí para acceder a la información

Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases

Tao Ai MD, PhD1 *, Zhenlu Yang MD, PhD1 *, Hongyan Hou, MD2 , Chenao Zhan MD1, Chong Chen MD1, Wenzhi Lv3 , Qian Tao, PhD4, Ziyong Sun MD2 , Liming Xia MD, PhD1
Radiology. In press

Pulsa aquí para acceder a la información

Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia

Fengxiang Song, MD* • Nannan Shi, MD* • Fei Shan, MD, PhD • Zhiyong Zhang, MD, PhD • Jie Shen, MD • Hongzhou Lu, MD, PhD • Yun Ling, MD, PhD • Yebin Jiang, MD, PhD • Yuxin Shi, MD, PhD From the Departments of Radiology (F. Song, N.S., F. Shan, Z.Z., J.S., Y.S.) and Infectious Disease (H.L., Y.L.), Shanghai Public Health Clinical Center, No. 2501 Caolang Road, Jinshan District, Shanghai 201508, China; Department of the Principal's Office, Fudan University, Shanghai, China (Z.Z.); Cancer Center, University of Michigan, Ann Arbor, Mich (Y.J.); and Shanghai Key Laboratory of Molecular Imaging, Shanghai, China (Y.S.).
Received February 2, 2020; revision requested February 5; final revision received February 5; accepted February 5.
Radiology 2020; 295:210–217 • https://doi.org/10.1148/radiol.2020200274

Pulsa aquí para acceder a la información

A role for CT in COVID-19? What data really tell us so far (CORRESPPONDENCE)

Michael D Hope, Constantine A Raptis, Amar Shah, Mark M Hammer, Travis S Henry, on behalf of six signatories
The Lancet
Published: March 26, 2020
Pulsa aquí para acceder a la información

Drive-Through Screening Center for COVID-19: a Safe and Efficient Screening System against Massive Community Outbreak.

Kwon KT, Ko JH, Shin H, Sung M, Kim JY.
J Korean Med Sci. 2020 Mar 23;35(11):e123. doi: 10.3346/jkms.2020.35.e123
Pulsa aquí para acceder a la información

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Kelvin Kai-Wang To, Owen Tak-Yin Tsang, Wai-Shing Leung, Anthony Raymond Tam, Tak-Chiu Wu, David Christopher Lung, and others
The Lancet Infectious Diseases
Published: March 23, 2020
Pulsa aquí para acceder a la información

Métodos prometedores para la detección de nuevos coronavirus SARS-CoV-2

Ran Liu , Aisi Fu,Zixin Deng , Yan Li , Tiangang Liu
Primera publicación:23 de marzo de 2020
https://doi.org/10.1002/viw2.4

Perfilar la respuesta humoral temprana para diagnosticar la nueva enfermedad por coronavirus (COVID-19Li Guo, Ph.D Lili Ren, Ph.D,Siyuan Yang, Ph.D,Meng Xiao, Ph.D,De Chang, MD, Ph.D,Fan Yang, Ph.D,Charles S Dela Cruz, MD , PhD,Yingying Wang, BS,Chao Wu, BS,Yan Xiao, MS..               

Enfermedades Infecciosas  Clínic0, Pulsa aquí para acceder a la información

Publicado:21 de marzo de 2020

INMUNIDAD

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas, David Veyer, […]Olivier Schwartz
Nature (2021) Published 08 July 2021
Pulsa aquí para acceder a la información

SARS-CoV-2-specific immune response in COVID-19 convalescent individuals
Yunbao Pan, Xianghu Jiang, Liu Yang, Liangjun Chen, Xiaojiao Zeng, Guohong Liu, Yueting Tang, Chungen Qian, Xinming Wang, Fangming Cheng, Jun Lin, Xinghuan Wang & Yirong Li
Signal Transduction and Targeted Therapy volume 6, Article number: 256 (2021) Published: 07 July 2021
Pulsa aquí para acceder a la información

Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
Cesheng Li, Ding Yu, […]Xiaoming Yang
Nature Communications volume 12, Article number: 4144 (2021) Published: 06 July 2021
Pulsa aquí para acceder a la información

Incidence of SARS-CoV-2 infection according to baseline antibody status in staff and residents of 100 long-term care facilities (VIVALDI): a prospective cohort study
Maria Krutikov, Tom Palmer, Gokhan Tut, Chris Fuller, Madhumita Shrotri, Haydn Williams and others
The Lancet Healthy Longevity Vol. 2No. 6 Published: June, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans
Jackson S. Turner, Wooseob Kim, Elizaveta Kalaidina, Charles W. Goss, Adriana M. Rauseo, Aaron J. Schmitz, Lena Hansen, Alem Haile, Michael K. Klebert, Iskra Pusic, Jane A. O’Halloran, Rachel M. Presti & Ali H. Ellebedy
Nature (2021) Published 24 May 2021
Pulsa aquí para acceder a la información

A population-based analysis of the longevity of SARS-CoV-2 antibody seropositivity in the United States
David Alfego, Adam Sullivan, Brian Poirier, Jonathan Williams, Dorothy Adcock, Stanley Letovsky
EClinical MedicinePublished: May 24, 2021
Pulsa aquí para acceder a la información

Reconocimiento de IgG prevalente, protector y convergente de epítopos de pico no RBD del SARS-CoV-2
William N. Voss, Yixuan J. Hou, Nicole V. Johnson, George Delidakis ,Jin Eyun Kim 4 ,Kamyab Javanmardi  and others
Science  4 de mayo de 2021: eabg5268 DOI: 10.1126 / science.abg5268
Pulsa aquí para acceder a la información

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
Victoria Jane Hall, Sarah Foulkes, Andre Charlett, Ana Atti, Edward J M Monk, Ruth Simmons and others
The Lancet Vol. 397No. 10283Published: April 9, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
Andrew G Letizia, Yongchao Ge, Sindhu Vangeti, Carl Goforth, Dawn L Weir, Natalia A Kuzmina and others
The Lancet Respiratory MedicinePublished: April 15, 2021
Pulsa aquí para acceder a la información

SARS-CoV-2 spike E484K mutation reduces antibody neutralisation (Correspondence)
Sonia Jangra, Chengjin YeRaveen Rathnasinghe, Daniel Stadlbauer, Personalized Virology Initiative study group Florian Krammer and others
The Lancet MicrobePublished: April 7, 2021
Pulsa aquí para acceder a la información

(R) Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study
Christian Holm Hansen, Daniela Michlmayr, Sophie Madeleine Gubbels, Kåre Mølbak, Steen Ethelberg
The Lancet  Published: March 17, 2021
Pulsa aquí para acceder a la información

Risk of SARS-CoV-2 reinfection after natural infection (Comment)
Rosemary J Boyton, Daniel M Altmann
The Lancet  Published: March 17, 2021
Pulsa aquí para acceder a la información

Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study
Zhenyu He, Lili Ren, Juntao Yang, Li Guo, Luzhao Feng, Chao Ma, and others
The Lancet, Vol. 397, No. 10279 Published: March 20, 2021
Pulsa aquí para acceder a la información

Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
Raymond A. Harvey, MPH1; Jeremy A. Rassen, ScD1; Carly A. Kabelac, BS1; et al
JAMA Intern Med. Published online February 24, 2021. doi:10.1001/jamainternmed.2021.0366
Pulsa aquí para acceder a la información

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
NPG Nature Publishing Group US New York Nature Portfolio 41591
Xuping Xie, Yang Liu[…]Pei-Yong Shi
Nature Medicine , 1–2
Pulsa aquí para acceder a la información

Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages
Els Wauters, Pierre Van Mol, […]Diether Lambrechts
Cell Research (2021) 21 January 2021
Pulsa aquí para acceder a la información

Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages
Els Wauters, Pierre Van Mol, […]Diether Lambrechts
Cell Research (2021) 21 January 2021
Pulsa aquí para acceder a la información

Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
Sheila F. Lumley, B.M., B.Ch., Denise O’Donnell, B.Sc., Nicole E. Stoesser, M.B., B.S., D.Phil., Philippa C. Matthews, F.R.C.P., D.Phil., Alison Howarth, Ph.D., Stephanie B. Hatch, Ph.D., Brian D. Marsden, D.Phil., Stuart Cox, Tim James, Ph.D., Fiona Warren, B.Sc., Liam J. Peck, D.Phil., Thomas G. Ritter, B.A., et al., for the Oxford University Hospitals Staff Testing Group*
The New England Journal of Medidicne December 23, 2020
DOI: 10.1056/NEJMoa2034545
Pulsa aquí para acceder a la información

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

Katharina Röltgen, Abigail E. Powell, Oliver F. Wirz, Bryan A. Stevens, Catherine A. Hogan et al.

Science Immunology  07 Dec 2020 Vol. 5, Issue 54, eabe0240 DOI: 10.1126/sciimmunol.abe0240

Pulsa aquí para acceder a la información

POLÍTICA SANITARIA

Mass infection is not an option: we must do more to protect our Young (Correspondence)
Deepti Gurdasani, John DruryTrisha Greenhalgh, Stephen Griffin, Zubaida Haque, Zoë Hyde and others
The Lancet Published: July 7, 2021
Pulsa aquí para acceder a la información

A beautiful idea: how COVAX has fallen short (World Report)
Ann Danaiya Usher
The Lancet Vol. 397 No. 10292 Published: June 19, 2021
Pulsa aquí para acceder a la información

India's COVID-19 crisis: a call for international action (Comment)

Krutika Kuppall, Pooja Gala, Kartikeya Cherabuddi, S P Kalantri, Manoj Mohanan, Bhramar Mukherjee and others
The Lancet Published: May 14, 2021
Pulsa aquí para acceder a la información

China's response to COVID-19: a chance for collaboration (Editorial)
The Lancet Vol. 397 No. 10282 Published: April 10, 2021
Pulsa aquí para acceder a la información

(R) Access to COVID-19 vaccines: looking beyond COVAX (Editorial)
The Lancet Vol. 397No. 10278Published: March 13, 2021
Pulsa aquí para acceder a la información

Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study
Kathryn E Mansfield, Rohini Mathur, John Tazare, Alasdair D Henderson, Amy R Mulick, Helena Carreira, and others
The Lancet Digital Health  Published: February 18, 2021
Pulsa aquí para acceder a la información

The COVID-19 exit strategy—why we need to aim low (Editorial)
The Lancet Infectious Diseases Published: February 11, 2021
Pulsa aquí para acceder a la información

(R) COVID-19 in Spain: view from the eye of the storm
María José Sierra Moros, Susana Monge, Berta Suarez Rodríguez, Lucía García San Miguel, Fernando Simón Soria on behalf of all signatories
The Lancet Public Health  Published: December 7, 2020
Pulsa aquí para acceder a la información

Insights From Rapid Deployment of a “Virtual Hospital” as Standard Care During the COVID-19 PandemicFREE
Kranthi Sitammagari, MD, Stephanie Murphy, DO, Marc Kowalkowski, PhD, et al.
Annals of Internal Medicine 11 November 2020
https://doi.org/10.7326/M20-4076
Pulsa aquí para acceder a la información

Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination
Sarah Kreps, PhD; Sandip Prasad, MD; John S. Brownstein, PhD; Yulin Hswen, PhD; Brian T. Garibaldi, MD, MEHP; Baobao Zhang, PhD; Douglas L. Kriner, PhD
JAMA Netw Open. 2020; 3(10):e2025594. October 20, 2020
doi: 10.1001/jamanetworkopen.2020.25594
Pulsa aquí para acceder a la información

(R) COVID-19 in Spain: a predictable storm? (Editorial)
The Lancet Public Health Published:October 16, 2020  DOI:https://doi.org/10.1016/S2468-2667(20)30239-5
Pulsa aquí para acceder a la información

Epidemiological changes on the Isle of Wight after the launch of the NHS Test and Trace programme: a preliminary analysis
Michelle Kendall, Luke Milsom, Lucie Abeler-Dörner, Chris Wymant, Luca Ferretti, Mark Briers, and others
The Lancet Digital Health  Published: October 14, 2020
Pulsa aquí para acceder a la información

(R) The need for detailed COVID-19 data in Spain (Correspondence)
Sergi Trias-Llimós•Ainhoa Alustiza•Clara Prats•Aurelio Tobias•Tim Riffe
The Lancet Public Health Published: October 9, 2020
Pulsa aquí para acceder a la información

(R) Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe
Emeline Han, Melisa Mei Jin Tan, Eva Turk, Devi Sridhar, Gabriel M Leung, Kenji Shibuya, and others
The Lancet  Published: September 24, 2020
Pulsa aquí para acceder a la información

Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study
Richard Williams•David A Jenkins•Darren M Ashcroft•Ben Brown•Stephen Campbell•Matthew J Carr•Sudeh Cheraghi-sohi•Navneet Kapur•Owain Thomas•Roger T Webb•Niels Peek
The Lancet Public Health Published: September 23, 2020

Pulsa aquí para acceder a la información

(R) Evaluation of the COVID-19 response in Spain: principles and requirements
Alberto L García-Basteiro, Helena Legido-Quigley, on behalf of the 20 signatories, and others
The Lancet Public Health Published: September 21, 2020
https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(20)30208-5/fulltext

Managing COVID-19 in a Novel, Rapidly Deployable Community Isolation Quarantine Facility
Ming Li Chia, MBBS, Dickson Hong Him Chau, MBBS, MMed(Ortho) et al.
Annals of Internal Medicine 17 September 2020 https://doi.org/10.7326/M20-4746
https://www.acpjournals.org/doi/10.7326/M20-4746

Attitudes Toward a Potential SARS-CoV-2 Vaccine: A Survey of U.S. AdultsFREE
Kimberly A. Fisher, MD, MSc, Sarah J. Bloomstone, BA, Jeremy Walder, DO et al.
Annals of Internal Medicine 4 September 2020 https://doi.org/10.7326/M20-3569
Pulsa aquí para acceder a la información

Necesidades de recursos de atención médica proyectadas para una respuesta eficaz al COVID-19 en 73 países de ingresos bajos y medios: un estudio de modelos
Tessa Tan-Torres Edejer, Odd Hanssen, Andrew Mirelman, Paul Verboom, Glenn Lolong, Oliver John Watson y otros
The Lancet Global Health  Publicado: 9 de septiembre de 2020
Pulsa aquí para acceder a la información

Automated and partly automated contact tracing: a systematic review to inform the control of COVID-19 (Review)
Isobel Braithwaite, Thomas Callender, Miriam Bullock, Robert W Aldridge
The Lancet Digital Health  Published: August 19, 2020
Pulsa aquí para acceder a la información

Coronavirus Disease 2019 Outcomes in French Nursing Homes That Implemented Staff Confinement With Residents
Belmin J, Um-Din N, Donadio C, et al.
JAMA Network Open August 13, 2020
Pulsa aquí para acceder a la información

(R) The need for an independent evaluation of the COVID-19 response in Spain (Correspondence)
Alberto García-Basteiro, Carlos Alvarez-Dardet, Alex Arenas, Rafael Bengoa, Carme Borrell, Margarita Del Val, and others
The Lancet  Published: August 6, 2020
Pulsa aquí para acceder a la información

Successful Elimination of Covid-19 Transmission in New Zealand (Correspondence)
Michael G. Baker, M.B., Ch.B. Nick Wilson, M.B., Ch.B., M.P.H. Andrew Anglemyer, Ph.D., M.P.H.
The New England Journal of Medicine August 7, 2020 DOI: 10.1056/NEJMc2025203
Pulsa aquí para acceder a la información

Ensuring Uptake of Vaccines against SARS-CoV-2
Michelle M. Mello, J.D., Ph.D., Ross D. Silverman, J.D., M.P.H., and Saad B. Omer, M.B., B.S., M.P.H., Ph.D.
The New England Journal of Medicine June 26, 2020 DOI: 10.1056/NEJMp2020926
Pulsa aquí para acceder a la información

COVID-19 Government Response Event Dataset (CoronaNet v.1.0)
Cindy Cheng, Joan Barceló, Allison Spencer Hartnett, Robert Kubinec & Luca Messerschmidt
Nature Human Behaviour Published: 23 June 2020
Pulsa aquí para acceder a la información

The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries
Patrick G. T. Walker, Charles Whittaker, Oliver J Watson, Marc Baguelin, Peter Winskill, Arran Hamlet, Bimandra A. Djafaara et al.
Science  12 Jun 2020: eabc0035 DOI: 10.1126/science.abc0035
Pulsa aquí para acceder a la información

(R) Waiting for Certainty on Covid-19 Antibody Tests — At What Cost?
Milton C. Weinstein, Ph.D., Kenneth A. Freedberg, M.D., Emily P. Hyle, M.D., and A. David Paltiel, Ph.D.
The New England Journal of Medicine June 5, 2020 DOI: 10.1056/NEJMp2017739
Pulsa aquí para acceder a la información

Beat COVID-19 through innovation.
Azoulay P, Jones B.
Science. 2020 May 8;368(6491):553. doi: 10.1126/science.abc5792.
Pulsa aquí para acceder a la información

COVID-19 immunity passports and vaccination certificates: scientific, equitable, and legal challenges (Comment)
Alexandra L Phelan
The Lancet Published: May 4, 2020
Pulsa aquí para acceder a la información

Logistics of Aggressive Community Screening for Coronavirus 2019
Kaplan EH, Forman HP
JAMA Health Forum May 4, 2020

Pulsa aquí para acceder a la información

Electronic Screening System through Community Engagement: A National Strategic Plan to Find COVID-19 Patients and Reduce Clinical Intervention Delays
Mehrdad Amir-Behghadami, Masoumeh Gholizadeh
Journal: Infection Control & Hospital Epidemiology /  04 May 2020, pp. 1-6
Pulsa aquí para acceder a la información

Electronic Screening System through Community Engagement: A National Strategic Plan to Find COVID-19 Patients and Reduce Clinical Intervention Delays
Mehrdad Amir-Behghadami, Masoumeh Gholizadeh
Journal: Infection Control & Hospital Epidemiology /  04 May 2020, pp. 1-6
Pulsa aquí para acceder a la información

Community Pharmacists in Taiwan at the Frontline Against the Novel Coronavirus Pandemic: Gatekeepers for the Rationing of Personal Protective Equipment
Huang-Tz Ou, PhD; Yea-Huei Kao Yang, BS Pharm
Ann Intern Med. 13 April 2020. doi:10.7326/M20-1404
Pulsa aquí para acceder a la información

COVID-19: hora de planificar un acceso universal rápido a diagnósticos y tratamientos (Comentario)
Luca Li Bassi, Lenias Hwenda
The Lancet Global Health Publicado: 16 de abril de 2020
Pulsa aquí para acceder a la información

Universal weekly testing as the UK COVID-19 lockdown exit strategy (Correspondence)
Julian Peto, Nisreen A Alwan, Keith M Godfrey, Rochelle A Burgess, David J Hunter, Elio Riboli, Paul Romer, on behalf of 27 signatories
The Lancet Published: April 17, 2020
Pulsa aquí para acceder a la información

Social Distancing—What Would It Mean for It to Work? (Editorial)
Melinda B. Buntin, PhD1,2
JAMA Health Forum April 15, 2020
Pulsa aquí para acceder a la información

Disease Control, Civil Liberties, and Mass Testing — Calibrating Restrictions during the Covid-19 Pandemic
David M. Studdert, L.L.B., Sc.D., and Mark A. Hall, J.D.
The New England Journal of Medicine April 9, 2020 DOI: 10.1056/NEJMp2007637
Pulsa aquí para acceder a la información

Ten Weeks to Crush the Curve (Editorial)

The New England Journal of Medicine 1 de abril de 2020
DOI: 10.1056 / NEJMe2007263

Pulsa aquí para acceder a la información

Older Clinicians and the Surge in Novel Coronavirus Disease 2019 (COVID-19)

Peter I. Buerhaus, PhD, RN1David I. Auerbach, PhD1Douglas O. Staiger, PhD2,3
JAMA. Published online March 30, 2020. doi:10.1001/jama.2020.4978
Pulsa aquí para acceder a la información

Covid-19: una evaluación remota en atención primaria

Trisha Greenhalgh ,Gerald Choon Huat Koh , Josip Car
BMJ 2020 ; 368 doi: https://doi.org/10.1136/bmj.m1182 (publicado el 25 de marzo de 2020)

Ensuring global access to COVID-19 vaccines (Comment)

Gavin Yamey, Marco Schäferhoff, Richard Hatchett, Muhammad Pate, Feng Zhao, Kaci Kennedy McDade
The Lancet Published: March 31, 2020
Pulsa aquí para acceder a la información

Asignación justa de recursos médicos escasos en tiempos de Covid-19

Ezekiel J. Emanuel, MD, Ph.D., Govind Persad, JD, Ph.D., Ross Upshur, MD, Beatriz Thome, MD, MPH, Ph.D., Michael Parker, Ph.D., Aaron Glickman, BA, Cathy Zhang, BA, Connor Boyle, BA, Maxwell Smith, Ph.D.,
y James P. Phillips, MD
23 de marzo de 2020  DOI: 10.1056 / NEJMsb2005114
Pulsa aquí para acceder a la información

Covid-19 expone debilidades en la respuesta europea a brotes (Editorial)

BMJ 2020 ; 368 doi: Pulsa aquí para acceder a la información (publicado el 18 de marzo de 2020)

Covid-19: control measures must be equitable and inclusive (Editorials)

BMJ 2020; 368 doi: Pulsa aquí para acceder a la información (Published 20 March 2020)

No se apresuren a implementar vacunas y medicamentos COVID-19 sin suficientes garantías de seguridad                                                                                                                                
Shibo Jiang

Nature, 16 DE MARZO DE 2020      
Pulsa aquí para acceder a la información

INVESTIGACIÓN

The major genetic risk factor for severe COVID-19 does not show any association among South Asian populations
Prajjval Pratap Singh, Anshika Srivastava[…]Gyaneshwer Chaubey
Scientific Reports 11 , 1–4 11 June 2021
Pulsa aquí para acceder a la información

(R) The major genetic risk factor for severe COVID-19 is inherited from Neanderthals
Hugo Zeberg & Svante Pääbo
Nature volume 587, pages610–612 (2020) Published: 30 September 2020
Pulsa aquí para acceder a la información

(R) Heterologous vaccination regimens with self-amplifying RNA and adenoviral COVID vaccines induce robust immune responses in mice
Alexandra J. Spencer, Paul F. McKay, Sandra Belij-Rammerstorfer, Marta Ulaszewska, Cameron D. Bissett, Kai Hu, Karnyart Samnuan, Anna K. Blakney, Daniel Wright, Hannah R. Sharpe, Ciaran Gilbride, Adam Truby, Elizabeth R. Allen, Sarah C. Gilbert, Robin J. Shattock & Teresa Lambe
Nature Communications volume 12, Article number: 2893 (2021) Published: 17 May 2021
Pulsa aquí para acceder a la información

Sequential infection with H1N1 and SARS-CoV-2 aggravated COVID-19 pathogenesis in a mammalian model, and co-vaccination as an effective method of prevention of COVID-19 and influenza
Linlin Bao, Wei Deng, Feifei Qi, Qi Lv, Zhiqi Song, Jiangning Liu, Hong Gao, Qiang Wei, Pin Yu, Yanfeng Xu, Yajin Qu, Fengdi Li, Jing Xue, Shuran Gong, Mingya Liu, Guanpeng Wang, Shunyi Wang, Binbin Zhao, Bin Cong & Chuan Qin
Signal Transduction and Targeted Therapy volume 6, Article number: 200 (2021)
Pulsa aquí para acceder a la información

SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation
Bingyu Yan, Tilo Freiwald, Daniel Chauss, Luopin Wang, Erin West, Carmen Mirabelli, Charles J Zhang, Eva-Maria Nichols, Nazish Malik, et al.
Science Immunology  07 Apr 2021: Vol. 6, Issue 58, eabg0833 DOI: 10.1126/sciimmunol.abg0833
Pulsa aquí para acceder a la información

IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals
Michal A. Stanczak, David E. Sanin, Petya Apostolova, Gabriele Nerz, Dimitrios Lampaki, Maike Hofmann, Daniel Steinmann, Marvin Krohn-Grimberghe, Robert Thimme, Gerhard Mittler, Cornelius F. Waller, Edward J. Pearce & Erika L. Pearce
Nature Communications volume 12, Article number: 2133 (2021) Published  09 April 2021
Pulsa aquí para acceder a la información

The MERS-CoV receptor gene is among COVID-19 risk factors inherited from Neandertals
Hugo Zeberg, Svante Pääbo
bioRxiv Posted December 12 2020doi: https://doi.org/10.1101/2020.12.11.422139
Pulsa aquí para acceder a la información

SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement?
Ming Yang & Ching Lung Lai
Cell Death Discovery volume 6, Article number: 130 (2020) Published: 25 November 2020
Pulsa aquí para acceder a la información

Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease
Mary E. Dolan, David P. Hill, Gaurab Mukherjee, Monica S. McAndrews, Elissa J. Chesler & Judith A. Blake
Scientific Reports volume 10, Article number: 20848 (2020) Published: 30 November 2020
Pulsa aquí para acceder a la información

Depletion of circulating IgM memory B cells predicts unfavourable outcome in COVID-19
Marco Vincenzo Lenti, Nicola Aronico, Ivan Pellegrino, Emanuela Boveri, Paolo Giuffrida, Federica Borrelli de Andreis, Patrizia Morbini, Laura Vanelli, Alessandra Pasini, Cristina Ubezio, Federica Melazzini, Alessandro Rascaroli, Valentina Antoci, Stefania Merli, Francesco Di Terlizzi, Umberto Sabatini, Ginevra Cambiè, Annamaria Tenore, Cristina Picone, Alessandro Vanoli, Luca Arcaini, Fausto Baldanti, Marco Paulli, Gino Roberto Corazza & Antonio Di Sabatino
Scientific Reports volume 10, Article number: 20836 (2020) Published: 30 November 2020
Pulsa aquí para acceder a la información

Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
Weina Sun, Sarah R. Leist, Stephen McCroskery, Yonghong Liu, Stefan Slamanig, Justine Oliva et al.
EBioMedicine volume 62, 103132, december 01, 2020  Published:November 21, 2020 DOI:https://doi.org/10.1016/j.ebiom.2020.103132
Pulsa aquí para acceder a la información

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
Ania Wajnberg1, Fatima Amanat, Adolfo Firpo, Deena R. Altman, Mark J. Bailey et al.
Science  28 Oct 2020: eabd7728 DOI: 10.1126/science.abd7728
Pulsa aquí para acceder a la información

The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing
Gang Xu, Furong Qi […] Zheng Zhang
Cell Discovery 6 , 1–14 20 October 2020
Pulsa aquí para acceder a la información

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms
M. Alejandra Tortorici, Martina Beltramello, Florian A. Lempp, Dora Pinto, Ha V. Dang, Laura E. Rosen, Matthew McCallum, John Bowen et al.
Science  24 Sep 2020: eabe3354  DOI: 10.1126/science.abe3354
Pulsa aquí para acceder a la información

COVID-19-activated SREBP2 disturbs cholesterol biosynthesis and leads to cytokine storm
Wonhwa Lee, June Hong Ahn, Hee Ho Park, Hong Nam Kim, Hyelim Kim, Youngbum Yoo, Hyosoo Shin, Kyung Soo Hong, Jong Geol Jang, Chun Gwon Park, Eun Young Choi, Jong-Sup Bae & Young-Kyo Seo
Signal Transduction and Targeted Therapy volume 5, Article number: 186 (2020) Published: 03 September 2020
Pulsa aquí para acceder a la información

Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals
Fan Zhang, Rui Gan, Ziqi Zhen, Xiaoli Hu, Xiang Li, Fengxia Zhou, Ying Liu, Chuangeng Chen, Shuangyu Xie, Bailing Zhang, Xiaoke Wu & Zhiwei Huang
Signal Transduction and Targeted Therapy volume 5, Article number: 156 (2020) Published: 14 August 2020
Pulsa aquí para acceder a la información

Sex differences in immune responses that underlie COVID-19 disease outcomes
Takehiro Takahashi, Mallory K. Ellingson, […]Akiko Iwasaki
Nature (2020) Published 26 August 2020
Pulsa aquí para acceder a la información

(R) Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19
Takuya Sekine, André Perez-Potti, Olga Rivera-Ballesteros, Hans-Gustaf Ljunggren, Soo Aleman, Marcus Buggert
Cell Published:August 14, 2020DOI:https://doi.org/10.1016/j.cell.2020.08.017
Pulsa aquí para acceder a la información

(R) SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
Julian Braun, Lucie Loyal, […]Andreas Thiel
Nature (2020) Published 29 July 2020
Pulsa aquí para acceder a la información

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus
Korber et al.
Cell  Published online: July 2, 2020
Pulsa aquí para acceder a la información

Making sense of mutation: what D614G means for the COVID-19 pandemic remains nuclear (Comentario sobre anterior artículo)
Grubaugh et al.
Cell Published online: July 2, 2020
Pulsa aquí para acceder a la información

Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome Daniela Weiskopf, Katharina S. Schmitz, Matthijs P. Raadsen 2 ,Alba Grifoni, Nisreen MA Okba, Henrik Endeman, Johannes PC van den Akker, Richard Molenkamp , Marion PG Koopmans, Eric CM van Gorp. Bart L. Haagmans, Rik L. de Swart, Alessandro Sette, y Rory D. de Vries
Science Immunology  26 Jun 2020: vol. 5, Number 48, eabd2071  DOI: 10.1126 / sciimmunol.abd2071
Pulsa aquí para acceder a la información

Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19) (Review)
Feng-Yee Chang, Hsiang-Cheng Chen, Pei-Jer Chen, Mei-Shang Ho, Shie-Liang Hsieh, Jung-Chung Lin, Fu-Tong Liu & Huey-Kang Sytwu
Journal of Biomedical Science volume 27, Article number: 72 Published: 04 June 2020
Pulsa aquí para acceder a la información

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum, Benjamin O. Fulton, Elzbieta Wloga, Richard Copin, Kristen E. Pascal, Vincenzo Russo, Stephanie Giordano, Kathryn Lanza, Nicole Negron, Min Ni, Yi Wei, Gurinder S. Atwal, Andrew J. Murphy, Neil Stahl, George D. Yancopoulos, Christos A. Kyratsous*
Science  15 Jun 2020: eabd0831 DOI: 10.1126/science.abd0831
Pulsa aquí para acceder a la información

Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
Mark Roschewski M, ichail S. Lionakis Jeff P. Sharman, Joseph Roswarski, Andre Goy5M. Andrew Monticelli et al.
Science Immunology  05 Jun 2020: Vol. 5, Issue 48, eabd0110 DOI: 10.1126/sciimmunol.abd0110
Pulsa aquí para acceder a la información

Emergence of SARS-CoV-2 through recombination and strong purifying selection
Xiaojun Li, Elena E. Giorgi, Manukumar Honnayakanahalli Marichannegowda, Brian Foley et al.
Science Advances  29 May 2020: eabb9153 DOI: 10.1126/sciadv.abb9153
https://advances.sciencemag.org/content/early/2020/05/28/sciadv.abb9153

Microglia influence host defense, disease, and repair following murine coronavirus infection of the central nervous system
Vrushali Mangale  Amber R. Syage  H. Atakan Ekiz  Dominic D. Skinner  Yuting Cheng  Colleen L. Stone  R. Marshall Brown  Ryan M. O'Connell  Kim N. Green  Thomas E. Lane
GLIA First published:25 May 2020 https://doi.org/10.1002/glia.23844
Pulsa aquí para acceder a la información

(R) Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins
Kangpeng Xiao, Junqiong Zhai, Yaoyu Feng, Niu Zhou, Xu Zhang, Jie-Jian Zou, Na Li, Yaqiong Guo, Xiaobing Li, Xuejuan Shen, Zhipeng Zhang, Fanfan Shu, Wanyi Huang, Yu Li, Ziding Zhang, Rui-Ai Chen, Ya-Jiang Wu, Shi-Ming Peng, Mian Huang, Wei-Jun Xie, Qin-Hui Cai, Fang-Hui Hou, Wu Chen, Lihua Xiao & Yongyi Shen
Nature (2020) Published: 07 May 2020
Pulsa aquí para acceder a la información

The proximal origin of SARS-CoV-2 (Correspondence)
Kristian G. Andersen ,Andrew Rambaut ,W. Ian Lipkin ,Edward C. Holmes yRobert F. Garry
Nature Medicine volumen 26 , páginas450 - 452 ( 2020 ) Published: 17 de marzo de 2020
Pulsa aquí para acceder a la información

Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids
Gerard Kian-MengGohaA. KeithDunkerbJames A.FostercdVladimir N.Uverskyef
Microbial Pathogenesis Volume 144, July 2020, 104177July 2020
https://doi.org/10.1016/j.micpath.2020.104177
Pulsa aquí para acceder a la información

Shell disorder analysis predicts greater resilience of the SARS-CoV-2 (COVID-19) outside the body and in body fluids
Gerard Kian-MengGohaA. KeithDunkerbJames A.FostercdVladimir N.Uverskyef
Microbial Pathogenesis Volume 144, July 2020, 104177July 2020
https://doi.org/10.1016/j.micpath.2020.104177
Pulsa aquí para acceder a la información

Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2
Vanessa Monteil , Hyesoo Kwon , Patricia Prado , Astrid Hagelkrüys , Reiner A. Wimmer , Martin Stahl , Alexandra Leopoldi , Elena Garreta , Carmen Hurtado del Pozo , Felipe Prosper , J.P. Romero , Gerald Wirnsberger , Haibo Zhang8 , Arthur S. Slutsky8 , Ryan Conder , Nuria Montserrat , Ali Mirazimi* , Josef M. Penninger
Cell  Prepublished after peer-review
DOI: 10.1016/j.cell.2020.04.004                      
Pulsa aquí para acceder a la información

SARS-CoV-2 and viral sepsis: observations and hypotheses
Hui Li, Liang Liu, Dingyu Zhang, Jiuyang Xu, Huaping Dai, Nan Tang, and others
The Lancet Published: April 17, 2020

Pulsa aquí para acceder a la información

Drug Evaluation during the Covid-19 Pandemic (Perspective)
Benjamin N. Rome, M.D., and Jerry Avorn, M.D.
The New England Journal of Medicine April 14, 2020
        DOI: 10.1056/NEJMp2009457
Pulsa aquí para acceder a la información

Key words to be adopted for COVID-19 research: A return to simple, large, randomized trials
Aldo Maggioni, Claudio Rapezzi, Luigi Tavazzi, Roberto Ferrari
European Heart Journal, ehaa322, https://doi.org/10.1093/eurheartj/ehaa322
Published: 15 April 2020
Pulsa aquí para acceder a la información

Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2
Vanessa Monteil1 , Hyesoo Kwon2 , Patricia Prado3 , Astrid Hagelkrüys4 , Reiner A. Wimmer4 , Martin Stahl5 , Alexandra Leopoldi4 , Elena Garreta3 , Carmen Hurtado del Pozo3 , Felipe Prosper6 , J.P. Romero6 , Gerald Wirnsberger7 , Haibo Zhang8 , Arthur S. Slutsky8 , Ryan Conder5 , Nuria Montserrat3,9,10,* , Ali Mirazimi1, 2,* , Josef M. Penninger4,11,12*
Cell Pre-proof  DOI: 10.1016/j.cell.2020.04.004

Pulsa aquí para acceder a la información

NOTA de la FUNDACION: Este artículo es un informe preliminar, que no se ha sido todavía revisado por pares

Inhibidores del sistema renina-angiotensina-aldosterona en pacientes con Covid-19

Muthiah Vaduganathan, MD, MPH, Orly Vardeny, Pharm.D., Thomas Michel, MD, Ph.D., John JV McMurray, MD, Marc A. Pfeffer, MD, Ph.D., y Scott D. Solomon, MD
The New England Journal of Medicine 30 de marzo de 2020
DOI: 10.1056 / NEJMsr2005760
Pulsa aquí para acceder a la información

Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools

 Yajing Fu1,2 • Yuanxiong Cheng3 • Yuntao Wu4
Virologica Sinica www.virosin.org  Pulsa aquí para acceder a la información

Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools

 Yajing Fu1,2 • Yuanxiong Cheng3 • Yuntao Wu4
Virologica Sinica www.virosin.org  Pulsa aquí para acceder a la información

Pulsa aquí para acceder a la información

Caracterización del dominio de unión al receptor (RBD) del nuevo coronavirus 2019: implicación para el desarrollo de la proteína RBD como inhibidor de la unión viral y vacuna                                                             
Wanbo Tai ,Él Lei , Xiujuan Zhang , Jing Pu , Denis Voronin , Shibo Jiang , Yusen Zhou y Lanying Du                                                                                                                                                      
Inmunología celular y molecular ( 17 de Marzo de 2020 )

Pulsa aquí para acceder a la información

Agotamiento funcional de linfocitos antivirales en pacientes con COVID-19

Meijuan Zheng ,Gao Yong ,Pandilla Wang ,Guobin Song ,Siyu Liu ,Dandan Sun ,Yuanhong Xu yZhigang Tian 
Inmunología celular y molecular ( 19 de Marzo de 2020 )
Pulsa aquí para acceder a la información

A human monoclonal antibody blocking SARS-CoV-2 infection

Chunyan Wang, Wentao Li, Dubravka Drabek, Nisreen M.A. Okba, Rien van Haperen, Albert D.M.E. Osterhaus, Frank J.M. van Kuppeveld, Bart L. Haagmans, Frank Grosveld, Berend-Jan Bosch
doi: https://doi.org/10.1101/2020.03.11.987958
Nature Communications volumen 11 , Número de artículo:  2251 ( 2020 )
Pulsa aquí para acceder a la información

MODELOS MATEMÁTICOS

Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study
Peter C Jentsch, Madhur Anand, Chris T Bauch
The Lancet Infectious Diseases Published: March 31, 2021
Pulsa aquí para acceder a la información

Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study
Sam Moore, Edward M Hill, Michael J Tildesley, Louise Dyson, Matt J Keeling
The Lancet Infectious Diseases Published: March 18, 2021
Pulsa aquí para acceder a la información

The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation
Frank G Sandmann, Nicholas G Davies, Anna Vassall, W John Edmunds, Mark Jit on behalf of the Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group, and others
The Lancet Infectious Diseases Published: March 18, 2021
Pulsa aquí para acceder a la información


Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling study
Hamada S Badr, Hongru Du, Maximilian Marshall, Ensheng Dong, Marietta M Squire, Lauren M Gardner
The Lancet Infectious Disease Published: July 1, 2020
Pulsa aquí para acceder a la información


Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
Andrew Clark, Mark Jit, Charlotte Warren-Gash, Bruce Guthrie, Harry H X Wang, Stewart W Mercer, and others
The Lancet Global Health  Published: June 15, 2020
Pulsa aquí para acceder a la información

Modelos matemáticos predictivos de los principios subyacentes de la pandemia COVID-19 y valor de las proyecciones
Nicholas P. Jewell, PhD 1,2 ; Joseph A. Lewnard, PhD 2 ; Britta L. Jewell, PhD 3
JAMA Publicado en línea el 16 de abril de 2020. doi: 10.1001 / jama.2020.6585
Pulsa aquí para acceder a la información

COVID-19 health service utilization forecasting team. Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months. 
Murray  CJL ; IHME
MedRxiv. Preprint posted March 30, 2020. doi:Pulsa aquí para acceder a la información

Proyectando la dinámica de transmisión del SARS-CoV-2 durante el período pospandémico
Stephen M. Kissler 1 , Christine Tedijanto2 , Edward Goldstein 2 ,Yonatan H. Grad 1 , Marc Lipsitch 2  et al.
Science  14 de abril de 2020: eabb5793 DOI: 10.1126 / science.abb5793
Pulsa aquí para acceder a la información

NOTICIAS DE INTERÉS

COVID-19 Update (10/05/21)
Pulsa aquí para acceder a la información

COVID-19 Update (03/05/21)
Pulsa aquí para acceder a la información

COVID research updates (30/04/21) (Nature )
Pulsa aquí para acceder a la información

COVID-19 Update  (26/04/ 2021)
Pulsa aquí para acceder a la información

COVID-19 Update  (19/04/ 2021)
Pulsa aquí para acceder a la información

COVID research updates (09/04/21) (Nature )
Pulsa aquí para acceder a la información

COVID-19 Update  (29/03/ 2021)
Pulsa aquí para acceder a la información

COVID-19 Update  (29/03/ 2021)

Pulsa aquí para acceder a la información

COVID-19 Update  (22/03/ 2021

)Pulsa aquí para acceder a la información

COVID-19 Update  (15/03/ 2021)

Pulsa aquí para acceder a la información

COVID-19 Update  (08/03/ 2021)
Pulsa aquí para acceder a la información

 COVID-19 Update  (22/02/ 2021)
Pulsa aquí para acceder a la información

COVID-19 Update  (15/02/ 2021)
Pulsa aquí para acceder a la información

COVID-19 Update  (08/02/ 2021)
Pulsa aquí para acceder a la información

One dose COVID-19 vaccine offers solid protection against severe disease (Science) (29/01/21)

Pulsa aquí para acceder a la información

Novavax offers first evidence that COVID vaccines protect people against variants (Nature) (29/01/21)

Pulsa aquí para acceder a la información

COVID-19 Update  (25/01/ 2021)

Pulsa aquí para acceder a la información

Health Workers’ Antibody Levels Wane After SARS-CoV-2 Infection (January 12, 2021)JAMA. 2021;325(2):122. doi:10.1001/jama.2020.25457
Pulsa aquí para acceder a la información

Third time’s the charm? Brazil scales back efficacy claims for COVID-19 vaccine from China (Science, 12/01/21)

Pulsa aquí para acceder a la información

COVID-19 Update  (11/01/ 2021)

Pulsa aquí para acceder a la información

An EUA for Bamlanivimab—A Monoclonal Antibody for COVID-19 JAMA. Published online December 11, 2020. doi:10.1001/jama.2020.24415

Pulsa aquí para acceder a la información

COVID-19 Update (21/12/20)

Pulsa aquí para acceder a la información

COVID-19 Update (14/12/20)

Pulsa aquí para acceder a la información

COVID-19 Update (07/12/20)

Pulsa aquí para acceder a la información

COVID-19 Update (23/11/20)

Pulsa aquí para acceder a la información

(R) ‘Just beautiful’: Another COVID-19 vaccine, from newcomer Moderna, succeeds in large-scale trial (Science) (16/11/20)

Pulsa aquí para acceder a la información

COVID-19 Update (02/11/20)

Pulsa aquí para acceder a la información

COVID-19 Update (02/11/20)

Pulsa aquí para acceder a la información

(R) COVID-19 Update (05/10/20)

Pulsa aquí para acceder a la información

(R) COVID-19 Update (21/09/20)

Pulsa aquí para acceder a la información

(R) COVID-19 Update (14/09/20)
Pulsa aquí para acceder a la información

COVACTA trial raises questions about tocilizumab's benefit in COVID-19  (The Lancet Rheumatology= (Published: September 9, 20)
Pulsa aquí para acceder a la información

(R) A leading coronavirus vaccine trial is on hold: scientists react  (Nature)  (09/09/20)

Pulsa aquí para acceder a la información

(R) Biopharma leaders unite to stand with science  (08/09/20)

Pulsa aquí para acceder a la información

(R) New treatments aim to treat COVID-19 early, before it gets serious (ScienceNews) (24/08/20)

Pulsa aquí para acceder a la información

(R) COVID-19 Update  (31/08/20)

Pulsa aquí para acceder a la información

(R) Here’s how the U.S. could release a COVID-19 vaccine before the election—and why that scares some (Science-28-August 2020)

Pulsa aquí para acceder a la información



(R) COVID-19 Update  (31/08/20)

Pulsa aquí para acceder a la información

(R)  COVID-19 Update (17/08/20)

Pulsa aquí para acceder a la información

Covid-19: Where are we on immunity and vaccines?  BMJ 2020; 370  doi: https://doi.org/10.1136/bmj.m3096 (Published 05 August 2020)
Pulsa aquí para acceder a la información


  How the pandemic might play out in 2021 and beyond (05/08/20)  (Nature)
Pulsa aquí para acceder a la información

(R) Primer tratamiento con COVID-19 recomendado para autorización de la UE

Pulsa aquí para acceder a la información

Covid-19: Hydroxychloroquine does not benefit hospitalised patients, UK trial finds BMJ 2020; 369 doi: https://doi.org/10.1136/bmj.m2263 (Published 08 June 2020)

Pulsa aquí para acceder a la información

J&J comenzará ensayos en humanos de vacuna contra Covid-19 en segunda quincena de julio

Pulsa aquí para acceder a la información

-Radiografías de tórax para detectar la COVID-19
Pulsa aquí para acceder a la información

(R) COVID-19 Research in Brief: December, 2019 to June, 2020  (Nature Medicine) Pulsa aquí para acceder a la información

COVID-19 Research in Brief: 6 June to 12 June, 2020 (Nature Medicine)
Pulsa aquí para acceder a la información

COVID-19 Research in Brief: 30 May to 5 June, 2020  
Pulsa aquí para acceder a la información

COVID-19 Research in Brief: 23 May to 29 May, 2020  (Nature Medicine) Pulsa aquí para acceder a la información

Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus (May 18, 2020)
Pulsa aquí para acceder a la información

Scientists are drowning in COVID-19 papers. Can new tools keep them afloat? (Science-May 13 2020)
Pulsa aquí para acceder a la información

(R) COVID-19 Research in Brief: 9 May to 15 May, 2020 (Nature Medicine)
Pulsa aquí para acceder a la información

Los genetistas ven “improbable” que el coronavirus circulara masivamente en España antes de febrero (SINC (Agencia de noticias científicas de la Fundación Española para la Ciencia y la Tecnología) (11/05/20)
Pulsa aquí para acceder a la información

(R) Resumen de la investigación de COVID-19: 2 de mayo a 8 de mayo de 2020 en la semana del 2 al 8 de Mayo de 2020 (Nature Medicine)

Pulsa aquí para acceder a la información

(R) How swamped preprint servers are blocking bad coronavirus research (Nature 7 May 2020)

Pulsa aquí para acceder a la información

Entrevista a Eduardo Gil Santos, investigador que ha coliderado el estudio en busca de un nanodispositivo universal capaz de detectar cualquier virus o bacteria
Pulsa aquí para acceder a la información

(R) The race for coronavirus vaccines: a graphical guide (Nature 28 April 2020)
Pulsa aquí para acceder a la información

Ciclo de seminarios web: 'Reflexiones transversales durante una pandemia: la importancia de más y mejor ciencia'
Pulsa aquí para acceder a la información

Científicos del CSIC buscan detectores de SARS-CoV2 más rápidos y baratos que las PCR con balizas moleculares
Pulsa aquí para acceder a la información

Una herramienta del CNB-CSIC integra información de todo el mundo sobre la estructura atómica del coronavirus
Pulsa aquí para acceder a la información

(R) Resumen de la Investigación de COVID-19 en la semana del 24 de Abril al 1 de Mayo de 2020 (Nature Medicine)
Pulsa aquí para acceder a la información

(R) Compartir la ciencia en tiempos de coronavirus, una prueba de fuego para el sistema (11/04/20)

Pulsa aquí para acceder a la información

El CSIC lanza un estudio genético para identificar el riesgo individual de desarrollar formas graves de Covid-19 (22/04/20)

Pulsa aquí para acceder a la información

La técnica inventada por Margarita Salas, candidata para detectar el coronavirus (22/04/20)

Pulsa aquí para acceder a la información

OTROS RECURSOS

(R) COVID reference 2021.6 (Junio/2021)
Bernd Sebastian Kamps & Christian Hoffmann
Pulsa aquí para acceder a la información

PRIMER ENCUENTRO INTERNACIONAL COVID-19  MEJORES PRACTICAS

Hospital de Emergencias Enfermera Isabel Zendal (23 y 24 de Junio de 2021)
Pulsa aquí para acceder a la información

(R)  Main Report- The Independent Panel for Pandemic Preparedness & Response (12/05/21)
Pulsa aquí para acceder a la información

(R)  GUÍA CLÍNICA PARA PARA LA ATENCIÓN AL PACIENTE LOG COVID/COVID PERSISTENTE (Consenso de Sociedades Científicas)

Pulsa aquí para acceder a la información

Webinar “El CSIS y la COVID 19. Un año después” (Consejo Superior de Investigaciones Científicas) (05/05/21 y quedará colgado posteriormente)
Pulsa aquí para acceder a la información

(R)  2º Congreso Nacional Interdisciplinar COVID-19 de las Sociedades Científicas de España (del 12 al 16 de Abril de 2021)
Pulsa aquí para acceder a la información

(R) Enlaces a recursos recomendados y gratuitos COVID-19 (Consejo Superior de Investigaciones Científicas)
Pulsa aquí para acceder a la información

(R) Informe científico sobre vías de transmisión SARS-CoV-2 (Para el Ministerio de Ciencia e Innovación de España)  (29-Oct-2020)

Contribuyen: Antonio Alcamí (CBM-CSIC), Margarita del Val (CBM-CSIC), Miguel Hernán (Harvard University), Pello Latassa (Gobierno La Rioja), José Luis Jiménez (University of Colorado), Xavier Querol (IDAEA-CSIC), Ana Robustillo (Hospital Universitario La Paz), Gloria Sánchez (IATA-CSIC), Alfonso Valencia (BSC-CNS)
Pulsa aquí para acceder a la información

Guía para ventilación en aulas (Instituto de Diagnóstico Ambiental y Estudios del Agua, IDAEA-CSIC)
Pulsa aquí para acceder a la información

(R) Rapid  Critical Care Consult- COVID (05/09)
Pulsa aquí para acceder a la información

(R) DRAFT landscape of COVID-19 candidate vaccines (OMS) (22/09/20)

Pulsa aquí para acceder a la información

(R)  UNA VISIÓN GLOBAL DE LA PANDEMIA COVID-19: QUÉ SABEMOS Y QUE ESTAMOS INVESTIGANDO DESDE EL CSIC (04/09/2020)
Pulsa aquí para acceder a la información

(R) COVID19 EN ESPAÑA: MANIFIESTO A FAVOR DE UNA RESPUESTA COORDINADA, EQUITATIVA Y BASADA EN LA EVIDENCIA CIENTÍFICA  (55 sociedades Científicas españolas ) 
Pulsa aquí para acceder a la información

(R) I Congreso Nacional Interdisciplinar COVID-19
Pulsa aquí para acceder a la información

CONCLUSIONES PARA LA RECONSTRUCCIÓN SOCIAL Y ECONÓMICA DEL CONGRESO DE LOS DIPUTADOS (29 de Julio de 2020)

Pulsa aquí para acceder a la información

 COVID-19 Drug Therapy  (Updated June 15)   
Tim Smith, PharmD, BCPS; Jennifer Bushek, PharmD; Aimée LeClaire, PharmD, BCPS; Tony Prosser, PharmD
Elsevier
Pulsa aquí para acceder a la información

(R) 123 PREGUNTAS SOBRE CORONAVIRUS (Divulgativo)

Pulsa aquí para acceder a la información

(R) Guía Interactiva de la Universidad de Liverpool sobre Interacciones farmacológicas con las terapias COVID-19

Pulsa aquí para acceder a la información

(R) GUÍA CLÍNICA DE LA “INFECTIOUS DISEASE SOCIETY OF AMERICA” SOBRE EL MANEJO Y TRATAMIENTO DE PACIENTES CON COVID-19 (11/04/2020)
Pulsa aquí para acceder a la información

(R) COVID REFERENCE 2020.1: MANUAL DE KAMPS & HOFFMANN (Español) (06/04/20)
Pulsa aquí para acceder a la información

Center for Disease Control and Prevention (CDC)-COVID19
Pulsa aquí para acceder a la información

Técnicas y sistemas de diagnóstico para COVID-19: clasificación, características, ventajas y limitaciones (Instituto Catalán de Nanociencia y  Nanotecnología)

Pulsa aquí para acceder a la información

 Biblioteca Cochrane: COVID-19:Medidas de control y prevención de la enfermedad
Pulsa aquí para acceder a la información

Biblioteca Cochrane: COVID-19: Evidencia relevante para cuidados críticos
Pulsa aquí para acceder a la información

Up to Date (Actualización continua)
Pulsa aquí para acceder a la información

Ministerio de Ciencia e Innovación
Pulsa aquí para acceder a la información

Recursos COVID por especialidades

Pulsa aquí para acceder a la información

Epidemixs Coronavirus (Recursos para profesionales sanitarios y pacientes

Pulsa aquí para acceder a la información

Recursos de web de SACYL

Pulsa aquí para acceder a la información

GUÍAS REINO UNIDO (British Medical Journal)

Modelización epidemiológica de la Universitat Politècnica de València del COVID-19

 Pulsa aquí para acceder a la información

Especial de “Investigación y ciencia” sobre Coronavirus

Pulsa aquí para acceder a la información

Handbook of COVID-19 Prevention and Treatment

The First Affiliated Hospital ,Zhejiang University School of Medicine
Pulsa aquí para acceder a la información

Protocolo de ventilación múltiple con un solo ventilador para situaciones de Pandemia/Catástrofe sanitaria

Comisión de Ingeniería médica y sanitaria del Colegio y la Asociación de ingenieros industriales

Pulsa aquí para acceder a la información

Agradecimientos: Agradecemos la colaboración de Ana Púa Bocos, Ricardo Santamaría Lozano, Cristina Velarde Mayol, Marta Ferrero Ros, Enrique Arrieta Antón, Tomas Casado, Enrique Guilabert, Pablo Carrero, Diana Oquillas, Juan Redondo Mateo, Raúl Gonzalo Gala y Jose Antonio Queizán.